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A theory is put forward in which change in the
level of cellular energy charge in response to the
differing energy demands of the sleeping/waking
rhythm is the fundamental reason why sleep is
associated with restorative processes.
Numerous reports from the literature are
presented in which the time of sleep is associated
with a higher rate of synthesis.
CHAPTER 2
The literature is surveyed relating eating,
sleeping and body maintenance.
Hunger is associated with motor restlessness
and feeding with sedation.
Human studies indicate that a bedtime snack
of milk and cereal promotes sleep.
Losing weight leads to a reduction whereas
gaining weight leads to an increased amount of sleep.
ii
CHAPTERS 3 and 4
A milk and cereal food (Horlicks) had no effect
on sleep, whereas nitrazepam 5mg improved sleep.
Withdrawal from the drug led to disrupted sleep.
A placebo pill had no effect on sleep.
Nitrazepam had no significant effect on the
plasma growth hormone, glucose, triglycerides or
cholesterol, but prolonged Horlicks administration
elevated triglyceride levels.
CHAPTERS 5 to 7
The effects on sleep were compared among a
placebo capsule, milk, Horlicks and a drink
nutritionally equivalent to Horlicks but containing
no milk or cereal. None of the three food drinks
had any significant effect on sleep when compared
with the inert capsule, but after Horlicks at bedtime
sleep was less broken than after the other two food
drinks.
The dietary habits of subjects were found to
have a considerable influence on how they slept after
food at bedtime.
iii
CHAPTERS 8 and 9
Correlational analysis revealed that body weight,
but not I.Q. was highly correlated with the mean
amount of REM sleep.
CHAPTER 10
It was also found that the mean sleep cycle length
correlated with the degree of over or under-weight.
CHAPTER 11
I attempt to answer questions raised by the
findings described in earlier chapters.
I tentatively propose a theory linking the
maintenance of body weight, sleep cycle length and
amounts of REM sleep.
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FOREWORD
In Chapter 1 I attempt to show how sleep plays
a vital role in body maintenance. A theory is
presented to explain why sleep must be a time of
relatively greater synthetic activity and included
in the chapter are the numerous examples I myself
have found scattered through the literature which
show protein synthesis and mitotic proliferation
to proceed at their highest rates at the time of
rest and sleep.
The studies described in the early chapters
appear rather pedestrian, but led to discoveries
that I believe to be more interesting.
Although not involved at the inception of the
work described in Chapters 3 and 4 I helped to conduct
it. I did the calculations and the statistical
analyses.
The investigation reported in Chapter 5 marks
the beginning of what is strictly my own research.
The results were unexpected and because of this I
did the post-hoc investigations described in
Chapters 6 and 7.
My experiment provided a wealth of normative
data and using this I was able to unearth some
interesting relationships between sleep and metabolism,
which are reported in Chapters 8, 9 and 10.
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CHAPTER 1
SUMMARY
I propose that the rest/activity cycle of simple
organisms and the sleeping/waking rhythm of higher
animals induce concomitant fluctuations in cellular
energy charge. Tn turn the metabolic balance alters
such that degradative processes are stimulated during
wakefulness and activity and restorative,synthetic
processes are inevitably favoured during inactivity
and sleep. This hypothesis is presented in broad
terms, to apply at all levels of biological
integration.
Feeding also induces oscillations in metabolism.
In simple organisms, food gathering and motor activity
go hand in hand, and the assimilative, synthetic
phase is associated with the resting period. Higher
organisms do not always rest or sleep after feeding
and have evolved complex systems for storage and re¬
trieval of nutrients which allow them to remain
active for relatively long periods of time.




The hungry animal is restless, it goes out to
seek for food, and only when satisfied does it lie
down to sleep. It assimilates the food and seems
restored by its sleep.
In this thesis I shall examine the relationships
between feeding, sleeping and restorative processes.
A few years ago Oswald (1969) saw evidence for
sleep as a period for restoration and repair of the
body and the brain. Restoration or repair must,
like growth, depend on protein synthesis. I shall
present evidence to support this proposition from
over 50 reports showing that rates of protein
synthesis or of mitotic division are higher at the
time of rest and sleep and shall put forward
fundamental reasons why this should be so.
There persists an assumption that degradation
and synthesis in tissues not only continue all the
time (as they do) but that they are continually
equal (which they are not), and upon this invalid
assumption has rested much clinical research into
protein metabolism. In reality, myocardial proteins
of rodents, for example, are synthesized more during
the daylight period when they rest and sleep (Rau
and Meyer, 1975), and the same is true of epiphyseal
cartilage (Simmons, 1968).
Oscillations about a mean are inherent in any
system subject to feed-back control, and this is true
of living systems. In the simplest organism there
are oscillations between food-engulfing activity on
the one hand and inactivity with assimilation on the
other. There will too be oscillations between a
state in which degradative chemical processes are
accelerated and one in which synthetic processes are
enhanced.
I propose that it is the differing energy demands
of the activity/inactivity rhythm that chiefly
determine the degradative/synthetic rhythm, such that
the synthetic period inevitably coincides with the
inactive or rest period, and that this is equally
true in higher organisms in which a central nervous
system ensures rest's integrity through positive
unresponsiveness during sleep and that such relation¬
ships, present throughout the animal kingdom rely
upon the fundamental metabolic co-ordinator, the
cellular energy charge. The energy charge is a




Figure 1.1 summarizes in simple terms the
proposition that, as cellular work is reduced energy
charge reaches higher levels and so protein synthesis
will be favoured and degradative processes will
diminish. Cellular work includes the processes
involved in motor activity, the maintenance of
ion gradients and active transport systems - all of
which use up ATP and so tend to lower the energy
charge. The demands of cellular work are thus in
competition with the needs of synthesis for ATP.
Feeding must play a vital role in this interplay,
for food supplies the substrates for energy production
and the building materials for the synthesis of
structural and storage macromolecules. The intra¬
cellular fate of the digestion products of food will
depend on the metabolic balance within cells and in
higher forms of life the assimilation of ingested
food will also depend on the hormonal environment,
for the endocrine systems of the body exert powerful
effects on metabolic processes in general and
influence the requirements for the various nutrients.
At least, in man the normal hormonal pattern
complements the more fundamental rhythms associated
with the sleeping/waking cycle.
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FIGURE 1.1 When the rate of cellular work is low
during sleep, energy charge rises. This higher
level of energy charge stimulates protein synthesis
and reduces the rate of degradative processes,
whereas when cellular work proceeds at a high rate
such as during motor activity, energy charge falls.
Lower levels of energy charge inhibits the rate of
protein synthesis and accelerates degradative
processes.
- 7 -
(i) activity/inactivity rhythms and
the energy charge
(a) Rates of synthesis and degradation controlled by
energy charge.
To sustain life an organism has to maintain a
chemical composition that differs from its surroundings
and to do so it must expand energy. It must repair its
structural molecules and it must reproduce, both of
which involve biosynthetic, energy-using processes,
reproduction requiring cell-division as well. The
necessary energy is furnished by the catabolism of
food and fuel stores to yield ATP (adenosine
triphosphate) and is released by cleavage of the
terminal phosphate(s), leaving ADP or AMP (the
adenosine di- and mono-phosphates). These energy-
releasing reactions are enzymically coupled to
synthetic reactions, to supply the energy that drives
them. The adenine nucleotides, AMP, ADP, and ATP,
accept, store and transfer chemical potential energy
and constitute a link among all the cell's activities.
These include the maintenance of chemical gradients
(e.g. Na+/K+ pumps), active transport, and energy for
motor activity. Hence the adenine pool is a link
between activity/inactivity rhythms and the catabolic/
anabolic balance of the cell.
To/
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To achieve co-ordination, some universal, internal
signal must operate to enhance or inhibit the cell's
chemical activities, all of which can be broadly
divided into energy-yielding (ATP-producing) reactions
and energy-using (ATP-depleting) processes. It is the
energy state of the cell that provides that signal.
Its influence on metabolic pathways has been defined
by Atkinson (1968), who proposes that the energy charge,
ATP + ADP/2^ = ' ' of a cell varies within a range
ATP + ADP + AMP
up to unity. Lower values of EC favour ATP-producing
pathways and higher values of EC promote ATP-utilising
sequences.
The loci of control are regulatory enzymes that
are sensitive to the levels of the adenine nucleotides
and catalyze the irreversible steps in biochemical
sequences. Every pathway has at least one such step,
without which no net flux could occur. Irreversible
steps mean that the end-product of a synthetic sequence
is not degraded by the reverse of the synthetic pathway,
and hence the rates of synthesis and degradation can be
controlled by a single signal which modifies the
activities of the regulatory enzymes in both synthetic
and degradative pathways simultaneously. The EC level
provides such a signal and affects these pathways in
opposite ways. Degradative pathways yield ATP and so
raise/
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raise the EC of a cell. A higher level of EC then acts
as a signal to reduce the rate of degradation.
Synthetic pathways depend on ATP to drive them and are
promoted by higher levels of EC. If EC falls then it
is a signal to increase degradation and curtail
synthesis, as the system tries to restore a higher EC,
which is thermodynamically more stable (Goldbeter,
1974).
Figure 1.2 shows the typical response to changes
in EC of the rates of reaction of regulatory enzymes
in synthetic and degradative pathways. The control
enzymes have response curves with steeper slopes in
the region of higher EC and physiological values lie
in the highly responsive, "cross-over" portion of the
graphs (Chapman et al., 1971; Atkinson, 1970) where
small changes in EC can disproportionately alter the
relative rates of synthesis and degradation. In
addition, both types of EC response curves can be
modified by the concentration of the biosynthetic end-
product in such a way that if, for example, a synthetic
end-product were in short supply, then the responsive¬
ness to EC of the control enzymes in the synthetic






FIGURE 1.2 Typical curves of the rates of reaction
of control enzymes in synthetic and degradative














FIGURE 1.3 Typical rate of reaction of a synthetic
pathway in response to different levels of cellular
energy charge and the modification of this response by
high and low concentrations of synthetic end-product.
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A prediction from this theory is that energy
metabolism (degradation) and synthetic processes will,
in broad terms, exhibit predictable rhythmic variations
which are oppositely phased so that when one rhythm has
a peak the other shows a trough. Later in this chapter
I present many examples of peaks in synthetic activity
at the time of rest and sleep. There is some evidence
that degradative processes do show the opposite
pattern. A 24h rhythm of oxygen consumption has been
found in starving birds, which when kept in darkness
exhibited very little motor activity, and yet the
lowest rates of oxygen consumption occurred at the time
of day when these birds sleep (Aschoff and Pohl, 1970).
The rate of weight loss in a starving swift was found
to be least at night (at the time of sleep) and to
parallel the body temperature rhythm (Koskimies, 1950).
Both these studies point to a 24h rhythm of degradative
metabolism.
(b) Protein synthesis, growth and activity.
The concept of energy charge was originally applied
to intermediary metabolism but other processes too are
sensitive to EC. The sensitivity of steps in protein
synthesis to changes in adenine nucleotides (Walton and
Gill, 1975; Ayuso-Parrilla and Parrilla, 1975) are of
particular/
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particular interest, as are the changes in EC that are
synchronized with growing and non-growing phases of
E. Coli (Chapman et al., 1971). Such synchronized
changes illustrate how EC correlates with anabolic
processes.
It is proposed that the simple organism's
oscillations between rest and activity must induce
concomitant oscillations in EC and so, in turn, in other
cellular processes. Motor activity demands ATP and
hence motility and food-gathering will lower EC, promote
degradative processes, temporarily suppress biosynthesis
and result in a relatively low concentration of protein.
After taking in sufficient nourishment it would be
economical to rest, the EC would rise and conditions
would be optimal for the biosynthetic processes
previously curtailed, and these would be the greater
because of the added signal of low protein concentration.
Evidence that motility does inhibit synthetic
processes can be seen in an experiment where the
unicellular Stentor coeruleus was cut in half, such
that each half received an equal share of the
macronucleus, but only one half had the ciliary
apparatus. Subsequent onset of mitotic activity occurred
much earlier in the cilia-free end (Guttes and Guttes,
1959). The EC must have risen during the enforced rest
of the non-ciliated end and acted as a trigger for
synthetic processes.
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(c) Synthesis during rest in higher organisms.
In complex organisms, motility and responsiveness
to the environment are not characteristics of each cell,
but the same principles apply. Responsiveness, through
the information-carrying system, is energy-consuming,
and so tends to lower the EC. The house cricket,
Acheta domesticus, has a 24h rhythm of RNA and protein
synthesis in its brain and sub-oesophageal ganglion,
with synthesis highest ivhen these insects are inactive.
Their activity increases sharply with the onset of
darkness, whereupon synthesis of RNA and protein in the
brain falls to its lowest (Cymborowski and Dutkowski,
1969, 1970).
Higher organisms store fuel foods to allow
prolonged activity without feeding. As in simple
organisms, the optimal time for synthetic processes
would be during a rest/sleep period following feeding.
Many higher animals are observed to rest/sleep after
feeding and indeed feeding and sleeping have been shown
in many investigations to be inter-related (See later
in this thesis).
During activity the energy-requiring, biosynthetic
pathways would be suppressed by a downward shift in the
EC, which would simultaneously stimulate catabolic
processes in tissues directly involved (e.g. muscles)
and/
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and those linked metabolically (e.g. liver and adipose
tissue). Even more tissues would be influenced if
their substrates for ATP production and synthesis of
macromolecules were diverted as fuel for motor
activity. Contracting muscle in vitro has a lower
ATP concentration than resting muscle, despite a
tripling of oxidative metabolism (Crabtree and
Newsholme, 1972; Newsholme and Start, 1973). Like¬
wise, brief exercise considerably reduces the EC of
rat skeletal muscle in vivo (Wojciechowska et al.,
1975). The concentration of ATP in biopsies taken
from human muscle after 2 min of exercise is 25% less
than from resting controls (Karlson and Saltin, 1970).
Conversely, the in vivo rate of protein synthesis in
rat diaphragm muscle is highest during the resting/
sleeping period (Rebolledo and Gagliardino, 1971).
It has been shown in man that exercise enhances the
output of alanine from muscle and its subsequent
re-uptake by the liver where it is a gluconeogenic
precursor (Ahlborg et al., 1974). As examples of
tissues linked indirectly the rate of protein
synthesis falls in the hypothalamus if rats exercise
(Bordeianu and Butculescu, 1971) and protein synthesis
in rat skin is at its highest during the daylight,
when rats rest and sleep (Chekulaeva, 3969).
The/
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The effect of 30 min of exercise, on the
incorporation rate of radioactive methionine into
liver, kidney, heart and muscle protein, was studied
in groups of young and old rats (Mateev et al., 1967).
Control rats for each age group were compared with
experimental rats sacrificed during exertion and with
others sacrificed at 30 min intervals up to 5h
following the period of exercise. During motor
activity biosynthesis sharply decreased. In young rats
the suppression of amino acid incorporation into
protein in heart, liver and muscle lasted for several
hours after the exertion ceased and for over an hour
in kidney, whereas the suppression following exercise
in older rats did not return to control values within
the 5h period in any of the tissues investigated.
In man exercise inhibits skin mitosis for many
hours afterwards (Fisher, 1968) and under certain
circumstances has been shoivn to induce protein
catabolism by Mole^ and Johnson (1971), who found a
paradoxical effect of surfeit feeding on protein
metabolism? it was anabolic at rest but catabolic
following exercise.
Peaks in mitotic rate in frog crystalline lens
epithelium coincide with episodes of motor inactivity
whereas/
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whereas troughs are associated xvith active periods
(Kuznetsov et al., 1972). It is important to
distinguish such phenomena from the increased use
of tissues that leads to their subsequent hypertrophy.
The latter involves the activation of genetic material
in the nucleus, with increased formation of RNA, and
subsequently of proteins many hours later (Meerson,
1975).
(d) Mitosis and ATP.
Mitosis depends upon synthesis, whether for tissue
maintenance or propagation of the species. There is a
strong relationship between mitotic activity and higher
concentrations of ATP (Guties and Guttes, 1959). A
fall in ATP below a critical level inhibits mitosis
(Epel, 1963). A positive correlation between the
rhythm of ATP level and cell division has been shown
for Tetrahymena pyriformis (Plesner, 1964). Moreover,
most tissues have a 24h variation of mitotic rate,
with the maximum during the resting/sleeping period,
when, as we must suppose, ATP and EC levels are
highest. Examples are listed in Table 1.1.
It could be that through evolution the rhythms of
energy-dependent mitotic proliferation were entrained
to/
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TABLE 1.1 MITOSES MAXIMAL DURING THE TIME OF REST AND SLEEP
Species Tissue Reference
Ectodermal Tissues
Cooper and Schiff (1938);
Scheving (1955); Fisher (^dS)
Halberg et al. (1965)
Chekulaeva (1969)
Gololobova (1960)
Sigelman et al. (1954)
Vasama and Vasama (1958)
Kuznetsov et al. (1972)
Renzoni and Quay (">964)
Nouet and Kujas (1975)
Brown and Berry (196£);
Izquierdo and Gibbs (1972)
Bertalanffy (1957)
Vonnahme (1974)
Echave Llanos and Piezzi (1963)
Bertalanffy (1960)
mucosa " "
Rat Anal epithelium tt It
Mesodermal Tissues
Man Bone marrow Mauer (1965)
Rat Epiphyseal cartilage Simmons (1964)
Rat Bone marrow Clark and Korst (I960); Hunt an
Perris (1974); Uryadnitskaya
(1974)
Mouse Bone marrow Clark and Korst ("!969)
Rat Kidney tubules Sharipov (1967); Saetren (1972)
Rat Thymus Hunt and Perris (1974); Kirk
(1972)
Rat Inner enamel epithelium,
incisor teeth Gasser et al. (1972a)
Endodermal Tissues
Rat Liver parenchyma Vonnahme (1974); Jaffe (1954)
Mouse Liver Barnum et al. (1958)
Rat Tongue Gasser et al. (1972b)
Mouse Squamous epithelium of
Burns et al. (1976)tongue and oesophagus
Rat Rectal mucosa after
injury Reeve (1975)
Rat Gastric epithelium Clark and Baker (1962)
Rat Lung interalveolar
septa Romanova (1966)
Rat Duodenum Scheving et al. (1972)
Mouse Duodenum Scheving et al. (1972)











Hamster Cheek pouch epithelium
Rat Sebaceous gland cells






to the variations in energy state associated with
the rest/activity cycle. The hormones of higher
organisms are sophisticated additions to more
primitive controls but where investigated they are
found to be complementary (Bullough, 1948;
Sigelman et al., 1954; Fisher, 1968; Vonnahme,
1974).
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( 13) FEEDING AND SYNTHESIS
Feeding also induces oscillations in metabolism
and in higher organisms it is the liver that has to
deal with the influxes of nutrients so that there are
not wide variations in the blood levels of the various
nutrients.
When a protein meal is fed to dogs more than
half of the incoming amino acids are degraded to urea,
a small proportion are retained as liver protein,
some are secreted as plasma proteins and only about a
quarter of the incoming load passes into the general
circulation as free amino acids (Elwyn, 1970).
The 24h rhythm of net protein synthesis in rat
liver (Richardson and Rose, .1971) is the only instance
that I found in the literature of a peak in synthetic
rate occurring during the activity period. It can be
readily understood why this organ should be the only
exception for, in response to an increased amino acid
supply, protein synthesis in the liver is accelerated,
while protein breakdown is reduced (Munro et al.,
1975) which results in the accumulation of enzymes
with short half-lives involved in the metabolism of
the incoming nutrients. In consequence there are
diurnal rhythms in the synthesis of liver proteins,
and in the accumulation and breakdown of liver RNA,
which are both related to the intermittent intake of
meals containing protein (Munro et al., 1975).
The/
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The plasma levels of amino acids are also affected
by dietary carbohydrate through an insulin-dependent
mechanism. Within about an hour of consuming carbo¬
hydrate the level of most plasma amino acids decrease,
owing to deposition in muscle through insulin-mediated
transport (Munro et al., 1959). Muscle represents
the major depot for retention of free amino acids in
the body (Munro, 1970) but deposition of amino acids
in muscle does not necessarily lead to an increase in
protein synthesis rate for protein synthesis depends
on many things and especially on the intracellular
ATP levels.
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(III)SLEEP PROMOTES SYNTHETIC PROCESSES
(a) Sleep is more than rest.
Rest reduces ATP depletion but sleep is more than
rest, it is a state of unresponsiveness brought about
by active nervous mechanisms, a highly-developed form
of rest than ensures that the whole body, including
the nervous system, has an opportunity to recuperate.
There are two types of sleep that alternate, one
being named NREM, or orthodox sleep, and the other REM
or paradoxical sleep. Human NREM sleep is divided
into stages 1-4, according to the electroencephalogram.
Stages 3 and 4 are called slow-wave sleep, or SWS.
The stages differ in their degrees of unresponsiveness,
with stage 2 being a less responsive state than stage 1,
SWS a state of even lesser responsiveness, while REM
sleep is about equal to stage 2 (Figure 1.4). These
relationships in the degree of responsiveness are true
for responses to auditory stimuli (Williams et al.,
1966), blood pressure reflexes (Coccagna et al., 1971),
or scratching by patients with itchy skins (Savin
et al., 1975). In harmony with the differing degrees
of responsiveness, the same relationships are true also
of the metabolic rates that accompany these sleep stages.
Human metabolic rate is some 10% lower in stage 2 than
in/
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FIGURE 1.4 In stages 3+4 (slow wave) sleep,
responsiveness is lowest to auditory signals,
scratching is least, blood pressure is lowest, and
whole-body oxidative metabolism is lowest: the
demands of cellular work, that compete with the
needs of synthesis, are at their lowest.
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in wakeful rest, with a further 2% fall during SWS
(Brebbia and Altshuler, 1968). Evidence that merely
resting in bed is no substitute for sleep is
indicated by the results of Lubin et al. (1976).
They compared three groups of young men on a schedule
60 min of treatment alternating with 160 min of
testing. The regime was kept up for 40h. Three
different treatments were compared; one group were
allowed to sleep during the 60 min treatment periods,
and another group exercised on bicycles. A third
group lay resting on a bed, but were not allowed to
sleep, during the 60 min periods. During the 160 min
testing sessions all groups listened to a 40 min
auditory vigilance task, did an arithmetic test, had
their short-term memory tested for digits and words,
rated their mood and rated how sleepy they felt. The
bed rest group showed significant impairment on all
eight measures and the authors concluded that bed
rest is no substitute for sleep. The exercise group's
performance was worse on all measures than either of
the other groups and suggests that exercise
exacerbates the detrimental effects of sleep loss.
Impairment of physical performance by sleep deprivation
was illustrated in another study where motor perform¬
ance in teenagers was tested across 50h of sleep
deprivation/
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deprivation (Copes and Rosentswieg, 1972). The results
showed a downward trend in performance as the
deprivation progressed, on such tests as the Harvard
step test, time to run a variety of races, length
jumped, reaction time and strength measured by the
time the youngster was able to hang from a beam with
bent arms, supporting his/her entire weight. One
night of sleep following the deprivation period
restored their performance on all these tests to normal.
(b) Sleep for growth and repair.
In an analysis of data from 53 species Zepelin
and Rechtschaffen (1974) found a positive correlation
between daily sleep durations and metabolic rates.
Their interpretation was in terms of energy conservation,
but, it can be seen from another viewpoint, the higher
the rate of metabolism (and hence degradation) during
the active period, the longer would be the sleeping
period needed for compensatory synthesis. In individual
men the customary duration of sleep correlates positively
with waking body temperatures, and hence presumably with
waking metabolic rate (Taub and Berger, 1976). Growth
too depends upon synthetic functions and in one invest¬
igation it was found that a group of children of short
stature had grown only one-third as fast at times of
poor/
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poor sleep as of good (Wolff and Money, 1973).
Growth and repair necessarily depend on net protein
synthesis and so a positive nitrogen balance. Rudman et
al., (1973) found that more nitrogen was retained in
humans deficient in growth hormone following an in¬
jection of growth hormone (GH) at 2300h than after a
similar dose at 0800h suggesting that subsequent sleep
facilitated nitrogen retention and presumably gro\vth in
GH deficient children. On the other hand sleep
deprivation for two nights in 19 young men led to a
significant increase in nitrogen excretion on the second
day of deprivation, which continued at high levels
during the first post-deprivation day and on the second
post-deprivation day fell to below baseline levels.
(Schrimshaw et al., 1966). Throughout the study
nitrogen intake was constant. Sleep deprivation must be
stressful (Kuhn et al., 1969) and so elevated corti¬
costeroids probably contributed to the increased
nitrogen excretion. Nevertheless the results suggest
that sleep deprivation enhanced protein and/or amino
acid catabolism. The apparent time delay before
nitrogen excretion increased following the commencement
of sleep deprivation was probably a reflection of the
inertia in urea excretion. Growth and repair of course
also depend on the ingestion of a diet adequate in both
energy/
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energy and protein but the fate of ingested food
depends on the metabolic conditions prevailing during
the assimulative period. The metabolic conditions
depend on the short and long term nutritional status,
the extent- of motor activity, the time of the 24h
and the hormonal environment, factors which are,
inevitably interdependent.
Even during total starvation more amino acids
are excreted in the urine over the hours 0800-1100h
than between 0200h and 0500b (Tewksbury and Lohrenz,
1970) and the same pattern is found for the degradation
of tryptophan (Rapoport and Beisel, 1968). Normal
subjects have been shown to have a 24h rhythm in their
plasma amino acid levels, with peaks during the day
and with lowest levels around 0200h. The rhythm
persisted in subjects fed a protein-deficient diet
(Wurtman et al., 1968a). The latter condition
distinguishes the tyrosine amino acid rhythm from the
rhythm of activity of the hepatic enzyme, tyrosine
transaminase, which is extinguished by a protein
deficient diet (Wurtman et al., 1968b). The biological
significance of the rhythm of amino acid levels is
unclear but it may represent a stimulation of the
uptake of amino acids into tissues at certain times
of the 24h. It is thus interesting that altering the
sleeping/
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sleeping period from 2200h - 0600h to lOOOh - 1800h
caused a rapid (within 48h) shift in the hour of
peak plasma concentration of amino acids - to 0400h
i.e. into the new activity period (Feigin et al.,
1968). The hormonal environment too depends on the
time of the 24h and on the sleep wake rhythm.
(c) The hormones of sleep.
The large nocturnal secretion of human growth
hormone (GH) (Takahashi et al., 1968; Honda et al.,
1969), is dependent upon the presence of sleep and
especially SWS (Sassin et al., 1969a; Schnure et al.,
1971). This itself reveals sleep as a time that
facilitates anabolic processes in man, since GH
stimulates amino acid uptake into tissues, promotes
protein and RNA synthesis (Korner, 1965) and has
wide inter-reactions, such as stimulating red blood
cell formation indirectly through erythropoietin
(Peschle et al., 1972). It raises blood free fatty
acids, whose subsequent degradation is a source of
cellular energy (ATP), thereby saving amino acids
from catabolism and increasing their availability for
protein synthesis during sleep.
Corticosteroids/
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Corticosteroids reduce net protein synthesis
(Ardeleanu and Sterescu, 1973; Friedman and Strang,
1966) and nocturnal GH comes at that time in the 24h
when corticosteroids are lowest (Weitzman et al.,
1971). Consequently, even greater protein synthesis
occurs during human sleep, as demonstrated by Rudman,
et al. (1973) who injected GH and found significantly
greater nitrogen retention after a 2300h dose than
after a dose at 0800h.
Three other sleep-dependent hormones are known:
prolactin (Sassin et al., 1973), luteinizing hormone
and testosterone (Boyar et al., 1972, 1974; Rubin et
al., 1973a, 1976): all four hormones released by
sleep are thus hormones that promote anabolism. Other
hormones can alter the metabolic balance within target
cells, and so, maybe, they too can influence the EC
level and then, indirectly, protein synthesis.
(d) Slow-wave sleep for compensatory restoration.
It has been suggested that sleep may have
compensatory features for the degree of waking activity.
After sleep-deprivation, men have extra SWS (Berger and
Oswald, 1962; Williams et al., 1964), and monkeys
extra GH (Jacoby et al., 1975a). The longer the
wakefulness/
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wakefulness prior to a nap, the more SWS and GH
(Karacan et al., 1974). Even one hour of extra wake¬
fulness during the night is followed by extra SWS and
GH in the later night (Beck et al., 1975). Extra
exercise leads cats to have more SWS (Hobson, 1968),
ordinary men to get more GH (Adamson et al., 1974),
and athletes greater amounts of SWS (Baekeland and
Lasky, 1966; Shapiro et al., 1975; Maloletnev and
Telia, 1975; Zloty et al., 1973; Maloletnev et al.,
1977).
Thyroid hormone increases degradation and whereas
hypothyroid patients lack SWS (Kales et al., 1967a),
hyperthyroid patients have an excess of it and more
GH (Dunleavy et al., 1974). After days when normal
men have had higher thyroxine secretion they get more
SWS (Johns et al., 1975). Acute starvation increases
both SWS (MacFadyen et al., 1973) and GH (Parker et al.,
1972; Karacan et al., 1973) at a time when the latter's
protein-sparing action would be of importance, while
after chronic starvation an increase of SWS is
associated with tissue-rebuilding (Lacey et al., 1975).
As earlier mentioned, SWS will also be most strongly
associated with anabolic repair because metabolic rate




The EEG waves have, of course, multiple determinants
and so SWS may be seen as a time that is simply facili-
tatory for enhanced synthesis. Durations of electrical
slow waves may be in part genetically dictated~or
altered by disease, without immediate regard to restor¬
ative needs.
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(IV)SLEEP AND THE BRAIN
(a) Sleep - a state of unresponsiveness
It is the brain that controls sleep and it is
brain functions such as the power to sustain attention
that are most obviously impaired by sleep deprivation.
Although the mature brain no longer grows it still
needs synthetic activity. It rivals the liver in its
high rate of turnover of proteins and nucleic acids
consistent with its role in information-processing,
storage and retrieval, which rely on synthetic activity
over and above the protein synthesis required for
enzymes and renewal of structural components. The
benefit of sleep is most obvious for the brain, since
during rest the nervous system remains responsive to
the environment, whereas in sleep it becomes unrespon¬
sive (Steriade, .1970). The responsiveness of the
wakeful cortex depends upon sustained ascending
activation from the mesencephalic reticular formation,
and the high levels of extracellular K+ so caused
(Katzman and Grossman, 1975). These higher levels of
K+ are closely coupled to higher energy consumption by
the ATPase ion pump (Bachelard, 1975a;Jobsis et al.,
1975; Lowry, 1975). Higher extracellular K+ implies
that intracellular K+ levels have been lowered.
Cerebral/
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Cerebral protein synthesis is sensitive to intra¬
cellular K+ concentration. A rise in intracellular
K+ concentration from 25mM to 80mM resulted in a six
fold increase in the rate of protein synthesis
(Roberts and Zomzely, 1966).
Sleep-deprivation impairs mental functions and
as the deprivation continues there is an increasing
'pressure* to sleep, which suggests some deficit in
cerebral re-charging or repair. Figure 1.3 enables
one to understand why, after prolonged sleep-
deprivation, restoration can be accomplished in
fewer hours than those lost.
(b) Synthesis and energy charge
Brain protein synthesis has its highest rates
at the time when rats rest and sleep (Richardson and
Rose, 1971} Rose et al., 1969; Gordon and Scheving,
3968). The cat has several sleep periods and with
each of these there is a rise in the protein content
of perfusates from the brain (Drucker-Colin et al.,
1975a). Jones (1971) found brain ATP levels of golden
hamsters were higher during sleep.
The parallelism that exists between the rate of
RNA synthesis and the ATP concentration in brain
slices/
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slices and the fact that the ATP concentration for
optimal amino acid incorporation by microsomal and
ribosomal preparations is more critical in the
cerebral cortex than in similar preparations from
liver (Zomzely et al., 1964) both suggest that the
cell content of available ATP is the regulating
factor in brain protein synthesis (Itoh and Quastel,
1969).
The protein and RNA content of supra-optic
nuclei was higher in sleeping rats than waking rats,
while the latter in turn had a higher content than
sleep-deprived animals (Doerain and Rubinskaya, 1974).
Van den Noort and Brine (1970) measured the ATP, ADP
and AMP concentrations in rat brain after 13h of sleep-
deprivation and after lh of subsequent sleep.
Calculations of EC using their results give a value of
0,77 after 13h of sleep deprivation but 0.83 after the
lh of sleep. This rise is in the highly responsive
portion of the curve and Figure 1.3 illustrates how
protein synthesis in the brain would differ under
these two conditions and how there could be additional
enhancement of protein synthesis during sleep at a
time when end-product concentration would presumably
be low.
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(c) NREM-REM sleep cycles and protein synthesis.
The different physiology of NREM and REM sleep
suggests that they differ in function but a causal
relationship has been proposed because NREM always
precedes REM sleep (Hartmann, 1973). The leading
ATP user of the brain is the Na+/K+ ATPase pump
(Bachelard, 1975^, the rate of activity of which is
determined by the rate of neuronal-firing (Lowry,
1975). During SWS the majority of neurones have a
much reduced firing-rate compared with waking
(McGinty et al., 1974). As a result of this low rate,
ATP depletion would be reduced and EC level would rise,
whereas during subsequent REM sleep the higher firing-
rate (McGinty et al., 1974) would lower intracellular
ATP and stimulate brain glycolysis and respiration.
The firing-rate during REM sleep approximates to walking
but this is not in response to the outside world and
may represent transfer of information among neurones.
The amount of REM sleep seems to be correlated
with the intensity of brain synthetic activity
(Oswald, 1969, 1970, 1976; Stern and Morgane, 1974).
If higher rates of protein synthesis occur during
REM sleep itself in conjunction with the higher rate
of cell-firing, this would imply compartments of ATP
pools between, for example, neurones and glia, or
intracellular compartments within neurones, as there
is for glucose transport (Bachelard, 1975b).
In/
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In higher organisms, protein is synthesized at
the rate of two amino acids per sec, which means 1-2
min to synthesize a medium-sized protein molecule
(Dintzis, 1961), in addition to the time required to
initiate the process. Oscillations have been found
in the rate of protein synthesis in a remarkable
diversity of tissues (Brodsky, 1975). There is a
theoretical minimum oscillation period of the order
of minutes, because of the inertia in the protein
synthetic machinery (Goodwin, 1963). The REM periods
of most species last only a few min, and this is so
short a time that the onset of a REM period could
hardly be the primary initiator of any increased
brain protein synthesis associated with that period.
Possibly, peak rates of brain protein synthesis might
coincide with the onset of REM periods, conditions
for stimulating the peaks having been generated during
the preceding SWS, when cell-firing would have been at
a minimum and when, therefore, EC would have risen.
It has been assumed by many (e.g. Drucker-Colin
et al., 1975a) that REM sleep stimulates protein
synthesis, but could it not be the other way round,
with peaks in protein level or rate of synthesis
stimulating the occurrence of REM sleep? There is
some evidence to suggest that this may be the case.
Prolonged/
- 37 -
Prolonged fasting in adult rats greatly reduced the
conversion of glucose to protein (Barkai et al., 1974)
and feeding deoxyglucose (which cannot be metabolised)
caused a decrease in amount of REM sleep in rats.
(Panksepp et al., 1973). Injection of bovine growth
hormone into rats resulted in a temporally related
increase in REM sleep and increased levels of whole
brain soluble proteins (Drucker-Colin et al., 1975b)
whereas a similar molecular weight protein, thyro¬
tropin, had no effect on the amount of REM sleep.
Anisomycin reduced the amount of sleep, but it ^vas
REM sleep in particular that was significantly
reduced. There was also a time-dependent decrease in
brain protein levels. Administration of growth hormone
at the same time as the antibiotic returned sleep to
control levels, suggesting that extra growth hormone
can compensate for the detrimental effects of the drug.
In humans the effect on sleep patterns of
administering glucocorticoid has been investigated by
Gillin et al.( 1972). They found a dose-related re¬
duction in the amount of REM sleep. Corticosteroids
are known readily to penetrate into the brain tissue
(Peterson and Chaikoff, 1963) and as these hormones
promote protein catabolism (Ardeleanu and Sterescu,
1973; Friedman and Strang, 1966) it may be that a
reduction/
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reduction in net protein synthesis led to the decrease
in REM sleep. So there does appear to be some evidence
to support the proposition that peaks in brain protein
concentration may stimulate REM sleep. And it is
tempting to speculate with Brodsky (1975) that
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Evidence from the animal literature suggests that
lack of food is associated with increased motor rest¬
lessness but that after feeding an animal is more
likely to fall asleep.
Human studies indicate that sleep is less restless
or less disrupted by waking when a small meal of milk
and cereal is taken prior to retiring to bed.
Loss of body weight in man and animals is
associated with a decreased amount of sleep, and gain
in weight in humans leads to an increased amount of
sleep.
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(I) EVIDENCE THAT NUTRITIONAL STATUS INFLUENCES SLEEP
(a) Hunger associated with increased restlessness
Many years ago Richter (1922) demonstrated an
increase in the daily activity of the rat when deprived
of food over a prolonged interval. He found that
activity increased up to the third day of deprivation and
thereafter declined.
In a similar study Siegel and Steinberg (1949)
measured the activity level in groups of rats deprived of
food for 12, 24, 36 and 48h. They found that the level
of motor activity increased as a negatively accelerating
function of the length of time without food. More
recently Treichler and Hall (1962) measured motor
activity in two groups of rats, using an activity wheel.
One group of 15 rats, fed ad lib, served as controls to
indicate the weight gain expected in rats of this age.
The other group of 30 rats were subdivided into three
groups of ten rats each: a food-deprived, a water-
deprived and a food and water deprived group. Apparently
the rate of weight loss in the three sub-groups did not
differ significantly and their data was combined. It was
found that running activity was increased as a function
of weight loss. Activity was increased to 200% above
their baseline rate when they had lost 10% of body weight
and so on until at a 40% loss of body weight activity had
increased to nearly 1400% above baseline levels.
These/
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These studies seem to be consistent with the idea
that hunger is an alerting signal leading to increased
motor activity in animals.
The evidence from humans is less clear-cut. Bryan
and Carlson (1962) failed to demonstrate any differences
in spontaneous activity when five men were deprived of
food for 99h. However, motor activity in babies has been
found to be a function of the hours since they were last
fed (Irwin, 1932). The above studies looked at amounts
of motor activity integrated over time and it can only
be supposed that the increased restlessness associated
with hunger also disturbed sleep.
(b) Hunger disturbed sleep
A number of studies have specifically investigated
the effects of hunger on sleep. Wada (1922) reported
that she found an association between periods of stomach
contractions and body movements in sleeping adult humans
and children. Body movements during sleep are commonly
regarded as an index of less restful and lighter sleep.
The following experiments move out of the realms of
normal hunger and into those of chronic starvation and
undernutrition and so may be measuring the effect of loss
of body mass on sleep.
In/
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In a recent study Ruckebusch and Gaujoux (1976a)
recorded the sleep/wake patterns of laboratory cats
and reported that cats fasted for three days spent less
time asleep in the 24h than when they had been allowed
to feed normally.
Jacobs and McGinty (1971) analyzed the sleep and
wake patterns of rats deprived of food over a prolonged
period. They found that the amount of wakefulness in a
daily 3h electrophysiological recording (always starting
betiveen 9 and 10 a.m.) progressively increased and that
the amount of sleep decreased in a reciprocal fashion
over the days of deprivation. After 6-11 days of food
deprivation sleep had virtually disappeared but re-feeding
reversed this effect. This study does suggest that the
amount of sleep was reduced by hunger, however only 3h
recordings were made and one cannot tell if the normal
circadian rhythm of sleeping and waking had been
displaced by food deprivation. The authors did say that
they had checked the validity of using 3h recordings by
undertaking several 24h recordings. Rats have a high
metabolic rate, relative to man, and so a week or more
of food deprivation resulted in an average loss of body
weight of more than 30% and so the disruption of sleep
may be due to loss of weight (or depletion of fuel
stores). An interesting point is that the most significant
effects of starvation on sleep in the above experiment
were/
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were not seen until some 6-9 days had passed without food,
which suggests that the loss of body mass below a critical
level may be the important factor for disruption of sleep
by wakefulness.
Chronic under-nutrition (and so loss of body tissues)
has been reported to be associated with less total sleep
and sleep fragmented by wakefulness. In a study of the
effects of under-nutrition in Wuppertal between 1946-9
(Russel Davis 1951) it was found that insomnia was a
common complaint in ex-prisoners of war and in civilians
who had lived on a restricted diet owing to severe
rationing of food. Both groups had lost body weight
owing to inadequate energy intakes.
Anorexia nervosa patients restrict their food intake
to such an extent that they become considerably under¬
weight and Crisp et al. (1971) have studied their sleep
before and after treatment to restore their body weight.
They found that after treatment the amount of time spent
awake or merely drowsy through the night was significantly
reduced. A finding that was later confirmed in another
study from the same laboratory (Lacey et al.,1975).
In a study of the sleep of obese patients during
weight loss Crisp et al. (1973) found that their patients
reported that they slept less as they lost weight on a
diet restricted to 500 cal/day and so it may have been
the lack of food or the loss of weight that was disrupting
sleep.
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However, in the Lacey et al. (1975) study the ten
anorexia nervosa patients were given approximately the
same diet throughout the refeeding period and yet the
improvment in sleep paralleled the gains in body weight
and, in the study by Crisp et al. (1973) above, the five
obese patients, on average, reported that their sleep
became progressively shorter as body weight was steadily
lost, yet their calorie intake was constant. These
studies suggest that losing body weight is associated
with less sleep and gaining body weight is associated
with sleep of longer duration. Subsequent to their
initial findings relating changing body weight to changes
in sleep, Crisp and Stonehill (1973) reported an invest¬
igation of 375 psychiatric out-patients. Each patient
was interviewed by three independent observers. One
interviewer made sin assessment of the patients' sleep
before the illness and of their recent sleep, another
interviewer assessed the present and previous body weight.
Thereafter a consultant rated the patients' psychiatric
status. Correlational analysis showed that gain in body
weight was associated with improvement in sleep, and loss
of weight was associated with a deterioration in sleep
which had become of shorter duration and more broken by
waking. The important point was that these associations
between change in weight and change in sleep remained
when factors such as age, mood and psychiatric diagnosis
were partialled out.
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(c) Sedative effect of food
It is a common experience to feel sleepy after a
large meal and who has not noticed that their pet cat
or dog often sleeps after feeding? Many people habit¬
ually take a hot milky drink or light snack at bedtime
to "help them sleep" and mothers know that a hungry baby
will not sleep soundly. Many might dismiss the belief
that food can act as a sedative and put it into the same
category as the effects of placebo pills in susceptible
people. However, in the last few years evidence has
accrued that points to there being connections between
the gut and the brain, which suggest that food may in
fact have a sedating influence. Introduction of milk
into the duodenum of cats resulted in drowsiness (shown
by EEG spindling) if the animal was active, or in a
transition to slow-wave, high-voltage sleep if the cat
was already drowsy. The authors, (Fara et al, 1969)
also reported that within an hour of the injection of
milk into the duodenum there was an increased frequency
and duration of REM sleep episodes if the injection was
into a sleeping animal. No such effects were found if
the milk was injected into the stomach. Subsequent
experiments indicated that it was the fat component of
milk that was the important factor in these effects for
none among water, saline, glucose, lactose or casein
elicited the effect, but corn-oil in the duodenum did.
The/
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The duration of the changes after corn-oil was also
found to be proportional to the amount of oil injected
(0,5 to 2*0 ml). In a later study Rubinstein ahdSonpenschein
(1971) again reported that intraduodenal fat (2ml corn
oil) led to an increase in total time spent asleep and
in the number of episodes and percentage of REM sleep
in three cats7during a 3h recording period. However,
on close inspection of their report I was unable to see
how they arrived at their conclusions. They had also
claimed that a single large meal increased the percentage
of the 3h recording time, spent asleep and that this was
accompanied by an increase in the amount and frequency
of REM sleep. This claim was based on a comparison of
cats when fed with when they had had no meal for 12h.
The unfed animals were monitored electrophysiologically
from 9 a.m. to 12 a.m. after 12h of food deprivation to
represent the unfed condition. On another day they were
exposed to food from 9 a.m. to 1 p.m. after 12h of food
deprivation and then recorded from 1 to 4 p.m. I do not
doubt that feeding has sleep-promoting effects in cats
but this experiment failed to demonstrate it because of
poor design. The sleep-wake cycle is a circadian rhythm
and so at different times of the 24h there is a greater
or lesser tendency to sleep. The above experiment
monitored cats in the fed and unfed state at different
times of day and so the authors may have contaminated
their results by interference from circadian rhythm
effects.
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The effect of altering the times for feeding on
sleep in the rat has been demonstrated by Mouret and
Bobillier (1971). The normal pattern in which there
was more sleep during the daylight hours than during
the dark was found when rats were fed ad libitium or
during the dark period only. By contrast rats fed only
during the light hours altered the temporal position
but not the total amount of slow wave sleep over a
number of days, and, more strikingly, the number of REM
episodes became more numerous during the dark hours
than during the light, and the relative percentage of
REM sleep was increased relative to the control rats.
These effects were not immediate but took about 2 weeks
to become established suggesting gradual readjustment
of the sleep-wake rhythm in response to an imposed
alteration in the feeding schedule. Similarly, a return
to ad li.bitium feeding reversed the changes in sleep
but this took about 2 weeks to be completed. The
lighting regime was the same throughout the entire period
(lightsdark, 12hsl2h). Folk (1954) also reported that
altering the feeding time from midnight (normal) to noon,
in rats kept entirely in darkness, shifted the pattern
of running activity from shortly before midnight in the
normal group to shortly before noon in the noon fed rats
and one assumes that the converse may be true of the
sleeping pattern. Interestingly enough, when the rats
were/
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were illuminated from 6 a.m. to 6 p.m., shifting the
feeding period did not shift the activity rhythm,
although the author did not record the sleeping
pattern.
In this Chapter I suggest in general terms that
feeding causes sedation. Although many people do
experience post-prandial drowsiness it is usually at
bedtime that they specifically eat to aid their sleep.
It seems reasonable to predict that the sleep-
promoting effects of food are greater at the time of
the 24h when the likelihood of being asleep is greatest.
An indication that this is the case was alluded to in a
letter by Rubinstein (1972), when he said that food in
the gut releases the intestinal hormones cholecystokinin
(CCK) and secretin (Wang and Grossman, 1951) and that he
and his colleagues had found that the intra-venous
infusion of CCK into cats was associated with an
increase in total sleep during the hour-long infusion
(Rubinstein and Sonnenschein, 1971). The interesting
point he added (which was not mentioned in their 1971
paper) was that the sedating effect of CCK was dependent
on the time of the 24h and the greatest effects were
found at the time of the circadian sleep/wake rhythm
when sleep was most likely to occur anyway. In
contrast CCK infusions during other periods had no
detectable/
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detectable effect, which suggests that the degree of
sedation after food may well depend on the timing of
the daily sleeping and waking rhythm.
(d) The effects of nourishment at bedtime on subsequent
sleep.
A warm milky drink at bedtime is popularly believed
to help you fall asleep more readily and lead to more
restful sleep and probably because of this a number of
studies have been undertaken over the years to invest¬
igate the influence of bedtime eating on sleep. Their
various conclusions are contradictory. Some, but not
all of the differences are, in retrospect, explainable.
Many years ago Stanley and Tescher (1932) undertook
an investigation into the effects on sleep of different
types of food eaten at bedtime. Movements during sleep
were monitored as an index of the restlessness of sleep.
Seven men prisoners were the subjects and each was
monitored for 10 nights after each of the following
forms of bedtime intake (1) nothing to eat at bedtime
(2) 4oz of cake as a carbohydrate snack (3) 4oz egg or
meat as a protein snack and (4) loz butter on toast
as a fatty snack.
The treatment order was not balanced.
The/
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The authors reported the mean movements per hour
for each subject on each treatment and the grand means
for each treatment were -
(1) Nothing to eat at bedtime 7.89 movements/hour
(2) Carbohydrate snack 8.56 movements/hour
(3) Protein snack 9.00 movements/hour
(4) Fatty snack 8.76 movements/hour
Without any statistical analyses of the results the
authors concluded that more restful sleep is had if
nothing is eaten on going to bed and that a protein rich
snack causes more disturbance than either a fatty or
carbohydrate rich snack. However, all seven subjects
received the four treatments in the same chronological
order and thus seasonal effects cannot be eliminated and
so little notice should be taken of the results.
Later Giddings (1934) reported the results of his
study of the effects of different forms of food on
children's sleep. Body movements were monitored by a
device which was an adaptation of a contact breaker
and this was set up under each bed in two dormitories of
a children's home. Each experiment was carried out over
five consecutive nights and involved six boys and six
girls. The effects on sleep of five different conditions
of bedtime nourishment were studied. He compared the
number of body movements after warm water with the number
after/
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after nothing to eat or drink at bedtime and found no
difference. Similarly, there was no significant effect
owing to cold water at bedtime compared with either
nothing or cold milk at bedtime. Also, a drink of
sweetened orangeade had no significant effects and
neither did a drink containing 0.6g of caffeine.
He reported that after warm milk at bedtime 41.7% of
children were less restless, 8.3% had more movements
and in 50% there was no change. From this he concluded
that "the drinking of 6oz of warm milk at bedtime seems
to produce quiet sleep in normal children". Stripped
of the percentages he had actually found that 5 children
slept better, 1 child slept worse and 6 showed no changes
in body movements after warm milk at bedtime, which is
not very convincing as evidence for the rather bald
statement above.
Giddings also investigated the effects on the number
of movements during the children's sleep of (1) a normal
evening meal of fruit, cereal or eggs and bread, butter
and milk (2) a 'heavy' meal of fruit, meat, vegetables,
a dessert and loz of sweets and (3) a light meal of just
a slice of bread and butter and a glass of milk. Meals
were taken at 1830h and the children retired to bed at
2030h. He found that in 23 out of 24 children motility
was increased after the heavy meal. No significant
difference was found between the normal and the light meal.
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The apparently detrimental effect on sleep of a
•hard to digest1 snack at bedtime was also found by
Laird and Drexel (1934) in their group of eight young
adult men. The quality of sleep was measured by the
number of body movements over an 8h sleeping period.
Body movements were measured by a mechanical system.
Subjects had their sleep monitored nightly over six
to eight weeks. On about one third of the nights no
bedtime snack was given, on another third the 'easy
to digest' snack of milk and cereal was eaten and on
the other third of the nights a 'hard to digest' snack,
rich in hemicellulose was given. The authors do not
mention whether they balanced the order of giving the
three treatments over the eight subjects. They found
that without exception all subjects had their fewest
body movements after a bedtime snack of milk and cereal,
the most after the 'hard to digest' supper whereas the
number of body movements after no bedtime snack was
intermediate between the two.
A similar study in eight children was reported in
the above paper. The children were compared with them¬
selves under three different conditions of evening
intake (1) their usual evening meal (2) an evening meal
based largely on milk and cereal (3) a "hard to digest"
meal made up of foods that were slow to digest, producing
flatulence or were diuretic. The children retired to bed
shortly after their evening meal. Apparently without
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without exception the children were more restless after
the 'hard to digest' meal than after their usual evening
meal and the most peaceful night was achieved after the
milk and cereal meal. It might be that a food containing
a combination of milk and cereal is more likely to
promote restful sleep than other sources of nourishment
and indeed this was also reported by Kleitman et al. (1937)
in their study of sleep after different types of food at
bedtime. The list of foods or drinks taken just prior to
going to bed included: one or two sandwiches, made of
bread and meat or cheese, an 8 oz. glass of hot milk or
cold milk, or hot or cold water and as an example of a
proprietary brand of food drink they tested Ovaltine
dissolved in milk or water (hot or cold). The Ovaltine
was tested at two concentrations of 8 and 14 g per 8 oz
glass in both media and at the two temperatures. Many
hundreds of nights of sleep were recorded in this
experiment to ascertain what type of food (if any) led
to more restful sleep. The restfulness of sleep was
determined by the number of body movements, expressed as
the average motility per hour. Many comparisons were
made but none among hot or cold milk, hot or cold water,
the lower concentration of Ovaltine in either medium at
either temperature or the sandwiches, had any significant
effect on sleep motility when compared with sleep after
the control condition of no bedtime snack. In contrast
the higher concentration of Ovaltine dissolved in hot
milk/
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milk led to significantly less restless sleep than after
the control condition. Analyses of the collective
results after the higher concentration of Ovaltine in
both media and at both temperatures in comparison with
the results after the control condition showed that
there was a significant reduction (p<0.01) in motility
after the Ovaltine-containing drinks. Similarly when
all the results for the higher concentration of Ovaltine
in all media were pooled and compared with the results
collected from all media without Ovaltine added, a
significant reduction (p<0.05) in sleep motility was
attributable to the addition of 14g of Ovaltine to the
media. In addition their statistical analysis showed
that the temperature at which a drink is taken has no
effect on subsequent motility during sleep. Ovaltine
is a food drink powder based on milk and cereal and so
the results of this extensive study again suggest that
a milk and cereal combination promotes more restful sleep
than other forms of nourishment. However, Hamilton et al.
(1966) reported that they found no significant differ¬
ences between sleep motility after a milk and cereal
snack and sleep after nothing to eat at bedtime in 36
male subjects. Their negative results may have arisen
partly because the subjects selected to take part in
the study were nine middle-age men convalescing from
tuberculosis and 27 young monastery students. The
authors/
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authors did not mention if the patients were being
given drugs which might affect their sleep and I
also wonder if, during this convalescent period, they
may well have been sleeping more soundly to aid the
restoration and repair of body tissues lost or damaged
by the disease, and therefore the consumption of a
bedtime snack might have little effect on sleep that was
already sound without any treatment being taken.
The 27 young monastery students also failed to show
any effects on their nocturnal motility when the milk
and cereal snack was taken at bedtime. Young men on
average, sleep so well that there is little room for
improvement and this may be the reason for the lack of
effect of the snack. It may also be a matter of habit
and taking a snack at bedtime may not be the normal
pattern in a monastery.
Southwell et al. (1972) also studied the effect on
sleep of a milk and cereal food drink (Horlicks) made
up in warm milk compared with nothing to eat or 350ml
of warm water prior to retiring to bed. Sleep quality
was assessed by the number of body movements. The
sleeper was filmed by time-lapse cinematography, where
a frame was taken automatically every 15 seconds. Body
movements were categorized into large and small from the
sequence of frames taken of the sleeper. Subjects were
allowed/
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allowed to sleep under the experimental conditions
several times before the results were recorded on two
nights for each treatment, in balanced order. There
were only four subjects and so the study can only be
regarded as a preliminary report. The whole night
(1 a.m. to 7 a.m.) results show no convincing
difference in the rate of occurrence of large body
movements among the three treatments, however they did
suggest that Horlicks was associated with a progressive
decline in the rate of small body movements, whereas
both water or nothing to drink at bedtime led to a
progressive increase in the rate of small body movements
as the night wore on. All that can be concluded from
this study is that there is a suggestion that food in
the form of milk and cereal, such as Horlicks, may be
better than nothing to eat in reducing the number of
small body movements through the night. The major
disadvantage of using body movements alone as an index
of the restfulness of sleep is that the method cannot
discriminate between movements made while asleep and
V /
those occurrxng when a subject is awake. Brezinova and
Oswald (1972) measured body movements during the night
in a group of ten young volunteers and at the same time
recorded their sleep electrophysiologically and so were
able to exclude body movements during wakefulness from
the/
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the analysis. The experiment compared the effects of
the milk and cereal food drink Horlicks made up in
milk with the effects on sleep of an inert yellow
capsule. After adaptation on two nights to the
laboratory situation, subjects' sleep was actually
recorded on eight nights each: four nights when the
food drink was taken and four nights when the placebo
was taken prior to retiring to bed. Treatment order
was balanced across the eight nights. In their group
of young subjects they found that the number of body
movements in the last three hours of sleep completed
by each individual (excluding periods of wakefulness)
were fewer after Horlicks at bedtime than after the
placebo and this approached statistical significance
(p<(0.C55). No other features of sleep in these young
subjects were found to be significantly different.
In contrast, when the same experiment was repeated in
a group of middle-aged subjects, significant differences
in their sleep were found when the nights when Horlicks
had been taken at bedtime were compared with the nights
on the inert capsule. The authors found that sleep was
of longer total duration and less broken by periods of
wakefulness after the food drink. The beneficial




To summarize these various studies into the effects
of bedtime nutrition on sleep it appears that the
general consensus of opinion would be that food taken at
bedtime composed of milk and cereal would favour a more
restful night than would nothing to eat, or other forms
of nourishment. These are, however, tentative
conclusions, as not all the studies referred to comfirm
them. In addition it would appear from the Giddings
(1934) and the Laird and Drexel (1934) studies that
eating food which was relatively hard to digest would
have a detrimental effect and make sleep more restless.
It certainly appears that the consumption of food,
shortly before retiring to bed, can exert an effect on
the quality of subsequent sleep and so it is not
surprising that altering the composition of the entire
daily intake of food also appears to influence sleep.
(e) Evidence that the specific composition of the diet
influences sleep.
Relationships between nutritional status and sleep
have been commented on above, e.g. chronic undernutrition
as seen in anorexia nervosa patients (Crisp et al.,L971;
Lacey et al.,1975) or acute starvation imposed experiment¬
ally (MacFadyen et al.,1973) both alter the pattern of
sleep. These studies, and others, were primarily
investigating/
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investigating the effects of either long or short term
food deprivation (and associated loss of body mass)
and thus a stressful situation for the organism. In
the previous section the experimental evidence
presented suggested that varying the composition of a
meal taken prior to sleep could alter the number of
body movements through the night implying that the
restful quality of sleep could be influenced, but no
indication of any changes in the composition of sleep
in terms of the electrophysiological stages of sleep
1,2,3,4 and REM sleep could be measured. If sleep
were frequently disrupted, say, by periods of waking,
and the total duration of sleep shortened, say, by
gastric discomfort then it can be assumed that the
pattern of sleep would be disrupted, as repeated
interruptions of sleep are known to lower the percentage
of the total time asleep which is spent in slow wave
(stages 3 and 4) or REM sleep. Recent evidence suggests
that the duration and composition of sleep can be
influenced by the composition of the daily diet even
when the energy intake remains the same.
Fara et al. (1969) found that it was, specifically,
the introduction of fat into the duodenum of drowsy cats
that led to the transition into slow wave sleep and
subsequent augmentation of the amount and frequency of
REM/
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REM sleep. They failed to find these effects with
solutions of glucose, lactose or casein. The energy
values of the different types of nourishment '.vere not
specified, which contrasts with the study reported by
Dallaire and Ruckebusch (1974) where they investigated
the effects, on the sleep of three ponies, of two
different conditions of nutritional intake (hay v, oats)
of approximately equal energy value. Sleep was recorded
electrophysiologically on three consecutive nights on
each diet. The three ponies were normally maintained on
a water and hay schedule and all were first recorded
under this dietary regime and this constituted their
baseline sleep pattern. Afiter adaptation to the diet
of oats, the ponies' sleep was recorded. It was found
that when oats were substituted for hay the amount of
time spent asleep between 1830h and 0630h increased and
this increase was in both slow wave and REM sleep. The
diets were not administered in balanced order, but the
authors do not think that this unbalanced design
contributed substantially to their results as over a
week elapsed between the recording periods. They
propose a number of possible explanations for these
changes. One possibility advanced was that the cellulose
content of oats (10%) is lower than that of hay (34%)
and the visceral information to the brain may be reduced
when oats are eaten, and so activation of the reticular
formation is reduced and sleep is more likely.
Moreover,/
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Moreover, less time is spent feeding under the oats
regime and so sensory input is decreased. Finally
they suggest that oats may stimulate the secretion
of gastrointestinal hormones more than hay, because
of the relatively higher concentration of amino acids
liberated during digestion. The facilitation of
sleep by gastrointestinal hormones has been suggested
(e.g. Fara et al. 1969). I will leave the discussion
of the possible explanations of the effects of
nutrition on sleep to section V of this Chapter.
Another study (Phillips et al.}1975), which
investigated the effects of altering the composition of
the diet on electrophysiologically-recorded sleep, used
eight young men as subjects and diets which were more
strictly iso-energetic than the study above. Three
diets were compared (1) a 'normal balanced' diet;
(2) a high carbohydrate, low fat diet and (3) a low
carbohydrate, high fat diet. The amount of protein
(75g) was the same in all diets. The experimental design
involved two blocks of four consecutive days separated
by two weeks. On days 1 and 2 of each block subjects
were fed the normal diet (1). Their sleep was recorded
electrophysiologically on nights 1 and 2 but only the
second night's results were used in the anlysis, the
first serving as a laboratory adaptation night. During
days/
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days 3 and 4 one of the experimental diets was fed and
on nights 3 and 4 sleep recordings were made. The
order of receiving the experimental diets (2) and (3)
was balanced over the eight subjects.
Experimental design (Phillips et al,, 1975)
Consecutive days 1 2 34
Normal diet Experimental Diet
Recordings Adaptation First night Second Third
night recorded
Two weeks later the above was repeated with subjects
eating the experimental diet (2) or (3) that they had
not had in the first part of the experiment. This study
design may be criticised in that the order of receiving
the experimental diets was balanced but this was not
so for the normal diet and hence any conclusions drawn
from the comparisons between the control diet and either
of the experimental diets must be viewed with caution.
In addition the sleep patterns recorded on the nights
after either of the experimental diets may have been
contaminated by adaptation effects carried over from the
first night spent at the sleep laboratory. The amount
of REM sleep is particularly likely to be reduced on
the first night under laboratory conditions and the
rebound increase in REM sleep occurs a night or two
later and so with the experimental design above any




on the second night actually recorded, namely the first
night recorded on either experimental diet. Thus the
increase in REM sleep found with both experimental diets
may be largely attributable to rebound effects. However,
these effects can probably be assumed to affect the
recordings on both experimental diets equally and so
comparisons between these two diets (2) and (3) are of
interest. The low carbohydrate, high fat diet (3) was
associated with significantly more slow wave sleep and
significantly less REM sleep than the high carbohydrate,
low fat diet (2) but the total time spent asleep did
not differ. These results suggest that changing the
carbohydrateifat ratio in the diet can alter the
proportion of sleep which is spent in slow wave and REM
sleep.
An indication that the amount of protein in the
diet can influence sleep is suggested by a report by
Ruckebusch and Gaujoux (1976b) who increased the dietary
nitrogen intake of two sheep by adding urea into the
rumen. The sheep were recorded polygraphically for over
two months. At variable intervals through this period
the nitrogen supplement was given for a number of days.
The authors found that when the diet was supplemented
with extra nitrogen (but not extra energy) the amount
of both NREM and REM sleep duration was increased in
the/
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the recording period (2000h to 0800h). Whether this
effect would operate in non-ruminants is, as yet, an
unanswered question.
No consistent pattern of effects of dietary
composition can be seen from these few reports and it
is difficult to compare studies which have used
different types of animals. It does, however, appear
that manipulation of the basic composition of the diet
within the normal range can alter the duration and/or
the amounts of REM and NREM sleep.
A further link between nutrition and sleep can
be seen in reports that manipulation of the amount
or the composition of the diet can modify the secretion
of at least two of the sleep-dependent hormones.
(II) EVIDENCE THAT NUTRITIONAL STATUS INFLUENCES THE
SECRETION OF SLEEP DEPENDENT HORMONES
Feeding patterns, metabolism and the endocrines are
intimately inter-related and so it is not surprising
that alterations in food intake can influence the
secretion of sleep-dependent hormones. The following
examples are from experiments carried out in man.
Lipman et al. (1972) reported that the nocturnal
elevation of plasma free fatty acids by corn-oil
ingestion was associated with an inhibition of the
sleep-dependent secretion of growth hormone. The
subjects/
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subjects were four non-obese young men. Their sleep
was recorded electrophysiologically using standard
techniques. A cannula was inserted into an arm vein
and blood samples were taken at 20 min intervals
beginning at 2300h and until one hour after the first
period of slow wave sleep. During the period of slow
wave sleep blood was sampled at 10 min intervals.
Subjects slept under these conditions on two nights,
the first served as a control night and on the second
they drank 90 ml of corn oil at 2100h and subsequently,
when their EEG showed delta activity indicating a
progression into slow wave sleep they had an I.V.
injection of 50 mg of heparin. The authors analyzed
plasma free fatty acids (FFA) and growth hormone (GH)
and found that on the control night the mean peak
level of FFA during SWS was 500uEq/l, but 2154uEq/l
during the experimental night. The mean peak in growth
hormone levels was 29.4 ng/ml on the control night and
only 2.3 ng/ml on the night when the corn oil had been
taken. Unfortunately, the control and experimental
nights were not balanced for order and we are not told
how many (if any) nights intervened between the two
recorded nights. The design appears not to have
included an adaptation night to the laboratory, which
is even more desirable when subjects have to adapt to
both/
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both the paraphernalia involved in the electrophysio¬
logical recording of sleep and having a cannula in a
vein. Nevertheless there was a considerable reduction
in the peak level of GH in all foiir subjects and the
results suggest that the sleep-related secretion of
GH can be dissociated from the electrical events by
inducing elevations in FFAs by a food. It would be
interesting to repeat this experiment but continue
blood sampling throughout the night to see if the GH
peak had been actually suppressed or merely delayed
until later in the night.
Another connection between nutritional status
and sleep-related GH release was reported by Karacan
et al. (1973) who found that acute starvation lasting
two days (and two nights) led to a significant elevation
in mean peak GH level over baseline levels in a group
of 11 young males. The mean baseline (fed) peak GH
level was 7.4 ng/ml whereas during the second night
of fasting the level was 15.8 ng/ml. Similarly when
the mean areas under the curves plotting GH level
against time were integrated, the mean area on the
night of fasting was significantly greater than on the
baseline night. The period of fasting was not only
associated with an alteration in the amount of sleep
dependent GH secretion but the number of minutes of
slow/
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slow wave sleep (SWS) was also increased during the
period of starvation. The nocturnal secretion of GH
is particularly associated with SWS (Sassin et al.,
1969a) and this too has been shown to be influenced
by starvation. MacFadyen et al. (1973) carried out
a more extensive study of the effect of acute
starvation on sleep in ten young men. After two
adaptation nights in the laboratory, subjects had their
sleep recorded on four consecutive nights to establish
their baseline sleep patterns when they were eating
normally. During the following four days they were
starved and their sleep recorded each night, thereafter
they were allowed to eat normally again and their sleep
was recorded on the four consecutive nights after
ceasing to be starved. During the starvation period
the mean amount of slow wave sleep (stages 3+4) was
significantly raised relative to the period of feeding
before and after starvation.
Prolactin is another hormone the nocturnal secretion
of which has been found to be dependent on sleep (Sassin
et al., 1973) but not associated with any particular
electrophysiologically-determined stage of sleep.
Recently Hill and Wynder (1976) showed that the source
of nourishment in the diet can modify the nocturnal
prolactin release. Four young women, who normally
consumed a typical Western diet, had their blood sampled
at/
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at regular intervals through the night (2200h to 0900h).
Thereafter they transferred to a vegetarian diet and
after two weeks had their blood sampled overnight.
Changing to the vegetarian diet and so removing meat
from the diet appeared to reduce the nocturnal secretion
of prolactin. Although this was obviously only a pilot
study, it points to yet another connection between diet
and sleep.
Obesity can be seen in simple terms as the net
result of a pattern of eating where energy has been
consumed in excess of that expended and the excess
stored as adipose tissue. In people of normal body
weight stimuli such as fasting (Beck et al., 1964), the
injection of insulin (Roth et al., 1963) or an infusion
of arginine (Burday et al., 1968) provokes a greater
rise in plasma hormone level than in obese patients.
This difference between people of normal weight and
those who are obese is thought to be an adaptation to
obesity rather than a cause, because weight gain in
normal volunteers can reproduce the effect (Sims and Horton,
1968) and weight loss in obese patients can reverse the
suppression (Lessof et al., 1966} Londono et al., 1969).
Obesity also suppresses the sleep-dependent secretion of
growth hormone (Kalucy et al., 1976) and it could be
predicted that weight loss would restore the normal
relationship/
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relationship between sleep and nocturnal growth hormone
secretion. Obesity is associated with elevated free
fatty acids and so the suppression of growth hormone
secretion in obese people may be because of the higher
levels of free fatty acids. Lipman et al. (1972) found
that raising the free fatty acids in people of normal
weight suppressed their nocturnal growth hormone
secretion. Growth hormone is a lipolylic hormone,
which raises the level of free fatty acids and so the
level of free fatty acids in the plasma could be part
of a negative feedback mechanism to modify growth
hormone secretion rate.
Finally, there is some evidence that suggests that
growth hormone may influence the amount of REM sleep.
In cats I.P. injection of bovine growth hormone during
sleep was associated with an elevation of the amount of
REM sleep relative to baseline levels in the 3h follow¬
ing the injection. Injection of saline, or thyrotropin
did not change the sleep pattern in comparison with the
baseline recording (Stern et al., 1975). Similarly,
Drucker-Colin et al. (1975b) injected growth hormone
into rats and found an increase in the amount of REM
sleep. Oswald et al. (1975) studied the effect of
injecting 5mg of human growth hormone into ten young
human volunteers while they were asleep and found no
difference/
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difference in the amounts of any of the sleep stages
on the nights when growth hormone had been injected
compared with those when only saline had been injected.
However, for ethical reasons the dose of growth hormone
we injected was small in contrast to the high doses
injected in the studies done in animals.
This section has been rather a pot pourri of
examples where alterations in nutritional status have
had effects on the secretion of sleep-dependent hormones
and a hint that these hormones may in turn influence
sleep, thus giving more evidence for the view that eating
and sleeping are interrelated.
The evidence presented in the preceding sections
strongly suggests that nutritional status can influence
both the pattern of sleep and/or the secretion of sleep
dependent hormones and so it would be no surprise to
find that changes in sleep can influence food intake.
(Ill )EVIDENCE THAT SLEEP CAN INFLUENCE FOOD INTAKE
Spontaneous feeding is dependent on many factors
such as the eating habits, nutritional status, hormonal
balance, energy metabolism and the psychological state
of the animal. In Chapter 1, I outlined how these
factors are inextricably related to the circadian rhythm
of sleeping and waking and so if changes in the pattern
of/
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of sleeping can modify metabolism then it is almost
inevitable that feeding should also be influenced.
In endocrinology, it is common to speculate about
the functions of a gland from the changes following
its removal. By analogy, the effects of sleep
deprivation are thought to indicate some of the
functions of sleep. As I indicated in Chapter 1 sleep
deprivation does seem to disturb metabolism and in gen¬
eral terms shift the metabolic balance in favour of
catabolic processes, which must, inevitable influence
the energy and nutritional balance and so presumably
subsequent food intake. Many years ago Manceau and
Yorda (1948, cited in Kleitman, 1963)induced continuous
wakefulness, in guinea-pigs, by injury at the level of
the preoptic and suprachiasmic zones. Most animals
died by the third day, but one survived for 26 days.
The interesting thing about this constantly awake animal
was that it lost weight despite an increased food intake.
This is obviously a rather extreme example but it does
link lack of sleep with food intake. A less dramatic
manipulation of sleep was carried out by Dement et al.
(1967), who deprived cats of REM sleep. The animals
were deprived of REM sleep by placing them either on a
platform in a watertank (the size of the platform was
such that the muscle relaxation associated with REM
sleep/
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sleep caused them to fall into the water) or by keeping the
cats on a slow-moving treadmill for 18 to 22h. For the re¬
maining 2 to 4h of the day the cats were recorded electro-
physiologically and allowed to sleep but were awakened
every time the recording showed an appearance of REM sleep.
The authors found that the *drive* to eat was enhanced
after REM deprivation in that, when hungry, the cats ate
faster, would more readily enter water to obtain food or
attempt to eat food in which a sparkler was burning than
they did when allowed to sleep normally. REM sleep
deprivation also increased the amount of food eaten.
However, REM sleep deprivation may be stressful (Mendleson
et al., 1973) and so it could be said that the effects on
food intake were non-specific. Evidence that REM sleep
may in fact be related to food intake comes from a study
of the patterns of sleep and spontaneous feeding in cats
(Siegel, 1975). He found that the amount of REM sleep in
a 12h period was an accurate predictor of the amount of
food eaten in the subsequent 12h period. The correlation
between min of REM sleep and amount of food eaten was
negative and so this finding is compatible with those of
Dement et al. (1967) in that it would be predicted that
REM deprivation would be associated with increased food
intake. Later in this thesis I shall present data linking
human REM sleep and body weight.
Finally, further evidence for a link between
nutritional status and sleep comes from a variety of
pathological/
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pathological conditions where a disorder of feeding is
associated with an abnormal pattern of sleep.
(IV) SOME EXAMPLES OF DISORDERS OF FEEDING
ASSOCIATED WITH DISORDERS OF SLEEP
Throughout the literature there are reports of
patients who have experienced episodes lasting days
or weeks where sleep filled most of the 24h of the
day. During brief periods of awakening the patients
would eat excessively. Critchley and Hoffman (1942)
named this the "Kleine-Levin" syndrome in deference to
two of the authors who were among the first to report
cases of excessive sleep associated with over-eating
(Kleine, 1925; Levin, 1936). Later Critchley (1962)
described this syndrome as "recurring episodes of
undue sleepiness lasting several days associated with
an inordinate intake of food". The patients often
apparently appear quite normal between attacks and are
not always overweight. The latter is in contrast to
the so called Pickwickian syndrome which in most, but
not all patients, is characterized by an extreme degree
of over eating and consequent gross obesity (Burwell
et al., 1956). The patients suffer impaired respiration
owing to the excessive amounts of adipose tissue and
oro-pharyngeal spasm during sleep and during the day
they tend to repeatedly fall asleep. The nocturnal
sleep pattern is one of frequent apneic periods
terminated by irregular snorts, with the EEG then show¬
ing the appearance of arousal, and consequently their
sleep/
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sleep pattern is abnormal with most of the night spent
in stages 1 and 2, with reduced amounts of slow wave
and paradoxical sleep. Weight loss does sometimes
improve the situation.
Idiopathic narcolepsy is a condition where patients
have recurrent attacks of overwhelming sleepiness
through the day. Patients are particularly vulnerable
when bored and the environment monotonous. The periods
of daytime sleep are usually relatively brief lasting
some 10 to 15 min. The striking characteristic of this
syndrome is that they rapidly pass into REM sleep
following sleep onset (Rechtschaffen et al., 1963),
which is not a feature of normal sleep where the appear¬
ance of REM sleep is delayed for about an hour following
sleep onset.
The first narcoleptic attack in a patient can often
be associated in time with a recent gain in body weight
and so this syndrome may also be related to alterations
in feeding pattern and/or metabolism.
Excessive post-prandial drowsiness and sleep
attacks during meals have been reported (e.g. Zarcone,
1973). Bell et al. (1975) surveyed the diet histories
of their narcoleptic patients and found a higher
incidence of unusual eating patterns and cravings for
specific foods than in a group of normals. Significant
differences/
- 76 -
differences of interest between their narcoleptics and
normals were: the high incidence of frequent, post¬
prandial sleepiness, the eating of both daytime and
bedtime snacks, eating during the night and a craving
for sweets and milk. Also of interest was that the
narcoleptic group were significantly heavier than the
ideal maximum body weight for their height than the
group of normals.
The three broadly defined syndromes referred to
above have the common feature that pathological
sleepiness is associated (in many of the cases), with
eating to excess and frequently with obesity as well.
The converse situation is seen in anorexia nervosa
patients at the times when they are chronically under¬
nourished and severely underweight. Crisp (1967) drew
attention to the poor sleep of these patients and
suggested that their insomnia was not a symptom of
anxiety but was largely due to the nutritional disturb¬
ance. The poor sleep was particularly in the later
night and awaking very early in the morning was common.
Subsequent research suggested that restoration of body
mass was the main factor associated with improvement in
sleep and not changes in mood (Crisp and Stonehill,
1970). In a further report changes in subjective
ratings of sleep, measured nocturnal motility,
psychiatric status and body weight, were measured before
and/
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and after refeeding ten anorexia nervosa patients
(Crisp and Stonehill, 1971). Analysis of the results
showed that treatment led to a statistically significant
increase in body weight and that the patients' assess¬
ment of sleep duration was significantly greater.
There was a tendency for sleep to be rated as less
broken, for the delay to sleep onset to be shorter and
for the final awakening in the morning to be estimated
as later. Nocturnal motility was found to be
significantly reduced after weight gain. Correlational
analysis, among the variables measured, showed that
weight gain was significantly associated with a later
time for awakening in the morning. Changes in weight
or the various measures of sleep did not correlate
significantly with the changes in the M.H.Q. (Middlesex
Hospital Questionnaire) or E.P.I. (Eysenck Personality
Index) scores used to assess psychiatric status before
and after treatment.
In another report Crisp et al. (1971) studied the
sleep of anorexia nervosa patients before and after
treatment, but this time sleep was recorded electro-
physiologically. They found that after refeeding for
six to 12 weeks the time spent awake or in a drowsy
state through the night was significantly reduced.
More recently, from the same laboratory, another study
was reported which further confirmed that improvement
in/
- 78 -
in sleep in anorexia nervosa patients was closely
related to restoration of body weight (Lacey et al.,
1975). So there seems to be little doubt that it is
change in nutritional status and associated alterations
in body weight that are primarily responsible for the
changes in sleep seen in these patients.
To summarize this section it certainly appears that
there are pathological conditions in which patterns of
sleep are related to nutritional status, such that over¬
eating and or overweight are associated with increased
amounts of sleep and that the severe weight loss and
undernutrition of anorexia nervosa patients are
associated with sleep that is fragmented and of shorter
duration.
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(V) HOW CAN FEEDING INFLUENCE SLEEP?
I have presented evidence that, at least in animals,
hunger is associated with motor restlessness. Lack of
food, however, cannot be separated from weight loss when
it is prolonged over days, and chronic weight loss in
humans and animals reduces the time spent asleep. On
the other hand, feeding seems to have a sedating action
and weight gain is associated with an increase in the
amount of sleep.
In this section I will put forward a number of
possible explanations for the sedating effect of food
intake and although they are put under separate headings
this does not imply that they are mutually exclusive.
The ingestion of any food is likely to initiate multiple
and interacting effects on the central nervous system by
several routes, including (a) direct neural connections
between the gut and the brain (b) stimulate the release
of hormones such as insulin and the apparently neuro-
active gastrointestinal hormones such as cholecystokinin
and (c) supply percursors for neurotransmitter synthesis.
(a) Direct neural connections between gut and brain.
Experiments in animals have shown that feeding is
associated with synchronization and increasedvoltage in
the electroencephalogram and that these changes are very
rapid and are functionally indicative of decreased
arousal,/
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arousal, higher states of arousal being associated with
low voltage and desynchronized electrical brain rhythms.
Hockman (1964) reported that the electrocorticogram of
fasted rats had a predominance of low voltage, high
frequency activity, whereas fed animals showed a marked
increase in high voltage slow waves. Food consumption
in cats was also found to be associated with high
voltage electrocortical activity (Hess et al., 1953;
Anokhin, 1961). Sterman et al. (1963) trained cats to
press a lever to obtain a reward of a small amount of
liquid food. In cats deprived of food obtaining the
reward was simultaneously associated with a synchroniz¬
ation of dftc-BSG.Later, Sterman and Wyrwicka (1967) and
Marcynzynski et al. (1968) obtained similar results.
In the latter experiment food-deprived cats, implanted
with electrodes in the cortex, had to press a lever to
obtain a reward of milk. During the consumption of the
reward their electrocorticogram displayed bursts of
relatively large amplitude spindle activity in the
parieto-occipital region. The authors reported that
this post-reinforcement synchronization was
indistinguishable from sleep-spindle electrocortical
activity recorded from the same area in satiated cats
and they concluded that there is a functional overlap
between reward centres and hypnogenic (synchronizing)
influences. They interpret their results in terms of
appetite/
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appetite gratification similar to other consummatory
activities such as copulation which in rabbits has been
shown to produce electrocortical synchronization
(Sawyer and Kawakami, 1959) and so presumably the
mechanism involves a direct neural connection.
Rosen et al. (1971) compared the electrocortico-
gram of rats deprived of food for 22h with that of
rats allowed to eat after a comparable period of food
deprivation. They found that satiated rats had more
high voltage, slow waves in their electrocorticogram
than the hungry rats and that transfusion of blood
from a satiated rat to a fasted rat led to electro-
cortical synchronization, the latter suggesting that a
humoral factor is also involved.
Rats appear to be able rapidly to recognize that
nourishment has entered the upper gastrointestinal
tract (Puerto et al., 1976). This was shown by an
experiment where rats were given a choice of two
differently-flavoured non-nutrient drinks. As an
animal drank one of the flavoured liquids, a nourishing
liquid was pumped into its stomach through an implanted
tube, but when the rat drank the other liquid no
nutrient was injected. The rats were found rapidly to
choose (within 10 min) the flavoured drink paired with
nourishment, but only when the nourishment was in the
form/
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form of pre-digested milk. Saline, fresh milk, glucose
or glucose plus digestive juice did not have that
effect, suggesting that stomach distention alone was
not responsible for the effect. The rapidity of the
effect and specificity for pre-digested milk rather
precludes the likelihood of a raised blood level of an
absorbed nutrient being the signal, and points to either
a direct neural link between the gut and the brain, or
the rapid secretion of a gastrointestinal hormone which
then acts on the central nervous system.
It would appear from the evidence presented in the
section above that the very rapid electrocortical
synchronization seen in food-deprived cats when they
receive a food reward must involve a neural connection
between the digestive track and the brain or it could
conceivable involve the sensory organs. The blood
transfusion experimerrt^where rats appeared specifically
to recognize when pre-digested milk had been injected
into the stomach, both point to a change in the blood
level of a humoral factor influencing the central nervous
system.
(b) Release of neuroactive gastrointestinal hormones.
The gut is an endocrine organ and its hormones have
multiple effects. These hormones include gastrin,
secretin,/
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secretin, cholecystokinin» bradykinin and enteicglucagon.
At present cholecystokinin is the hormone most clearly
implicated in the sedating effect of food.
Fara et al. (1969) found that intraduodenal fat
had a sedating effect on the EEG pattern of cats and
because fat in the duodenum releasescholecystokinin
(CCK) they tested the effect of intravenous infusion
of CCK. Infusion into awake but drowsy cats induced
high-voltage sleep suggesting that the sedating effect
of fat was, at least in part, mediated by CCK. A
further experiment (Rubinstein and Sonnenschien, 1971)
involved infusions of CCK and secretin (another hormone
the release of which is stimulated by intraduodenal
fat). From the text of this paper it is not clear what
had been found but in a later publication Rubinstein
(1972) said that in the 1971 report they had found that
during the one-hour infusion of the intestinal hormones,
especially CCK, there were long-lasting episodes of
slow wave and REM sleep. There is, however, no
indication if this is more or less than the normal for
the time of day when the recording was made. The
possibility that gastrointestinal hormones do play a




(c) Supplying precursors for neurotransmitter synthesis
Brain serotonergic (5HT) neurones have been
implicated in the mechanisms underlying sleep (e.g.
Jouvet, 1967) and 5HT raay also antagonize the systems
promoting walking (Koella and Czicman, 1966), It is
thus of great interest that the levels and synthesis of
serotonin in the mammalian brain have been shown to
depend on the availability of the precursor amino acid
1-tryptophan and so depend ultimately on the diet.
Experiments have shown that the brains of rats
chronically fed tryptophan-deficient diets contained
much less serotonin than normally fed animals (Gal and
Drewes, 1962),however deficiency of any essential amino
acid cam inhibit protein synthesis and so the lowered
levels of serotonin found could have been due to
reduced levels of the enzymes in the serotonin
synthetic pathway. Other studies found that feeding
amimals normal diets supplemented with tryptophan
raised brain serotonin levels (Green et al.f 1962)
and so taken together these experiments suggested that
the diet could influence brain serotonin levels.
A great deal of subsequent research was undertaken
to elucidate by what mechanism changes in the diet
could influence brain serotonin levels.
Changes/
- 85 -
Changes in brain tryptophan were shown to modify
the rate of brain serotonin synthesis (Jequier et al.,
1967). The locus of control was found to be the first
step in the metabolic pathway between tryptophan and
serotonin, namely the hydroxylation of tryptophan.
Evidence suggests that it is precursor availability
and not end-product inhibition which modifies the
activity of tryptophan hydroxylase. In vitro studies
of this enzyme have shown that physiological levels of
serotonin do not appear to suppress its activity
(Jacoby et al., 19751). The possibility that precursor
availability might be the important factor was
suggested by finding that the Km of the enzyme tryptophan
hydroxylase for tryptophan was 3 x 10~4M (Jequier et al.,
1969) which is considerably greater than the tryptophan
—5
concentration in whole brain: 2 to 5 x 10 M (Fernstasom
and Wurtman, 1971a). This rather large difference
between the Km and the brain concentration would hardly
allow fine control of hydroxylase activity so the Km of
-5
5 x 10 M calculated using the enzymes natural cofactor
biopterin seems more likely (Kaufman, 1974).
Nevertheless with either Km tryptophan hydroxylase is
not normally saturated with its substrate in vivo.
Thus fluctuations in brain tryptophan level can alter
the degree of saturation, consequently the rate of
tryptophan hydroxylation and so the rate of serotonin
synthesis./
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synthesis. From the point of view of feeding
influencing brain serotonin, having established that
the rate of brain serotonin synthesis is vulnerable
to changes in brain tryptophan concentration, the next
question is how can plasma levels of tryptophan
influence brain levels of tryptophan?
The investigation of this question has been
actively pursued over the years and a number of
interesting points have arisen:
r
(1) The level of brain -tryptophan (and so brain
serotonin) depends on the plasma level of tryptophan.
This was shown by injecting rats with physiological
amounts of tryptophan (Fernstrom and Wurtman, 1971a).
(2) A high protein diet was found to raise plasma
tryptophan levels but paradoxically brain tryptophan and
serotonin levels were unaffected (Fernstrom et al., 1973).
It was realized that the plasma tryptophan level alone
is no-t a reliable indicator of brain levels, but instead
it is the ratio of the plasma tryptophan level to that
of the other neutral amino acids which compete with
tryptophan for the common transport carrier across the
blood-brain barrier (Fernstrom and Wurtman, 1972} Perez-
Cruet et al., 1974).
(3) Injection of insulin into fasted rats rapidly
elevated plasma tryptophan, brain tryptophan and sero¬
tonin/
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serotonin (Fernstrom and Wurtman, 1971b). In humans
plasma tryptophan is little affected following an
injection of insulin (Lipsett et al., 1973) however the
level of the competing amino acids falls (Wurtman, 1970)
and so the plasma level of tryptophan rises in relation
to the level of the other neutral amino acids in plasma
and so presumably brain tryptophan is elevated.
(4) Rats fasted overnight and then fed with only
carbohydrate and fat were found to have elevated plasma
tryptophan, brain tryptophan and serotonin levels when
compared with fasted controls (Fernstrom and Wurtman,
1971b) and the carbohydrate-induced elevation of brain
serotonin was later shown to be due to an increased rate
of serotonin synthesis (Colmenares et al., 1975).
While the evidence above clearly demonstrates that
the composition of the diet can modify brain tryptophan
and serotonin levels it does not establish whether
there are corresponding changes in the amounts of the
amine released into synapses. In other words, can
behaviour such as sleeping, sexual activity, pain
sensitivity and feeding, which are thought to depend
on serotonergic neurones, be changed by dietary
manipulation? There is a little evidence that some of
these behaviours can be modified.
Corn is deficient in tryptophan and rats fed on
it have been shown to have lowered levels of brain
tryptophan/
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tryptophan and serotonin when compared with well-
nourished rats (Fernstrom and Wurtman, 1971c). The
brain serotonin level of corn-fed rats could be
restored to normal by injection of 1-tryptophan
(Fernstrom and Hirsch, 1975). It has been found that
the pain sensitivity threshhold of the well-nourished
rats was higher than the corn-fed rats, a difference
that could be reversed by tryptophan supplementation
of the deficient diet or by transferring the corn-fed
rats to a casein diet (lytie et al., 1975, Messing
et al., 1976).
A few studies have investigated the effects of
oral tryptophan in humans. Oswald et al. (1964)
reported that it reduced the latency to the first
appearance of REM sleep and Hartmann et al. (1974) have
claimed that subjects fall asleep more quickly after
tryptophan (administered in a milk shake!) given 20 min
before retiring to bed. It has also been suggested
(Wyatt et al., 1970) that tryptophan can enhance total
sleep time by increasing non REM sleep. So it seems
that there is, as yet, no clear picture as to what
effect tryptophan has on sleep.
In this Section V, I have put forward a variety
of mechanisms whereby feeding could have a sedative
effect. These proposed mechanisms are not mutually
exclusive/
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exclusive and would undoubtedly interact, e.g. the
gastrointestinal hormones CCK, secretin and glucagon
are known to stimulate insulin secretion which in
turn can influence brain tryptophan levels. In
addition the operation of any of these mechanisms
will depend on the rhythms that pervade life.
Virtually every physiological, psychological and
biochemical function investigated has shown rhythmicity
e.g. the effectiveness and toxicity of a drug can be
modified by the time of the 24h when it is administered
(Walker, 1974). The circadian fluctuations in the
levels of biogenic amines (Friedman and Walker, 1968)
and the activity of hepatic enzymes metabolizing drugs
(Nair et al., 1970; Chedid and Nair, 1972) must play a
part in this.
Plasma amino acid levels are subject to 24h rhythms
(Wurtman, 1970) and the fate of ingested tryptophan
depends on whether it is taken at 9 a.m. or 9 p.m.
(Rapoport and Beisel, 1968). Pain sensitivity (Reinberg
et al., 1967) and the level of cortical arousal
similarly exhibit rhythms (Lavie et al., 1975).
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AN INVESTIGATION INTO THE EFFECTS OF A PLACEBO. OF
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Ten middle-aged subjects had their sleep recorded
electrophysiological^ before, during and after taking
Horlicks nightly for ten weeks and before, during and
after taking nitrazepam 5mg nightly for ten weeks.
Nitrazepam significantly improved sleep
throughout the period of administration, whereas
Horlicks at bedtime had no effect on sleep.
A comparison between sleep after a placebo pill




In a study comparing sleep after an inert capsule
with sleep after a hot, milk cereal food drink
(Horlicks) B^ezinova and Oswald (1972) found that the
food drink at bedtime was associated with sleep of
longer total duration and with less interruption by
periods of wakefulness, in a group of eight middle-
aged volunteers. They also reported that the
improvement in sleep associated with the food drink
was most obvious in the second half of the night and
that the beneficial effects increased over repeated
administration.
The effects of Horlicks on sleep were deemed
weak, by these investigators, in comparison with those
found with hypnotic drugs, however, hypnotic drugs
often become less effective when taken for long periods
of time and their withdrawal can lead to considerable
disruption of sleep for many nights. Horlicks had been
found to become more effective with serial administr¬
ation and the authors speculated that Horlicks might be
comparable to an hypnotic drug in efficacy in long-term
use.
Nitrazepam is one of the most commonly prescribed
hypnotics and it was selected to test the speculation
that with chronic use the bedtime food drink would
become/
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become more effective in improving sleep and that
nitrazepam would become less effective with long-
term use.
In addition, a study to investigate the power
of suggestion associated with a placebo treatment
was incorporated into the experimental design,
because of the criticism (Iverson and Mackay, 1972)
that the effectiveness of Horlicks in improving
sleep could be largely attributable to a placebo
effect, the suggestion of sleep-promoting properties
associated with Horlicks through advertisements.
For reasons which I hope will become clear when
the results are seen, I have divided the presentation
of the experiment into five parts. First, a general
description of the experimental method, and thereafter
treating the investigations into the effects of a
placebo, Horlicks and nitrazepam as three separate
reports and finally an overview of the entire
experiment.
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PART (I): GENERAL DESCRIPTION OF EXPERIMENT
(a) Subjects and Experimental Design
Ten volunteers took part in this cross-over study
between the food drink, Horlicks and the benzodiazepine,
nitrazepam 5mg. There were six women and four men of
mean age 57y (range 41-62y). They had taken no drugs
in the preceding months and were asked not to take any
drugs other than those given by us, and to consume no
alcohol.
Subjects attended the laboratory in pairs differing
from each other in the treatment they received, and thus
treatment order was balanced. They each slept in a
quiet and comfortable bedroom on a total of 58 nights
spread over 38 weeks according to the experimental
design:
Weeks 1 and 2 2 adaptation nights
6 baseline nights
Weeks 5 and 6 1 adaptation night
6 early treatment nights
Weeks 7,8,9 and 10 treatment continued at home
Weeks 11 and 12 1 adaptation night
6 late treatment nights
Weeks 13 and 14 treatment continued at home
Weeks 15 and 16 1 adaptation night
6 withdrawal nights
The treatment was taken every night, from the first
early treatment night to the night preceding the
recording of the first withdrawal night. Thus every
subject/
- 95 -
subject took the treatment for ten weeks.
Six weeks later subjects repeated the above
schedule on the alternative treatment. Treatments
were administered 30 min before lights-out (approx¬
imately 2230h to 0715h).
The days of the week that subjects came to the
sleep laboratory were not exactly the same for each
period but their 7/8 attendances were evenly spread
over each two week period.
On half the baseline nights and in balanced order
each subject was given a pink placebo pill. They were
given a written statement which said that the pill was
a mild sleeping pill.
The food drink was made from 32g of Horlicks powder
mixed with 250ml of hot milk.
(b) Recording of sleep
On all nights the parieto-occipital electroenceph¬
alogram, bipolar eye-movements and submental muscle
tone were recorded.
The 580 electrophysiological recordings of sleep
were coded and read "blind" as to the experimental
condition, and categorized into the different stages
of sleep and wakefulness according to the criteria of
Rechtschaffen and Kales (1968). Using this raw data a
computer programme was used which calculated the time
it took a subject to fall asleep, the total amount of
time/
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time slept and the time from sleep onset to the first
appearance of REM sleep. The number of min spent in
each stage of sleep in the accumulation of each
successive hour of sleep was also determined.
Wakefulness was treated as intruding into sleep
and any wakefulness through the night is presented
in terms of the amount of waking that occurred in the
accumulation of each successive hour of sleep. Thus,
if 20 min of waking had intruded into the first hour
of sleep, then it had actually taken 80 min to achieve
the first 60 min of sleep.
The number of transitions to wakefulness plus the
number of transitions to stage 1 that occurred in
each successive hour of sleep was also calculated as
this gives an index of the restlessness of sleep.
The results of all ten subjects for each night
were avaraged for each of the stages of sleep and wake¬
fulness by collecting together all the data from the
first, second, to the seventh hour of sleep and dividing
each hourly total by ten. If any subject slept for less
than seven hours the denominator was reduced.
Incomplete hours of sleep were treated as follows»-
If, for example, a subject slept for 4h 40min then his
sleep data for this incomplete fifth hour of sleep was
included in the fifth hour total of all subjects, but
when/
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when the mean for the fifth hour was calculated, the
denominator would be 9.5 instead of ten. If several
subjects had slept for less than five complete hours,
then the divisor was calculated by adding the number
of complete fifth hours plus all the decimal fractions
and then dividing the grand total minutes of the
particular sleep measure, in that fifth hour, by the
calculated denominator.
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PARTJ.21: EFFECT OF A PLACEBO ON SLEEP
INTRODUCTION
There have been remarkably few investigations into
the effects of a placebo on sleep. This is surprising
in view of the fact that many studies involve the
administration of a treatment whose nature cannot be
disguised, and with which subjects may associate an
effect. Also, there is pressure on doctors to prescribe
fewer sleeping pills and many must wonder if an inert
substitute might be effective through suggestion alone.
Kales et al. (1971) compared the effect of a
placebo with no-treatment on the sleep of eight young
men, who had complaints about their sleep. No significant
differences were found between the five nights on each
treatment for such measures as the time it took to fall
asleep, the total time spent asleep, the distribution
of the various sleep stages, or the subjective ratings
of the quality of sleep. The subjects had been told that
they might be given a Mummy1 pill at some time during
the experiment.
Davis and Hartmann (1973) recorded sleep
electrophysiological^ in two groups of nine subjects.
One group comprised young males and the other middle-aged
women. No significant differences were found in the
total time asleep or in the time to fall asleep between
the means of three placebo and three no-treatment nights.
- 99 -
In a later experiment involving 12 young men,
Hartmann and Cravens (1973a) compared the mean of
nine all-night sleep recordings collected at intervals
through a 28-day period of daily placebo administration
with the mean of three preceding no-treatment nights.
The authors reported a rather tenuous connection
between placebo administration and an increased amount
of REM sleep. They also reported an increase in REM
sleep following ♦withdrawal* of the placebo, but this
may have been an artifact of the unbalanced design.
The present investigation into the effects of a
placebo on sleep differs from those referred to above
in that our ten middle-aged subjects were told that
the inert pill was a mild sleeping pill which would
have a beneficial effect on their sleep and hence more
specifically investigated the power of suggestion.
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METHODS
As mentioned in the general description of the
experiment (Part 1) this study was carried out on the
baseline nights, which preceded both the period of
Horlicks and the period of nitrazepam administration.
(a) Experimental Design
Subjects were given a written statement, before
the experiment began, which read, "You will be given
a mild sleeping pill, it will help to make your sleep
more restful without causing any hangover". An inert,
pink pill was administered, 30 min before lights-out,
on half the recorded nights. Subjects attended the
laboratory in pairs, always differing from each other
as to whom received the pill on any one night.
The experiment, out of necessity, was divided
into two halves, separated by 21 weeks. During each
period, subjects had their sleep recorded electro¬
physiological ly on eight nights, of which the first
two served for adaptation and were discarded. Thus
each of the ten subjects received, in balanced order,
the inert pill on six nights and nothing on the other
six experimental nights.
(b) Statistical Analysis
Correlated t-tests (Ferguson, 1959) were used to
compare/
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compare the 60 placebo nights with the 60 no-treatment
nights using each subject's mean under either condition.
Friedman's analysis of variance (Siegel, 1956) was used
to compare the mean latency to the first appearance of
REM sleep when the placebo had been taken with the
nights when nothing had been given.
RESULTS
The overnight recordings of sleep revealed no
significant differences between the 60 placebo pill
nights and the 60 no-treatment nights. Table 3.1 shows
the lack of influence of the placebo on the accumulation
of wakefulness that intervened during the night's sleep
and this was true throughout the night (Figure 3.3).
Similarly, the accumulated min of intervening wakefulness
combined with the min of stage 1 (drowsiness) were
unchanged by placebo administration (Figure 3.2).
The amounts of stage 1, stage 2, stages 3+4, ancj
REM sleep (Table 3.2) were so obviously unaffected that
statistical analyses were not undertaken. The mean total
sleep duration, the time taken to fall asleep and REM
sleep latency were also unaffected (Table 3.3). The
number of times that sleep was disrupted by waking or
periods of drowsiness (stage 1) were combined and also
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FIGURE 3.1 Mean cumulative min of wakefulness
interrupting the first 7h of sleep of 10 middle-aged
subjects.
The placebo pill was taken on 6 nights
and no treatment (Non-pill) on 6 nights.
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FIGURE 3.2 Mean cumulative min of intervening
wakefulness combined with the mean cumulative min
of stage 1 (drowsiness) occurring in the first 7h
of sleep of lO middle-aged subjects.
The placebo pill was taken on 6 nights
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Successive hours of sleep
FIGURE 3.3 Mean number of times that sleep was
disrupted by periods of wakefulness combined with
the mean number of shifts to stage 1 (drowsiness)
in the first 7h of sleep of 10 middle-aged subjects.
The placebo pill was taken on 6 nights
and no-treatment (Non-pill) on 6 nights.
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NOTE: The slight discrepancy between the mean total
min of intervening wakefulness accumulated in the
first 7h of sleep shown in Table 3.1 when compared
with Table 3.2 is a consequence of the different
methods used to calculate the means. The means shown
in Table 3.2 were calculated as described in section
(b) of Part 1 of this chapter, whereas the values
listed in Table 3.1 were obtained by summing each
individual subject's mean total min of wakefulness
in the accumulation of the first 7h of sleep.
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DISCUSSION
The sleep of older people is frequently broken
by periods of wakefulness (Feinberg et al .f 1967;
Agnew et al .f 1967; Kales et al .f 1967b; Williams et altj
1972; Bj&ezinova, 1975) and hence more likely to show
any beneficial effects of a treatment. Their sleep
also appears to be more vulnerable to any adverse
influence, such as the disruption of sleep following
caffeine ingestion shortly before going to bed
(Bfezinova, 1974a), whereas the sleep of younger
subjects is affected less (Gresham et al. 1963). Had
the negative result in the present investigation been
found in young subjects it could be said that younger
people usually sleep so well that there is little
room for improvement. In an earlier study of the
food drink *Horlicks' no significant effect was found
in EEG recorded sleep of young people, whereas the
sleep of a group of older subjects, similar to those
studied here, was significantly less broken after the
food drink when compared with sleep after an inert
pill (Brezinova and Oswald, 1972).
Any experiment which investigates the value of
a treatment whose identity cannot be concealed is
faced with the problem of how large a part suggestion
may play in the results. In the present investigation
subjects/
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subjects were specifically told that their sleep would
be improved and yet this was not reflected in the
results.
To conclude, the results of this study offer no
support for the supposition that the beneficial
effects of hypnotics or bedtime food on sleep are
attributable to suggestion, nor do they give evidence
for any belief that the sleep of middle-aged people
would be substantially altered by prescribing a
placebo.
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TABLE 3.1. EFFECT OF A PLACEBO ON SLEEP
Individual subjects mean total min spent awake in the accumulation
of the first 7 h of sleep. Each value for each of 10 subjects is


















t-test for paired observations (2-tailed)
Placebo v. No-treatment nights: t - 1.02, df » 9 (n.s.)
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TABLE 3.2. EFFECT OF A PLACEBO ON SLEEP
Mean total min spent in each of the sleep stages, wakefulness and
shifts of sleep stage to awake and to stage 1 in the accumulation
of the first 7 h of sleep. Each value is the mean of 60 subject













stage 2 214.5 213.6
stages (3 + 4) 82.4 84.4
stage REM sleep 84.2 86.8
Number of shifts




TABLE 3.3. EFFECT OF A PLACEBO ON SLEEP
Whole night measures. Each value is the mean of 60 subject






















onset to 79.8±22.0 81.2+24.3 X »0.4, df"l# (n.s.)
the first ^ r
REM period
*non-parametric test (Friedman's analysis of variance) used because
data not normally distributed
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PART (3)8 EFFECT OF HORLICKS ON SLEEP
METHODS
Subjects attended the sleep laboratory on 29 nights
according to the experimental design described in Part 1
of this chapter. On 24 of these nights electrophysio¬
logical recordings were made and comprised six pre-food
drink baseline nights, six early food drink, six late
food drink nights and six withdrawal nights. The four
conditions were spread over 16 weeks for each of the
ten subjects.
RESULTS
No significant differences were found on the
objective measures of sleep among the four conditions.
Table 3.4 summarizes the analyses of the means of the
whole-night measures: total time asleep, latency to
sleep onset and latency from the first onset of sleep
to the first appearance of REM sleep. Table 3.5 shows
the individual subject's mean total time asleep under
the four conditions and Table 3.6 shows the same for
the total min of intervening wakefulness occurring in
the first 7h of accumulated sleep. Table 3.7 summarizes
the mean totals of the 7h of sleep for the different
sleep stages, intervening wakefulness and the combined
shifts of sleep stage to wakefulness and to stage 1.
It was unnecessary to apply statistical tests to
confirm these statements, as it was obvious from the
group means that there were no significant differences.
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NOTEj The small discrepancies between the mean total
rain of intervening wakefulness in the first 7h of sleep
shown in Table 3,6 compared with Table 3.7 are due to
the difference between the methods of calculating the
means. The values shown in Table 3.6 were arrived at
by calculating the mean number of min of intervening
wakefulness in the first 7h of sleep for each subject
under each condition. Thereafter the mean min over
the ten subjects was calculated for each condition.
Whereas the data shown in Table 3.7 was calculated by
averaging the min of intervening wakefulness occurring
in the first hour of sleep for all ten subjects and
similarly for the second, third and so on up to the
seventh hour of accumulated sleep. Then the seven
hourly means for each night were added together.
Thereafter the six 7h means for the baseline period
were averaged, as were the six means for the early and
late drink and withdrawal periods.
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DISCUSSION
The complete absence of effect of Horlicks at
bedtime came as a surprise at the time. In retrospect,
however, it will be found not so surprising. The
volunteers in this experiment had been given no
instructions to abstain from food and drink in the
evening which contrasts with the restriction on eating
and drinking after 1900h in the earlier study comparing
sleep after Horlicks with sleep after an inert capsule
(B^ezinova and Oswald, 1972) No dietary restriction
had been imposed because it had been intended that the
comparisons between the bedtime food drink and the drug
should be as near to the "at home" conditions as possible.
I would now predict that, had there been a
restriction imposed on eating and drinking in the evening,
I would have obtained different results.
Some of the subjects in the present study, were
definitely taking a snack shortly before coming to the
sleep laboratory during the baseline period and commented
that they would feel hungry during the night without it*
The lack of any significant differences under these
circumstances between the subjects' sleep during the pre-
food drink baseline and the subsequent periods of food
drink administration suggests that the food drink
Horlicks might have no special sleep-promoting powers
other than its basic nutritional composition and that
the/
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the superiority of Horlicks over a placebo capsule,
found by Brezinova and Oswald (1972), was largely
attributable to the detrimental effects on sleep of
the lack of bedtime nourishment when subjects had had
nothing to eat or drink after 1900h. If that were
the case then one would predict that other types of
bedtime nourishment would be comparable to Horlicks
when compared with a placebo capsule, with the proviso
that subjects curtail their food intake in the early
evening.
The question of whether the composition of a
bedtime snack has any bearing on its effects on
subsequent sleep is dealt with in Chapter 5 of this
thesis.
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TABLE 3.4. EFFECT OF HORLICKS ON SLEEP
Whole night measures. Each value is the mean of 60 subject nights:














452.0±27.8 452.6±35.0 452.8±38.3 451.5131.7








79.4121.4 69.5112.6 79.5115.0 76.2121.7
No significant differences among conditions
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TABLE 3.5. EFFECT OF HORLICKS ON SLEEP
Mean total min asleep for each individual subject. Each value
for each of 10 subjects is the mean of 6 nights.









BB 405.6 411.6 388.8 394.3
MC 443.7 407.8 411.1 441.9
JG 443.3 427.5 481.0 453.5
GH 436.9 479.0 479.4 480.2
GJ 505.7 515.1 509.9 494.5
DJ 488.6 489.3 485.9 493.7
RMcD 441.9 462.8 467.3 442.7
JR 453.4 458.9 445.5 442.7
MS 457.4 430.0 421.8 419.1
MT 443.0 443.5 437.1 452.6
*
MeanlS.D. 452.0±27.8 452.6±35.0 452.8±38.3 451.5±31.7
No significant differences among conditions
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TABLE 3.6. EFFECT OF HORLICKS ON SLEEP
Mean min of intervening wakefulness occurring in the first 7 h of
accumulated sleep. Each value for each of 10 subjects is the mean
of 6 nights.
Subjects








BB 41.1 53.5 26.8 67.3
MC 25.2 41.8 66.5 42.1
JG 55.9 49.8 19.7 33.2
GH 40.2 15.4 10.9 15.4
GJ 9.1 2.4 4.7 21.2
DJ 21.6 14.5 20.5 19.4
RMcD 45.7 26.3 32.6 54.8
JR 30.9 26.1 33.8 28.2
MS 5.6 24.7 55.2 25.9
MT 55.7 56.0 59.6 32.9
MeantS.D. 33.1117.7 31.1118.3 33.0121.0 34.0116.4
No significant differences among conditions
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TABLE 3.7. EFFECT OF HORLICKS ON SLEEP.
Mean total min spent in each of the sleep stages, wakefulness and
shifts of sleep stage to awake and to stage 1 in the accumulation
of the first 7h of sleep. Each value is the mean of 60 subject









plus Stage 1 71.1
Stage 2. 214.3
Stages (3 + 4) 84.1











of sleep stage to
awake and Stage 1 43.S 44.5 42.9 44.1
*N0TE: slight discrepancies in totals because of rounding error.
- 119 -
PART (4): EFFECT OF NITRAZEPAM ON SLEEP
INTRODUCTION
The benzodiazepine nitrazepam was selected for the
comparison of efficacy between chronic use of an
hypnotic and long-term administration of the food drink
Horlicks because it is the most commonly prescribed
sleeping pill in Britain and thus a study of its effect¬
iveness over many weeks of use would be of interest.
Insomnia, especially in older people, appears to be
a common problem (Dunnell and Cartwright, 1972) and
hypnotic drugs are frequently taken over long periods of
time and yet there are few reports investigating the
effects of their long-term administration. 'Insomnia'
is a blanket term which covers several different aspects
of inadequate sleep, which can occur singly or in
combination. A patient may have difficulty in falling
asleep at the beginning of the night, wake repeatedly
through the sleep period or awaken very early in the
morning. Electrophysiological recording of sleep can
tell us accurately how long it took a person to fall
asleep, how often and for how long they were awake and
how many minutes of sleep they accumulated through the
night. In addition, recordings of sleep reveal any
changes in a subject's usual number of min and chacter-
istic distribution of the different stages of sleep





Subjects attended the sleep laboratory on 29 nights
according to the experimental design described in Part 1
of this chapter. On 24 of these nights electrophysio¬
logical recordings were made: six baseline nights, six
early drug, six late drug and six withdrawal nights
spread over 16 weeks for each of the ten subjects.
Subjects took 5mg of nitrazepam nightly for ten weeks.
The first night on the drug and the first night
after coming off the drug were recorded for every subject.
(b) Statistical Analysis
It is a perennial problem in this type of invest¬
igation to find a statistical test which can satisfactorily
be applied, because treatment order cannot be balanced and
the different periods of the study are not independent of
each other. For example, on the first night without the
active drug after several weeks of use (first withdrawal
night), the effects of the drug are often still present
and so the withdrawal period is contaminated by the
persistence of the drug or its metabolites in the body.
Averaging the results over the withdrawal period cam
conceal the sequence of events that frequently occur when
the active drug is withdrawn. Similarly, measurements
made/
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made after chronic use of a drug are not independent
of the measurements made during the period of initial
administration of the drug, as the former evolves from
the latter.
The questions we wanted to answer were:-
(i) Do the patterns of sleep differ among the four
conditions of the experiment, namely, pre-drug baseline;
early drug; late drug and drug withdrawal?
(ii) When the drug is first taken are there any
effects on sleep?
(iii) Do these effects persist?
(iv) When the drug is withdrawn do the sleep patterns
of the subjects return to those found during the pre-drug
baseline period?
I attempted to analyse these questions statistically*
(i) By using the non-parametric Friedman*s analysis of
variance by ranks (Siegel, 1956). I used this ranking
method to eliminate the effects attributable to inter-
individual differences, as I only wanted to see if there
were any consistent differences across the four
conditions.
(ii) to (iv) By using t-tests for paired observations
(Ferguson, 1959) between the appropriate pairs of
experimental conditions. A one-tailed level of
significance was employed, when a prior prediction had
been made e.g. it was predicted that nitrazepam would
significantly improve sleep and that its withdrawal
would lead to sleep that was more broken by wakefulness
and of shorter total duration.
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RESULTS
Table 3.8 shows a summary of the mean total min of
each of the sleep stages, wakefulness and the number of
shifts of sleep stage to awake and to stage 1
accumulated in the first 7h of sleep. Inspection of
these group means revealed which measures would merit
statistical analysis.
(a) Effects of nitrazepam on induction, duration and
brokenness of sleep.
Subjects slept significantly longer while taking
the drug (Table 3.9). This improvement in sleep was
maintained throughout the period of drug administration
as comparison of the early and late drug results
illustrates. However, on withdrawal from the drug, the
time spent asleep was significantly shorter than recorded
during the baseline period, before the drug had been
taken.
The interruption of sleep by periods of wakefulness
was reduced by the drug, throughout the period of
administration, with no apparent tolerance as there was
no significant difference between the early and late drug
periods. Withdrawal from the drug increased intervening
wakefulness, when compared with baseline as Figure 3.4
shows. Withdrawal from the drug affected some subjects'
sleep/














FIGURE 3.4 Mean cumulative min of intervening
wakefulness occurring in the first 7h of sleep
of 10 middle-aged subjects.
Six nights were recorded under each
condition for every subject.
Statistical analysis (where applicable) and a
measure of the inter-individual variance in
Table 3.10.
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sleep profoundly, in one case total sleep time was
reduced to 42 min, and, because of this, statistical
assessment of these particular data using individual
means was impracticable. Table 3.10 shows the
individual means and group means for the total amount
of intervening wakefulness in the first 7h of sleep
for the baseline, early drug and late drug periods and
how wakefulness interrupting sleep was significantly
reduced during both the early and late drug periods.
The early and late drug periods did not differ
significantly.
A statistical assessment of the effect on wakeful¬
ness of withdrawing the drug was obtained by comparing
the total wakefulness occurring between first falling
asleep and the end of the recording in the morning. The
recordings lasted the same length of time and therefore
the measure does give a reliable indication of the amount
of waking occurring after subjects had first fallen asleep.
This amount of time awake was significantly higher during
the withdrawal period and considerably higher two nights
after the last dose of nitrazepam had been taken
(Figure 3.5 + Table 3.11). All subjects had their first
night, without the drug, recorded. The 'second1 with¬
drawal night recorded was for some subjects the second
night without the drug but for others it was actually the
third night without the drug. The mean number of nights
without/
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FIGURE 3.5 Mean total wakefulness recorded after
the first onset of sleep in 10 middle-aged subjects.
Each point on the graph is the mean of
the 10 subjects.
Statistical analysis and a measure of the inter-
individual variance in Table 3.11.
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without the drug, when the 'second1 withdrawal night was
recorded was 2.3 nights.
The time it took subjects to fall asleep was not
significantly changed (Table 3.12).
(b) Effect of nitrazepam on amount and distribution
of REM sleep.
Table 3.13 shows that the total minutes of REM sleep
accumulated in the first 7h of sleep was significantly
reduced during the early drug period when compared with
the baseline mean whereas the late drug mean was not
significantly different from the baseline mean. The
reduction in REM sleep during the early drug period
occurred almost exclusively within the first 3h of sleep
(Table 3.14) and this significant early night reduction
was still present in the late drug period. However, by
the late drug period a significant increase in REM sleep
had appeared in the later night, hours 4 to 7 of sleep,
(Table 3.15) suggesting the development of a later night
rebound in REM sleep. Withdrawal of the drug returned
the distribution of REM sleep between the early and late
night, to baseline values.
The latency from sleep onset to the first appearance
of REM sleep did not differ significantly among the four
periods of the study. This measure is not normally dis¬
tributed and so only the non-parametric test was employed
(Table 3.16).
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(c) Effect of nitrazepam on amount of slow-wave sleep (SWS)
The mean duration of SWS (stages 3+4) accumulated in
the first 6h of sleep (Table 3.17) was significantly
reduced during early drug and during late drug administr¬
ation when compared with baseline levels. The mean
values recorded during the late drug period were
significantly lower than those of the early drug period.
Withdrawal of the drug returned values to baseline
values, without a rebound increase over baseline, in the
nights immediately following withdrawal.
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DISCUSSION
Normal ageing is associated with a reduction of sleep
duration and more interruption by periods of waking
(Agnew et al.,1967; Kales et al♦,1967b; Feinberg et al. ,
1967; Williams et al,,1972; Brezinova, 1975). The
subjects involved in our study were of an older age group
and so more representative of those who complain of
inadequate sleep.
The overnight recordings of sleep were sufficiently
long (8.75h) to allow any increase in sleep duration to
be detected and reveal any changes in the distribution of
sleep stages which might occur towards the end of the
period of sleep. The latter is particularly true of REM
sleep which occurs predominantly in the later part of the
night and thus if the duration of the sleep period was
curtailed information about changes in this sleep stage
could be lost.
Nitrazepam proved effective in reducing the amount
of wakefulness interrupting sleep and sleep duration was
increased. The maintenance of nitrazepam*s action for
over two months of use is paralleled by flurazepam when
studied during four weeks of administration and contrasts
with the ineffectiveness of pentobarbital revealed after
only two weeks of use (Kales et al,,1975). Glutethimide
500mg, lOOOmg chloral hydrate (Kales et al., 1970; 197Qb)
lOOmg secobarbital (Kales et al., 1976a) and triazolam
0.5mg/
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0.5mg (Kales et al., 1976b) nightly have also been shown
to become less effective over a two-week period of
administration. The longer period of drug-taking in our
study was thus even more likely to reveal any tolerance
effects. The fact that it did not suggests that
nitrazepam might be a choice for long-term use.
The mean min from lights-out to sleep onset ranged
from 8.8 min to 48.4 min (mean 22.8 min). This
relatively short latency to sleep onset may account for
the lack of effect of the drug on the induction of sleep.
In patients who have difficulty in falling asleep a
reduction might well have been found.
Nitrazepam was found to reduce the amount of REM
sleep in the first 3h of sleep and during chronic
administration a late-night REM sleep rebound developed,
suggesting that the initial reduction of REM sleep had
some adverse consequences to which the central nervous
system had to adapt. It has yet to be elucidated if
distortion of the normal sleep pattern has any
deleterious effects and whether a reduction in the
electrophysiologically recorded min of a sleep stage can
be taken to mean that its underlying function has been
suppressed.
The within-night rebound in min of REM sleep during
protracted use of hypnotics has been previously reported
for/
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for barbiturates (Kales et al., 1970c) and for the
benzodiazepine flunidazepam (Oswald et al. , 1973).
The lack of a REM sleep rebound following withdrawal of
nitrazepam contrasts with that found with larger doses
(Oswald and Priest, 1965). Rebound increases in the
min of REM sleep recorded, whether as a later night
rebound during a long-term use or following withdrawal,
does suggest that some necessary process has been
diminished by the drug and that the rebound constitutes
some compensatory restoration of that process.
The lack of effect of nitrazepam on REM latency
may be due to the relatively low dose 5mg used, for a
higher dose has been shown to lengthen REM latency
(Haider and Oswald, 1971). Similarly, flurazepam 30mg
was reported to lengthen REM latency (Kales et al., 1975).
Nitrazepam caused a progressive decline of slow
wave sleep (stages 3+4) as has been reported during
chronic use of other benzodiazepines, e.g. flurazepam
(Kales et al., 1970c, 1971, 1975), chlordiazepoxide
(Hartmann and Cravens, 1973b), diazepam (Fisher et al.,
1973; Kales and Scharf, 1973), flunidazepam (Oswald
et al., 1973), fosazepam (Allen and Oswald, 1976) and
triazolam (Kales et al., 1976b).
The/
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The lack of a rebound increase in slow wave sleep
(SWS) following withdrawal from the drug suggests that,
although the electrophysiological appearance of SWS was
reduced the underlying function of SWS may not have
been impaired.
The poor sleep following withdrawal of nitrazepam
and other hypnotics must tend to perpetuate their
consumption.
Patients trying to give up their hypnotics should
be reassured that the disrupted sleep, which will last
for several nights after stopping the drug, is a temporary
consequence of withdrawal from the drug and that their
sleep will improve over time.
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TABLE 3.8. EFFECT OF NITRAZEPAM ON SLEEP
Mean total min in the first 7 h of sleep for objective measures
of sleep and wakefulness. Each value is the mean of 60 subject











35.1 20.9 18.9 56.1
Stage 1 37.2 31.0 33.4 40.2
Stage 2 211.7 249.5 250.9 213.9
Stages (3+4) 82.8 64.2 52.4 79.9







44.4 38.6 38.9 47.1
Note: All these results were obtained by averaging the minutes of
each sleep measure achieved by the subjects in the first, second, etc.
hour of sleep. Thereafter the means of the first, second and so on up
to the seventh hour of sleep were added together for each of the 24 nights.
Thus the totals differ slightly from Tables 3.10 and 3.13.
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TABLE 3.9. EFFECT OF NITRAZEPAM ON SLEEP
Mean total rain spent asleep. Each value for each of 10 subjects
is the mean of 5 nights.
Mean total rain asleep
Subjects Baseline Early Late Withdrawal
pre-drug drug drug
BB 419.8 424.8 418.7 376.9
MC 423.2 466.2 450.4 422.7
JG 446.1 465.1 472.9 417.3
GH 470.3 479.7 490.4 468.4
GJ 494.2 496.7 496.2 477*1
DJ 507.5 487.1 504.4 461.9
RMcD 443.0 485.9 464.0 457.4
JR 444.8 472.1 465.8 453.9
MS 407.1 499.0 486.9 371.6
MT 413.3 433.8 441.3 379.6
Mean 446.9 471.0 469.1 428.7
+ + . + + +
-S.D. -34.1 -24.9 -26.8 -40.8
Statistical analysis
(a) Friedman 's analysis of variance to test overall significant
of differences among conditions.
X J - 20
r .04, df - 3, p < 0.001.
(b) t-tests for paired observations (1-tailed)
baseline v. early drug, t - 2.50, df » 9, p < 0.025
baseline v. late drug, t - 2.97, df - 9, p < 0.01
baseline v. withdrawal, t - 2.61, df - 9, p < 0.025
early drug v. late drug , t - 0.48 , df « 9 (n. s.) 2-tailed
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TABLE 3.10. EFFECT OF NITRAZEPAM ON SLEEP
Mean total min of intervening wakefulness occurring in the first
7 h of accumulated sleep. Each value for each of 10 subjects
is the mean of 6 nights.
Mean min intervening wake in 1st 7 h sleep
Subjects Baseline Early Late
pre-drug drug drug
BB 37.7 28.5 67.1
MC 71.2 27.0 23.0
JG 25.0 41.1 15.3
GH 32.6 7.8 9.8
GJ 16.7 10.3 10.1
DJ 1.2 7.7 0.9
RMcD 72.2 26.0 7.4
JR 20.0 9.2 25.5
MS 5.3 1.0 1.1
MT 69.4 49.8 30.2
Mean 35.1 20.8 19.0
+ + +




t-tests for paired observations (1-tailed)
baseline v. early drug, t « 2.26, df ■ 9, p < 0.05
baseline v. late drug, t - 1.83, df - 9, p < 0.05
early drug v. late drug, t ■ 0.30, df » 9 (n.s.)
- ! 35 -
TABLE 3.11. EFFECT OF NITRAZEPAM ON SLEEP.
Mean total min of wakefulness occurring after first falling asleep
and until the recording ended. Each value for each of 10 subjects
is the mean of 6 nights.








BB 84.4 77.7 83.6 117.7
MC 68.8 39.4 46.8 84.1
JG 71.3 49.0 40.6 96.2
GH 39.2 10.5 15.8 15.4
GJ 34.9 28.0 23.6 42.8
DJ 12.6 27.5 12.6 58.7
RMcD 74.6 28.7 46.9 52.4
JR 34.5 16.9 28.8 29.4
MS 78.1 7.3 9.6 137.2
MT 97.8 73.1 58.1 125.3
Mean 59.6 35.8 36.6 75.9
-S.D. -27.3 -24.3 -23.2 -42.4
Statistical analysis
(a) Friedman's analysis of variance
Xr" - 19.,17, df » 3, p < 0.001
(b) t-tests for paired observations (1-•tailed)
baseline v. early drug, t - 3.24, df - 9, p < 0.01
baseline v. late drug, t - 3.50, df - 9, p < 0.005
baseline v. withdrawal, t - 1.87, df « 9, p < 0.05
early drug v. late drug, t - 0.24, df » 9 (n.s.)
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TABLE 3.12. EFFECT OF NITRAZEPAM ON SLEEP
The latency to the first onset of sleep (min). Each value for
each of 10 subjects ia the mean of 6 nights.
Mean min to sleep onset
Subj ects Baseline Early Late Withdrawal
pre-drug drug drug
BB 18.5 21.0 20.3 26.5
MC 37.7 24.9 29.2 21.9
JG 8.8 12.4 14.3 12.5
GH 19.0 31.6 18.9 42.0
GJ 9.2 10.6 13.1 18.8
DJ 9.0 10.8 9.5 8.0
RMcD 16.7 19.2 23.8 21.4
JE¬ 48.4 39.3 33.1 45.4
MS 37.2 14.3 19.8 18.2
MT 23.9 20.5 30.3 30.4
Mean 22.8 20.5 21.2 24.5
+ + + + +. „
-S.D. -13.9 -9.4 -7.8 -12.0
Friedman'8 analysis of variance
Xra - 2.28, df - 3, (n.s.)
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TABLE 3.13. EFFECT OF NITRAZEPAM ON SLEEP
Mean total min of stage REM sleep accumulated in the first 7 h
of sleep. Each value for each of 10 subjects is the mean of
6 nights.









BB 85.3 80.6 69.3 83.8
MC 106.9 96.4 100.5 102.3
JG 90.3 79.8 88.1 95.3
GH 91.6 63.7 67.3 102.6
GJ 94.7 88.2 91.8 79.7
DJ 94.6 87.5 110.1 97.1
RMcD 58.2 57.3 58.6 59.8
JR 99.6 76.6 94.7 78.5
MS 71.5 65.6 82.5 89.6












(a) Friedman's analysis of variance
Xr2 - 11.88, df - 3, p<0.01
(b) t-tests for paired observations (2-tailed)
baseline v. early drug, t - 3.84, df ■ 9, p<0.01
baseline v. late drug, t » 0.25, df - 9, (n.s.)
baseline v. withdrawal, t - 0.43, df - 9, (n.s.)
early drug v. late drug, t ■ 2.21, df - 9, (n.s.)
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TABLE 3.14. EFFECT OF NITRAZEPAM ON SLEEP
Mean total min of stage REM sleep accumulated in the first 3 h of
sleep. Each value for each of 10 subjects is the mean of 6 nights.
Miean min of REM sleep ir. 1st 3 h of sleep
Subjects Baseline Early Late Withdrawal
pre-drug drug drug
BB 31.1 8.8 10.9 23.4
MC 43.5 24.2 23.9 35.1
JG 27.8 24.3 22.3 32.2
GH 35.8 12.1 12.6 28.4
GJ 27.1 22.5 18.5 27.9
DJ 33.8 28.1 37.3 39.0
RMcD 17.0 12.7 10.3 13.9
JR 19.9 15.9 22.1 25.2
MS 15.6 10.9 21.0 26.3
MT 10.8 3.4 7.4 13.5
Mean 26.2 16.3 18.6 26.5
+ •f +„ +„ _
-S.D. -10.3 —8.1 —8.8 - 8.2
Statistical analysis
(a) Friedman 's analysis of variance
X • -18,
r .84, df - 3, p < 0.001
(b) t-tests for paired observations (2-tailed)
baseline v. early drug, t » 3.80, df = 9, p < 0.01
baseline v. late drug, t » 2.33, df - 9, p < 0.05
baseline v. withdrawal, t » 0.12, df ■ 9, (n.s.)
early drug v. late drug , t - 1.51, df - 9, (n.s.)
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TABLE 3.15. EFFECT OF NITRAZEPAM ON SLEEP
Mean total min of stage REM sleep accumulated in hours 4 to 7
of sleep. Each value for each of 10 subjects is the mean of
6 nights.
Mean min of REM sleep in hours 4 to 7 of sleep
Subjects
Baseline Early Late Withdrawal
pre-drug drug drug
BB 54.5 71.8 61.4 60.4
MC 66.5 72.2 76.6 67.2
JG 63.1 55.5 65.3 63.1
GH 55.0 51.6 54.8 74.2
GJ 67.6 65.7 73.3 51.8
DJ 60.8 59.4 72.8 58.1
RMcD 40.4 44.6 48.5 45.9
JR 79.7 60.7 72.6 53.3
MS 56.9 54.7 61.5 63.3
MT 48.7 49.1 70.9 33.1
Mean 59.3 58.5 65.8 57.0
± S.D. ± 10.9 ± 9.3 ± 9.1 ± 11.7
Statistical analysis
(a) Friedman's analysis of variance
Xr2 - 8.07, df - 3, p<0.05
(b) t-tests for paired observations (2-tailed)
baseline v. early drug, t ■ 0.27, df - 9, (n.s.)
baseline v. late drug, t - 2.61, df « 9, p<0.05
baseline v. withdrawal, t ■ 0.54, df ■ 9, (n.s.)
early drug v. late drug, t - 2.75, df « 9, p<0.05
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TABLE 3.16. EFFECT OF NITRAZEPAM ON SLEEP
Lack of influence of nitrazepam 5 mg on the latency from sleep
onset to the first appearance of REM sleep. Each value for each
of 10 subjects is the mean of 6 nights.










BB 70.6 64.5 96.8 60.3
MC 45.9 84.5 69.1 49.8
JG 80.5 87.4 86.7 72.0
GH 107.8 120.0 68.6 82.7
GJ 82.8 78.1 86.1 78.6
DJ 48.4 66.8 56.2 37.5
RMcD 61.7 137.6 118.5 104.8
JR 107.8 109.7 105.1 100.8
MS 90.8 76.3 76.4 63.3











Friedman's analysis of variance
Xr2 - 5.88, df - 3 (n.s.)
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TABLE 3.17. EFFECT OF NITRAZEPAM ON SLEEP
Mean total min of stages 3+4 accumulated in the first 6 h
of sleep for each individual subject. Each value for each of








































































(a) Friedman's analysis of variance
Xr2 - 14.88, df - 3, p<0.005
(b) t-tests for paired observations (2-tailed)
baseline v. early drug, t ■ 4.22, df • 9, p<0.01
baseline v. late drug, t » 4.34, df « 9, p<0.01
baseline v. withdrawal, t - 1.42, df » 9, (n.s.)
early drug v. late drug, t » 2.40, df ■ 9, p<0.05
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PART (5): GENERAL DISCUSSION OF CHAPTER 3
AN INVESTIGATION INTO THE EFFECTS OF A PLACEBO, HORLICKS
AND OF NITRAZEPAM ON SLEEP
The original intention behind the design of this
experiment had been to compare the long-term effective¬
ness of the bedtime food drink, Horlicks, with -that of
nitrazepam in improving sleep, but the failure of
Horlicks to influence sleep showed that it obviously
does not possess sleep-promoting qualities comparable
to an hypnotic drug. This was very apparent in this
experiment where nitrazepam was so superior in reducing
wakefulness that interrupted sleep and in prolonging
the sleep of the same ten subjects, who showed no
significant change when Horlicks was taken at bedtime.
However, this does not negate the findings of B^ezinova
and Oswald (1972), for their study included a restrict¬
ion on eating after 1900h and in retrospect this may
well be a crucial point, for although Horlicks may not
possess inherent sleep-promoting properties it may well
have proved better than nothing at bedtime had subjects
been instructed not to eat or drink after about 1900h.
The study did show the effectiveness of nitrazepam
as an hypnotic over a relatively long period of use,
but it also underlined the disadvantages of drug-
induced sleep. From the point of view of the patient
taking/
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talking the drug, the greatly increased aimounts of
waking through the night following withdrawal from the
drug is an obvious disadvamtage. Other negative points
include the slowness of elimination of the drug from
the body (Rieder and Wendt, 1973). The slowness of
elimination must contribute to the hangover effects
manifested as impairment in psychomotor performance
the following day (Malpas et al., 1970).
The distortion of the normal pattern of REM sleep
and the reduction of slow wave sleep during nitrazepam
administration raises the question of whether drugged
sleep is as good as drug-free sleep. I suppose it
depends upon what you think sleep is for. If it is just
a behavioural adaptation to the environment, then
presumably modifications of the distribution of sleep
stages is of little consequence. However, this strikes
me as a naive approach to the function of sleep in view
of the wealth of evidence linking restorative processes
with sleep and so if the normal pattern of REM sleep
and slow wave sleep is disturbed by talking nitrazepam,
and these are the stages of sleep which have been
particularly linked with the recuperative role of sleep,
then maybe drugged sleep is inferior. However, I will
leave discussion of this question until the end of the




In contrast to the changes in sleep found with
nitrazepam, was the absence of any measureable effect
on sleep when the placebo was compared with no-treatment.
Subjects were specifically told that the placebo was a
sleeping pill and so this indicates, at least in these
subjects, that suggestion alone is not sufficient to
alter sleep and that the influence of nitrazepam is
due to its pharmacological actions.
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Seven middle-aged volunteers had their blood
sampled overnight before and during chronic
administration of Horlicks and of nitrazepam 5mg.
Nitrazepam had no significant effect on the
plasma levels of growth hormone, glucose,
triglycerides or cholesterol, but Horlicks at




The aim of this study was to investigate any changes
in the nocturnal plasma levels of growth hormone, glucose,
cholesterol and triglycerides when volunteers took either
a food drink or nitrazepam at bedtime.
Human growth hormone (GH) is released soon after
sleep onset (Takahashi et al., 1968; Honda et al., 1969)
and at least in young adults is linked to the appearance
of slow wave sleep stages 3+4 (Sassin et al., 1969a).
Factors which alter GH secretion during walking hours have
much less effect on the sleep related release of GH, for
example, induction of acute or chronic hyperglycemia
prior to or with the onset of deep sleep has not been
found to alter subsequent GH release (Parker and Rossman,
1971; Schnure et al., 1971). The sleep dependent release
of GH immediately responds to a shifted sleep schedule.
If sleep is delayed for several hours then GH release is
withheld until after the new time of onset of sleep
(Takahashi et al., 1968) and if subjects are selectively
deprived of slow wave sleep then GH secretion is
suppressed (Sassin et al., 1969b; Schnure et al., 1971).
GH promotes RNA and protein synthesis and stimulates
uptake of amino acids into tissues (Korner, 1965).
In/
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In Chapter 1 of this thesis, evidence was
presented in favour of the view that the major function
of sleep is for restoration and repair of both the
body and the brain and that the sleep-dependent
secretion of growth hormone is complementary to the
already favourable conditions for anabolic processes.
Many hypnotic drugs, particularly the benzodiazepines,
reduce the amount of time spent in slow wave sleep.
In the previous chapter (part 4) nitrazepam was
reported progressively to reduce the min of SWS over
a number of weeks of administration and this has been
found for other benzodiazepines by various investigators,
referred to in that section. So the question arises,
is there a concomitant diminution in the amount of GH
secreted during sleep? What evidence there is, suggests
that during drug administration GH secretion is not
reduced. Ogunremi et al. (1973) reported that chronic
ingestion of either sodium amylobarbitone or the
tranquillizer benzoctamine did not effect the nocturnal
GH levels of their eight young men volunteers although
SWS was reduced by amylobarbitone. Withdrawal from
either drug resulted in an elevation in the GH peak
which returned to baseline levels by the third week
after withdrawal. It was not stated if this elevation
of the GH peaks was significant but if they were then it
does/
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does suggest that during use, some process related to
GH production, secretion, action, and/or inactivation
has been affected. Rubin et al. (1973b) similarly
reported that the release pattern of GH was not
altered by administration of flurazepam 30mg 'tiiree one
subject. GH secretion was not consistently altered
by the administration of the benzodiazepines,
diazepam (Stokes et al., 1972) or flurazepam (Bixler
et al., 1976). In the latter study two young male
insomniacs were studied before, during and after drug
administration. Drug administration in both studies
was associated with reduction in slow wave sleep.
Nitrazepam is also a benzodiazepine and so was
predicted not to influence GH secretion. No predictions
were made about the other blood constituents.
I said earlier that the sleep-dependent GH
secretion is remarkably resistent to hyperglycemia and
no correlation has been found between plasma glucose,
Cortisol or insulin concentrations and GH release during
sleep (Takahashi et al., 1968), however, elevation of
plasma free fatty acids (FFA), by oral administration of
corn oil and iv heparin, resulted in a considerable
depression of growth hormone release during sleep
(Lipman et al., 1972). GH is a lipolytic hormone and
so elevates FFA. The reduction of GH secretion
associated/
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associated with an elevation of FFA suggests that a
negative feedback operates between GH secretion and
plasma FFA, and raises the possibility that evening
nutrition could influence the nocturnal secretion of
GH. The bedtime food drink Horlicks is made from
triple concentrated full cream milk, sucrose, malted
barley and wheat flour and was predicted to raise
the plasma glucose and triglyceride levels. No




(a) Subjects and experimental design
Seven volunteers, four men and three women, took
part in this study. Their average age was 59y
(ranging from 53y to 63y). They had taken no drugs in
the preceding months and during the entire experimental
period they were asked to consume no alcohol and take
no drugs other than those given by us. In this
experiment, there was no restriction on the time for
eating their evening meal, or taking a snack prior to
attending the sleep laboratory.
Subjects attended the laboratory in pairs to sleep
in quiet and comfortable bedrooms.
On all nights subjects had one channel of parieto¬
occipital electroencephalogram, two channels of bipolar
eye movements and one channel of submental muscle tone
recorded. On treatment nights one of the pair received
nitrazepam 5mg and the other Horlicks (32g Horlicks
powder mixed with 250ml hot milk) half an hour before
the evening recording began. This investigation was
an adjunct to the experiment which was designed to
compare sleep after the food drink Horlicks with sleep
after the benzodiazepine, nitrazepam (described in
Chapter 3). The combined experimental design is shown
below to illustrate that the apparently isolated blood
night /
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night during week 6, did in fact occur after several
nights of sleep at the laboratory.
Experimental designt
Weeks 1 and 2 2 Adaptation nights, 6 baseline nights,
1 Adaptation blood night,
1 BASELINE BLOOD NIGHT
Weeks 5 and 6 1 Adaptation night, 6 early treatment
nights, 1 EARLY TREATMENT BLOOD NIGHT
Weeks 11 and 12 1 Adaptation night, 6 late treatment
nights, 1 Adaptation blood night,
1 LATE TREATMENT BLOOD NIGHT
Weeks 15 and 16 1 Adaptation night, 6 withdrawal nights
Each treatment was taken from the first recorded
night during week 5 and every night up to and including
the night preceding the first withdrawal night during
week 15.
After six weeks on no treatment the entire 16 week
schedule above was repeated, for the other treatment.
Subjects took their treatments in balanced order.
(b) Nocturnal sampling of blood
The study of nocturnal constituents of plasma
involved the ten blood nights in the schedule above
(four adaptation and six measurement blood nights).
The results presented are from the six measurement
BLOOD NIGHTS. On all nights, subjects had a catheter
inserted into a forearm vein. The catheter had an
extension/
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extension of fine plastic tubing of sufficient length
(approx. 8 ft) to pass through the bedroom wall and
allow the subject freedom of movement. The catheter
plus extension had a deadspace volume of about 6ml,
which was filled with heparinized saline (10,000 IU/l)
to prevent clotting. On the six measurement nights,
blood was sampled every 30 min. First the dead space
volume of heparinized saline plus lml of blood was
drawn into a 10ml syringe attached to the experimenter-
end of the extension tube. The syringe was discarded,
a new syringe attached and a 10ml blood sample taken.
As the blood sample was taken a mark was made by a
marker pen on the EEG machine on the sleep recording
to pin-point the time that the sample was taken. After
each blood sampling the catheter and extension dead-
space were quickly refilled with heparinized saline.
The 10ml blood sample was centrifuged for 4 min at
1200g to separate the plasma, aliquots were taken and
then stored deep-frozen (-20°C) in labelled tubes until
assayed.
(c) Analysis of sleep recordings
The electrophysiological recordings of sleep made
on the measurement blood nights were read 'blind' as
to the experimental condition and categorized into the
various sleep stages according to the criteria of
Rechtschaffen/
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Rechtschaffen and Kales (1968). As the recordings
were read a note was made of each of the page numbers
where there was a marker to show a blood sample had
been taken. A computer programme calculated the number
of minutes spent in each of the sleep stages, 1, 2, 3,
4 and REM and wakefulness in the accumulation of each
successive hour of sleep.
(d) Analysis of blood constituents
(i) Plasma growth hormone (GH)
The GH concentration in each sample was assayed
•blind* as to the experimental condition by the Edinburgh
MRC Radioimmunoassay Team using the method of Hunter
(1972).
The GH results v/ere expressed as the concentration
in mU/l (in terms of human GH international reference
preparation 66/217) at the clock time when the blood
sample was taken. However, the page numbers where the
EEG paper was labelled by the marker pen were used in
the calculations.
In conjunction with the recordings of sleep, the
page number when a blood sample was taken was converted
into min after the first onset of sleep. This was done
by subtracting the number of the page, on the overnight
recording, when the subject first fell asleep from the
page number of the first blood sample. The difference
was/
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was then divided by the paper speed (calculated by
computer), to give the time that elapsed from sleep
onset in min. The same procedure was used to convert
all the page numbers when a blood sample had been
taken into min after sleep onset.
Graphs were plotted, for each subject, of the GH
concentration at the time in min after the first onset
of sleep. Wakefulness occurring after the first onset
of sleep was included in the calculations. Some of
the GH concentrations were below the sensitivity
threshold of the assay system and were reported as a
concentration of <(lmU/l. These results were plotted
on the graphs as equal to 0.5mU/l.
The area under the GH curves from sleep onset to
2
six hours later, was measured by a planimeter in cm
for each individual night. The vertical scale was
lcm/lmU/l of GH and the horizontal scale was 2cm/hour.
To average the GH results from all seven subjects,
the times when the blood samples were taken were
converted into minutes after sleep onset. This was
done for each subject on every blood night and then
the results were averaged for any one experimental
condition by collating all the samples taken during the
first 30 min, during 30.1 to 60 min after sleep onset
and so on in blocks of 29.9 min up to 390.1 to 420 min
after sleep onset. If any subject had had two blood
samples taken within one period, the average was used
in the calculation of the group mean.
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(ii) Plasma glucose concentrations
The plasma glucose (as well as plasma cholesterol
and triglycerides) were estimated by the Department of
Clinical Chemistry of the Edinburgh Royal Infirmary.
Plasma samples for estimation of the glucose
concentration were collected on some but not all nights
for each subject. The samples were later assayed, by
the method of Morley et al. (1968) and the concentration
expressed in mg glucose/lOOml plasma at the clock time
that the blood sample was taken.
(iii) Plasma cholesterol and triglyceride
concentrations
The cholesterol concentration (mg/lOOml plasma)
was measured in each sample and the results were
presented as the concentration at the clock time when
the sample was taken.
The cholesterol concentration was assayed by the
automated colorimetric method of Levine and Zak (1964).
The triglyceride concentration was estimated in each
plasma sample by the method of Kessler and Lederer
(1965). The results were reported in terms of the
triglyceride concentration (mg/lOOml plasma) at the time
on the clock when the blood was sampled.
To/
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To obtain means of the results from all seven
subjects for the plasma cholesterol and triglyceride
levels each blood night was divided into 30 min periods,
i.e. 2300h to 2330h; 2330h to 2400h and so on through
the night. The results from each subject, for each
constituent, were allocated to their appropriate 30 min
periods according to the clock time when the blood
sample had been taken. Thus, for example, all the
plasma triglyceride results for the early Horlicks
blood night were collected together into their
appropriate 30 min periods through the night. There¬
after the mean of each 30 min period was calculated.
The data for all the tables of means for the
thirds of the night (2300h to 0130h, 0130h to 0400h and
0400h to 0630h) were calculated by averaging all the
values of the particular blood constituent for each
subject sampled within the specified hours.
The data for the graphs of the mean levels were
achieved by dividing the night into a series of 30 min
periods as described above. An attempt was made to
sample blood every 30 min but occasionally it was
impossible to obtain a sample and so some of the 30 min
periods lack a value from one or more subjects and the
mean for that period was attained by dividing by a




t-tests for paired observations (Ferguson, 1959)
were used to compare the results of each of the treat¬
ments with the baseline values.
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RESULTS
(a) Nocturnal growth hormone concentration
Figure 4.1 shows the mean GH concentrations plotted
for the baseline period and during early and late
Horlicks administration. The mean concentrations are
plotted at the midpoints of the spans of time after
sleep onset over which the means were calculated i.e.
the mean of the GH values falling in the block of time
0 to 30 min after the first onset of sleep is plotted
on the graph at 15 min after the first onset of sleep.
Figure 4.2 similarly shows the mean baseline results
and those, during early and late nitrazepam
administration.
Table 4.1 shows the areas under these curves between
the onset of sleep and 360 min after first falling
asleep. Individual areas are presented to illustrate
the influence on the mean values of one subject (MT)
in particular, who contributed disproportionately to
the relatively higher GH values on the mean late drug
blood night. The areas under the individual subjects*
GH curves were used for statistical comparison of the
nocturnal GH responses under the different conditions.
There were no significant differences between either
of the treatments and their corresponding baseline





FIGURE 4.1 Mean nocturnal plasma growth hormone
concentrations before, near the beginning and near
the end of a 10 week period of taking a milk and
cereal food drink (Horlicks) every night.
Each value is the mean of 7 subjects.
Note: The graphs above have been photographically
reduced (x 0.72). The areas under each of the
curves is presented in Table 4.1 and refer to the
areas before photographic reduction.
For clarity the S.D. of each point on
the graph has been omitted but Table 4.1 gives an




min after sleep onset
FIGURE 4.2 Mean nocturnal plasma growth hormone
concentrations before, near the beginning and near the
end of a 10 week period of taking nitrazepam 5mg every
night.
Each value is the mean of 7 subjects.
Notes The graphs above have been photographically
reduced (x 0.72). The areas under each of the curves
is presented in Table 4.1 and refer to the areas before
photographic reduction.
For clarity the S.D. of each point on the
graph has been omitted but Table 4.1 gives an
indication of inter-individual variance.
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However, there does appear to be a trend of higher
values during nitrazepam administration. Six out of
seven subjects in the early drug period and five out
of seven during the late drug period had higher
values than baseline for their GH response graphs,
integrated from sleep onset to 360 min after the
first onset of sleep. Conversely there is an
indication of lower GH levels during Horlicks administ¬
ration, with six out of seven subjects having loxver GH
responses in the early food drink period and five out
of seven in the late drink period than on the baseline
blood night. However, the variance was high on all
these means and none of the differences were significant.
Table 4.2 shows the mean integrated GH responses sub¬
divided into the first 3h and second 3h after sleep
onset. No significant differences were found during
the first 3h after sleep onset for either Horlicks or
nitrazepam, when compared with their respective baseline
periods. Statistical comparison, by t-tests for paired
observations, of the GH responses, under the different
conditions, integrated from 180 to 360 min after sleep
onset showed that the GH responses during the early
drug period were significantly greater than those found
during the preceding baseline period. As this was the
only significant finding in all the integrated GH
results, and it is only at the 1 in 20 level of
significance, not too much weight should be given to it.
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(b) Nocturnal plasma glucose concentration
Samples for blood glucose estimation were not
taken under all conditions for all subjects, there¬
fore group means on the raw data are inappropriate.
Figures 4.3; 4.4; 4.5 illustrate the graphed results
of the three subjects who had had their blood sampled
for glucose estimation before and during Horlicks
administration. Figures 4.6; 4.7 show the individual
results for the two subjects who had their blood sampled
before and during nitrazepam 5mg administration. No
consistent pattern of change in nocturnal blood glucose
level can be seen either after taking Horlicks before
retiring to bed or during nitrazepam administration.
(c) Nocturnal plasma cholesterol concentration
Figure 4.8 shows the mean concentration of plasma
cholesterol at 30 min intervals through the night. The
group means are plotted at the midpoint of each 30 min
span. There appears to be a slight elevation through¬
out the night of plasma cholesterol when Horlicks had
been taken 30 min before bed, but no consistent changes
during nitrazepam administration. Table 4.3 shows the
lack of effect of both Horlicks and nitrazepam
administration on levels of plasma cholesterol through
the night.
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FIGURE 4.3 Nocturnal plasma glucose concentrations
of the female subject JR before, near the beginning
and near the end of a 10 week period of taking a
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FIGURE 4.4 Nocturnal plasma glucose concentrations
of the male subject MC, before, near the beginning
and near the end of a 10 week period of taking a
milk and cereal food drink (Horlicks) every night.
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FIGURE 4.5 Nocturnal plasma glucose concentrations
of the male subject JG before, near the beginning
and near the end of a 10 week period of taking a




























0500 h 0700 h
FIGURE 4.6 Nocturnal plasma glucose concentrations
of the female subject JR before, near the beginning
and near the end of a 10 week period of taking
nitrazepam 5mg every night.
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Subject MC ( 59 y)
plasma
glucose
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clock time
FIGURE 4.7 Nocturnal plasma glucose concentrations
of the male subject MC before, near the beginning
and near the end of a 10 week period of taking
nitrazepam 5mg every night.
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FIGURE 4.8
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0500 h 0700 h
(a) Mean nocturnal plasma cholesterol concentrations
before, near the beginning and near the end of a 10
week period of taking a milk and cereal food drink
(Horlicks) every night.
Each point on the graph is the mean of 7 subjects.
Notes For the sake of clarity the S.D. of each mean
value has been omitted. Table 4.3 gives an
indication of inter-individual variance.













(b) Mean nocturnal plasma cholesterol concentrations
before, near the beginning and near the end of a 10
week period of taking nitrazepam 5mg every night.
Each point on the graph is the mean of 7 subjects.
Notes Table 4.3 gives an indication of inter-
individual variance.
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(d) Nocturnal plasma triglyceride concentration
Figure 4.9 illustrates the elevation of plasma
triglycerides found after Horlicks had been taken 30 min
before bedtime. There was no such rise after nitrazepam
5mg. Table 4.4 shows the mean triglyceride levels
during the first, second and last thirds of the night,
t-tests for paired observations revealed that the plasma
triglyceride levels were significantly elevated during
the late Horlicks period, whether the means for the
whole night (2300 - 0600h), the first two-thirds of the
night (2300h - 0400h) or the first third (2300h - 0l30h)
were considered. Table 4.5 lists individual subjects
mean triglyceride levels subdivided into three sections
of the night before, at the beginning and after
prolonged nightly Horlicks administration.
(e) Lack of correlation between amount of time spent in
SWS and growth hormone output.
Table 4.6 shows the mean min of slow wave sleep
(SWS) accumulated by each subject in the first 6h of
sleep on the blood night recorded during the pre-drug
baseline period and the blood night recorded during
the pre-food drink period paired with the integrated
growth hormone response data (From Table 4.1). The mean
min of SWS were not significantly correlated with the
integrated growth hormone data on either the pre-drugs
r = -0.42, df = 5 (n.s.) or the pre-food drinks
r =s 0.35, df = 5 (n.s.) blood night.
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FIGURE 4.9
PLASMA TRIGLYCERIDES - HORLICKS
mg/100ml
clock time
(a) Mean nocturnal plasma triglyceride concentrations
before, near the beginning and near the end of a lO
week period of taking a milk and cereal food drink
(Horlicks) every night.
Each point on the graph is the mean of 7 subjects.
Notei For the sake of clarity the S.D. of each mean
value has been omitted. Table 4.5 gives an
indication of both intra and inter-individual variance.
PLASMA TRIGLYCERIDES - NITRAZEPAM
mg/100mt
200-
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50
2300h OlOOh ' 0300h ' 0500h ' 0700h
clock time
(b) Mean nocturnal plasma triglyceride concentrations
before, near the beginning and near the end of a 10 week
period of taking nitrazepam 5mg every night. Each point
on the graph is the mean of 7 subjects.
Note: Table 4.4 gives an indication of the inter-
individual variance.
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NOTE: The data for all the tables of means for the
thirds of the night were calculated by averaging all
the values of levels of the particular constituent
for each subject within the hours specified. The data
for the graphs of the mean levels were achieved by
dividing the night into a series of 30 min periods.
We tried to sample blood every 30 min but occasionally
it was impossible to obtain a sample and so some of
the 30 min periods lacked a value from one or more
subjects and the mean for that period was attained by
dividing by a number smaller than seven. This
difference in the method of calculation is the reason
why there is a discrepancy among the group means
illustrated in the graphs and the average of the
individual subjects' means shown in the tables.
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DISCUSSION
The design of this study allowed at least eight
weeks on both Horlicks and nitrazepam by the time of
the late treatment blood night and so any effects due
to chronic use were expected to appear by then.
Unfortunately, there was no blood night during with¬
drawal from either treatment. It would have been
interesting to see if the suggestion of an upward trend
in GH secretion during chronic nitrazepam use was
followed by a decrease or increase in GH response on
withdrawal of the drug. The trend of increased GH
during drug use was not significant and so any
speculations may be spurious but it is tempting to
think that an adaptive increase in GH secretion had
occurred during drug administration to offset some
detrimental effect of the drug and that on withdrawal
this adaptation would still be present and could thus
lead to a further increase in nocturnal GH release
when the drug was no longer present in the body.
In Chapter 3, it was reported that chronic
administration of nitrazepam 5mg led to a progressive
reduction in the total min of slow wave sleep (SWS),
however the present study showed that there was not
a parallel diminution in the nocturnal secretion of
growth/
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growth hormone. This finding is consistent with the
reports by other investigators, which I cited in the
Introduction to the present section. The apparent
independence of the amount of growth hormone secretion
from the amount of slow wave sleep under conditions of
drug administration, has been commented on before
(Rubin et al., 1974; Bixler et al., 1976) and suggests
that the relationship between the two is 'permissive*
and that there is not an obligatory rate of growth
hormone secretion associated with x min of SWS.
The lack of correlation between integrated plasma
GH levels and the total min of slow wave sleep (SWS)
has also been reported by Rubin et al. (1973b) and
Schnure et al. (1971) apd suggests that although the
two may be associated it must be a rather flexible
relationship.
It has been proposed by Carlson et al. (1972)
and Finkelstein et al. (1972) that there is an age-
related diminution in the GH peak during sleep.
Carlson et al. found that four out of six of their
subjects over 50 years old had no GH peak. All seven
subjects in our study were over 50y, but only one of
them consistently failed to show a GH peak during
sleep. This particular subject was overweight and his
body weight was 20% above the ideal for his height and
frame/
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frame size. Obese patients have been found to lack
the sleep-dependent GH peak (Kalucy et al.,1976) and
obesity may have accounted for the lack of GH peak
in some of the older subjects in the studies above.
The reduction in the GH peak after artificial
elevation of FFA (Lipman et al., 1972) may provide
a clue to the lack of GH peak in obese subjects for
studies on fat metabolism suggest that after a short
fast (overnight) an obese person tends to have a
higher plasma concentration of FFA than normal controls
(Bjorntorp et al., 1969).
Blood glucose levels were not consistently changed
by either Horlicks or nitrazepam. The absence of
effect of Horlicks may be due to the lack of dietary
restriction in the later evening. Some of the subjects
were taking a snack shortly before coming to the sleep
laboratory, on the nights that they knew they were not
to be given the food drink, and this might explain the
lack of influence of Horlicks on plasma glucose levels.
Horlicks has a fairly high fat content, especially
when made up in milk (approximately 20% fat) and this
probably accounts for the significant elevation of
plasma triglycerides after prolonged intake of the
food drink. It is interesting that there was no
associated rise in plasma cholesterol, as a high intake
of/
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of triglycerides is frequently blamed for elevations
in cholesterol levels. However with only seven
subjects one cannot make bold statements about causes
and effects.
High levels of plasma triglycerides have been
implicated in ischaemic heart disease (DHSS Report,
1974) and so the elevation of TG during Horlicks use
might be a contraindication for people at risk.
To conclude no significant effects of chronic
nitrazepam administration were found for nocturnal
plasma levels of triglycerides, cholesterol or blood
glucose. There were no significant differences among
the integrated growth hormone response curves but
there was a suggestion of increased growth hormone (GH)
secretion during drug administration, which might mean
there was a compensatory adaptation in the control of
GH levels.
Chronic use of Horlicks had no significant effects
on plasma GH, glucose or cholesterol, but there was a
significant elevation in triglycerides through the
night, which suggests that Horlicks at bedtime should
be avoided by patients liable to arteriosclerotic
vascular disease.
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TA3LE 4.1. THE EFFECTS OF BEDTIME EATING AND OF NITRAZEPAM
ON THE NOCTURNAL COMPOSITION OF PLASMA.
The integrated growth hormone response (GHR).
Each value for each of seven subjects is the area (cm*) under the GER
curve from sleep onset to 360 min after sleep onset on one blood night.
1 cm2 = 30 mU/$-min














MC 30.8 64.8 42.0 30.8 47.0 65.8
JG 7.0 6.4 6.0 7.4 .9.8 12.8
GJ 37.6 14.0 8.6 21.0 14.0 24.8
DJ 22.2 9.4 31.0 16.2 17.6 6.0
RMcD 38.2 17.0 16.8 25.4 30.4 20.8
JR 29.6 12.8 19.6 22.6 36.6 47.6
MT 32.8 19.6 18.4 7.6 16.6 77.8
Mean 23.3 20.6 20.3 18.7 24.6 36.5
- S.D. -10.8 -20.0 -12.5 - 8.8 -13.7 -27.6
t - tests for paired observations: df « 6 (2-tailed).
a) IIORLICKS
baseline v early drink: t = 1.03 (n.s.)
baseline v late drink : t = 1.40 (n.s.)
b) NITRAZEPAM
baseline v early drug : t = 1.95 (n.s.)
baseline v late drug : t « 1.68 (n.s.)
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TABLE 4.2. TEE EFFECTS OF BEDTIME FATING AND OF NITRAZEPAM ON THE
NOCTURNAL COMPOSITION OF PLASMA.
The integrated growth hormone response (GhR) sub-divided into the first
3h and the second 3h after sleep onset.
(a) First 3h after sleep onset.
Each value is the mean area (cm2) under the GHR curve from sleep onset to
"180 min after sleep onset. The mean calculated using data from 7 subjects.
HORLICKS NITRAZEPAM
Mean area - S.D. Mean area - S.D.
baselines 21.1 - 10.5 baseline: 14.7 - 8.3
early drink: 14.8 - 21.0 early drug: 17.6 - 13.3
late drink: 12.8 - 11.3 late drug: 30.8 - 27.9
t - tests paired observations: d£ ° 6 (2-tailed).
baseline v early drink: t m 0.82(n.s.) baseline v early drug: t • 0.95(n
baseline v late drink: t ■ 1.78(n.e.) baseline v late drug : t «• 1.50(n
(b) Second 3h after sleep onset.
Mean areas (cm2) under GHR curves from 180 min after sleep
onset to 360 nin after sleep onset
HORLICKS
Mean area - S.D.
baseline: 7.2 - 5.1
early drink: 5.8 - 3.9
late drink: 7.6 - 4.9
t - tests for paired observations: df
baseline v early drink: t * 0.72(n.s.)
NITRAZEPAM
Mean area - S.D.
baseline: 4.0 - 1.7
early drug:7.0 - 3.8
late drug: 5.7 - 4.4
6 (2-tailed).
baseline v early drug: t = 2,83
p(0.05
baseline v late drink: t = 0.17(n.s.) baseline v late drug: t = 1.55(n.
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TABLE 4.3. THE EFFECTS OF BEDTIME EATING AND OF NITRAZEPAM ON THE
NOCTURNAL COMPOSITION OF PLASMA.
Plasma cholesterol levels before and during both Horlicks and nitrazepam
administration.
Each value is the mean - S.D. of 7 subjects for the plasma cholesterol level
(mg/100 ml plasma) over the particular 2£h sector of the night.
Mean cholesterol level (mg/100 ml)
2300 - 0130h 0130 - 0400h 040G - 0630h
Mean baseline 217.1 - 35.5 212.4 - 34.4 zlO.63 - 39.9
early drink 210.9 - 49.0 211.2 - 50.8 211.2 - 49.7





189.5 - 17.7 195.6 - 24.2
213.6 - 56.2 211.5 - 51.0
No significant differences were found between baseline values and either
treatment.
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TABLE 4.4. THE EFFECTS CF BEDTIME EATING AND OF NITRAZEPAM ON THE
NOCTURNAL COMPOSITION OF PLASMA.
Plasma triglyceride levels before and during both Horlicks and nitrazepam
administration.
Each value is the mean - S.D. of 7 subjects for the plasma triglyceride (TG)
level (mg/100 ml plasma) over the particular 2jh sector of the night.
Mean TG level (rag/100 ml) in the three sectors of the night
2300 - 0130h 0130 - 0400b 0400 - 0630h

























t - tests for paired observations: df = 6
KORLICKS:
a) Mean level 2300h - 0130h
Baseline v early drink t 35 0.69 (n.s.)
Baseline v late drink t - 1.97, p^0.05, 1-tailed
b) Mean level 2300h - 0400h
Baseline v early drink t S3 1.07 (n.s.)
Baseline v late drink t - 2.30, p<(0.05, 1-tailed
c) Mean level 2300h - 0630h
Baseline v early drink t S3 0.90 (n.s.)
Baseline v late drink t as 2.23, p<0.05, 1-tailed
NITRAZEPAM:
No significant differences were found between the baseline values and either
early or late drug results (2-tailed level).
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TABLE 4.5. THE EFFECTS OF BEDTIME EATING ON THE NOCTURNAL COMPOSITION OF
PLASMA.
Individual subjects' plasma triglyceride levels before and during Horlicks
administration.
Each value is the subject's mean - S.D. plasma triglyceride (TG) level
(mg/lOOml plasrra) over the particular 2{h sector of the night. The majority
of values for each of 7 subjects are the mean of 5 estimations.
Mean TG level (mg/lOOml plasma)
































































































































































* Only one sample taken from this subject in this sector of the night
owing to technical difficulties.
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TABLE 4.6. THE EFFECTS OF BEDTIME EATING AND OF NITRAZEPAM ON THE
NOCTURNAL COMPOSITION OF PLASMA.
Lack of correlation between the total rnin of slow wave sleep (stages 3+4)
accumulated in the first 6h of sleep and the nocturnal growth hormone
output integrated over the first 6h of sleep.
The slow wave sleep (SWS) data for each baseline blood night is paired
with the corresponding growth hormone (GH) data for each of 7 subjects.
Baseline blood nights











MC 27.8 30.8 12.1 30.8
JG 72.9 7.0 32.3 7.4
GJ 102.7 37.6 88.8 21.0
DJ 89.3 22.2 74.6 16.2
RMcD 150.8 38.2 67.1 25.4
JR 48.1 29.6 57.1 22.6
MT 99.4 32.8 107.6 7.6
Correlation coefficient (r) between min of SWS and the integrated GH
output on:
(a) Pre-food drink blood night: r ■ 0.35, df » 5 (n.s.)
(b) Pre-drug blood night: r - ~°'^2>df - 5 (n.s.)
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16 middle-aged subjects had their sleep recorded
for five nights under each of four conditions of
bedtime intakes
A placebo capsule, milk, Horlicks and a drink
formulated to be nutritionally equivalent to Horlicks
but containing no milk or cereal.
None among the three food drinks had any
significant effect on sleep when compared with sleep
after the capsule, but Horlicks was associated with
significantly less broken sleep than either of the
other two food drinks.
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INTRODUCTION
In Chaper 2, I reviewed a number of papers which
indicated that bedtime nutrition can influence sleep
and in particular that a combination of milk and cereal
taken prior to sleep may lead to a less restless night
than after other forms of nourishment (Laird and
Drexel, 1934; Kleitman et al., 1937). The proprietary
brand of malted milk and cereal food drink, Horlicks,
is such a combination and earlier studies indicated
that when taken prior to bedtime, it too, diminished
the amount of restlessness through the night (Southwell
et al., 1972), reduced the min of waking interrupting
sleep and extended the total duration of sleep
v /
(Brezinova and Oswald, 1972). In neither of these two
recent studies was a comparison made between Horlicks
and any other form of nourishment. The obvious
comparison is between Horlicks and milk, as Horlicks
powder is normally added to milk. B^ezinova and Oswald
considered this comparison but rightly discarded the
idea on the grounds that had no difference in sleep been
found after milk compared with Horlicks, then they would
not have known whether neither nor both were influencing
sleep. In the light of the studies referred to above,
the equivocal results of others (Giddings, 1934) and the
negative/
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negative results reported by Hamilton et al. (1966)
and by me in Chapter 3, Part 3, it was of interest
to undertake a further study of the influence of
bedtime eating on sleep. In view of the lack of
effect of Horlicks on the sleep of subjects whose
food intake was not limited in any way (Chapter 3),
I decided to revert to the more controlled experimental
approach and to restrict my subjects' evening eating
V /
and drinking to before 1900h, as Brezinova and Oswald
(1972) had done.
This experiment was designed to investigate a
number of questions which have arisen out of the
previous studies into nutrition and sleep, e.g.
(1) Are different forms of nourishment better than
nothing to eat at bedtime in reducing waking through
the night?
(2) Is a milk and cereal combination at bedtime (in
the form of Horlicks) better than milk alone in
promoting a less broken and longer lasting sleep period?
(3) Would a food drink having an identical basic
composition of carbohydrate, fat, protein and
contributing an equal number of calories, but not made
from any cereal of dairy products, differ from Horlicks
in its influence on subsequent sleep?
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METHODS
(a) Subjects and treatments
Sixteen healthy volunteers of mean age 59 years
(range 52 to 67) took part in the experiment. They
were asked not to take any alcohol and to keep their
times of going to bed and of arising in the morning
as constant as possible. In addition, subjects were
instructed not to eat or drink anything after 1900h,
except the treatment given them, for the 15 weeks that
each was involved in the experiment.
The four treatments compared were:
(A) A yellow placebo capsule taken with a little
water. This treatment was to represent the no
bedtime nourishment condition. Subjects were
told that the capsules contained a herbal
preparation, which would help them sleep.
(B) Flavoured drink, a powdered mixture (specially
formulated by Beecham Products Ltd of soya flour,
dried whole egg and glucose syrup solids, which
when mixed with 250ml of hot water, was
equivalent in energy (1260KJ or 300kcals),
protein (12.8g), carbohydrate (34.9g) and fat
(12.1g) content to treatment (D), Horlicks.
(C) /
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(C) Whole fresh milk (280ml) estimated to be equivalent
to 800KJ or 190 kcals.
(D) fHorlicks» powder, a proprietary brand of malted
barley, wheat flour and triple concentrated full
cream milk. 30g of the powder was mixed with 250ml
of fresh whole milk which together contained about
1260KJ or 300 kcals.
Treatments (B), (C) and (D) were all made up as hot
drinks and taken by the subjects at the temperature they
preferred.
(b) Experimental design.
Each of the 16 subjects took all four treatments
during the 15 weeks they were involved in the experiment.
The order they took the treatments was according to a
4x4 Latin square designs
Treatment
order Subjects
B A D C A.W. J.R. M.T. G.J.
C D B A M.W. J.G. R.McD. M.S.
D C A B A.H. G.H. F.C. R.R.
A B C D K.B. W.H. M.C. F.W.
Subjects attended the laboratory in pairs, always
differing in the treatment they received, starting with
the first pair A.W. and M.W. and so on down each row
finishing with pair R.R. and F.W. Each treatment was
taken at about 2200h every night for a total of 21 nights.
The/
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The experimental design was such that subjects
took each treatment at home every night for 15 days
before coming to the sleep laboratory to be recorded
electrophysiologically on six consecutive nights.
On each laboratory night subjects had nine silver disc
electrodes attached to their skin. Two pairs of
electrodes above and below the outer canthi of the
eyes recorded two channels of electro-occulogram (EOG),
two parieto-occipita.1 electrodes gave a channel of
electroencephalogram (EEG) and two submental electrodes
measured muscle tone (EMG). The ninth electrode served
as an earth. Recordings began at 22l5hi 15 min and
terminated at 0700hi 15 min. The times for lights-off
and for arising in the morning for each pair were
selected to fit in with work commitments and their usual
pattern of life, but all subjects were recorded for an
equal length of time i.e. 8.75h and for any pair of
subjects the times for lights on and off were kept the
same on all 24 attendances at the sleep laboratory.
Subjects slept in comfortable beds in sound-attenuated
bedrooms and the temperature was thermostatically
controlled. The laboratory bedrooms have no windows,
but a dimmer switch on the bedroom lights allowed
volunteers to have some light if they so wished. At
the beginning of the experiment subjects were asked
what/
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what type of bedding they preferred, either blankets
or continental feather quilts and on all nights at
the laboratory they had the same bedding.
For each treatment the experimental design was:
Weeks 1 and 2 Subjects took their treatment on each
of 15 nights at home
Week 3 1 adaptation night and 5 recording
nights at the laboratory on treatment
Week 4 At home - no treatment
The above four week regime was repeated for each
of the three other treatments except the last when week 4
was not included, making 15 weeks in all. The six
consecutive nights at the sleep laboratory were always
Monday to Saturday. The Monday nights were for adapt¬
ation and have not been included in the results. On the
first and last nights of attendance on each treatment
subjects were weighed in light indoor clothing on a beam
balance by the experimenter. Their weights (in stones
and lbs) were obtained by moving the poises along the
weighing beam until it was hanging horizontally and the
positions noted to the nearest ^lb. Each subject was
thus weighed on eight occasions.
Only once during a six-night run was a subject
unable to attend owing to illness. On that occasion
the subject continued to take his treatment until the
following week when, after another adaptation night,
the missing recordings were made.
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(c) Reading of electrophysiological records.
The 20 electrophysiological recordings made for
each subject were coded by another person so that when
the records were read at the end of the sxperiment,
the scorer was unaware of the experimental condition.
The criteria of Rechtschaffen and Kales (1968) was
used to score the records. In the case of one subject
(subject M.C.) the minimum voltage requirement for
stages 3+4 was reduced from 75uV to 40 uV. This 60
year old subject had periods of slow waves which were
quite distinct from stage 2 but never attained the
75uV criteria for slow wave sleep.
The records were read visually by me, page by
page and categorized into the various sleep stages
according to the criteria above. This sequence of
sleep stages and page numbers were then punched on to
computer cards and with the aid of a computer programme
these raw scores were converted into the number of min
awake and in each of the sleep stages (1,2,3,4 and REM
sleep) in the accumulation of each successive hour of
sleep.
Wakefulness was treated as intruding into sleep
and was not included in the calculation of each
successive hour of sleep, so it may take more than 60
min on the 'clock* to achieve one hour of sleep, e.g.
it/
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it may take 130 min on the clock to accumulate 60 min
of sleep if 70 min of wakefulness interrupted that
hour of sleep. The 70 min could be one or many periods
of waking. Wakefulness such as this, which occurs
within sleep is termed * intervening wakefulness*, to
differentiate it from wakefulness occurring before
the onset of sleep or after the sleeping period has
ended in the morning and before the recording has
finished. The latter will be called 'morning wake-
time*. The computer programme also calculated the
total time the subject was asleep during the recording-
total sleep time, how long it took him/her to fall
asleep after the recording began - sleep onset latency,
the latency from sleep onset to the first appearance
of REM sleep - REM latency, and the number of times
that the subject's sleep shifted from any stage of
sleep to another particular stage of sleep or wakeful¬
ness, in each successive hour of sleep.
(d) Calculations using sleep data.
(i) Whole night measures
For each individual subject the mean of the
5 recorded nights on each treatment was calculated for
total time asleep, latency to sleep onset, latency to
the first appearance of REM sleep, the total amount of
time spent awake after first falling asleep and until
lights/
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lights on in the morning (intervening wakefulness plus
morning wake-time), the mean total min spent in each
of the sleep stages 1,2,3,4 and REM. The mean total
number of times that a subject awoke or shifted sleep
stage into stage 1 while taking each treatment was
also calculated.
Grand means for each of the four treatments were
obtained by averaging the 16 individual mean scores
for each treatment. This procedure was carried out
for all the whole-night sleep measures listed above.
For statistical analysis of these whole-night measures
I employed data in the form of the subjectrs individual
mean totals for each treatment.
(ii) Hour/hour analysis of sleep data.
The computer printed out an analysis of the number
of min spent in each of the sleep stages 1,2,3,4 and
REM, and the number of shifts of sleep stage to stage 1
and awake in each successive 60 min period of
accumulated sleep.
Intervening wakefulness, as described earlier,
was treated as an interruption of sleep and was
calculated in terms of the min of wakefulness which
occur in the accumulation of each successive hour of
sleep. The amount of time spent in each of the sleep
stages/
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stages, wakefulness and the number of shifts of sleep
stage in each hour of accumulated sleep was analysed
by collecting together the data from all 16 subject-
nights for each of the nights: capsules 1,2,3,4 and 5
and similarly for the other sets of five nights for
the three other treatments. In this way all 16
subjects first, second, third and so on hours of
sleep on each particular night of a treatment were
brought together. This was carried out for all the
sleep measures listed above. Thereafter, the mean
number of min were calculated for each of the sleep
measures, for the first, second, third and so on
hours of sleep.
Most subjects achieved at least six hours of
sleep on treatment nights, however, when an individual
subject slept for less than six hours, the following
procedure was carried out. For example, if the
subject slept for 5h 45min then his sleep data for
the incomplete sixth hour of sleep was included in the
sixth hour total for all 16 subjects. When the mean
for the sixth hour was calculated the division would
be by 15.75 instead of 16. If several subjects
failed to sleep for six complete hours, then the
divisor was calculated by adding the number of complete
sixth hours plus all the decimal fractions of an hour
and then dividing the grand total min of the
particular sleep stage measured in that sixth hour
by the calculated divisor.
For/
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For statistical purposes a different method of
extrapolation had to be employed. The statistical
tests used in the analysis of this data involved the
comparison of individual subjects* means, for example,
when the amounts of intervening wakefulness interrupt¬
ing the first 6h of accumulated sleep were compared
among conditions, the individual totat of intervening
wakefulness were added up for the first 6h of sleep on
each of 20 nights for each subject. If on any night
a subject did not achieve 6h of sleep then the total
he achieved was extrapolated to 6h, e.g. if a total
of 40 min of wakefulness interrupted a total night*s
sleep of 5h 30 min then this was extrapolated to 6h
of sleep by multiplying 40 min by = 43.6 min.
This method of extrapolating intervening wakefulness
was considered superior to merely extrapolating the
final incomplete hour of sleep to 1 hour. Similar
extrapolations were done, where necessary, for min
in stage 1 and 2 and shifts of sleep stage to awake
plus shifts to stage 1. If a subject did not achieve
6h of sleep then the amount of REM sleep in the first
6h of sleep was obtained by extrapolating the min of
REM sleep in hours 4 to 6 of sleep and adding this
to the min recorded in hours 1 to 3. This method was
employed because the majority of REM sleep occurs in
the/
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the later night. No extrapolation procedure was
employed for SWS as it mostly occurs in the early
night and so for nights when less than 6h of sleep
were achieved the individual's whole night total
for min in SWS was used in the calculations.
Thereafter, the results from the five nights on
each treatment were averaged for each subject and
these individual means used in the statistical tests.
(e) Subjective ratings.
During the entire experimental period subjects
rated their daytime anxiety and in the morning made
an assessment of the quality of their sleep and how
alert and refreshed they felt after that night's sleep.
Subjective ratings were made using analogue scales,
where ratings were made by putting a mark on a 100mm
line. The mid-point on the line was to represent
their 'average' state and deviations from usual as
marks to the left or right of the mid-point. The mid¬
point was a hypothetical point on the line and its
position was not indicated. Sleep quality ranged
from 'worst ever' on the extreme left end of the line
to 'best ever' on the extreme right hand end of the
line. The subjective anxiety rating form was
similarly designed such than an extremely anxious
state/
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state was represented by the left hand end of the line
and an extremely calm state by the right hand end,
whereas the subjective rating form to assess morning
vigilance had its extreme poles reversed so that the
more 'positive' state of alertness was placed at the
left side and the more 'negative' feelings of
sluggishness were represented by the right hand side
of the line.
The distance from the left hand end of the line
to the mark made by the subject was subsequently
measured in mm. The mean subjective rating in mm
was calculated for each subject for the 15 days that
he/she was taking the treatment at home prior to
attending the sleep laboratory. The mean ratings were
also calculated for the six days when they slept at
night in the laboratory and the mean total of the 21
consecutive days over which a subject took a treatment
were also calculated and this was done for all four
treatments. The individual mean scores were used for
statistical analysis. Subjective ratings were also
collected for continuity during weeks 4,8,12 of the
experiment when subjects slept at home and took no




The approach I used in the statistical analysis of
this study is best explained in conjunction with the
table below which summarizes the attributes of bedtime
nutrition that were to be comparedj-
(i) (ii) (iii)
Contains Contains milk Contains about
calories and cereal 300 calories
Capsules NO NO NO
Flavoured drink YES NO YES
Milk YES NO NO
Horlicks YES YES YES
As mentioned in the Introduction of this chapter, the
previous studies into the influence of food on sleep
generated certain questions, e.g.
(a) Does bedtime nutrition improve sleep? To investigate
this, I compared the results from each of the three bed¬
time food drinks, in turn, with capsules using correlated
t-tests (Ferguson, 1959).
(b) Does the number of calories make any difference?
Comparison between Horlicks and milk were carried out,
again using correlated t-tests.
(c) Does the source of the calories matter? To investi¬
gate this I compared the iSo-caloric food drinks,
Horlicks and flavoured drink, using correlated t-tests.
Evidence from the literature suggested the pre¬
diction that bedtime nourishment in the form of milk and
cereal would be more likely to improve subsequent sleep
than other forms of nourishment and thus a 1-tailed level
of/
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of significance could justifiably be used for comparisons
between Horlicks and each of the other bedtime treatments.
Three specific predictions were made:-
(L) That Horlicks would be better than capsules was
predicted from both the Brezinova and Oswald (1972) study
and Kleitman et al. (1937).
(2) That Horlicks would be better than milk was predicted
from Kleitman et al. (1937).
(3) That Horlicks would be better than flavoured drink was
predicted from both Laird and Drexel (1934) and Kleitman
et al. (1937).
I realise that if many t-tests are carried out then
the probability of getting a significant result by chance
alone, is increased, i.e. the probability of at least one
comparison out of three being significant at the 5% level
by chance alone is 14.26%. The probability of two out of
three reaching the 5% level of significance by chance is
0.725% and the probability of all three of my predictions
being significant at the 5% level by chance alone is
negligible, i.e. 0.0125%.
Two other comparisons were made, i.e. sleep after
milk with sleep after capsules and sleep after flavoured
drink compared with sleep after capsules. No specific
prediction was made for either comparison but evidence
from the Kleitman et al. (1937) study suggests that sleep
after milk would not be significantly different from




(a) Comparison of each of the food drinks with capsules.
(i) Whole night measures.
There were no significant differences in the mean
total time that subjects were asleep when any one of
the food drinks had been taken at bedtime in comparison
with their sleep after capsules (Table 5.1). Similarly,
there were no significant differences between any of the
three bedtime drinks when compared with capsules in the
mean total min of wakefulness occurring after the first
onset of sleep and before the end of the recording in
the morning (Table 5.2).
The mean total number of min spent in stage 1 sleep,
stage 1 sleep plus total wakefulness after sleep onset,
sleep stage 2, stages 3+4 and REM sleep were unchanged
by taking any of the three bedtime food drinks when
compared with the distribution of sleep during the
nights recorded when the capsules were being taken
(Tables 5.3; 5.4; 5.5; 5.6 and 5.7 respectively).
(ii) Totals accumulated in the first 6h of sleep.
The mean min spent awake in the accumulation
of the first 6h of sleep were not significantly
different when the results from each of the food drinks
were compared with the means of the nights when subjects
had the capsules (Table 5.8). Neither were the results
significantly/
- 201 -
significantly different when the min of intervening
wakefulness were combined with the min spent in stage
1 (drowsiness) (Table 5.9).
Flavoured drink tended to impair sleep, compared
with capsules, in that intervening wakefulness and
intervening wakefulness plus stage 1 were increased.
However, this was not significant (Tables 5.8; 5.9).
Bedtime nutrition did not appear to influence the
mean min of stages 3+4 (Table 5.10) or mean min of
stage REM sleep in the accumulation of the first 6h
of sleep (Table 5.11), when each of the three bedtime
drinks was compared with capsules.
The mean number of times that subjects shifted
their sleep stage into stage 1 or awake in the first
6h of sleep were combined and together were found not
to differ significantly between the four bedtime
treatments (Table 5.12).
(iii) Totals accumulated in the first 3h of sleep.
Comparisons between the mean min of intervening
wakefulness (Tables 5.13 and 5.14) stages 3+4 (Table
5.10) and stage REM (Table 5.15) accumulated in the
first 3h of sleep did not differ significantly when
the results from each of the three bedtime food drinks
were compared with those recorded during the
administration of the capsules.
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(b) Comparison of the three bedtime drinks with each
other.
(i) Whole night measures
There were no significant differences between the
three bedtime drinks in the mean total min spent asleep
(Table 5.1). Horlicks compared with flavoured drink
was associated with fewer total min awake between the
first onset of sleep and the end of the recording
(Table 5.2) and less stage 1 plus total min waking
after sleep onset (Table 5.4) but because in both cases
only one out of three of my predictions was fulfilled,
only the latter comparison was considered to be
significant.
The three bedtime food drinks did not differ in
the mean total min spent in stage 1 (Table 5.3), stage
2 (Table 5.5),stages 3+4 (Table 5.6) or stage REM sleep
(Table 5.7) accumulated during the whole night.
(ii) Totals accumulated in the first 6h of sleep.
Horlicks at bedtime significantly reduced inter¬
vening wakefulness (Figure 5.1 and Table 5.8) and
intervening wakefulness plus stage 1 (Figure 5.2 and
Table 5.9) in the first 6h of sleep when compared
with both flavoured drink and with milk. The mean min
spent in slow wave sleep (stages 3+4) (Table 5.10) and
REM sleep (Table 5.11) in the first 6h of sleep did
not/
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FIGURE 5.1 Mean cumulative min of intervening
wakefulness occurring in the first 6h of sleep
in 16 middle-aged subjects.
Each subject was recorded for 5 nights
under each condition.
Statistical analysis and a measure of the inter-
individual variance in Table 5.8.
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successive hours of sleep
FIGURE 5.2 Mean cumulative min of intervening
wakefulness combined with the mean cumulative min of
stage 1 (drowsiness) in the first 6h of sleep in 16
middle-aged subjects.
Each subject was recorded for 5 nights
under each condition.
Statistical analysis and a measure of the inter-
individual variance in Table 5.9.
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not differ among the three bedtime food drinks.
Neither did the mean number of transitions of sleep
stage into stage 1 plus shifts to wakefulness in the
first 6h of sleep differ significantly among the
three food drinks (Table 5.12).
(iii) Total intervening wakefulness occurring in
the first 3h and second 3h of accumulated sleep.
The improvement in sleep, when Horlicks had
been taken at bedtime, appeared to be greater in the
first 3h of sleep than the second 3h. Intervening
wakefulness after Horlicks when compared with both
milk and flavoured drink was reduced more during
the early hours of sleep than in the later half
(Tables5.13; 5.14). No prior prediction to this
effect had been made and so 2-tailed tests were
employed. The comparison between Horlicks and
flavoured drink for the first 3h totals only reached
the 5% level of significance and thus was not
considered to be significant.
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(II) Subjective Measures
No significant differences were found for any
of the mean subjective ratings among the four
experimental treatments (Tables 5.16; 5.17; 5.18).
This was true if the data was in the form of the
means of the entire 21 days on each treatment, the
15 days on each treatment at home prior to attending
the sleep laboratory, or if only the six laboratory
nights alone were considered.
(Ill) Body Weight Measurements
Table 5.19 illustrates that subjects' body
weights changed little over the 13 weeks of attendances




Older subjects were selected to take part in this
study for the same reason indicated in the previous
Chapters, namely, on average they do not sleep as well
as younger people and thus there is more scope for
improving their sleep.
B^ezinova and Oswald (1972) suggested that the
beneficial effect of Horlicks on sleep increased with
serial administration and because of this, I asked my
subjects to take a treatment every evening for the 15
days preceding the six attendances at the laboratory.
In addition this regime meant that the sleep recordings
were made when subjects were used to taking their
treatment and any novelty value of a treatment would be
diminished. However, this design may also have re¬
duced any likelihood of showing that sleep after a
bedtime snack would be less broken than sleep after an
acaloric capsule and so if some subjects had found that
they felt hungry during the night in the 'at home'
period on capsules they could adapt their eating
pattern by having an unusually large evening meal to
compensate for the lack of an evening snack without
breaking the "no eating/drinking after 1900h" rule. I




The subjects were weighed frequently during the
study because changes in body weight have been
associated with changes in the nightly duration of
sleep. Crisp et al. (1973), reported that obese
patients slept less as they lost weight and Crisp
et al. (1971) and Lacey et al. (1975) found that
anorexia nervosa patients slept longer as their
weight was regained. Further evidence for this
relationship was revealed in a study that involved
interviewing 375 psychiatric out-patients where
Crisp and Stonehill (1973) found on correlation
analysis of the answers that a report of loss of
body weight was associated with shorter sleep
duration and that a gain in weight correlated with an
increased amount of sleep. Fortunately, there ware
only small fluctuations in the weights of my subjects
and so changes in weight were unlikely to have
contributed appreciably to the changes in sleep.
The results from the recordings of sleep were
not completely as expected in that the comparisons
between each of the food drinks with capsules showed
no significant differences on any of the measures
investigated. Looking at the results from 20 nights
I noticed that some subjects did consistently sleep
better after milk or Horlicks compared with capsules,
whereas/
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whereas others slept best after capsules, and certainly
during the experiments some of the subjects said they
felt hungry on the nights they had capsules, whereas
others complained of feeling over-full after half-a-
pint of food drink. This led me to think that the
usual dietary habits of subjects must, in part,
determine whether their sleep is improved or disrupted
by taking food at bedtime. The next Chapter (6) is
about my attempts to clarify this problem and I discuss
it in more detail there.
In retrospect, it appears that the original
intention of the experiment, which was to compare the
effects on sleep of four different types of bedtime
nutrition, was complicated by the fact that the form
of presentation of the four treatments were not
comparable, i.e. the three types of bedtime food were
taken as hot liquids whereas the no nourishment
condition was a capsule.
Comparisons between Horlicks and the other two
food drinks (flavoured drink and milk) did reveal
significant differences on measures of the disruption
of sleep by waking. Presumably, this is because the
factor of dietary habit is reduced, in that all three
drinks comprised half a pint of warm, nourishing
liquid and so might be considered equally good or
bad depending on bedtime nutritional predilections.
Thus/
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Thus any differences in their effects on sleep were
more likely to be due to differences in their
nutritional content and so the following tentative
conclusions are made, based on the comparisons between
Horlicks and each of the two bedtime drinks:
Flavoured drink tended to impair sleep, although not
significantly. Soya products are perhaps unfamiliar
to subjects or they could have caused gastrointestinal
distress by increasing the flatus volume (Rackis,
1974).
Interruptions of sleep by periods of waking were
less after Horlicks than after either flavoured drink
or milk. The superiority of Horlicks over flavoured
drink suggests that the source of calories is important
for the effects on sleep, for flavoured drink and
Horlicks contained the same number of calories and
percentages of protein,carbohydrate and fat. However
this conclusion must be tempered by the suggestion
above that the flavoured drink may be less easily
digested. Laird and Drescel (1934) found that an
easily digested milk and cereal snack at bedtime was
associated with fewer body movements during subseauent
sleep than after a less easily digested snack at
bedtime. The differences I found in sleep after
Horlicks and after flavoured drink are thus comparable
to/
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to their findings. Several of the subjects complained
that they did not like the taste of the flavoured drink
and so palatability may also be a factor in this
comparison.
The comparison between Horlicks (made up with
milk) and milk showed that there was less intervening
wakefulness when Horlicks had. been taken at bedtime.
In retrospect it would have been of interest to have
mademilk and Horlicks iso-energetic by enriching the
milk with the equivalent of about 100 calories of
either powdered or condensed milk.
No effects of bedtime nutrition were found on
the min accumulated of either slow wave sleep or REM
sleep, whether the first 3h, 6h or total sleep time
were considered. Phillips et al. (1975) suggested that
changes in the carbohydrate and fat content of the diet
might influence the total amount of REM sleep in that a
high carbohydrate/low fat diet was associated with higher
levels of REM sleep than a low carbohydrate/high fat
diet. The diets were iso-energetic and the percentages
of protein were the same. However, they altered the
entire daily intake of food, whereas I only altered
a relatively small part, amounting to no more than 300
calories of the daily intake.
Siegel (1975) found that the amount of REM sleep
that cats accumulated during daytime sleep was
negatively/
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negatively correlated with the amount of food that
the cat ate during the following 12h. In my
experiment, taking food at bedtime did not appear to
reduce the amount of REM sleep when food-drink nights
were compared with nights after capsules, however no
measure was made of the food intake of subjects over
the days that they came to the laboratory at night
and subjects may have been consciously reducing or
increasing their daytime intake depending on which
treatment they were to take at bedtime, and thus
subjects1 overall caloric intake would be little
affected. It would be very interesting to see if
there was a relationship between the amount of REM
sleep at night and the next day's caloric intake in
man. I suspect that social cues may be more important
than internal ones in humans, but it might be possible
to detect a relationship in babies on a "feeding on
demand" schedule where their internal drives determine
their food intake.
To conclude, in some subjects, sleep appeared to
be less broken after either milk or Horlicks when
compared with sleep after capsules, whereas other
subjects slept better after capsules (or worse after
food at bedtime , depending on your point of view) and
because of this all the comparisons between the food
drinks/
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drinks and capsules were insignificant. I speculated
that differing dietary habits among the subjects was
responsible for this and thus comparisons between
Horlicks and the other two bedtime food drinks were
made in order to study the effects on sleep of
differing nutritional composition and energy content.
The comparisons of Horlicks with flavoured drink and
with milk demonstrated that sleep after Horlicks was
less broken than after either of the other two drinks
and so possibly the amount and the source of calories
does matter. However, some subjects found the
flavoured drink unpleasant and so palatability may
also be a factor.
I had made three predictions. One prediction
that sleep after Horlicks would be less broken by
wakefulness than sleep after capsules, was not
confirmed. However, the two other predictions that
sleep after Horlicks would be less broken than after
either milk or flavoured drink, were both confirmed.
Probability theory showed that the likelihood of two
out of three predictions reaching a p<0.05 criterion
by chance alone, is remote.
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TABLE 5.1. COMPARISON OF FOUR BEDTIME TREATMENTS: WHOLE NIGHT
MEASURES. :Mean total time asleep (min). Each value for each of
subjects is the mean of 5 consecutive nights.
Mean min total sleep time
Subjects Capsules Flavoured drink Milk Eorlicks
KB 441.0 457.6 439.0 442.3
MC 412.5 392.5 361.7 371.9
FC 475.5 481.3 488.2 477.7
JG 426.3 433.8 477.1 429.6
GH 458.4 465.6 476.1 487.8
AH 470.0 461.0 486.1 477.6
WH 448.7 439.9 466.2 444.3
GJ 499.2 501.3 505.2 504.3
RMcD 435.7 387.6 466.6 465.5
JR. 422.4 433.0 441.7 442.4
PJl 495.6 457.7 491.6 496.6
MS 454.4 429.7 414.2 437.7
MT 446.3 420.8 456.0 453.1
FW 473.4 428.7 453.8 459.8
AW 452.0 488.7 482.8 476.6
MW 470.1 468.8 402.6 435.3
Mean 455.1 446.8 456.8 456.4
-S.D. -24.8 -32.0 -37.8 -32.1
t-tests for paired observations between planned comparisons: df »
(2-tailed).
Flavoured drink Milk Horlicks
Capsules t » 1.42 (n.s.) t ■ 0.22(n.s.) t ■ 0.26
Flav. drink - - t - 1.43
Milk — t ■ 0.09
15
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TABLE 5.2 COMPARISON OF FOUR BEDTIME TREATMENTS: WHOLE NIGHT MEASURES.
Mean total min of wakefulness occurring between the first onset of sleep
and the end of the recording. Each value for each of 16 subjects is
the mean of 5 consecutive nights.
Mean total wake time after sleep onset (min)
Subjects Capsules Flavoured drink Milk Hor1icks
KB 33.0 20.7 41.2 31.9
MC 81.6 88.6 106.8 111.5
FC 27.9 18.8 15.9 23.4
JG 90.5 81.3 29.0 87.7
GH 32.4 42.5 41.4 12.1
WH 55.1 56.3 33.8 49.7
AH 19.8 24.0 9.9 12.8
GJ 15.2 15.0 9.0 8.3
RMcD 70.7 107.4 42.7 45.0
JR 49.6 36.3 37.6 38.3
SR 11.8 47.1 11.2 6.8
MS 57.0 83.3 92.8 75.9
MT 49.0 84.6 52.6 53.4
FW 29.2 72.7 32.0 39.6
AW 57.8 22.6 25.0 29.5
MW 25.8 29.4 65.4 40.4
Mean 44.2 51.9 40.4 41.6
-S.D. -23.6 -30.3 -28.0 -29.5
t-tests for paired observations: df » 15.
Flavoured drink Milk Horlicks
Capsules t ■ 1.40(n.s.) t ■ 0.58(n.s!.) t * 0.64
Flav. drink - - t « 1.78,
Milk mm t ■ 0.26
*not significant.
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TABLE 5.3. COMPARISON OF FOUR BEDTIME TREATMENTS: WHOLE NIGHT MEASURES
Mean total min stage 1 accumulated during the whole night. Each
value for each of 16 subjects is the mean of 5 consecutive nights.





KB 36.8 49.1 45.7 42.5
MC 80.9 76.3 65.4 71.8
FC 48.2 47.8 39.2 43.4
JG 37.2 45.3 60.5 43.4
GH 27.2 28.1 31.7 32.5
WH 91.2 81.2 82.0 80.3
AH 45.4 39.2 41.7 37.8
GJ 45.1 42.7 57.3 46.4
RMcD 39.9 35.9 37.5 47.6
JR 47.9 53.3 47.1 40.9
RR 42.0 60.5 51.6 47.0
MS 34.0 33.5 42.8 30.9
MT 33.6 45.4 48.8 46.4
FW 52.7 67.5 53.9 51.0
AW 50.3 47.5 47.8 45.2
MW 37.9 45.8 39.3 41.4
Mean 46.9 49.9 49.5 46.8
± S.D. ± 16.8 ± 14.8 ± 12.3 ± 12
No significant differences between treatments
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TABLE 5.4. COMPARISON OF FOUR BEDTIME TREATMENTS: WHOLE NIGHT MEASURES
Mean total min of wakefulness and stage 1 combined occurring between
the first onset of sleep and the end of the recording. Each value
for each of 16 subjects is the mean of 5 consecutive nights.





KB 69.8 69.8 36.9 74.4
MC 162.5 164.9 172.2 183.3
FC 76.1 66.6 55.1 66.8
JG 127.7 126.6 39.5 131.1
GH 59.6 70.6 73.1 44.6
WH 146.3 137.5 115.8 130.0
AH 65.2 63.2 51.6 50.6
GJ 60.3 57.7 66.3 54.7
RMcD 110.6 143.3 30.2 92.6
JR 97.5 89.6 34.7 79.2
RR 53.8 107.6 62.8 53.8
MS 91.0 116.8 135.6 106.8
MT 82.6 130.0 101.4 99.8
FW 81.9 140.2 85.9 90.6
AW 108.1 70.1 72.8 74.7











t-tests for paired observations: df - 15
Flav. drink Milk Horlicks
Capsules t « 1.62 (n. s.) t ■ 0.18 (n.s.) t - 0.65 (n.s.)
Flav. drink - - t - 2.40, p<0.025
Milk t - 0.33 (n.s.)
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TABLE 5.5. COMPARISON OF FOUR BEDTIME TREATMENTS: WHOLE NIGHT MEASURES
Mean total min stage 2 sleep accumulated during the whole night.
Each value for each of 16 subjects is the mean of 5 consecutive
nights.





KB 207.7 224.2 215.3 210.5
MC 234.7 227.4 199.6 215.0
FC 270.1 271.2 263.7 275.9
JG 219.8 214.6 222.4 227.4
GH 260.7 263.2 255.1 254.0
WH 194.3 187.2 193.2 217.0
AH 270.8 259.0 284.0 274.3
GJ 272.7 288.6 288.0 282.9
RMcD 213.0 211.0 246.9 257.2
JR 235.4 245.2 262.2 247.2
RR 311.1 275.0 306.1 280.0
MS 293.5 273.9 285.2 300.0
MT 262.2 223.1 252.6 238.7
FW 274.0 269.7 287.1 277.2
AW 238.0 250.0 223.3 256.6











No significant differences between treatments
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TABLE 5.6. COMPARISON OF FOUR BEDTIME TREATMENTS: WHOLE NIGHT MEASURES
Total min of slow wave sleep (stages 3+4) accumulated over the whole
night. Each value for each of 16 subjects is the mean of 5 consecutive
nights.





KB 72.6 89.2 71.7 91.2
MC 12.9 17.3 16.7 10.4
FC 76.7 82.3 93.4 85.3
JG 73.1 81.7 93.3 63.5
GH 73.2 68.9 91.3 95.2
WH 64.1 70.5 79.1 52.5
AH 68.5 63.1 66.9 75.7
GJ 78.1 65.8 62.9 69.2
RMcD 100.2 71.5 85.1 80.2
JR 63.0 63.7 41.4 77.9
RR 33.5 44.5 25.4 54.4
MS 40.9 39.8 29.0 41.0
MT 99.9 102.6 105.8 119.0
FW 50.4 16.8 31.3 37.7
AW 64.7 76.4 103.9 74.3
MW 88.6 87.6 85.6 80.5
Mean 66.3 65.1 67.7 69.3
± S.D. ± 23.1 ± 24.5 t 29.8 ± 25,
No significant differences between treatments
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TABLE 5.7. COMPARISON OF FOUR BEDTIME TREATMENTS: WHOLE NIGHT MEASURES
Mean total min of stage REM sleep accumulated over the whole night.
Each value for each of 16 subjects is the mean of 5 consecutive nights.




KB 123.9 95.1 106.2 98.1
MC 83.7 72.7 80.1 74.8
FC 80.4 80.0 91.9 73.0
JG 96.1 92.3 100.9 95.2
GH 97.2 105.4 97.9 106.2
WH 94.8 100.9 111.9 94.5
AH 85.3 99.7 93.4 87.9
GJ 103.4 104.2 96.9 105.6
RMcD 82.7 69.2 97.1 80.4
JR 76.1 70.8 91.2 75.8
RR 109.1 77.9 106.4 110.0
MS 86.0 82.6 57.2 65.8
MT 50.5 49.6 48.9 48.9
FW 96.2 74.9 81.3 93.8
AW 118.9 114.8 107.5 100.4











No ©ignifisant differences between treatments
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TABLE 5.8. COMPARISON OF FOUR BEDTIME TREATMENTS: FIRST 6 h TOTALS
Mean min of intervening wakefulness occurring in the accumulation of
the first 6 h of sleep. Each value for each of 16 subjects is the
mean of 5 consecutive nights.





MW 11.7 7.1 71.1 17.2
AW 31.4 8.3 16.2 19.2
AH 17.7 21.5 9.3 11.2
KB 25.3 11.1 33.4 27.9
JR 45.3 24.1 29.0 29.3
JG 48.2 38.1 13.6 2.8
GH 22.3 36.2 36.2 8.3
WH 20.0 24.5 19.2 15.7
MT 23.2 73.5 30.9 29.5
RMcD 56.5 101.3 30.6 23.1
FC 11.9 6.4 6.5 8.4
MC 20.7 32.2 64.7 74.4
GJ 0.0 3.2 3.0 0.0
MS 0.0 1.8 49.2 0.6
FW 17.9 78.1 17.6 26.5
RR 3.2 48.2 9.6 2.4
Mean 22.2 32.2 27.5 18.5
± S.D. ± 16.5 ± 29.7 ± 20.1 ± 18,
t-tests for paired observations, between planned comparisons:
Flav. drink Milk Horlicks
Capsules t = 1.53 (n.s.) t » 0.80 (n.s.) t - 0.70 (n,
Flav. drink
Milk
t » 1.77, p<0.05
i
t - 1.92, p<0.05*
* 1-tailed level of significance
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TABLE 5.9. COMPARISON OF FOUR BEDTIME TREATMENTS: FIRST 6h TOTALS
Mean min of intervening wakefulness plus stage 1 occurring in the
accumulation of the first 6 h of sleep. Each value for each of
16 subjects is the mean of 5 consecutive nights.
Mean min intervening wake + stg 1 in 1st 6 h sleep
lavoure
drinkSubjects Capsules Flavoured Milk Horlicks
MW 35.1 34.8 103.5 49.0
AW 68.8 42.6 50.1 51.2
AH 52.6 52.8 41.0 38.3
KB 41.3 45.5 63.5 59.8
JR 79.5 63.6 69.6 60.4
JG 78.7 71.8 57.2 36.9
GH 43.1 57.6 59.8 29.4
WH 85.1 84.3 75.2 75.8
MT 42.8 109.5 61.4 62.0
RMcD 88.6 135.2 61.1 55.2
FC 43.5 38.0 28.9 37.7
MC 88.1 100.5 132.5 143.9
GJ 22.6 23.1 34.5 21.1
MS 23.0 23.3 81.5 21.7
FW 54.6 138.4 57.0 66.4
RR 34.2 92.3 48.2 36.3
Mean 55.1 69.6 64.1
*
52.8
± S.D. ± 23.1 ± 37. 1 ±25. 7 ± 29.1
t-tests for paired observations between planned comparisons: df»
Flav . drink Milk Horlicks
Capsules t-1.83 (n.s.) t-1.25 (n.s.) t=0.39 (n.s.)
Flav. drink - - t-1.98, p<0.05* (1-tailed)
Milk - t-2.14, p<0.025* <1~tailed)
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TABLE 5.10. COMPARISON OF FOUR BEDTIME TREATMENTS :
FIRST 3h AND SECOND 3h TOTALS.
Mean min of stages 3+4 accumulated in the first 3h and the first 6h of
sleep. Each value for each of 16 subjects is the mean of 5 consecutive
nights.














MW 72.9 83.9 67.7 87.4 74.2 91.7 61.4 78.6
AW 40.8 59.6 39.7 62.9 60.6 90.1 52.3 69.9
AH 35.2 67.8 45.0 64.8 31.2 60.8 54.1 63.4
KB 65.5 72.6 69.1 83.7 59.7 68.9 65.3 91.2
JR 47.3 61.0 46.8 62.2 37.6 41.3 49.4 70.7
JG 45.5 63.4 50.4 77.1 45.2 79.7 41.2 59.3
GH 57.8 69.5 47.1 63.1 65.2 88.3 51.7 85.4
WH 53.6 65.0 48.5 68.0 69.3 79.1 38.4 45.4
Mr 68.6 93.2 73.9 95.9 68.5 96.0 89.0 109.9
RMcD 66.3 96.1 47.3 76.3 59.9 80.2 54.6 77.7
FC 49.3 70.8 45.1 72.0 67.0 87.6 55.2 75.4
MC 5.7 10.2 6.8 18.5 6.7 18.9 7.6 10.4
GJ 50.6 71.5 47.1 62.2 40.7 59.2 44.5 65.0
MS 26.8 41.1 27.5 38.1 24.7 30.9 32.0 41.0
FW 31.3 48.3 10.1 13.3 17.1 31.3 25.6 35.7



















No significant differences between treatments.
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TABLE 5.11. COMPARISON OF FOUR BEDTIME TREATMENTS: FIRST 6 h TOTALS
Mean min of stage REM sleep accumulated in the first 6 h of sleep.
Each value for each of 16 subjects is the mean of 5 consecutive
nights.




MW 56.5 52.2 57.8 48.1
AW 62.4 71.6 69.8 60.1
AH 50.8 56.6 52.4 49.0
KB 73.7 53.6 74.7 57.5
JR 56.1 49.0 62.3 57.3
JG 84.4 63.4 70.5 70.2
GH 66.0 68.6 56.5 66.3
WH 63.3 69.6 65.5 66.4
MT 29.4 37.8 32.5 29.8
RMcD 55.1 58.3 63.3 52.6
FC 53.6 50.7 57.3 46.6
MC 68.3 58.6 68.0 65.3
GJ 65.0 65.9 61.6 66.9
MS 52.0 62.5 47.0 43.0
FW 59.8 49.0 53.7 66.1











No significant differences between treatments
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TABLE 5.12. COMPARISON OF FOUR BEDTIME TREATMENTS: FIRST 6 h TOTALS
Mean number of transitions of sleep stage to wakefulness plus transitions
to stage 1, in the accumulation of the first 6 h of sleep. Each value
for each of 16 subjects is the mean of 5 consecutive nights.






































































































No significant differences between treatments
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TABLE 5.13. COMPARISON OF FOUR BEDTIME TREATMENTS: FIRST 3h AND
SECOND 3h TOTALS.
Mean min of intervening wakefulness occurring in the accumulation of the
first 3h and the second 3h of sleep. Each value for each of 16 subjects
is the mean of 5 consecutive nights.




1st 2nd 1st 2nd 1st 2nd 1st 2nd
3h 3h 3h 3h 3h 3h 3h 3h
MW 2.3 9.3 5.3 1.9 35.3 35.8 6.8 7.5
AW 27.0 4.4 1.5 6.8 11.1 5.0 16.3 2.7
AH 14.6 3.0 21. L 0.4 9.3 0.0 9.1 2.0
KB 0.8 24.5 4.7 6.4 11.1 22.3 2.1 25.8
JR 34.2 11.1 7.0 17.2 20.0 9.0 10.5 18.9
JG 0.0 48.2 0.8 37.3 1.6 12.0 0.9 1.9
GH 18.6 3.7 29.1 7.1 35.6 0.7 2.8 5.5
WE 5.9 14.1 7.3 17.2 4.1 15.1 3.4 12.2
MT 1.6 21.6 37.1 36.3 0.4 30.5 0.9 28.6
RMcD 31.3 25.2 56.2 45.0 25.4 5.2 3.6 19.5
FC 6.3 5.6 0.5 5.9 2.3 4.2 4.8 3.6
MC 9.9 10.8 10.0 22.1 21.2 43.4 17.7 56.5
GJ 0.0 0.0 0.0 3.2 1.8 1.1 0.0 0.0
MS 0.0 0.0 1.8 0.0 0.9 48.3 0.0 0.6
FW 14.2 3.7 46.9 31.2 13.5 4.1 25.2 1.3
RR 2.6 0.6 38.7 9.5 3.0 6.6 1.8 0.7
Mean min 10.6 11.6 16.8 15.5 12.3 15.2 6.6 11,7
+
—S.D. -11.7 -12.9 -18. 8 -14.7 -12.0 -15.9 -7.4 *15
t - tests for paired observations
(see Table 5.14).
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TALLE 5.14. STATISTICAL ANALYSIS OF DATA TN TABLE 5»13
Mean mln of intervening wakefulness occurring in the acciaaulation of
the first 3 h and the second 3 h of sleep
(a) First 3 h of sleep
Mean ain intervening wakefulness
Capsules Flsv. drink Milk Horlicks
Mean min +S.D. 10.6 + 11.7 16.8 ♦ 18.8 12.3 + 12.0 6.6 ♦ 7.4
mm mm mm mm mm
t-tasts for paired observations: df » 15 (2-tailed)
Flav. drink Milk Borlicks
Capsules t • 1.31 (a.s.) t » 0.57 (n.s.) t « 1.49 (n.s.)
Flav. drink - - t ■ 2.13p ~ 0.05*
Milk - t • 1.87 (n.s.)
*not significant
(b) SecorH 3 h of sleep
Mean tain intervening wakefulness
Capsules Flav. Drink Milk Horlicks
Mean sin +S.D. 11.6 + 12.9 15.5 + 14.7 15.2 + 15.9 11.7 £ 15.3
t-teste for paired observations: df « 15 (2-tailed)
Flav. drink Milk Horlicks
Capsules t « 1.37 (n.s.) t « 0.73 (n.s.) t » 0.02 (n.s.)
Fiav. drink t - 0.88 (n.s.)
Milk t « 1.27 (n.s.)
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TABLE 5.15. COMPARISON OF FOUR BEDTIME TREATMENTS:
FIRST 3h AND SECOND 3h TOTALS.
Mean min of stage REM sleep accumulated in the first 3h and the second 3h
of sleep. Each value for each of 16 subjects is the mean of 5 consecutive
nights.
Subjects Capsules





MW 18.6 37.9 18.4 33.8 IS.5 38.1 16.9 31.2
AW 18.7 43.8 28.8 42.3 21.9 48.0 21.7 38.5
Ail 20.5 30.3 23.1 33.5 26.5 26.0 19.4 29.6
KB 23.1 50.6 19.0 34.6 21.3 53.4 24.3 33.2
JR 14.9 41.2 18.7 30.3 16.8 45.5 18.3 38.9
JG 30.7 53.7 25.2 38.2 33.6 37.0 29.6 40.6
GH 18.9 47.1 22.5 46.1 21.2 35.3 29.3 37.0
WH 24.1 39.2 28.6 41.0 19.7 45.7 27.2 39.2
MT 4.7 24.6 8.3 29.5 10.8 21.7 8.3 21.5
RMcD 26.3 28.8 25.6 32.7 13.4 50.0 12.4 40.2
FC 17.5 36.1 22.6 28.1 24.7 32.7 14.6 32.0
MC 25.9 42.4 28.2 30.4 28.4 39.5 26.4 38.8
GJ 29.4 35.6 17.3 48.6 24.7 36.3 23.3 43.6
MS . 15.3 36.7 21.5 41.0 8.6 38.4 9.8 33.2
FW 23.5 36.3 18.8 30.2 12.0 41.7 14.1 52.0
RR 22.1 49.0 20.9 40.1 17.3 58.1 30.4 40.4
Mean 20.9 39.6 21.7 36.3 20.0 40.5 20.4 36.9
±6 .3 -8.1 -5 .2 -6.3 ~6. 8 -9.6 -7 .2 -i
No significant differences betvxeen treatments.
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TABLE 5.16. COMPARISON OF FOUR BEDTIME TREATMENTS: SUBJECTIVE RATINGS
Mean subjective rating from each of 16 subjects for sleep quality during
(a) The 15 nights at home prior to attending the sleep laboratory
(b) The 6 nights that subjects attended the sleep laboratory




(a) (b) (a) (b) (a) (b) (a) (b)
AW 57 45 56 45 50 45 50 46
MW 53 45 50 49 55 45 52. 47
AH 72 77 76 76 63 71 66 69
KB 50 43 50 43 48 40 46 44
JR 62 49 53 54 61 65 55 49
JG 51 47 53 41 54 41 56 53
GH 60 54 57 59 56 52 53 48
WH 56 42 56 45 55 53 51 47
MT 49 45 49 39 52 41 50 42
RMcD 53 61 53 49 55 50 53 58
FC 50 51 50 59 49 56 55 47
MC 48 46 49 49 47 46 51 46
GJ 50 43 52 40 52 47 51 46
FW 69 60 66 56 67 66 68 58
RR 53 54 53 57 52 49 48 51
MS 71 85 61 65 52 64 64 58
Mean 57 53 55 52 54 52 54 51
± S .D. ± 8 ± 13 ± 7 ± 10 ± 6 ± 10 ± 6 ± 7
*0mm = "Worst possible" sleep quality
100 mm *> "Best possible" sleep quality
No significant differences between treatments
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TABLE 5.17. COMPARISON OF FOUR BEDTIME TREATMENTS: SUBJECTIVE RATINGS
Mean subjective rating from each of 16 subjects for morning vigilance
during: (a) The 15 days at home prior to attending the sleep laboratory
(b) The 6 days that subjects attended the sleep laboratory
Mean subjective morning vigilance in mm
Subjects Capsules Flavoureddrink Milk Horlicks
(a) (b) (a) (b) (a) (b) (a) (b)
AW 48 49 43 51 44 47 47 46
MW 49 52 54 51 45 57 46 56
AH 56 56 59 47 54 50 53 55
KB 51 53 50 56 50 55 49 53
JR 49 34 48 38 43 42 49 39
JG 52 51 56 49 62 58 51 48
GH 54 49 54 52 52 50 53 53
WH 49 39 45 43 45 44 60 53
MT 58 62 56 55 56 52 53 54
RMcD 49 53 49 49 39 44 46 47
FC 48 49 45 49 48 42 42 35
MC 48 47 49 44 46 47 50 47
GJ 46 47 46 48 48 48 54 47
FW 42 34 39 39 41 49 44 49
RR 49 50 49 51 49 51 51 46



















*Where 0 mm - "Marvelously alert and energetic"
Where 100 mm - "Awfully sleepy and lack-lustre"
No significant differences between treatments
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TABLE 5.18. COMPARISON OF FOUR BEDTIME TREATMENTS: SUBJECTIVE RATINGS
Mean subjective rating from each of 16 subjects for daytime anxiety
during (a) The 15 days at home prior to attending the sleep laboratory
(b) The 6 days that subjects attended the sleep laboratory at night
Mean subjective anxiety in mm
Subjects Capsules Flavoureddrink Milk Horlicks
(a) (b) (a) (b) (a) (b) (a) (b)
AW 47 52 51 53 48 48 49 49
MW 51 52 53 54 60 59 51 56
AH 62 55 52 55 59 66 49 62
KB 51 50 48 50 49 47 48 49
JR 45 44 48 50 52 57 49 59
JG 48 51 51 45 51 64 48 64
GH 54 49 53 49 53 51 53 50
WH 46 48 42 47 42 47 40 43
MT 41 48 51 50 51 52 50 49
RMcD 46 50 46 47 50 46 47 49
FC 51 51 52 52 50 51 47 48
MC 51 46 50 48 48 47 53 46
GJ 52 49 55 54 56 53 53 51
FW 56 57 54 54 48 53 47 46
RR 50 49 51 49 50 50 48 49



















*Where 0 mm » "Terrible agitation"
Where 100 mm - "Imperturbable tranquility"
No significant differences between treatments
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TABLE 5.19. COMPARISON OF FOUR BEDTIME TREATMENTS.
The 16 subjects' body weights treasured 8 times over 13 weeks. On the first
and sixth nights of attendance at the sleep laboratory on any one treatment.
Body Weight (lb)
First Second Third Fourth
treatment treatment treatment treatment
Subjects Night Night Night Night Mean body wt.
16161616- S.D.
MS 101.5 102.0 103.0 104.5 104.0 104.5 105.0 105.0 103.69 - 1.36
JR 119.25 118.0 119.5 117.25 119.0 118.0 119.75 117.75 118.56 - 0.92
MT 128.75 126.5 127.0 126.5 129.0 128.0 130.0 129.75 128.19 - 1.41
RMcD 137.0 136.5 136.0 136.0 135.0 135.0 135.0 135.5 135.75 - 0.76
FW 140.0 139.25 139.0 140.0 141.0 139.0 140.0 140.0 139.78 - 0.69
RR 141.5 141.75 141.75 143.5 143.0 142.0 142.5 144.0 142.50 - 0.92
MW 147.75 148.5 147.25 145.75 145.75 145.75 144.25 144.5 146.19 - 1.52
AH 148.0 147.75 148.75 147.5 146.25 148.5 149.5 149.0 148.16 - 1.03
WH 147.75 146.5 149.5 147.0 148.0 149.0 150.0 148.5 148.28 - 1.21
MC 152.5 155.5 155.75153.5 149.5 150.5 151.5 151.5 152.53-2.26
FC 158.5 157.25 157.5 157.25 157.5 156.5 159.5 158.5 157.81 - 0.95
GH 161.3 161.5 161-5 160.5 159.25 158.0 158.0 154.5 159.34 - 2.46
GJ 164.0 164.5 164.5 162.75 164.0 163.5 165-0 163.0 163.91 - 0.79
AW 171.75 171.0 170.75 170.0 171.75 170.5 170.5 170.5 170.84 - 0.64
KB 168.75 169.5 172.0 173.0 170.5 174.5 172.25 171.75 171.53 ? 1.88
JG 202,5 202.25 202.75 203.75 201.5 201.0 201.5 199.5 201.84 - 1.29
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Subjects who usually had something to eat before
retiring to bed slept better after talcing milk or
Horlicks at bedtime than after taking an inert capsule,
whereas those accustomed to having little or nothing
slept better after the capsule.
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INTRODUCTION
In the experiment described in the previous
Chapter where four bedtime treatments were compared
I commented that the sleep of some subjects appeared
to be consistently less broken by wakefulness after
they had drunk Horlicks or milk than after taking
capsules at bedtime, whereas other subjects consist-
entry slept worse after talking a bedtime food drink
than they did after capsules.
I thought that differences in the usual evening
dietary habits of the subjects might be the reason
as several subjects had spontaneously commented that
they felt hungry in the later evening when they took
the capsule whereas other subjects said they did not
normally take as much food at bedtime and that they
preferred the capsule. A post-hoc investigation
of each volunteer's dietary habits was undertaken
to determine whether a subject's evening dietary
pattern was related to his or her changes in sleep
in response to bedtime nutrition.
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METHODS
(a) Assessment of dietary habits.
Subjects were sent, by post, a diet questionnaire
(Figure 6.1) and a daily diet diary, an explanatory
letter and a stamped return envelope.
All 16 subjects answered the diet questionnaire
and in the diet diary gave a detailed report of all
they ate on a typical day. They were specifically
asked to list as accurately as possible the amounts and
the times they usually ate. All six men and eight of
the women were married and this, together with the fact
that the subjects were of an older age group, made it
more likely that their dietary habits would be fairly
stable.
Three methods were tried to separate out the subjects
into a rank order according to their differing dietary
habits in the evening. However, only the third method
gave a satisfactory separation of the subjects so that
a rank correlation test could be employed.
It was assumed that subjects who normally had a
bedtime snack would sleep better in the laboratory
after a bedtime food drink than after the capsules,
when they had had nothing to eat or drink after 1900h.
Conversely it was predicted that subjects who usually
ate little or nothing later in the evening would sleep
better after the capsules and that their sleep might be
impaired by the ingestion of unaccustomed food.
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FIGURE 6.1 ASSESSMENT OF DIETARY HABITS
DIET QUESTIONNAIRE
(b) I usually have
(c) I usually have
Would you please answer the following questions by
ticking the answer which is nearest to your typical day.










(iii) small lunch _____
(iv) no lunch _____
(i) large evening meal _____
(ii) medium evening meal _____
(iii) small evening meal _____
(iv) no evening meal _____













(f) If I have something to eat or drink later in
the evening (please describe and please specify
any alcohol taken) I usually have:
(g) Do your answers above differ from those you would
have given at the time just before you took part
in the *nutrition and sleep' experiment?
(i) yes
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(i) Unsuccessful ranking methods I and II
A colleague was asked to assign ranks to the
subjects' answers to the Diet Questionnaire. This
first attempt to rank subjects according to their
evening eating habits only employed their answers
to questions (c), (d) and (e) of the Diet Questionnaire
(Figure 6.1). All subjects answered "no" to question
(g). Their answers to these questions were given
numbered scores, i.e.
question (c) I usually have (i) large evening meal ...
A tick against (i) scores 1 point (ii) 2 points
(iii) 3 points, (iv) 4 points, on the assumption that
the larger evening meal (in relative terms) the less
likely the person would need a bedtime snack. The timing
of the evening meal was also considered to have a bearing
on whether a subject would benefit from a bedtime food
drink and thus the earlier the evening meal was eaten
the higher the score, i.e.
question (d) The time I usually have my evening meal
is between (i) 4-5 p.m. )
(ii) medium evening meal
(iii) small evening meal











The frequency of having a bedtime snack was
investigated by question (e).
I usually have something to eat or drink later
On this scoring system it was predicted that the
subjects with the higher scores would sleep better
after bedtime food drinks than after the acaloric
capsules whereas subjects with the lower scores would
not. This method failed to separate subjects adequately
into a rank order and it did not take into account the
size of the bedtime snack.
The second method of ranking included some
weighting for the contribution of the bedtime eating
habits of subjects. The answers to questions (c), (d)
and (ei), in the Diet Questionnaire were scored as
described above but in addition the size of the evening
snack, described in answer to question (f), was rated
on a three-point scale and added to the score obtained
above if they answered always or sometimes to question
(e). Subjects who had only a cup of tea or coffee had
nothing added to their score, those who had a small
snack such as a biscuit had 1 point added, and a more
substantial snack was given an extra score of 2 points.











This method was better in separating subjects into
a rank order as it included a rating of the size of the
bedtime snack and indicated that an even better
separation would be achieved if the evening energy
intakes of subjects were analysed.
(ii) Method III used to assess dietary habits
The third method was the one actually used to
rank subjects and involved an assessment of the calorie
intake of subjects on a typical day and thus was a more
sensitive measure of the usual bedtime intake of each
subject.
McCance and Widdowson's (1960) book of the
composition of common foodstuffs and a booklet of calorie
values of branded foods (Slimming Magazine, 1974) xvere
used to estimate the energy intake of subjects. The
average calorie intake through the day was estimated
first by myself and then independently by a dietician
not involved in this study. Many of the subjects
listed a range of typical lunches, evening meals and,
if they had one, bedtime snacks. The method I used to
estimate their calorie intake through the day was to
score all the alternative meal menus listed by a subject
and then calculate the maximum and minimum calorie
intake/
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intake for the whole day and for both the evening
meal and the bedtime snack. Thereafter the means,
of the maximum and minimum calorie intakes were
calculated.
The independent dietician used a different method
to assess calorie intake. She selected one set of the
alternatives listed for each meal and estimated the
energy content taking into account the age, sex,
weight and occupation of each subject.
(b) *Predicted* order of benefit from bedtime nutrition:
Ranking subjects according to their dietary habits.
I devised the following method of assessment of
dietary habit in order to rank subjects according to
the relative amount of food they ate in the later
evening. All the subjects took their evening meal
sometime between 1700h and 2000h and none took their
bedtime snack before 2130h (ascertained from answers
to the diet questionnaire).
A rating of "predicted" benefit from later evening
nourishment was made by the ratio below, which was
designed to give a measure of the relative contribution
of bedtime eating to the total energy intake after 1700h.
calorie intake after 2100 x 100 = N%
total calorie intake after 1700h
Subjects were then ranked, according to their N%
score/
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score in order of "predicted" benefit from food eaten
later in the evening on the assumption that those who
normally took relatively more calories after 2100h
would sleep better after a nourishing bedtime drink
than after an acaloric capsule. The subject who was
predicted to sleep best after bedtime food compared
with after capsules was ranked number one. If two
subjects tied on their N% score, then the size of
their evening meal (food between 1700h and 2l00h) was
taken into account by converting the calorie content
of their evening meal into a percentage of their
daily intake:
calorie intake between (!7©0h and 2100h)
total daily calorie intake X 100 = EM%*
It was predicted that the lower the EWo score the
more likely that food taken later in the evening would
have a beneficial effect on sleep. The EM% score was
used to rank the two subjects who had an N% score of
0%. Subjects covered a wide range of N% (0% to 41%).
The dietician's ordering of subjects according to her
estimates of N% was used for all calculations.
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(c) Ranking subjects according to changes in sleep
in response to bedtime nutrition.
A measure of benefit (i.e. improvement in sleep
for each of the three bedtime drinks compared with
capsules) was calculated for each subject by, for
example, subtracting his/her mean total time asleep
recorded while taking one of the bedtime drinks from
the mean total time asleep when he/she was taking
capsules. This procedure was repeated for all the
measures of sleep i.e. total sleep time, total
wakefulness recorded after sleep onset and until the
recording finished, the total min of intervening
wakefulness in the first 3h, second 3h and first 6h of
accumulated sleep and the total min of intervening
wakefulness plus total min of stage 1 sleep in the
first 6h of accumulated sleep. The differences were
then ranked in descending order for the "measured"
benefit derived from bedtime food, i.e. for each
food drink, the subject who slept best after the
bedtime food drink in comparison with his sleep
after the capsule was rated 1 and the subject who
slept worst after the food drink compared with that
after the capsule was ranked 16.
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(d) Statistics
Spearman's rank correlation test (Siegel, 1956)
was used to compare the "predicted" order of benefit
to sleep from bedtime food (N%'s ranked 1 to 16) with
the "measured" rank orders of the differences between
the results on capsules and those after each of the
three bedtime food drinks.
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RESULTS
(a) Ranking the 16 subjects into a *predicted' order
of benefit from bedtime nutrition.
(i) Methods I and II
Table 6.1 shows the ratings given to the different
subjects using Method I and Method II. These two
methods were discarded as they gave insufficient
separation to rank subjects in order 1 to 16.
(ii) Method III
Table 6.2 shows the author's predicted order 1 to
16 of benefit from food at bedtime using the method
described earlier to calculate N% and EM%. N% scores
(the usual intake of calories after 2100h as a
percentage of the individual's intake after 1700h)
ranged from 0% to 41.14%. Only the two subjects with
N% = 0% had to have their EM% taken into account. EM%
(the usual calorie intake at the evening meal as the
percentage of the total intake of calories through the
day) varied from 28% to 56%.
Table 6.3 shows the independent dietician's rank
order 1 to 16 of predicted benefit from bedtime
nourishment using her values of N% and EM% for each
subject. Her estimates of N% ranged from 0% to 40.63%
and only two subjects tied on their N%, those with N%
= 0%, and had their EM% considered. EM% ranged from
26% to 50%.
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The ranking of subjects into the predicted order
of benefit from food eaten at bedtime calculated by
me and by the dietician were very similar (Table 6.4)
and the correlation between our rank orders was
j^ = 0.982, p<0.00002, 1-tailed. However, the
dietician's rank order was used in all the calculations.
(b) Correlations between 'predicted' and 'measured'
orders of benefit from bedtime food.
The predicted order was of the subjects ranked in
descending order 1 to 16 according to their N% scores
such that the subject ranked 1 was predicted to gain
the most benefit to his sleep from food eaten at bed¬
time compared with his sleep xvhen taking capsules at
bedtime. Conversely the subject ranked 16 was
predicted to sleep better after capsules than after a
food drink at bedtime. The results are presented for
each measure of sleep and wakefulness as the difference
in min between the mean over the five nights on capsules
and the mean over the five nights on each of the food
drinks and these differences were ranked 1 to 16 in
descending order of benefit from bedtime nourishment.
(i) Whole night measures.
The rank orders of measured benefit to sleep from
milk and Horlicks were both significantly correlated
with the order predicted from the subjects' usual eating
pattern/
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pattern. This was true for the mean total time that
subjects slept (Table 6.5) and for the total time that
subjects were awake between first falling asleep and
before lights on in the morning (Table 6.6). The
results obtained from flavoured drink gave no significant
correlations between the measured and predicted orders of
benefit from bedtime nourishment (Tables 6.5; 6.6).
The rank orders calculated for the benefit of milk
and of Horlicks were significantly correlated with each
other, e.g. the rank correlation between the orders of
differences in total sleep time for milk and Horlicks
was rs =0.82, p<0.001 (Table 6.5) and similarly for
total wakefulness after first falling asleep the
correlation between the rank orders on milk and Horlicks
was r^= 0.66, p<0.01 (Table 6.6).
(ii) Brokenness of sleep in the first 6h, first
3h and second 3h of sleep.
Table 6.7 lists the differences and the rank order
of the differences between capsules and each of the
three bedtime drinks in the mean min of intervening
wakefulness occurring in the accumulation of the first
6h of sleep. The rank orders of benefit for both
Horlicks and milk were positively correlated with the
order predicted from subjects* N% scores: % = 0.64,
p<C0.01; = 0.53, p<0.05 respectively (Figures 6.2;
6.3). The/
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"Predicted" order of benefit from later evening nutrition
13 14 15 16
FIGURE 6.2 The measured difference in min of
intervening wakefulness accumulated in the first
6h of sleep between the mean of the 5 nights
recorded while on capsules and mean of the 5 nights
while taking Horlicks, for each of the 16 subjects.
The horizontal axis is the 16 subjects
ranked in ascending order of predicted benefit from
bedtime food (i.e. 1 = least and 16 = most benefit)
Statistical analysis in Table 6.7.
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"Predicted" order of increasing benefit from later evening nutrition
FIGURE 6.3 The measured difference in min of
intervening wakefulness accumulated in the first
6h of sleep between the mean of the 5 nights recorded
while on capsules and the mean of the 5 nights while
taking milk for each of 16 subjects.
The horizontal axis is the 16 subjects
ranked in ascending order of predicted benefit from
bedtime food.
Statistical analysis in Table 6.7.
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The rank order for milk was positively correlated with
the rank order for Horlicks =0.74, p<0.002. The
rank order for flavoured drink was not correlated with
the predicted order of benefit (Figure6.4).
If the night was treated as the first 3h (Table 6.8)
and the second 3h (Table 6.9) the only significant
correlation with the predicted order was found for the
benefit of milk in the second 3h of sleep.
The rank orders of benefit to sleep, measured as a
reduction of both intervening wakefulness and stage 1
in the first 6h of sleep from Horlicks or milk at
bedtime are shown in Table 6.10. Horlicks and milk
both gave positive correlations between their measured
order and their predicted order of benefit: rs =0.68,
p<0.01; Xg- 0.50, p<0.05 respectively (Figures 6.5; 6.6).
Again, the rank order for flavoured drink was not
significantly correlated with the ranked N% scores
(Figure 6.7). The rank order of measured benefit for
milk was significantly correlated with that for Horlicks
rs = 0.83, p<0.001.
(iii) No correlation with treatment order
In the original experimental design the order of
administering the four bedtime treatments was balanced
over the 16 subjects, but in the method of investigating
dietary habit described above this exact balancing is
diminished/
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"Predicted" order of increasing benefit from later evening nutrition
-T"
16
FIGURE 6.4 The measured difference in min of
intervening wakefulness accumulated in the first
6h of sleep between the mean of the 5 nights recorded
while on capsules and the mean of the 5 nights while
taking flavoured drink, for each of 16 subjects.
The horizontal axis is the 16 subjects
ranked in ascending order of predicted benefit from
bedtime food.
Statistical analysis in Table 6.7.
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"Predicted" order of increasing benefit from later evening nutrition
1—
15 16
FIGURE 6.5 The measured difference in min of
intervening wakefulness combined with min of stage 1
accumulated in the first 6h of sleep between the mean
of the 5 nights recorded while on capsules and the
mean of the 5 nights while taking Horlicks, for each
of 16 subjects.
The horizontal axis is the 16 subjects
ranked in ascending order of predicted benefit from
bedtime food.
Statistical analysis in Table 6.10.
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"Predicted" order of increasing benefit from later evening nutrition
16
FIGURE 6.6 The measured difference in min of
intervening wakefulness combined with the min of
stage 1 accumulated in the first 6h of sleep between
the mean of the 5 nights recorded while on capsules
and the mean of the 5 nights while taking milk, for
each of 16 subjects.
The horizontal axis is the 16 subjects
ranked in ascending order of predicted benefit from
bedtime food.
Statistical analysis in Table 6.10.
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"Predicted" order of increasing benefit from later evening nutrition
-I-
16
FIGURE 6.7 The measured difference in min intervening
wakefulness combined with the min of stage 1 accumulated
in the first 6h of sleep between the mean of the 5 nights
recorded while on capsules and the mean of the 5 nights
v/hile taking flavoured drink, for each of 16 subjects.
The horizontal axis is the 16 subjects
ranked in ascending order of predicted benefit from
bedtime food.
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diminished and so Friedman's analysis of variance by
ranks (Siegel, 1956) was employed to test if treatment
order had any influence on the total min of wakeful¬
ness accumulated between sleep onset and the end of
the recording and intervening wakefulness in the first
6h of sleep. Tables 6.11; 6.12 illustrate that there
was no significant relationship between treatment order
and either of these measures of disturbed sleep.
(iv) Subjective ratings.
The mean subjective ratings of sleep quality over
the six consecutive nights when subjects slept at the
laboratory at night on capsules was subtracted from
the corresponding means for the six nights at the
laboratory on each of the three bedtime food drinks.
These differences in mm were ranked 1 to 16 in descend¬
ing order of magnitude. Table 6.13 shows the
differences for the mean ratings of sleep quality and
the corresponding rank orders. There were no significant
correlations between the predicted order of benefit and
the measured order of benefit for any of the food drinks.
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DISCUSSION
Three methods were tried to separate the 16
subjects into a rank order of their differing dietary
habits. Method III proved the most satisfactory in
it's separation of subjects into a rank order and it
also took more account of the relative energy value
of the usual bedtime food intake of subjects. The
size of the bedtime snack obviously had to be in
relative terms, for a bedtime snack, of say 300 cal,
is a relatively greater bedtime energy intake for
someone whose entire evening intake is only 600 cal
in comparison with someone who eats 1200 cal over
the evening i.e. 50% compared to 25% respectively of
evening intake eaten at bedtime.
Bank order correlations were used in preference
to product moment correlations because although I
did have actual values of N% scores these were based
on only one typical day's dietary intake. Subjective
recall of the amount eaten is known often to be an
under or over-estimate. Madden et al. (1976) found
that small intakes were frequently over-estimated
whereas large intakes were under-estimated and a fair
amount of latitude is assumed in the actual number of
calories consumed. However, in the calculation of N%
a/
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a ratio of calorie intakes was used and I assumed
that subjects would consistently under or over¬
estimate their intake and so numerator and denominator
of the formula calculating N% would be affected in the
same direction and so would roughly cancel out.
Admittedly, subjects would probably recall their bed¬
time snack more accurately than their usual evening
meal and the percentage error in an under or over-
estimation of the evening meal would be greater as its
energy content is usually more than the bedtime snack.
Energy intake through a typical evening varied widely
over the 16 subjects and so even with the disadvantages
above, I feel that the Method III used to assess
subjects relative energy intake at bedtime was
sufficiently accurate to be able to put subjects into
a rank order of predicted benefit from bedtime nutrition.
Had I wished to use raw values of I would have had
to ask subjects to keep detailed diet diaries over about
seven consecutive days and then take the mean, because
studies have shown that about this length of time is
required to estimate energy intake accurately (Young
et al., 1952). I asked subjects to list a usual day's
food and drink consumption and not a particular day,
in case it was atypical.
1/
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I found that those who usually ate most near
bedtime slept well after Horlicks or milk and those
who usually ate little or nothing slept worse. And
finding all the significant correlations between the
predicted and the measured orders of benefit from
bedtime food supports the idea that a subjects dietary
habits are an important factor in how his or her sleep
will change in response to food eaten at bedtime and
the close correlations between the rank orders of
benefit from milk and from Horlicks give added evidence
that this is a genuine relationship. My findings may
help to explain the contradictory reports in the
literature, where some authors found that bedtime
nutrition improved sleep whereas others reported no
effect or even a detrimental effect attributable to
food eaten near bedtime. I reviewed a selection of
these contradictory reports in Chapter 2 and so I will
not repeat myself here. Suffice to say that a few of
the early reports were based on research of poor
quality and lacked any statistical evaluation so that
little credence can be placed upon their conclusions.
Among the papers that do stand critical appraisal
the lack of agreement remains and I feel sure that
differences in the dietary habits of the subjects
used in these experiments may, in part, be responsible
for the contradictory results.
Closer/
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Closer inspection of the results reported by
Giddings (1934) of nocturnal motility after different
bedtime intakes of food, does in fact give an indication
of differences between the individuals in their response
to bedtime nutrition. To quote "On the nights on which
the warm milk was received, it was seen that in 41.7 per
cent of the children the activity was diminished; the
movement was increased in 8.3 per cent of the children
and in 50 per cent of the children there was no change
noted" (compared with nothing to eat at bedtime). From
which he concludes "The drinking of 6 oz of warm milk
at bedtime seems to produce quiet sleep in normal
children". He reported that any change in an individual
child's sleep owing to bedtime nutrition were consistent
over the five nights that motility was recorded on each
treatment. His results suggest to me that the children
varied in their response to bedtime nutrition but each
individual child was consistent within himself (and not
the blanket statement that warm milk produced less
restless sleep in children) and so his and my results
seem to be compatible.
The lack of any correlation between the predicted
order of benefit from nourishment taken at bedtime and
any of the orders of measured 'benefit* from flavoured
drink compared with capsules, was I think due mainly to
the apparently detrimental influence of this food drink
on/
- 260 -
on the sleep of the majority of the subjects and so
this may have overridden any benefit from its nutritional
composition. A possible explanation might have been
that when the drink mixed with stomach acid, large
particles were formed and that sleep was disrupted by
the mechanical irritation of these particles on the
stomach wall during gastric contractions. However,
when I mixed each of the three bedtime drinks with
hydrochloric acid (pH 1 to 2) the resulting particles
did not noticably differ. It may be that flavoured
drink was less easily digestible and was comparable to
Laird and Drexel's (1934) 'hard to digest' snack at
bedtime which they found led to more restless sleep
than a light snack of milk and cereal.
Differences in dietary habits have been commented
H
on before. Ostberg (1973) assessed the cumulative
intake of energy in one group of students that he
classified by questionnaire as the more extreme morning
people (early to bed, early to rise) and in another
group rated as more extreme evening people (late to bed,
late to rise) and he found that the evening people not
only started eating later in the day (which seems
logical) but also had a higher rate of food intake




Richards (1972) studied the effect of having
breakfast or nothing to eat in the morning on
performance on various psychometric tests (e.g.
auditory vigilance, short-term memory, coding task)
in two groups of nine adult volunteers. One group
comprised those who habitually took breakfast and
the other group was composed of those who normally
took nothing to eat in the morning. Subjects were
tested five times between 1200h and 1300h and although
she reported no significant differences in performance
between the two experimental conditions of breakfast
intake she did comment that there was a tendency
toward better performances, when subjects were tested
after the breakfast intake that coincided with their
normal pattern.
I found no correlation between the predicted
order of benefit from bedtime food and the measured
orders of benefit on subjective ratings of sleep
quality and this implies that there was no correlation
between the subjective and objective rank orders of
benefit from each of the bedtime drinks on the measures
of sleep quality. Differences in sleep quality
assessed while on each of the food drinks compared with
subjectively rated sleep when on capsules was the only
subjective rating in which I thought a correlation
might be found with the predicted order of benefit
based on dietary habits. Lack of correlation may be
due/
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due to insensitivity of the methods of getting subjective
ratings. However, the visual analogue method of
assessing sleep quality has been shown in our laboratory
to be very sensitive to abrupt changes in sleep such as
going on to or coming off hypnotic drugs, e.g. fosazepam
(Allen and Oswald, 1976); mesoridazine (Adam et al.,
1976). Perhaps because the changes in sleep in response
to bedtime eating were less profound and may have
occurred gradually, subjects' assessment of what
constituted their usual sleep quality may have shifted
over time. For this reason objective measurement of
sleep seems superior to subjective assessment, when
treatments with relatively weak effects on sleep are
investigated.
To summarize, the habitual pattern of eating in the
evening appeared to influence how people slept, after
either capsules or a warm nutritious drink of milk or
Horlicks at bedtime. Those used to talking nourishment
near bedtime slept better after milk or Horlicks than
after an acaloric capsule, whereas those who normally
ate little or nothing at bedtime slept best after no
nourishment. The people who slept better on milk also
slept better on Horlicks than on capsules and similarly
those who slept better on capsules than milk also slept




The source of nourishment appeared to be important,
for the iso-energetic flavoured drink and Horlicks had
very different effects on sleep, even though they
contained the same proportions of carbohydrate, protein
and fat. Palatability or digestibility of the
flavoured drink may be possible reasons for the
difference.
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TABLE 6.1. DIETARY HABITS AND SLEEP.
Ratings given to each of the 16 subjects, based on their usual eating
pattern, using the first two unsuccessful methods to separate them into
a rank order according to their dietary habits. .
i
Points awarded using the two different methods




KB 4 1 4 1
MC 6 2= 6 2=
MS 6 2= 6 2=
MW 6 2= 6 2=
AH 7 5= 7 5=
MT 7 5"= 7 5=
RMcD 7 5= 8 7=
m 7 5= 9 9=
JG 7 5= 9 9=
FC 8 10= 8 7=
GJ 8 10= 10 12=
AW 8 10= 10 12=
RR 9 13= 9 9=
FW 9 13= 10 12=
JR 9 13= 11 15=
GH 9 13= 11 15=





























































































































































































































































































































































































































































TABLE 6.4. DIETARY HABITS ARD SLEEP
Correlation between the Author's and the independent Dietician's
rank orders of predicted benefit from bedtime nutrition based on
the 16 subjects'diet diaries.
Predicted order of benefit from bedtime nutrition


















Spearman's rank correlation, df - 14.
Tg » 0.982, t * 19.63, p <_ 0.00002, 1-tailed
calculations in Table 6.3
**:- " " » 6.2
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TABLE 6.5. DIETARY HABITS AND SLEEP : WHOLE NIGHT MEASURES
Total sleep time (TST).
Measured benefit from each of the three bedtime food drinks in comparison
with capsules.
Each value for each of 16 subjects is the mean TST over 5 nights on the
food drink minus the mean TST over the 5 nights recorded while on capsules.
(Raw data in Table 5.1).
The rank orders are in descending order of benefit from bedtime nutrition:
1» most to 16«= least.








A min Rank order
KB 15 16.6 2
MC 16 -20.0 11
FC 14 5.8 6
JG 1 7.5 4
GH 2 7.2 5
AH 10 - 9.0 10
WH 6 - 8.8 9
GJ 4 2.1 7
RMcD 7 -48.1 16
JR 3 10.6 3
RR 9 -37.9 14
MS 12 -24.7 12
MT 11 -25.5 13
FW 5 -44.7 15
AW 8 36.7 1







































Spearman's rank correlations (rg): df ® 14 (2-tailed)
Ranked benefit from:
Flavoured drink Milk Horlicks
Ranked NX scores 0.15 (n.s.) 0.64, p^O.Ol 0.51, p<0.01
Ranked benefit
from milk - - 0.82, p<,0.001
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TABLE 6.6. DIETARY HABITS AND SLEEP WHOLE NIGHT MEASURES
Total wakefulness occurring after the first onset of sleep and before the
end of the recording (TWT).
Measured benefit from each of the three bedtime drinks in comparison with
capsules.
Each value for each of 16 subjects is the mean TWT over 5 nights on cap¬
sules minus the mean TWI over the 5 nights recorded on the food drink.
(Raw data, in Table 5.2).
The rank orders are in descending order of benefit from bedtime nutrition:
1 » most to 16 = least.





-Flav. drink - Milk
Capsules
- Horlicks
Subjects Score A min Rank order Amin Rank order Amin. Rank order
KB 15 12.3 3 - 8.2 12 1.1 11
MC 16 - 7.0 10 -25.2 14 -29.9 16
FC 14 9.1 5 12.0 5.5 4.5 9
JG 1 9.2 4 61.5 1 2.8 10
GH 2 -10.1 11 - 9.0 13 20.3 3
AB 10 - 4.2 9 9.8 7 7.0 5
WH 6 - 1.2 7 21.3 4 5.4 7
GJ 4 0.2 6 6.2 8 6.9 6
RMcD 7 -36.7 15 28.0 3 25.7 2
JR 3 13.3 2 12.0 5.5 11.3 4
RR 9 -35.3 13 0.6 9 5.0 8
MS 12 -26.3 12 -35.8 15 -18.9 15
MT 11 -35.6 14 - 3.6 11 - 4.4 12
FW 5 -43.5 16 - 2.8 10 -10.4 13
AW 8 35.2 1 32.8 2 28.3 1
MW 13 - 3.6 8 -39.6 16 -14.6 14
Spearman's rank correlations (r ): df » 14 (2-tailed)
Ranked benefit from:
Flav. drink Milk Horlicks
Ranked N%
score 0.06 (n.s.) 0.51, p<^0.05 0.55, p<0.05
Ranked
benefit from
milk — — 0,66, p<0.01
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TABLE 6.7. DIETARY HABITS AND SLEEP ! FIRST 6h TOTALS.
Intervening wakefulness occurring in the accumulation of the first 6h
of sleep.
Measured benefit from each of the three bedtime food drinks in comparison
with capsules.
Each value for each of 16 subjects is the mean inin of intervening wake¬
fulness (IW) over 5 nights on capsules minus the mean min IW over 5 nights
recorded on the food drink. (Paw data in Table 5.8).
The rank orders are in descending order of benefit from bedtime nutrition:
1 = most to 16 * least.
Differences in mean min IW in 1st 6h sleep:A min.
Rank
order Capsules - Capsules - Capsules -
of N% Flavoured drink Milk Horlicks
Subjects score A min Rank order A min Rank order Amin Rank order
MW 13 4.6 6 -59.4 16 - 5.5 13
AW 8 23.1 1 15.2 4 12.2 5
AH 10 - 3.8 9 8.4 5 6.5 6
KB 15 14.2 3 - 8.1 12 - 2.6 12
JR 3 21.2 2 16.3 3 16.0 3
JG 1 10.1 4 34.6 1 45.4 1
GH 2 -13.9 12 -13.9 13 14.0 4
WH 6 - 4.5 10 0.8 7 4.3 7
MT 11 -50.3 15 - 7.7 11 - 6.3 14
RMcD 7 -44.8 13 25.9 2 33.4 2
FC 14 5.5 5 5.4 6 3.5 8
MC 16 -11.5 11 -44.0 14 -53.7 16
GJ 4 - 3.2 8 - 3.0 9 0.0 10
MS 12 - 1.8 7 -49.2 15 - 0.6 11
FW 5 -60.2 16 0.3 8 - 8.6 15
RR 9 -45.0 14 - 6.4 10 0.8 9
Spearman's rank correlations (r ): df •» 14 (2-tailed)s
Ranked benefit from:
Flavoured drink Milk Horlicks







TABLE 6.8. DIETARY HABITS AND SLEEP : FIRST 3 h TOTALS
Intervening wakefulness occurring in the accumulation of the first 3 h
of sleep.
Each rank for each of 16 subjects is based on the mean difference in min
of intervening wakefulness (IW) over 5 nights on capsules minus the mean
IW over 5 nights recorded on the food drink. (Raw data in Table 5.13).
The rank orders are in descending order of benefit from bedtime nutrit¬
ion: 1 ■ most to 16 ■ least.
Ranked differences : mean min IW in 1st 3 h sleep
Rank order Capsules - Capsules - Capsules ■
Subjects of N% score Flavoured drink Milk Horlii
KB 15 10 13 13
MC 16 5 14 15
FC 14 3 5 7
JG 1 6 11 12
GH 2 12 15 3
AH 10 11 4 5
WH 6 7 6 6
GJ 4 4 12 10.5
RMcD 7 13 3 1
JR 3 1 2 2
RR 9 16 9 8
MS 12 8 10 10.5
MT 11 15 7 9
FW 5 14 8 16
AW 8 2 1 4
MW 13 9 16 14
Spearman's rank correlations (r ): df ■ 14 (2-tailed)
s
Ranked benefit from:
Flavoured drink Milk Horlicks
RankedN Z score 0.05 (n.s.) 0.17 (n.s.) 0.38 (n.s.)
Ranked benefit - - 0.65, p<^ 0.01
from milk
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TABLE 6.9. DIETARY HABITS AND SLEEP : SECOND 3 h TOTALS
Intervening wakefulness occurring in the accumulation of the second
3h of sleep.
Each rank for each of 16 subjects is based on the mean difference in
min of intervening wakefulness (IW) over 5 nights on capsules minus
the mean IW over 5 nights recorded on the food drink. (Raw data
in Table 5.13).
The rank orders are in descending order of benefit from bedtime
nutrition: 1 » most to 16 ■ least.
Ranked differences: mean min IW in 2nd 3h sleep
Subjects Ranked N% Capsules - Capsules - Capsules -
Score Flavoured drink Milk Horlicks
KB 15 1 5 12
MC 16 13 15 16
FC 14 6 7 4
JG 1 2 1 1
CH 2 10 3.5 13
AH 10 4 3.5 8
WH 6 8 10 5
GJ 4 9 11 9
RMcD 7 15 2 2
JR 3 11 6 15
RR 9 12 12 10
MS 12 5 16 11
MT 11 14 13 14
FW 5 16 8 3
AW 8 7 9 7
MW 13 3 14 6
Spearman's rank correlations (r ) : df « 14 (2-tailed)s
Ranked benefit from:
Flavoured drink Milk Horlicks
Ranked N% score -0.20 (n.s.) 0.51, p<^0.05 0.27 (n.s.)
Ranked benefit - - 0.41 (n.s.)
from milk
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TABLE 6.10. DIETARY HABITb AND SLEEP : FIRST 6h TOTALS.
Total rain of intervening wakefulness plus total min of stage 1 in the
accumulation of the first 6h of sleep (IW + stg.l).
Measured benefit from each of the three bedtime drinks in comparison with
capsules.
Each value for each of 16 subjects is the mean (IW + stg.l) over 5 nights
on capsules minus the mean (IW + stg.l) over the 5 nights recorded on the
food drink. (Raw data in Table 5.9).
The rank orders are in descending order of benefit from bedtime nutrition:
1 B most to 16 =* least.
Differences in mean min (IW + stg.l) in 1st 6hs A min
Ranked
N% Capsules - Capsules - Capsules -
Subjects score Flavoured drink Milk Horlicks
A min Rank A min Rank A min Rank
order order order
MW 13 0.3 6 -68.4 16 -13.9 13
AW 8 26.2 1 18.7 3 17.6 4
AH 10 - 0.2 7 11.6 5 14.3 5
KB 15 - 4.2 10 -22.3 13 -18.6 14
JR 3 15.9 2 9.9 6.5 19.1 3
JG 1 6.9 3 21.5 2 41.8 1
GH 2 -14.5 12 -16.7 11 13.7 6
WH 6 0.8 5 9.9 6.5 9.3 7
MT 11 -66.7 15 -18.6 12 -19.2 15
RMcD 7 -46.6 13 27.5 1 33.4 2
FC 14 5.5 4 14.6 4 5.8 8
MC 16 -12.4 11 -44.4 14 -55.8 16
GJ 4 - 0.5 9 -11.9 9 1.5 9
MS 12 - 0.3 8 -53.5 15 1.3 10
FW 15 -83.8 16 - 2.4 8 -11.8 12
RR 9 -58.1 14 -14.0 10 - 2.1 11
Spearman's rank correlations (r )s df » 14 (2-tailed)s
Ranked benefit from:
Flavoured drink Milk Horlicks
Ranked N% 0.12 (n.s.) 0.50, p<0.05 0.68, p<0.01
scores
Ranked benefit - - 0.83, p<,0.001
from milk
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TABLE 6.11. DIETARY HABITS AND SLEEP.
Lack of correlation between the order of receiving the four treatments
and the mean total min of intervening wakefulness in the accumulation
of the first 6h of sleep.
Each value for each of 16 subjects is the mean of 5 nights.
Mean min intervening wakefulness in 1st 6h on each treatment










AW 8.3 (B) 31.4 (A) 19.2 (D) 16.2 (C)
MW 71.1 (C) 17.2 (D) 7.1 (B) 11.7 (A)
AH 11.2 (D) 9.3 (C) 17.7 (A) 21.5 (B)
KB 23.3 (A) 11.1 (B) 33.4 (C) 27.9 (D)
JR 24.1 (B) 45.3 (A) 29.3 (D) 29.0 (C)
JG 13.6 (C) 2.8 (D) 38.1 (B) 48.2 (A)
GH 8.3 (D) 36.2 (C) 22.3 (A) 36.2 (B)
WH 20.0 (A) 24.5 (B) 19.2 (C) 15.7 (D)
MT 73.5 (B) 23.2 (A) 29.5 (D) 30.9 (C)
RMcD 30.6 (C) 23.1 0» 101.3 (B) 56.5 (A)
FC 8.4 (D) 6.5 (C) 11.9 (A) 6.4 (B)
MC 20.7 (A) 32.2 (B) 64.7 (C) 74.4 (D)
GJ 3.2 (B) 0.0 (A) 0.0 (D) 3.0 (C)
MS 49.2 (C) 0.6 (D) 1.8 (B) 0.0 (A)
RR 2.4 (D) 9.6 (C) 3.2 (A) 48.2 (B)










Friedman* s Analysis of Variance by ranks
Xr2 - 1.031, df =* 3 (n.s.)
NOTE: treatment in parenthesis:
A » Capsules; B •» Flavoured drink
C » Milk ; D " Horlicks
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TABLE 6.12. DIETARY HABITS AND SLEEP.
Lack of correlation between the order of receiving the four treatments and
the mean total min of wakefulness occurring after the first onset of sleep
and before the end of the recording (TWT).
Each value for each of 16 subjects is the mean of 5 nights.
Mean TOT on each treatment arranged in chronological order
First Second Third Fourth
Subjects treatment treatment treatment treatment
AW 22.6 (B) 57.8 (A) 29.5 Co) 25.0 (C)
MW 65.4 (C) 40.4 (D) 29.4 (B) 25.8 (A)
AH 12.8 (D) 9.9 (C) 19.0 (A) 24.0 (B)
KB 33.0 (A) 20.7 (B) 41.2 (C) 31.9 (D)
JR 36.3 (B) 49.6 (A) 38.3 (D) 37.6 (C)
JG 29.0 (C) 87.7 (D) 81.3 (B) 90.5 (A)
GH 12.1 (D) 41.4 (C) 32.4 (A) 42.5 (B)
WH 55.1 (A) 56.3 (B) 33.8 (C) 49.7 (D)
MT 84.6 (B) 49.0 (A) 53.4 (D) 52.6 (C)
RMcD 42.7 (C) 45.0 (D> 107.4 (B) 70.4 (A)
FC 23.4 0>) 15.9 (C) 27.9 (A) IS.8 (B)
MC 81.6 (A) 88.6 (B) 106.8 (C) 111.5 (D)
GJ 15.0 (B) 15.2 (A) 8.3 (D) 9.0 (C)
MS 92.8 (C) 75.9 (D) 83.3 (B) 57.0 (A)
RR 6.8 (D) 11.2 (G) 11.8 (A) 47.1 (B)
FW 29.2 (A) 72.7 (B) 32.0 (C) 39.6 (D)
Mean 40.2 46.1 46.0 45.8
is.D. -27.7 +,26.5 -31.6 -26.8
Friedman's Analysis of Variance by ranks
Xr2 ® 1.88, df - 3 (n.s.).
NOTE J treatment in parenthesis:
A = Capsules B = Flavoured drink
C - Milk D - Hor licks
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TABLE 6.13. DIETARY HABITS AND SLEEP : SUBJECTIVE RATINGS OF SLEEP
QUALITY.
Measured differences between each of the three bedtime drinks and capsules.
Each value for each of 16 subjects is the mean sleep quality rating over
the 6 laboratory nights on the food drink minu3 the mean rating for the
6 nights on capsules. The differences listed below are based on the data
used to compile Table 5.16, but using the data when it was to one decimal
place. This was done to reduce the number of tied ranks.
Rank orders are in descending order of benefit from bedtime nutrition:
1 = most to 16 ■ least.
Differences in mean sleep quality ratings: A mm
Ranked
NZ Flavoured drink Milk Horlicks
Subjects score - capsules - capsules - cap*i
A mm Rank order A. ram Rank order Ana Rank i
AW 8 0.3 8 - 0.3 7.5 0.7 6
MW 13 4.0 4 0.5 6 2.4 4
AH 10 - -0.5 10 - 5.7 13 - 7.8 15
KB 15 0.1 9 - 2.7 10 1.0 5
JR 3 4.3 3 15.3 1 - 0.4 8
JG 1 - 5.8 14 - 5.8 14 5.7 1
GH 2 5.5 2 - 1.4 9 - 5.9 14
WH 6 3.1 5 11.5 2 5.6 2
MI 11 - 5.7 13 - 3.5 11 - 2.9 11
RMcD 7 -12.0 15 -10.9 15 - 3.2 12
FC 14 8.2 , 1 5.8 4 - 3.5 13
MC lb 3.0 6 - 0.3 7.5 0.5 7
GJ 4 - 3.5 11 3.9 5 3.0 3
FW 5 - 4.0 12 6.0 3 - 1.4 9
RR 9 2.8 7 - 4.7 12 - 2.8 10
MS 12 -20.3 16 -21.0 16 "27.5 16
Spearman's rank correlations (r ): df = 14 (2-tailed).s
Ranked benefits from:
Flavoured drink Milk Horlicks
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A group of eight subjects who usually had something
to eat at bedtime were found to sleep better after milk
or Horlicks than after an inert capsule, whereas a group
of eight subjects who normally had little or nothing to




Brezinova and Oswald (1972) found that sleep after
the bedtime food drink Horlicks was significantly less
broken than sleep after a placebo pill at bedtime. In
view of the findings described in the previous chapter
it is possible that in their study eight volunteers
were selected who usually had something to eat at bed¬
time. And as their subjects were also instructed not
to eat or drink anything after 1900h except the treat¬
ment then their results may be due largely to the
detrimental effects on sleep of lack of food on the
nights when the placebo pill was taken.
The following calculations were undertaken to see
if I could replicate the findings of Brezinova and
Oswald (1972), using the data collected during the
experiment described in Chapter 5.
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METHODS
The 16 subjects in the experiment were divided
into two groups of eight according to their W>
scores (Table 6.3 previous chapter). One group
comprised those ranked 1 to 8 according to their N%
scores and thus were the eight subjects who normally
ate relatively more food at bedtime. These eight
subjects were called the bedtime 'Eaters' group whereas
those ranked 9-16 according to their Wo scores were the
•Non-Eaters' group.
The mean total sleep time, the mean min of
intervening wakefulness accumulated in the first 6h of
sleep and the mean min of intervening wakefulness plus
the mean min of stage 1 in the first 6h of sleep were
computed for each subject for the five nights recorded
when taking each of the four bedtime treatments (capsules,
flavoured drink, milk and Horlicks).
The mean min of each of the above sleep measures
were calculated for the bedtime Eaters group and the
bedtime Non-Eaters group. Sleep after each of the three
bedtime food drinks was compared (within each group) with
sleep after capsules by means of t-tests for paired
observations (Ferguson, 1959). The bedtime Eaters
group was predicted to sleep better after Horlicks
than/
- 281 -
than after capsules and so 1-tailed levels of
significance were employed for comparisons between
Horlicks and capsules, other comparisons within the
two groups had no prior grounds for predictions and
so 2-tailed levels of significance were used.
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RESULTS
(a) Total sleep time (Table 7.1)
The members of the bedtime Eaters group slept
significantly longer after both milk and Horlicks when
compared with their sleep after capsules. Whereas
those in the Non-Eaters group slept longest when on
capsules but, the comparisons failed to reach
statistical significance. The comparisons between the
flavoured drink and capsules were significantly
insignificant for both groups.
(b) Intervening wakefulness in first 6h of sleep
(Table 7.2)
The first six hours of accumulated sleep of the
bedtime Eaters group was less broken by wakefulness
after Horlicks than when they had taken capsules at
bedtime, but the level of significance was only 5%
and so this can only be regarded as a trend. The sleep
of the bedtime Non-Eaters group was least broken after
capsules at bedtime. However the variance was high
and the comparisons between sleep after the bedtime
food drinks with capsules in the Non-Eater group were
not statistically significant.
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(c) Intervening wakefulness plus stage 1 in the first
six hours of sleep (Table 7.3).
Subjects in the bedtime Eaters group had
significantly less (p<0.025) intervening wakefulness
plus stage 1 in the accumulation of the first 6h of
sleep after Horlicks at bedtime when compared with
their sleep after capsules. The comparisons between
milk or flavoured drink and capsules were not
significantly different.
The bedtime Non-Eaters sleep was least interrupted
by waking and periods of drowsiness on the nights they
took capsules at bedtime, however only the comparison
between capsules and milk reached the 5% level of
significance and so the results only indicate a tendency




The intention of this Chapter was to explore the
possibility that the apparent disparity between my
results and those of Brezinova and Oswald (1972), in
the effects on sleep of Horlicks when compared with
capsules, might be due to differences in the dietary
habits of the subjects.
The 1-tailed level of significance was regarded
as justified for the comparisons between capsules and
Horlicks as these had been predicted. However, any
conclusions put forward from this post-hoc treatment
of the data are only pointers for future research
which may confirm or otherwise these tentative findings.
The data collected from the bedtime Eaters group
showed that these eight subjects slept significantly
longer and their sleep tended to be less broken by
wakefulness in the first 6h of sleep when they took
Horlicks at bedtime when compared with sleep after
capsules. These results are in the same direction as
V /
those of Brezinova and Oswald (1972), and so suggest
that their eight subjects were a group of people who
normally had something to eat or drink at bedtime. It
may be that those who usually eat at bedtime would more




The bedtime Non-Eater group slept longest and
had least interruption of their sleep by waking when
they took capsules at bedtime, however, none of the
comparisons reached statistical significance.
Inspection of Table 6.3 (previous Chapter) shows
that the division of subjects into two groups of
eight according to the rank orders of their N% score
was rather arbitary and included two subjects in the
Non-Eater group who in fact normally ate at bedtime
(AH and RR) , However this division of subjects was
done post-hoc and so I did not feel entitled to divide
the subjects into groups in any other way.
It would be interesting to compare sleep after
capsules with sleep after Horlicks in subjects pre¬
selected into one group who normally ate a lot and
another group who eat nothing at bedtime. I would
predict that with these highly polarized groups clear
differences would emerge and the Non-Eater group would
sleep significantly worse after food at bedtime.
The main conclusion to be drawn from this post-hoc
inspection of my data is that you can probably
influence the results of experiments into nutrition and
sleep, by the selection of suitable subjects.
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TABLE 7.1. EE0TIME EATERS/NON-EATERS
Differences betvean the bedtime (a) Eater3 group and (b) Non-eaters
group in the mean total rain asleep (total sleep time), when taking
each of the four bedtime treatments.
Each value is the mean of AO subject-nights: Eight subjects in each
group recorded for 5 nights on each treatment.
(a) Bedtime Eaters (N% scores 19% to 41%)
n - 8















t = 0.46 (n.s.) t «• 2.64,p<0.05(2t) t " 2.03,p<0.05(lt)
2-tailed: It » 1-tailed level
(b) Bedtime Non-eaters (N% scores 0 to 17%)
n * 8















t - 1.35 (n.s.)
NOTE: Individual subjects data listed in Table 5.1.
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TABLE 7.2. BEDTIME EATERS/NON-EATERS
Differences between the bedtime (a) Eaters group and (b) Non-eaters
group in the mean total min of intervening wakefulness occurring in
the accumulation of the first 6 h of sleep, when taking each of the
four bedtime treatments.
Each value is the mean of 40 subject-nights: Eight subjects in each
group recorded for 5 nights on each treatment.
(a) Bedtime Eaters (n «■ 8)
Mean - S.D. min intervening wakefulness in 1st 6 h sleep
Capsules Flavoured Milk Horlicks
drink
30.2 39.1 20.7 15.6
- 18.8 -34.1 ±10.7 ±10.9
t-tests for paired observations, df » 7
Flavoured Milk Horlicks
drink
Capsules t - 0.83 (n.s.) t » 1.66 (n.s.) t « 2.35,p<(0.05*
*not statistically significant
(b) Bedtime Non-eaters (n ■ 8)
Mean ± S.D. min intervening wakefulness in 1st 6 h sleep
Capsules Flavoured Milk Horlicks
drink
14.2 25.2 34.3 21.5
±9.2 ±24.9 ±25.4 ±23.9
t-tests for paired observations, df » 7 (2-tailed)
Flavoured Milk Horlicks
drink
Capsules t <■ 1.30 (n.s.) t » 2.15 (n.s.) t " 1.06 (n.s.)
Note: Individual subjects data listed in Table 5.8
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TABLE 7.3. BEDTIME EATERS/NON-EATERS
Differences between the bedtime (a) Eaters group and (b) n;on-eaters
group in the mean total min of intervening wakefulness plus the mean
total min of stage 1 occurring in the accumulation of the first 6 h
of sleep, when taking each of the four bedtime treatments.
Each value is the mean of 40 subject-nights: Eight subjects in each
group recorded for 5 nighcs on each treatment.
(a) Bedtime Eaters (n « 8)
mean + S.D. min interv. wake + stg 1 in 1st 6 h sleep
Capsules Flavoured Milk Horlicks
drink
65.1 77.1 58.1 49.6
-23.2 -41.2 -12.3 *18.9
t-tests for paired observations, df « 7
Flavoured Milk Horlicks
drink
Capsules t ■» 0.93 (n.s.) t ■ 1.23 (n.s.) t - 2.60, p<^0.025*
*l-tailed level of significance
(b) Bedtime Non-eaters (n ■ 8)
mean + S.D. min interv. wake + stg 1 in 1st 6 h sleep
Capsules Flavoured Milk Horlicks
drink
45.1 62.1 71.2 56.2
-19.4 -33.4 -33.5 -37.8
t-tests for paired observations, df ■ 7 (2-tailed)
Flavoured Milk Horlicks
drink
Capsules t » 1.68 (n.s.) t ■» 2.55, p<T).05/ t = 1.45 (n.s.)
•f « not significant
NOTE: Individual subjects data listed in Table 5.9
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The body weights of 16 middle-aged subjects were
found to be highly correlated with their average
quotas of REM sleep. This was true of the mean total
min of REM sleep accumulated over the whole night,
the mean min of REM sleep accumulated in the first 6h
of sleep and the mean total min of REM sleep as a
percentage of the total time spent asleep.
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INTRODUCTION
The association between REM sleep and the bizarre
mental life of dreams has led to sin emphasis of
research interest upon psychological correlates of REM
sleep and a neglect of attention toward somatic
functions for REM sleep. Attempts to find any
correlations between personality and REM sleep have
been unsuccessful (reviewed by Foulkes, 1966).
A number of investigations have shown that the
amount of REM sleep is reduced in mental retardates (e.g.
Petre-Quadens and Jouvet, 1966), that babies have
very large amounts of REM sleep at the time when their
brains are maturing rapidly (Roffwarg et al.f 1966)
and that when information processing is reduced, as
might be expected, in severely deaf children, the
amount of REM sleep is below normal levels (StojanovicT
and Diirrigl, 1975).
After poisoning by CNS-affecting drugs there is an
increase in the amount of REM sleep lasting for many
weeks, suggesting that REM sleep is associated with
repair processes in the brain (Oswald, 1969; Haider
and Oswald, 1970), All of these findings point to a
role for REM sleep in brain function and metabolism and
in consequence investigations into and speculations
about/
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about the function of REM sleep have tended to think
only of the brain (Oswald, 1969, 1970; Hartmann, 1973;
Stern and Morgane, 1974). Yet during REM sleep muscle
tone in the body is at its lowest (Jacobson et al.,
1964; Pompeiano, 1967), which means less cellular work
is being done in the musclesand (if the theory put
forward in Chapter 1 of this thesis is correct) synthetic,
restorative processes will then be promoted. This
suggests that REM sleep may also have a role in bodily
repair processes more general than the brain alone.
Such a role has previously been proposed for slow wave
sleep (Oswald, 1969, 1970; Hartmann, 1973).
The sleep pattern of any one individual can vary
considerably from night to night and to obtain a reliable
measure of a person's sleep many, and preferably
consecutive, recordings should be made, because one
night's sleep can be unrepresentative as it depends on
how a person slept on previous nights. This is
particularly true of REM sleep, which of all the sleep
stages is the most vulnerable to disruption and the
amount recorded is reduced by a variety of different
treatments or environmental circumstances.
The data generated by the experiment described
earlier in Chapter 5 appeared well suited to an invest¬
igation of REM sleep. The subjects were well adapted
to/
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to the laboratory procedure, in fact, 14 out of 16
of the subjects had previously participated in at
least one other sleep study.
Body weight and daily metabolic rate are highly
correlated when both are in logarithmic form (Kleiber,
1961) and so the present investigation was undertaken
to see if body weight (and so daily metabolism) was
related to mean amounts of REM sleep, slow wave sleep
or total sleep time. The latter was shown to be
correlated with metabolic rate (rate/kg) in a study




(a) Subjects and electrophysiological recordings
There were 16 subjects of average age 59y
(52 to 67y). The group comprised ten women and six
men. Each slept in the laboratory on six consecutive
nights (1 adaptation and 5 recordings) every four
weeks during a 13-week period, making 20 nights in all.
Lights-out was from 2215h i 15 min to 0700h - 15 min
and all recordings lasted the same length of time -
8.75h.
The 320 electrophysiological records were scored
into the various sleep stages and wakefulness in
terms of the usual criteria (Rechtschaffen and Kales,
1968). The amounts of stages 3+4 and REM sleep on
each night were computed and the means for each subject
for his or her 20 nights were calculated. The same was
done for the total amount of time that subjects were
asleep during the recording.
(b) Body weight measured
On the first and last nights of each week of
attendance subjects were weighed, by the investigator,
in light indoor clothing. The wight weight measures
(in lbs) were averaged for each person.
The mean weight was converted into kg by multiplying
the weight in lbs by 0.454. The mean weights in kg were
also converted into logarithmic form.
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STATISTICS
Pearson's product-moment correlation coefficient
(Ferguson, 1959) was calculated to test the significance
of the relationship between various measures of sleep
and body weight.
Two-tailed levels of significance are quoted for
all the results except for the correlation between total
min REM sleep and total sleep time where there was a
prediction of a positive correlation.
Linear regression by the method of least squares
(Ferguson, 1959) was used to fit a straight line through
the graphically presented data points.
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RESULTS
(a) Mean body weight of subjects
The 16 subjects covered a wide range of body weight
i.e. 104 lb to 202 lb (47kg to 92kg), but the individual
weights varied little over the eight separate weighings
e.g. the largest standard deviation for any subject's
weight was 2.46 lb over 13 weeks (Table 8.1).
(b) Correlations (r) between body weight and REM sleep
Body weight was found to be significantly correlated
with the mean total min of REM sleep whether the mean of
all 20 nights recorded per subject was used: r = 0.633,
p^O.Ol (Table 8.2 and Figure 8.1), or the means of the
five nights on each of the four bedtime treatments
(Table 8.3). There were no significant differences
among the mean min of REM sleep accumulated during
administration of the four bedtime treatments (Table 5.11
Chapter 5). Subjects slept, on average, for differing
lengths of time and the amount of REM sleep was related
to the total length of time that subjects slept:
r = 0.481, p<0.05, 1-tailed (Table 8.2), but body weight
and percentage of total sleep spent in REM sleep were
more highly correlated: r = 0.631, p<O.01 (Table 8.2 and
Figure 8.2) and body weight was not significantly
correlated/
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FIGURE 8.1 Correlation between mean total min of
REM sleep and body weight in 16 middle-aged subjects.
Each value of total REM sleep is the mean
of 20 recorded nights.
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FIGURE 8.2 Correlation between mean percentage
REM sleep and body weight in 16 middle-aged subjects.
Each value of % REM sleep is the mean of
20 recorded nights.
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correlated with the mean total time that subjects were
asleep (Table 8.2).
The relationship between body weight and REM sleep
was equally significant, when the min of REM sleep
accumulated in the first 6h of sleep were considered:
r = 0.651, p<0.01 (Table 8.2).
(c) Correlations (r) between log body weight and REM sleep.
Log body weight was significantly correlated with the
mean total min of REM sleep: r = 0.645, p<0.01 (Table 8.4
and Figure 8.3) and with the percentage of total time
asleep spent in REM sleep: r = 0.634, p<,0.0l (Table 8.4
and Figure 8.4).
(d) Correlations (r) between body weight, total sleep time,
slow wave sleep (SWS) and percentage SWS.
Table 8.5 lists the inter-correlations between mean
body weight, total sleep time, total min of slow wave
sleep (stages 3+4) and percentage SWS.
There was no significant correlation found between
body weight and, total sleep time, total min slow wave
sleep or percentage SWS nor was there any significant
correlation between total sleep time and total min of
slow wave sleep or percentage slow wave sleep.
(e) Lack of correlation between REM sleep and age
Table 8.6 shows that none among the total min of
REM sleep accumulated in the first 6h, in the whole
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FIGURE 8.3 Correlation between mean total min of
REM sleep and log body weight in 16 middle-aged
subjects.
Each value of total REM sleep is the
mean of 20 recorded nights.
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FIGURE 8.4 Correlation between the mean percentage
of REM sleep and log body weight in 16 middle-aged
subjects.
Each value of % REM is the mean of 20
recorded nights.
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whole night, or the percentage of total sleep spent in
REM sleep correlated significantly with age.
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DISCUSSION
The significance level of the correlations found
between body weight and measures of REM sleep were
sufficiently high (p<0.01) to make chance an unlikely
explanation. The overall daily energy expenditure of
an animal is closely related to its body weight
(Kleiber, 1961) and this suggests that REM sleep may
have a role associated with whole body energy balance.
It could be said that brain weight is related to
body weight and that the fundamental relationship
might be between brain weight and REM sleep. However,
evidence from other experiments tend to suggest that
it is with body weight. For example, when anorexia
nervosa patients gained weight to reach their target
body weight, the most striking change in their sleep
pattern was an increase in REM sleep averaging about
40 min, which, even taking into account the increase in
total sleep time, was still a significant rise (Lacey
et al., 1975). In other experiments, compatible
results were found, e.g. when ten young men were
starved for four days the mean weight loss was 5.3kg
and the percentage of total sleep spent in REM sleep
declined by an average of 5.33 per cent (MacFadyen
et al., 1973) and when three hyperthyroid patients
gained weight as they became euthyroid, the amount of
time they spent in REM sleep increased (Dunleavy et al.,
1974).
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These three reports suggest that changes in body weight
are associated with parallel changes in the amount of
time spent in REM sleep and so give support to ray
proposition, that it is with body weight that the
amount of REM sleep is associated, for it is highly
unlikely that brain weight was altered to any
appreciable extent in the above studies. It may be
that there is some other explanation for the changes
in REM sleep associated with alteration in body weight
due to both being mutually dependent on a third factor.
A likely candidate would seem to be some aspect of the
diet, either its quantity or composition.
In cats the amount of REM sleep during a 12h
the
period including daytime sleep (whenA cats accumulated
most of their sleep in the 24h) \vas found to be
inversely correlated with the quantity of food they ate
If12
in the following 12h including the night-time (when^cats
eat most of their food), which suggests that relatively
small day-to-day variations in the amount of REM sleep
may be associated with the day-to-day differences in
food intake (Siegel, 1975). In another study Dement
et al. (1967) reported that cats deprived of REM sleep
ate voraciously, again linking REM sleep with food intake.
Normally body weight changes are related to alterations
in food intake and so this could be a possible link
between/
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between body weight and REM sleep. In the 'set-point1
theory of body weight maintenance (Powley and Keesey,
1970; Keesey et al., 1976) it is proposed that for any
individual there is a pre-set level of body weight,
deviations from which are monitored by the lateral
hypothalamus and rectified by the appropriate
alterations in appetite. It is tempting to speculate
that some process involved with REM sleep is linked
to a hypothalamic feeding control system for maintaining
body weight. Obviously, in humans, food intake is not
exclusively dependent on some internal cue and can be
altered by many external factors. However, an internal
regulator of body weight must surely exist to explain
the extraordinary accuracy in maintaining body weight,
considering the quantity of food we consume over the
years.
Kleiber (1961) reported that log body weight was
highly correlated with log daily metabolic rate (total
calories/24h) over a number of species and I found that
log body weight was correlated with total min and
percentage of REM sleep. This suggests that REM sleep
is related to daily energy expenditure. A large
proportion of energy expenditure, even at rest about 40%,
is attributable to muscle metabolism (Andres et al., 1956).
A characteristic feature of REM sleep is the loss of
muscle/
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muscle tone, and hence a reduction in oxidative
metabolism and thus a lower rate of degradation (in¬
cluding that of amino acids). It could be that this
heretofore unexplained feature of REM sleep is a device
to compensate for the relatively large energy
expenditure of muscle during daytime activity.
Williams et al. (1974) presented normal data for
all the usual measures of sleep and wakefulness in
humans across all ages from infancy to old age. However,
looking at their mean REM sleep data for the age group
in which my subjects fall, I found no indication of
higher amounts of REM sleep in middle-aged men compared
with middle-aged women. I had thought that men would,
on average, be heavier than women, but, on closer
inspection of their methods, it appears that after a
single adaptation night, only one sleep recording was
made on each subject and that recordings only lasted
about 7h. A possible explanation for the lack of
difference in amount of REM sleep between the sexes
in their work could be that the number of recordings that
were made on each subject was insufficient to get a




To conclude, I report a significant correlation
between body weight and the average quota of REM sleep
over a sequence of nights. This was true of the mean
of each of the four blocks of five consecutive nights
and the mean of the total 20 nights recorded.
I proposed that because of the high correlation
between body weight and daily metabolism (total
cals/24h) reported by Kleiber (1961), a relationship
between the mean amount of REM sleep and daily metabolism
may exist, which in turn suggests that REM sleep may have
a role in body maintenance. This of course, does not
exclude other functions for REM sleep, which must exist
to account for such things as the high quotas of REM
sleep recorded in babies at a time when the nervous
system is rapidly maturing and the large increase in
REM sleep following poisoning by CNS drugs. Neither of
which can be explained by a bodyweight-REM sleep
relationship.
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TABLE 8.1. BODY WEIGHT AND REM SLEEP
Mean body weights (lb) of each of 16 subjects. Each subject weighed
eight times over 13 weeks. Weight in lb converted to kg. using con¬
version factor: 1 lb - 0.454 kg. (Raw data in Table 5.19).
Mean body weight
Subjects Sex lb - S.D. kg.
MS F 103.69 - 1.36 47.08
JR F 118.56 - 0.92 53.83
MT F 128.19 - 1.41 58.20
RMcD F 135.75 - 0.76 61.63
FW F 139.78 - 0.69 63.46
RR F 142.50 * 0.92 64.70
MW F 146.19 * 1.52 66.37
AH F 148.16 - 1.03 67.27
WH M 148.28 - 1.21 67.32
MC M 152.53 - 2.26 69.25
FC F 157.81 - 0.95 71.65
GH F 159.34 - 2.46 72.34
GJ M 163.91 * 0.79 74.42
AW M 170.84 * 0.64 77.56
KB M 171.53 * 1.88 77.88
JG M 201.84 - 1.29 91.64
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TABLE 8.2. BODY WEIGHT AND REM SLEEP.
Correlations between mean body weight, mean total min of REM sleep, mean
percentage of total sleep time spent in REM sleep, mean total min of REM
sleep in the first 6h of sleep and mean total tain asleep.
Each value for each of 16 subjects is the mean of 20 nights.
Subjects Mean Total min Percentage Min REM in Total
Body wt(kg) REM sleep REM sleep 1st 6h sleep Sleep time
MS 47.08 72.9 16.8 52.1 434.0
JR 53.83 78.5 18.1 59.5 434.9
MT 58.20 49.5 11.2 32.7 444.1
RMcD 61.63 82.4 18.8 58.9 438.9
FW 63.46 83.6 18.4 57.7 453.9
RR 64.70 100.3 20.7 70.1 485.4
MW 66.37 82.3 18.5 58.2 444.2
AH 67.27 91.6 19.3 55.1 473.7
WH 67.32 100.5 22.3 72.4 449.8
MC 69.25 77.8 20.2 68.0 384.7
FC 71.65 81.3 16.9 52.5 480.7
GH 72.34 101.7 21.6 65.8 472.0
GJ 74.42 102.5 20.4 69.8 502.5
AW 77.56 110.4 23.2 67.9 475.0
KB 77.88 105.8 23.8 73.2 445.0
JG 91.64 96.1 21.8 77.9 441.7
Correlation coefficients (r); df = 14 (2-tailed).
Total min Percentage Min REM in Total
REM sleep REM sleep 1st 6h sleep sleep time
Body weight 0.633 0.631 0.651 0.232
p<0.01 p<0.01 p<0.01 (n.s.)
Total sleep time 0.481 0.142 0.065
p<0.05 (n.s.) (n.s.)
(1-tailed)
TABLE 8.3. BODY WEIGHT AND REM SLEEP.
Correlations between mean body weight and the mean total roin of REM sleep
recorded when subjects had taken each of the four bedtime treatments.
Each value for each of 1G subjects is the mean of the 5 nights recorded
while on the treatment.
Mean total minutes of REM sleep






JR 53.83 76.1 70.8 91.2 75.8
MT 58.20 50.5 49.6
. 48.9 48.9
RMcD 61.63 82.7 69.2 97.1 80.4
FW 63.46 96.2 74.9 81.3 93,8
RR 64.70 109.1 77.9 106.4 110.0
MW 66.37 96.9 85.4 74.4 72.6
AH 67.27 85.3 99.7 93.4 87.9
WH 67.32 94.8 100.9 111.9 94.5
MC 67.25 83.7 72.7 80.1 74.8
FC 71.65 80.4 80.0 91.9 73.0
GH 72.34 97.2 105.4 97.9 106.2
GJ 74.42 103.4 104.2 96.9 105.6
AW 77.56 118.9 114.8 107.5 100.4
KB 77.88 123.9 95.1 106.2 98.1
JG 91.64 96.1 92.3 100.9 95.2
Correlation coefficients (r); df ■ 14 (2-tailed)
Mean total min REM sleep on:
Capsules Flavoured Milk Horlicks
_{lrink —__—
Mean body weight 0.530 0.559 0.600 0.562
p<0.05 p<0.05 p<0.02 p<0.05
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TABLE 8.4. BODY WEIGHT AND REM SLEEP
Correlations between 1°S^q body weight (kg) of 16 subjects and
their mean total min of REM sleep and the mean percentage of total sleep
time spent in REM sleep averaged over 20 recorded nights.
Subjects log1Q Body weight Total min REM sleep Percentage REM
sleep
MS 1.6728 72.9 16.8
JR 1.7310 78.5 18.1
MT 1.7649 49.5 11.2
RMcD 1.7898 82.4 18.8
FW 1.8025 83.6 18.4
RR 1.8109 100.3 20.7
MW 1.8220 82.3 18.5
AH 1.8278 91.6 19.3
WH 1.8281 100.5 22.3
MC 1.8404 77.8 20.2
FC 1.8552 81.3 16.9
GH 1.8594 101.7 21.6
GJ 1.8717 102.5 20.4
AW 1.8896 110.4 23.2
KB 1.8914 105.8 23.8
JG 1.9621 96.1 21.8
Correlation coefficients (r); df « 14 (2-tailed)
Total min REM sleep Percentage REM
sleep
los10 body weight 0.645 0.634
p<0.01 p<0.01
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TABLE 8.5. BODY WEIGHT AND HEM SLEEP.
Correlations between mean body weights of 16 subjects and their mean
total time asleep, mean total min slow wave sleep (SWS) and percentage











MS 47.08 434.0 37.7 8.7
JR 53.83 434.9 61.5 14.1
MT 58.20 444.1 106.8 24.1
RMcD 61.63 438.9 84.3 19.2
FW 63.46 453.9 34.1 7.5
RR 64.70 485.4 39.5 8.1
MW 66.37 444.2 85.6 19.3
AH 67.27 473.7 68.6 14.5
WH 67.32 449.8 66.6 14.8
MC 69.25 384.7 14.3 3.7
FC 71.65 480.7 84.4 17.6
GH 72.34 472.0 82.2 17.4
GJ 74.42 502.5 69.0 13.7
AW 77.56 475.0 79.8 16.8
KB 77.88 445.0 81.2 18.3
JG 91.64 441.7 77.9 17.6
Correlation coefficients (r); df - 14 (2-tailed)
Total sleep time Total min SWS Percentage SWS
Body weight 0.232 0.264 0.224
(n.s.) (n.s.) (n.s.)
Total sleep time - 0.352 0.227
(n.s.) (n.s.)
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TABLE 8.6. BODY WEIGHT AND REM SLEEP
Lack of significant correlation with age in 16 subjects among mean total
min REM sleep, mean min REM sleep accumulated in the first 6h of sleep or











MS 59 72.9 52.1 16.8
JR 62 78.5 59.5 13.1
MT 50 49.5 32.7 11.2
RMcD 64 82.4 58.9 18.8
FN 67 83.6 57.7 13.4
RR 58 100.3 70.1 20.7
MW 52 82.3 58.2 18.5
AH 62 91.6 55.1 19.3
WH 54 100.5 72.4 22.3
MC 60 77.8 68.0 20.2
FC 62 81.3 52.5 16.9
GH 58 101.7 65.8 21.6
GJ 55 102.5 69.8 20.4
AW 55 110.4 67.9 23.2
KB 62 105.8 73.2 23.8




df - 14 (2-tailed)
Min REM Percentage
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The same 16 subjects, whose average quota of
REM sleep correlated highly with body weight, were
ranked 1-16 according to their performance on tests
designed to measure intelligence. No significant
rank correlations were found between I.Q. and the
mean amounts of REM sleep in the whole night or




In the previous Chapter I reported a highly
significant correlation between body weight and the
mean amount of REM sleep. A number of investigations
have indicated a relationship between intelligence
quotient (IQ) and the amount of REM sleep. Petre-
Quadens and Jouvet (1966) found that mental retardates
had less REM sleep than normal. Feinberg et al. (1969)
reported a significant correlation between the percentage
of total sleep time spent in REM sleep and IQ, in 32
adult mental retardates. Another study in mongoloids,
found that the reduction of REM sleep was greater in the
severely retarded group than in a less retarded group
(Castaldo, 1969). Castaldo and Krynicki (1973) found a
positive correlation between the amount of REM sleep
and IQ in retardates. The same authors later reported
(Castaldo and Krynicki, 1974) a positive correlation
between min of stage REM and IQ and a negative
correlation between REM cycle length and IQ.
However, it has long been recognized that physical
growth and mental development are connected. At the
beginning of this century, Goddard (1912) reported that
both body height and weight were less throughout life
in mentally retarded patients than age-matched normals
and that the impairment of physical growth was related
to the severity of the mental retardation. More
recently/
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recently it has been shown that the degree of mental
retardation correlates with the decrement in height
and weight in children (Cully and Jolly, 1963) and
in children and adults (Mosier et al., 1965).
In view of the apparent relationship between REM
sleep and IQ found by Feinberg et al. (1969) in adult
mental retardates, I decided to measure the performance,
on IQ tests, of the 16 subjects whose body weights
correlated so highly with the amounts of REM sleep
recorded. In addition, I used the many tables of
data given by Mosier et al. (1965) to investigate the




(a) Performance measured on psychological tests
The 16 subjects, who had taken part in the study
of the four bedtime treatments described in Chapter 5,
were invited to come to our laboratory for an hour-
long session of psychometric tests. This invitation
came about a year after the sleep study and so their
mean age was 60y. Ten of the subjects came at llOOh
on one Sunday and the other six the following Sunday.
The day of the week, the time of the day and order
of tests were identical for both groups.
In consultation with a clinical psychologist,
Mr. D. Peck in Edinburgh University Department of
Psychiatry, it was decided to try and test both verbal
and non-verbal skills. The intention was to rank
subjects in order of performance on the type of tests
used to measure IQ. Two standard tests were selected.
One was to measure vocabulary and comprised words
numbered 12 to 44 of the Mill-Hill (Senior) Set A list
of 44 words (Raven, 1958) preceded by the first six
words on the WAIS (Wechsler Adult Intelligence Scale
Wechsler, 1955). An additional word plus an accept¬
able definition was included at the beginning of the
list as an example of what was required (Figure 9.1).
The/
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WAIS AND MILLHILL SCALE (SENIOR)
NAME:
INSTRUCTIONS: Please write down in a few words the meaning of each of the
following words. The first word has been done for you as an
example.








































FIGURE 9.1 MILLHILL VOCABULARY TEST. The figure is a
photographically reduced (x 0.83) copy of the vocabulary
test given to the 16 middle-aged subjects.
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The first six 'easy' words from the WAIS test
were included at the beginning of the test to give
the subjects practice in composing meanings of words,
and the answers to those were not included in the
assessments. Subjects were allowed 30 min to complete
this assignment.
The aim of this test was to measure subjects1
"present recall of acquired information and ability
for verbal communication".
The other test was Raven's Matrices test
(Raven, 1960), where subjects are asked to match one
of six (or eight) alternative pieces of pattern to a
space in a large pattern. Subjects were allowed 30 min
on this test. The test was designed to measure a
person's present capacity for intellectual activity
and rational judgement.
The combination of the vocabulary test and the
Matrices test has apparently proved reliable in
assessing intelligence (Raven, 1958).
The vocabulary test was supposed to be given
orally to a subject and the subject's answers written
down verbatum by the investigator. It was, however,
decided to give the test as a written paper because of
the time required to test the 16 subjects individually,
for most of them could only attend the laboratory in
the/
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the later evening or on a Sunday, but perhaps the
more important reason was that I know all the subjects
so well that I felt some of them might have been
embarrassed if they felt they performed poorly on the
test.
The two groups were given the tests in the same
order, first the Raven's Matrices test, then the
vocabulary test, and the identical instructions were
read to them prior to each test. Figure 9.2 is a
copy of the information read to the subjects before
the Matric% test and the instructions listed at the
top of the vocabulary test (Figure 9.1) were read
aloud by the investigator and in addition they were
told that they should not be worried if they failed
to define all the words as this was a very difficult
test. There was a five-minute break between the tests.
Both tests were scored by the psychologist who
knew none of the subjects. He scored the subject's
definitions of words 7 to 40 on the vocabulary list
on a three point scale viz. Q, 1 and 2. Marks were
awarded in accordance with the standards listed in
the instruction manual accompanying the test (Raven,
1958). Each subject's total score on the test,
taking into account his/her age, was interpolated






If you open the book in front of you at page Al, you will see a large patterned
rectangle with a vacant slot in one corner. Beneath the rectangle, there are
6 figures, one of which will fit into the vacant slot to complete the pattern of
the rectangle. Each figure is the same shape as the slot, but only the one
with the matching pattern is the missing piece. In this case, the missing
piece is figure 4.
If you look on the answer-sheet you will find the answer to Al has already
been done.
In a minute, we would like you to turn over the page and work through the
book, carefully selecting the figure, which represents the missing piece
from the pattern on the rectangle.
Working down each column of the answer-sheet as you go through the book,
write down the number of the figure you choose as the missing piece, for
each of the pictures.
You will have half-an-hour to do as many as you can. Do not worry if you
cannot finish - it does not matter. Some of them are quite hard. If you
come to one which you can't do don't spend too much time over it, go on
and try the next one. But, always make sure you write your answer in the
space labelled with the same letter and number as the page you are doing
Does any one have any questions?
FIGURE 9.2 Instructions read to subjects before
they attempted the Raven1s progressive matrices.
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The answers to the Raven*s matrices test were
marked as correct (1 point) or wrong (0 points) and
the score converted into an IQ using the standard
tables of this test and taking into account subject's
age (Raven, 1960).
Spearman's rank correlation test (Siegel, 1956)
was used to test the significance of any correlation
between the IQ of subjects and the amount of REM
sleep recorded and their body weights.
(b) Calculations using the data of Mosier et al.
Mosier et al. (1965) reported the mean body
weights and mean heights of a very large number of
mentally retarded patients. They sub-divided patients
into the two sexes, three IQ ranges and 21 age groups
(from a group comprising those less than 30 months old
to one of those over 40 years old. I selected out the
body xveight data from the six highest age groups for
both the male and female adults (over 16y). This data
was collected from 1253 patients. For every age group
and for either sex a mean body weight was presented
for each IQ band so there were 12 mean body weights
for those adults with IQs below 20. 12 age-matched
mean body weights for those with IQs of 20 or above
but below 50 and a matched set of mean body weights
for/
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for those with IQs of 50 or above. I calculated the
mean body weight for each IQ band. I used Friedman's
analysis of variance by ranks (Siegel, 1956) to test
whether the lowest IQ band was associated with the
lowest mean body weights and the highest IQ band with
the highest mean body weights.
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RESULTS
(a) Subjects ranked in order of their performance on
the IQ tests.
I will use the term IQ for brevity but really
mean their relative performance on these psychological
tests.
Table 9.1 lists the IQs estimated from the two
tests and the mean IQ for each subject.
It was never intended to use the numerical values
of IQs but only to rank the subjects in order of
performance on the two IQ tests, and so the rank order
listed in the Table is what was used in the statistical
testing of the results. Unfortunately, the range of
mean IQ was rather narrow, 93 to approximately 125.
(b) Spearman's rank correlations (x^ _ (Table 9.2)
In this group of middle-aged subjects, the rank
order of IQ was not significantly correlated with the
rank order of mean percentage of total sleep spent in
REM sleep or mean total min of REM sleep recorded.
Nor was IQ significantly correlated with body weight
whereas body weight was highly correlated with both
percentage REM sleep: = 0.774, p 0.001 (2-tailed)
and mean min of REM sleep: = 0.721, p 0.005 (2-tailed).
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(c) Analysis of the results of Mosier et al.
The mean weights of each age group were sub¬
divided into the three IQ bands. The overall mean
body weight for each IQ band showed that the mean
weight for the highest IQ band was greater than the
intermediate IQ band, which in turn was higher than
the lowest IQ band. Analysis of variance by ranks,
using each age group's mean body weights for each IQ
band, revealed a highly significant association








Body Weight Correlates With IQ in Adult Retardates




0 to 19 I 20 to 49 I 50 to 80
Intelligence Quotient
FIGURE 9.3 Correlation between I.Q. and body weight
in adult mental retardates.
Each point on the graph is the mean body weight of
one age group of adult mental retardates in the
particular I.Q. band. Men and women were treated
separately. For statistical purposes the mean body
weights of each age group (and either sex) in the
three I.Q. bands were compared.
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DISCUSSION
The psychological testing of the 16 subjects showed
that they differed in their ability to perform the tests
and could be separated into a rank order. However the
spread of estimated IQ was rather narrow and so the lack
of relationship found between performance on these tests
and REM sleep cannot be extrapolated to other groups.
Nevertheless, the correlations found between their body
weights and measures of REM sleep were highly
significant and this, coupled with the highly
significant relationship between IQ and body weight in
groups of adult mental retardates (Mosier et al., 1965)
does suggest that the correlation between REM sleep and
IQ in adult retardates reported by Feinberg et al. (1969)
may in fact be largely attributable to the relationship
of both these variables to body weight.
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TABLE 9.1. LACK OF CORRELATION BETWEEN I.Q. AND REM SLEEP.
16 Subjects ranked in order of their intelligence quotient based on the
I.Q.'s estimated, on:
(a) Millhill vocabulary test.
(b) Raven's matrices test.
Then the scores on (a) and (b) averaged.
(a) (b) Mean of
Subjects Vocabulary test Raven's matrices (a) and (b)
I.Q. Rarnc Order I.Q. Rank Order I.Q. Rank Order
KB 126 1 104 13 115.0 7
Gil 111 8 130 2 120.5 4
JG* 110 9 130+ 1 125+ 1
GJ 116 4.5 123 6 119.5 5
MS 112 6.5 101 14 106.5 13
JR 118 2.5 109 11.5 113.5 10
Wfi 109 10 109 11.5 109.0 11
FW 116 4.5 128 3 122.0 2
AW 101 14 114 9.5 107.5 12
MW 96 15.5 114 9.5 105.0 14
RR 108 11.5 126 4 117.0 6
MT 118 2.5 125 5 121.5 3
KMcD 112 6.5 117 8 114.5 8
AH 108 11.5 120 7 114.0 9
FC 102 13 83 16 92.5 16
MC 96 15.5 98 15 97.0 15
NOTE*: This subject performed so well on the Raven's matrices test
that the psychologist could not give me a value for this
subject's I.Q. on that test. It was nevertheless well in
excess of 130, and so this particular subject was ranked
first overall.
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TABLE 9.2. LACK OF CORRELATION BETWEEN I.Q. AND REM SLEEP.
16 Subjects ranked in order of their mean body weight, assessed intelligence
quotient (I.Q.) and mean percentage of total sleep spent in REM sleep and
the mean total min of REM sleep (the latter two averaged over 20 recorded
nights).
Variables ranked 1 to 16
Subjects Body wt. I.Q. % REM Total REM
1 ~ heaviest 1 « highest 1 » highest 1 » highest
MS 16 13 15 15
JR 15 10 13 13
MT 14 3 16 16
RMcD 13 8 10 10
FW 12 2 12 9
RR 11 6 6 6
MW 10 14 11 11
AH 9 9 9 8
WH 8 11 3 5
MC 7 15 8 14
FC 6 16 14 12
GH 5 4 5 4
GJ 4 5 7 3
AW 3 12 2 1
KB 2 7 1 2
JG 1 1 4 7
Spearman's rank correlations (rs): df - 14 (2-tailed).
Rank order of:
I.Q. Percentage Total min
REM sleep REM sleep
Body weight 0.12 (n.s.) 0.774, p<0.001 0.721, p<0.005
I.Q. - 0.174 (n.s.) 0.288 (n.s.)
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In a group of 16 middle-aged subjects it was
found that the more obese individuals had longer
NREM-REM sleep cycles than those of normal body
weight, and the under-weight subjects had shorter
sleep cycles. Also the more obese an individual
was the longer he/she slept each night and
conversely the more underweight subjects slept, on
average, less than the subjects of normal weight.
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INTRODUCTION
NREM-REM sleep cycles are a feature of normal
nocturnal sleep. A cycle is made up from a period of
NREM sleep plus an adjacent period of REM sleep and
each cycle lasts, on average, around 100 min in the
human adult.
These sleep cycles are thought to be the
manifestation of an ultradian rhythm present throughout
the 24h (Kleitman, 1963) and a daytime rhythm of
similar periodicity has been reported on a number of
different measures. For example, may years ago Wada
(1922) described how gastric contractions recurred
every 90-100 min during the waking period. Oral
activity has also been shown to have a similar period¬
icity in waking man. Friedman and Fisher (1967) studied
the oral habits of normal individuals, through a one¬
way window, over a period of hours. They found that all
subjects displayed rhythmicity in their oral behaviour
and the mean periodicity was 96 min. Friedman (1972)
also studied obese patients under a similar regime. He
found they had a marked and regular pattern or oral
activity but with a higher frequency than in the normal
subjects (mean interval of 78.8 min). The cycle length
was found to be inversely correlated with the degree of
obesity. In both these studies the different items
available/
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available for oral activity were graded according to
psychoanalytical concepts, so that milk a supposedly
primal food scored more points than, say, a doughnut.
A better controlled study, using an unweighted
scoring system for any feeding or drinking behaviour,
confirmed that in a neutral environment cyclic oral
activity occurred at about 97 min intervals in adults
(Oswald et al., 1970).
Other studies have shown similar rhythmicity in
physiological measures such as heart rate (Orr and
Hoffman, 1974; Orr et al., 3974) in performance on
various psychometric tests, for example, on complex
signal detection tasks (Orr et al., 1974; Globus et al.,
1971), in day-dreaming (Kripke, 1974) and cortical
arousal (Lavie et al., 1975).
Studies have suggested that the cyclical appear¬
ance of REM sleep (REM cycles) is related to metabolic
rate (cal/kg) in such a way that higher metabolic rate
is associated with shorter REM cycle lengths. This has
been found in studies across species (Hartmann, 1968;
Zepelin and Rechtschaffen, 3974) and within a species,
rats, (Weiss and Roldan, 1964). From this one might
predict that sleep cycle length would be related to
body weight, because body weight is inversely related
to metabolic rate (cal/kg),
1/
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I set out to investigate this apparent relationship
between metabolic rate and sleep cycle duration and to
see if the degree of overweight (or underweight) was
related to the length of sleep cycles. The latter
question was raised by Friedman's report (1972) that
the daytime oral activity rhythm of obese patients
displayed a higher frequency than was found in normals.
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METHODS
(a) Electrophysiological recordings of sleep
Each subject had his/her sleep recorded on 20
nights as described in Chapter 4. For the purposes
of this study the mean total min asleep, meaA total
min of slow wave sleep, mean total min of REM sleep
and the mean NREM-REM sleep cycle length were
calculated for each subject over the 20 nights.
The mean length of the first three NREM-REM
cycles of sleep was calculated as follows. Each
cycle started with a period of NREM sleep and the
first cycle commenced with the onset of sleep (first
appearance of stage 2). The first cycle comprised
all the NREM sleep stages occurring after this first
stage 2 plus the following REM period. The end of
the first cycle and the beginning of the second was
marked by the first appearance of stage 2 after
completion of the period of REM sleep. The period of
REM sleep was judged complete when the amount of NREM
sleep following the last page scored as REM sleep
exceeded 15 min.
Only NREM-REM sleep cycles containing one minute
or less of wakefulness were included in the calculations,
V , /
because Brezmova (1974b) found that sleep cycles broken




The mean lengths of a subject's first, second
and third sleep cycles were calculated, using data
from intact cycles only (as defined above). There¬
after the mean lengths of the first, second and third
sleep cycles were averaged to give a mean value for
each subject's first three sleep cycles. This method
of calculating the mean sleep cycle length (of the
first three cycles) was chosen because the first NREM-
REM cycle in adults is on average shorter than the
second and third cycles (Feinberg, 1974; B^ezinova,
1974b). If a person had, on average, many broken
cycles later in the night and few broken first cycles,
then the above method of calculation would allow an
equal contribution to the mean from each of the three
mean cycle lengths.
(b) Measurement of body weight
Subjects were weighed on eight occasions and the
mean taken (as described in the Methods section of
the previous Chapter).
(c) Measurement of standing height
The standing height of each subject was measured
(Figure 10.1), without shoes, using a wall-mounted
stadiometer (designed by Tanner and Whitehouse, and




technique viz. the subject is asked to stand with his
or her heels, bottom, shoulders and back of the head
touching the vertical surface of the stadiometer,
with arms hanging loosely at the sides of the body.
The investigator then rests the sliding board on the
top of the head and adds a weight on top of the board
to ensure contact between the under surface of the
board and the top of the head. The investigator then
adjusts the position of the subject's head so that an
imaginary line between the outer corner of the subject's
eye and the top of the ear is judged to be horizontal.
Thereafter the investigator asks the subject to breath
in and then stretches the subject to his/her maximum
height by lifting upwards while pressing on the mastoid
bones with the tips of the fingers. Subjects were
asked not to lift up their heels and, in practice, it
was easy to detect this, as subjects feel 'too elastic*
when this hapjpens. On expiration the subject is held
in the 'stretched' position and his/her height read off
a counter calibrated in mm.
(d) Calculation of the ideal body weight for each
subject.
The heights of subjects, measured as above, were
converted into feet and inches and the Metropolitan
Life Insurance Company tables (1960) consulted to
determine/
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determine the ideal weight for each subject. Before
consulting the tables I rated subjects' frame sizes
into small, medium or large. All except two subjects
were considered to be of medium build and the two
exceptions, i.e. MS and JG, were very obviously of
small and large frame respectively.
The standard tables, referred to above, list a
range of weights for each frame size and the mean of
each range of weights in the table was used in the
calculations. The tables include an allowance for a
2" heel on women's and 1" heel on men's heights and
these allowances were added to the heights of my
subjects as they had been measured in their stocking-
soles. The mean ideal body weight for each subject
was subtracted from his/her mean measured weight and
the positive or negative deviation from the ideal
expressed as a percentage of ideal, i.e.
Percentage deviation _ mean measured BW-mean ideal BW ^
from ideal body weight ~ ideal body weight
(e) Calculation of Quetelet's index
W
Quetelet's index of obesity -rr (where W is the body
weight and H the standing height of the subject) was
calculated for each subject using the mean body weight
in lbs and measured height in inches (Khosla and Lowe,
1964). The value of the index was multiplied by 100.
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STATISTICS
Pearson's product-moment correlation test (Ferguson,
1959) was used to test the significance of the
relationship between the various measures. In a case
where significant correlations were found among three
variables then partial correlation analysis was
carried out (Ferguson, 1959) to ascertain what
percentage of the association between one pair of
variables was attributable to the third variable.
Linear regression by the method of least squares
was employed to fit a straight line through data
points graphically presented (Ferguson, 1959).
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RESULTS
(a) NREM—REM sleep cycles
The mean length of the first three sleep cycles
was 105.2 - 12.4 min and ranged from 82.8 min to
122.1 min over the 16 subjects (Table 10.1). The
mean length of the first sleep cycle was 102.4 i
21.2 min, the second 110.8 £ 13.5 min and the third
cycle 102.4 - 12.9 min.
I felt justified in averaging only the first
three cycles, because many of the subjects only had
three complete cycles and the number of later cycles
was too small,
(b) Lack of correlation between body weight and
NREM-REM cycle length.
Mean body weight was not significantly correlated
with the mean length of a subject• s MREM-HEM c^cl-es* -where
all the intact first, second and third sleep cycles had
been averaged: r = 0.164 (Table lO.l).
(c) Correlations between percentage deviation from
ideal body weight and the mean NREM-REM cycle length.
Table 10.2 lists the 16 subjects in order of
increasing body weight paired with their measured
height converted into feet and inches. The ideal body
weight/
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16 Healthy subjects, mean age 59 years
Percentage deviation from ideal body weight
FIGURE 10.2 Correlation between the percentage
deviation from ideal body weight and the mean
NREM-REM sleep cycle length (averaged over the first
three intact cycles). Sleep cycle data for each of
the 16 middle-aged subjects collected over 20 nights.
Data in Table 10.3.
- 344 -
weight for each subject, taking into account their
height and frame size is listed in lbs. Eleven of the
subjects weighed more than their ideal body weight
(from + 4 lb to + 42 lb) and only five weighed the
same or less (from 0 lb to -9 lb) than their ideal
body weight.
The deviations from ideal body weight were
transformed into percentages of ideal body weight and
the percentage deviations ranged from -7.14% to
+ 36.21%. The percentage deviation from ideal body
weight was significantly correlated with the mean
sleep cycle length: r = 0.563 p<0.03 (Table 10.3 and
Figure 10.2)
(d) Correlation between Quetelet's index and mean
NREM-REM cycle length.
The value of Quetelet's index ranged from 2.71
-2 2
to 4.25 lb xnch x 10 over the 16 subjects. There
was a significant positive correlation between the
value of the index and the mean length of the first
three sleep cycles: r = 0.498, p<0.05 (Table 10.4).
(e) Correlations between mean sleep cycle length and
other measures of sleep.
Mean NREM-REM sleep cycle length was significantly
correlated with the mean total sleep time: r = 0.572,
p/0.03 but not with total min of REM sleep: r = -0.022
or total min of slow wave sleep: r = 0.405 (Table 10.3)
but/
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but the mean sleep cycle length was significantly
correlated with the mean total min of REM sleep
accumulated in the first three sleep cycles: r =
0.575, p<0.03 (Table 10.5).
(f) Correlations with percentage deviations from ideal
body weight.
The mean total time that subjects slept was
positively correlated with the percentages by which
their measured body weights deviated from the ideal:
r = 0.536, p^0.04 (Figure 10.3), whereas neither
total min of REN\ sleep nor total min of slow wave
sleep significantly correlated with the percentage
deviation from ideal body weight (Table 10.3).
(g) Partial correlations
The mean sleep cycle length was significantly
correlated with both percentage deviation from ideal
body weight and the mean total sleep time. Table 10.6
shows the partial correlation (r12.3) and the product-
moment correlation coefficients (r) between pairs of
these three variables. From these two correlation
coefficients the percentage of the total association (r),
between two of the variables, attributable to the third





















-10% 0 107. 207. 307.
Percentage deviation from ideal body weight
FIGURE 10.3 Correlation between the percentage
deviation from ideal body weight and the mean
total sleep time. Sleep data for each of the 16
middle-aged subjects collected over 20 nights.
Data in Table 10.3.
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sleep cycle length and percentage deviation from ideal
body weight is due to their joint association with
mean total sleep time.
54% of the association between sleep cycle length
and total sleep time owes to their joint association
with percentage deviation from ideal body weight.
65% of the association between total sleep time
and percentage deviation from ideal body weight is




NREM-REM sleep cycles have been found, by a number
of investigators, to be positively correlated with
metabolic rate (Weiss and Roldan, 1964; Hartmann, 1968;
Zepelin and Rechtschaffen, 1974),
Metabolic rate and body weight are inversely
related, but I found no significant correlation between
crude body weight and sleep cycle length. Admittedly
there are a number of differences between my study and
those above, all the latter were cross-species
investigations, except the Weiss and Roldan study of
rats and they all defined sleep cycles as the min
between the onset Qf one period of REM sleep and the
beginning of the following period of REM sleep. But
it has been suggested (e.g. Hartmann, 1973; Feinberg,
1974) that the appearance of REM sleep is dependent
on some process occurring during the preceding period
of NREM, because NREM sleep always precedes REM sleep
(except in rare pathological conditions) and so it
seemed more sensible to regard a sleep cycle as a
period of NREM sleep plus its following period of REM
sleep. However, this is just a technical quibble as
these are two ways of looking at the same rhythm and
you would expect agreement between the two methods.
1/
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I did find a significant correlation between
the mean NREM-REM sleep cycle length and the percentage
by which a person's body weight deviated from his/her
ideal body weight, which suggests a connection between
the degree of over-or underweight for height and the
frequency of a fundamental brain rhythm.
I found that the degree of obesity was positively
correlated with the length of the cycle, which is the
opposite of what might be expected from Friedman's
(1972) finding that the frequency of obese patients'
oral activity rhythm was inversely related to the
degree of obesity. Of course the question arises,
are we measuring manifestations of the same fundamental
rhythm? I do not think this can be answered until a
study over 24h is done and the phase relationship
between the oral activity rhythm and sleep cycle rhythm
investigated. To expect the sleep cycle rhythm to be
of a frequency similar to that of a waking rhythm
implies that there is an endogenous clock controlling
these different rhythms and that the cyclical appear¬
ance of REM sleep is dependent on an ultradian rhythm
and not on sleep itself. Globus et al. (1969) tried
to show that REM periods were the manifestation of a
sleep-independent internal clock, however Brezinova
(1974b) demonstrated that the composition (i.e.
amounts/
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amounts of wakefulness, slow wave and REM sleep) of
a sleep cycle influences its duration, which suggests
that this rhythm must, at least in part, be dependent
on sleep and is not purely an ultradian rhythm.
Evidence for this proposition is seen in the variation
in sleep cycle length across the night. Globus,(1970)
sees this as the result of an ultradian rhythm with a
cycle duration of about lOO min interacting with the
circadian sleeping-waking rhythm and resulting in
frequency modulation.
Further evidence that the cyclical appearance of
REM sleep is probably dependent on sleep was reported
by Brezinova et al. (1975). They investigated the
effect of awakening subjects for one hour, after the
end of their second REM period. Thereafter subjects
were allowed to fall asleep and the time until the
third REM period reappeared was measured. From their
results they concluded that REM periods are not locked
to certain times of the 24h, for interruption of sleep
by lh of waking seemed to reset the rhythm. The third
REM period did not appear at the expected time but was
delayed for nearly an hour, when uninterrupted nights
were compared with interrupted nights, suggesting that
the timing of the appearance of a REM sleep period is
dependent on the preceding non-REM sleep period.
Moses/
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Moses et al. (1977) came to the same conclusion,
using a different approach. They analysed the data
collected from three separate studies of altered
sleep-wake schedules, where subjects accumulated sleep
across the 24h in a series of naps:
(a) Alternating 30 min sleep - 60 min awake for five
days (b) 60 min sleep-20 min awake for ten days
(c) 60 min sleep - 160 min awake for 40h. In all
three studies a series of uninterrupted baseline
nights had been recorded to establish each subject's
usual REM sleep cycle duration. The hypothesis was
that if the cyclical appearance of REM sleep is sleep-
dependent then the mean baseline REM sleep cycle
length should not differ significantly from the
average length of the interval between the onset of
REM periods on the sleep/nap regimes when the wake
periods are subtracted. Their hypothesis was con¬
firmed, in other words, a certain amount of non-REM
sleep and not just time must be accumulated before REM
sleep reappears. The authors believe that their
results show that the ultradian rhythms found in
various waking activities are not an expression of
the REM cycle found in sleep, but are dependent on a
separate neurophysiological process. If this is the
case it may explain why I found the opposite relation¬
ship between obesity and cycle length to that reported
by Friedman in his oral activity experiment.
There/
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There is some evidence to support the positive
correlation between degree of overweight and sleep
cycle length in the report by Boccalon et al. (1976)
that body weight in seven obese subjects was
positively correlated with REM cycle length, but
this was only an abstract and no details were given.
I would predict that increasing body weight among
their obese subjects would be associated with
increasing percentage deviation from ideal body
weight, and so our results would seem to be compatible.
It would be interesting to see if mean sleep
cycle length is static or if its frequency changes as
body weight moves above or below the ideal body weight
for an individual. The former would suggest that
people are inherently programmed to be a certain weight
and the latter that this brain rhythm is related to
alterations in metabolism associated with changes in
body weight.
I also found that total sleep time was positively
correlated with the percentage deviation from ideal
body weight, which is evidence for the popular view
that fat people sleep longer. It also is consistent
with the findings of Crisp et al. (1973) who reported
that obese patients slept less as they lost weight
and of Lacey et al. (1975) who found that anorexia
nervosa/
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nervosa patients slept longer as their weight was
regained.
Total sleep time was also positively correlated
with the mean sleep cycle duration, so the three
factors: total sleep time, sleep cycle length and
percentage deviation from ideal body weight were all
found to be associated. Partial correlation analysis
showed that the correlation found between any two of
these variables was not independent of the third.
Of the three pairings of variables, the influence of
sleep cycle length on the correlation between total
sleep time and percentage deviation from ideal body
weight was marginally greater than the influence of
either of the other two on correlations with sleep
cycle duration. The correlations between these three
variables may of course be due to all of them being
associated with a fourth variable.
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TABLE 10.1. SLEEP CYCLES AND BODY WEIGHT.
Lack of any significant correlation between mean body weight and the
mean NREM-REM cycle length (the mean lengths of the first three intact
NREM-REM cycles were averaged). NREM-REM cycle data collected over
20 nights for each of the 16 subjects.











MS 89.4 (18) 94.6 (18) 100.7 (16) 94.9 47.08
JR 107.9 (4) 97.7 (6) 86.6 (7) 97.4 53.83
MT 151.6 (11) 105.9 (11) 87.0 (11) 114.8 58.20
RMcD 93.0 (11) 107.6 (10) 99.8 (13) 100.1 61.63
FW 92.2 (3) 88.3 (8) 90.8 (9) 90.4 63.46
RR 101.4 (8) 129.1 (14) 131.2 (11) 120.6 64.70
MW 125.9 (12) 125.7 (10) 114.8 (4) 122.1 66.37
AH 113.9 (5) 110.1 (17) 112.2 (14) 112.1 67.27
WH 71.4 (12) 91.7 (8) 85.4 (8) 82.8 67.32
MC 71.2 (2) 103.5 (8) 107.2 (7) 94.0 69.25
FC 113.4 (14) 125.9 (10) 109.3 (13) 116.2 71.65
GH 109.0 (13) 127.9 (16) 107.1 (8) 114.9 72.34
GJ 126.6 (16) 119.6 (19) 112.4 (17) 119.5 74.42
AW 95.8 (12) 112.9 (8) 107.9 (12) 105.5 77.56
KB 80.7 (16) 108.4 (10) 86.0 (11) 91.7 77.88
JG 95.3 (17) 124.1 (20) 99.5 (12) 106.3 91.64





-13. 5 -12.9 -12.4
Correlation coefficient (r) between body weight and mean NREM-REM sleep
cycles length: r • 0.164, d£ •= 14 (n.s.)
NOTE: n* ■ number oi intact sleep cycles (containing 1 min or less of
wakefulness) contributing to the iieta.
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TABLE 10.2. SLEEP CYCLES AND BODY WEIGHT.
The deviation of each subject's measured body weight, from the ideal body
weight for his/her measured height. This deviation (in lbs) from the
ideal was then converted into a percentage deviation from the ideal body
weight.
Mean Deviation
measured Ideal (lb) from
body wt. Height weight ideal body %
Subjects (lb) ft. in. (lb) weight Deviation
MS 104 5' 2" 112 - 8 - 7.14
JR 119 5' 4" 128 - 9 - 7.03
ME 128 5' 5" 132 - 4 - 3.03
RMcD 136 5' 5" 132 4 3.03
FW 140 5' 3" 123 17 13.82
RR 143 5' 3" 123 20 16.26
MW 146 5' 2" 120 26 21.67
AH 148 5» 6" 136 12 8.82
WH 148 5' 9" 153 - 5 - 3.27
MC 153 5*' '9" 153 0 0.0
FC 158 5* 1" 116 42 36.21
GH 159 5' 3" 123 36 29.27
GJ 164 5' 8" 149 15 10.07
AW 171 5' 6" 141 30 21.28
KB 172 5' 13" 158 14 8.86
JG 202 5' 10" 169 33 19.53
* All subjects judged to be of medium build except,
MS - small frame and JG - large frame.
Ideal weights calculated, from Metropolitan Life
Assurance Tables.
TABLE 10.3. SLEEP CYCLES AND BODY WEIGHT.
Correlations between the mean NREM-REM sleep cycle length (average of the
mean first, second and third intact sleep cycles), percentage deviation
from ideal body weight (BW), mean total sleep time, mean total min REM
sleep and mean total min slow wave sleep (SWS).
All the values for the sleep measures for each of the 16 subjects are the
means over 20 nights.
Sleep cycle % Total Total Total
length Deviation sleep min. min.
(min.) from ideal time REM SWS
Subjects body weight (min.) sleep
WH S2.8 - 3.27 449.8 100.5 66.6
FW 90.4 13.82 453.9 83.6 34.1
KB 91.7 8.86 445.0 105.8 31.2
MC 94.0 0.0 384.7 77.8 14.3
MS 94.9 - 7.14 434.0 72.9 37.7
JR 97.4 - 7.03 434.9 78.5 61.5
RMcD 100.1 3.03 438.9 82.4 84.3
AW 105.5 21.28 475.0 110.4 79.8
JG 106.3 19.53 441.7 96.1 77.9
AH 112.1 8.82 473.7 91.6 68.6
MT 114.8 - 3.03 444.1 49.5 106.8
GH 114.9 29.27 472.0 100.7 82.2
FC 116.2 36.21 480.7 81.3 84.4
GJ 119.5 10.07 502.5 102.5 69.0
RR 120.6 16.26 485.4 100.3 39.5
MW 122.1 21.67 444.2 82.3 85.6
Correlation coefficients (r) : df » 14 (2-tailed)
% Total sleep Total min. Total min.
Deviation
from ideal BW time REM sleep SWS
Sleep cycle 0.563 0.572 - 0. 022 0. 405
length p< 0.03 p< 0.03 (n. s.) (n • s.)
% deviation - 0.536 0. 417 0. 293




TABLE 10.4. SLEEP CYCLES AND BODY WEIGHT.
Correlation between the Quetelet's index of obesity and the nean length
of the first three intact NREIi-REM sleep cycles. The sleep cycle data
for each of 16 subjects was collected over 20 recorded nights.
Quetelet's
W
index • —*• x
H
100 lb inch "2 x 102














MS 2.71 2.91 94.9
JR 2.91 3.13 97.9
MT 3.03 3.12 114 8
RMcD 3.22 3.12 100.1
FW 3.53 3.10 90.4
RR 3.60 3.10 120.6
MW 3.80 3.12 122.1
AH 3.40 3.12 112.1
WH 3.11 3.21 82.8
MC 3.21 3.21 94.0
PC 4.25 3.12 116.2
GH 4.01 3.10 114.9
GJ 3.55 3.22 119.5
AW 3.93 3.24 105.5
KB 3.51 3.23 91.7
JG 4.12 3.45 106.3
Correlation coefficient between Quetelet's index and NREMHBBK sleep
cycle length.
r « 0.493, p < 0.05, df • 14 (2-tailed)
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TABLE 10.5 SLEEP CYCLES AND BODY WEIGHT
Correlation between the mean total min of REM sleep accumulated in the
first three NREM-REM sleep cycles and the mean sleep cycle length. Each
value for each of 16 subjects is the mean over 20 recorded nights.
Mean total
min REM sleep





















NOTE: *Raw data in Table 10.1.
Correlation coefficient (r):
Between mean sleep cycle length and the mean amount of
REM sleep accumulated in the first three sleep cycles,
r - 0.575, p^O.03, df - 14 (2-tailed).
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TABLE 10.6. SLEEP CYCLES AND BODY HEIGHT.
Partial correlations between mean sleep cycle length, mean total sleep
time (TST) and mean percentage deviation from ideal body weight (% IBW).
Notation: r^0 ^ = partial correlation between variables 1 and 2 with
the effect of variable 3 eliminated and r » the usual
Pearson's product-moment correlation between two variables.
(Raw data in Table 10.3).
(a) Sleep cycle length(l) v. % IBW(2)
r - 0.563
rl2 3 " °*370 (effect of TST eliminated)
. . 57% of the association between 1 and 2 due to their
associations with total sleep time.
(b) Sleep cycle length(l) v. total sleep time(2)
r - 0.572
r., , 1 0.387 (effect of % IBW eliminated)IZa J
.. 54% of the association between (1) and (2) due to
their associations with percentage deviation from
ideal BW.
(c) Total sleep time(l) v. percentage deviation from IBW (2)
r » 0.536
r.„ _ « 0.316 (effect of sleep cycle length eliminated)
IZa J
. . 65% of the association between (1) and (2) due to
their associations with sleep cycle length.
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GENERAL DISCUSSION AND A SUMMARY OF CONCLUSIONS
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The experiments and subsequent treatments of the
data described in Chapters 3 to l§/ctocumented in their
chronological order. The results of each section are
discussed in the light of the results of the preceding
experiments and not in relation to studies which
followed them. The present section is a general
overview of all the results and the questions they
provoked, discussed in the light of what I know now
and how some of my results perhaps provide an
explanation of the apparently contradictory reports
in the literature, about the effects of bedtime eating
on sleep.
(a) Is bedtime nutrition comparable to hypnotic drugs
in promoting sound sleep?
The simple answer to this question is obviously no,
when the results of Parts 3 and 4 of Chapter 3 are
compared. There was a striking difference between the
efficacy of nitrazepam in prolonging sleep and reducing
the interruption of sleep by wakefulness in contrast with
the total lack of effect of Horlicks at bedtime on
subsequent sleep. In that experiment no restrictions
were imposed on the subjects' eating and drinking in
the/
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the later evening. In retrospect, had the subjects in
that study been a group of people who normally ate a
snack at bedtime and had they been instructed not to
eat or drink anything after about 1900h then I think
the results would have been entirely different and the
bedtime food drink might well have appeared as effect¬
ive as the drug over prolonged use.
(b) Is drugged sleep as good as natural sleep?
The question cannot be adequately answered until
research is done to develop quantitative measures of
the restorative properties of sleep. Changes in the
electrophysiologically-recorded pattern of sleep tells
us that a drug has prolonged the duration of sleep, but
nothing about any changes in the underlying processes,
so we cannot tell if a minute of drugged sleep is
1worth* more or less than a minute of natural sleep,
in terms of restorative power. Slow wave sleep and REM
sleep are often reduced or disrupted by drugs and these
are the stages of sleep that are thought to be
particularly associated with the restorative functions
of sleep (Oswald, 1969, 1970, 1973, 1976* Hartmann,
1973; Stern and Morgane,1974), We do not know if the
reduction, by the criteria of electrophysiological
recordings, in the amount of a sleep stage, is
associated with a comparable impairment in the biological
functions/
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functions of the sleep stage. The only indicator we
have at the moment in humans is the sleep-dependent
nocturnal secretion of growth hormone, which of course
may not be a comprehensive measure of the biological
functions of slow wave sleep. It has been reported
by me in Chapter 3, Part 4, and by others before me,
that benzodiazepine drugs reduce the number of min
recorded in slow wave sleep (refs in Chapter 3, Part 4).
However, when the associated growth hormone secretion
was investigated no parallel diminution was found, as
reported in Chapter 4 and by others (Stokes et al.,
1972; Rubin et al., 1973b; Bixler et al., 1976). This
can be interpreted in a number of ways. It could
indicate that the association between nocturnal growth
hormone secretion and slow wave sleep (SWS) is not a
proportional one but rather that SWS acts as a trigger
to promote growth hormone secretion and thus only a
few min of SWS provide the necessary stimulus. The
latter interpretation is supported by the fact that
even in the undrugged state those whose sleep usually
includes a lot of SWS are not necessarily those who
secrete relatively more growth hormone and visa versa
(Table 4.6 and e.g. Schnure et al., 1971). An
alternative explanation could be that the drug-induced
reduction in min of SWS initially leads to a reduction
in the biological processes associated with this type
of/
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of sleep but that over time there is an adaptive
change so that the min spent in SWS become, so to
speak, more biologically efficient. An indication
that this may be true was reported by Stokes et al.
(1972) who found that nocturnal growth hormone
secretion was slightly decreased on the first two
nights of diazepam administration. Since our study
(Chapter 4) and the others did not measure growth
hormone secretion on the first few nights on the drug
we may have missed an initial depression of nocturnal
growth hormone secretion. The Stokes et al. (1972)
study only involved two subjects so no statistical
evaluation was possible thus the question really
remains unanswered for the present.
As I said earlier, growth hormone (GH) secretion
may not be a direct measure of the biological role of
SWS. GH is an anabolic hormone that promotes protein
synthesis (Korner, 1965) but obese patients secrete
only very small quantities of GH in response to SWS
(Kalucy et al., 1976) and as one must assume that
restoration and repair still occur in these patients
this suggests that the nocturnal secretion of GH is a
facilatory and not obligatory accompaniment to the
restorative processes associated with sleep.
A/
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A more direct index of the restorative power of
sleep would be a measure of net protein synthesis,
which of course must occur if you believe that sleep
is a time for tissue synthesis and repair. The few
studies investigating nitrogen metabolism during
drugged and drug-free sleep in humans have been done
in patients undergoing 'therapeutic sleep'. The
induction of sleep for therapeutic purposes involves
keeping patients asleep for the majority of the 24h
of each day for a period of weeks. Sleep is induced
either by low doses of hypnotics, tranquillizers or
by a conditioned reflex technique. The conditioned
reflex (CR) induction method does not involve drugs
and so the comparison between nitrogen retention
during say, barbiturate induced therapeutic sleep and
CR sleep, could give an indication of a difference
between drugged and natural sleep. According to Kuhn
(1963) barbiturate-induced sleep led to positive
nitrogen balance over a two-week period whereas CR
sleep was associated with a negative nitrogen balance
over a similar period. I should point out that the
experimental subjects were hospital patients and although
the author did not specify their ailments the usual
reasons for sleep therapy treatment are e.g. for nervous
and/
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and mental illness, gastrointestinal problems, or post¬
operative cases, conditions which might be expected to
lead to negative nitrogen balance. What we are not
told in this study is how much sleep was achieved under
either treatment and whether the patients in each group
were matched for ailments and so it is difficult to
interpret the results.
Voronka and Rubinskaya (1974) have studied the
effects of low and high doses of barbiturate on the
protein and RNA content of neurones and glia of rat
supra-optic nucleus. They found that a low dose of
barbiturate was associated with enhanced protein and
RNA content compared with undrugged control rats,
whereas a high dose of barbiturate depressed the RNA
and protein content. These studies may suggest that
low doses of barbiturates do not impair synthetic
processes but a lot more work will have to be done
before any definite conclusions can be drawn.
I have only considered the restorative value of
drugged sleep in comparison with natural sleep, but
hypnotic drugs are taken by people who feel that their
natural sleep is inadequate and so the distortions of
sleep caused by drug administration must be balanced
against the presumably detrimental effects of broken
and/
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and/or shorter sleep. Perhaps a more pertinent point
is that the belief that sleep is inadequate can cause
anxiety which can lead to elevated corticosteroids.
Subjects who described themselves as poor sleepers
were found to have higher corticosteroid levels during
the night than a group of subjects who rated themselves
as good sleepers (Monroe, 1967). Corticosteroids are
generally catabolic hormones and enhance amino acid
degradation and reduce protein synthesis (Friedman and
Strang, 1966; Ardeleanu and Sterescu, 1973) and so
elevated corticosteroids will oppose synthetic
processes, with the net effect of impaired recuperation
during sleep. So if drugs can attenuate a patient's
anxiety about the quality of his/her sleep then the
detrimental effects of anxiety will also be reduced.
This supposition has not been extensively investigated
but a study of two tranquillizers did find that plasma
corticosteroids were reduced during drug administration
(Ogunremi et al., 1973). However, the crucial question
has not been answered, namely, does an increase in sleep
duration and reduction in anxiety achieved by drugs
offset deleterious effects (if any) of the distortion
of the amount and distribution of sleep stages by
hypnotic drugs?
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(c) Previous studies into bedtime nutrition and sleep -
can the sometimes contradictory results be explained?
In Chapter 2, I referred to a number of different
studies which have investigated the effects of bedtime
nutrition on subsequent sleep. Taken at face value,
the results of these studies are contradictory, but on
closer inspection of the results or the experimental
methods, some of them may, perhaps, be explained in
the light of the results of my studies.
For example, Giddings (1934) reported that after
a drink of warm milk at bedtime 41.7% of the children
in his study had fewer body movements during the night
when compared with the nights when they had had nothing
to eat or drink before bed. In 8.3% of the children
motility was increased after the milk drink and in 50%
there was no difference. He interpreted this as
meaning that drinking 6 oz of milk at bedtime produces
quiet sleep in normal children. What he did not comment
on was that the children who slept more peacefully
after milk did so consistently over the five nights
recorded and similarly for those whose sleep was
unaffected or made more restless after milk. This would
appear to be an example of individual differences in the
response to bedtime nutrition which may be due to
differences in the usual dietary habits of the children.
Laird/
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Laird and Drexel (1934) investigated the effects
on nocturnal motility of a 'hard to digest', but
unspecified, snack compared with an 'easy to digest'
snack of milk and cornflakes at bedtime. They found
that sleep was less restless after the milk and cereal
food snack. I found that when a bedtime food drink
based on soya (flavoured drink) was taken the subsequent
sleep was more broken by wakefulness than sleep after
the malted milk and cereal beverage, Horlicks, at
bedtime (Chapter 5). If the soya-based product was
less easily digested than the milk and cereal drink then
my results would seem to confirm those of Laird and
Drexel.
Kleitman et al. (1937) studied nocturnal motility
in subjects after a number of different bedtime
nutritional intakes and found that sleep was less
restless after the milk and cereal bedtime food drink,
Ovaltine, than after hot milk alone. I found that
sleep was less broken after Horlicks than after milk
alone and so my results would appear to be comparable.
They also compared motility after hot milk with that
after nothing to eat or drink and found no significant
difference and I too, found no significant differences
between milk and a placebo capsule on various measures
of sleep. Included in their experiment was a comparison
between/
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between Ovaltine in hot milk and nothing to eat or drink.
They found that, on average, the sleep of 20 subjects was
less restless, but one subject showed no change and,in
seven,sleep was more restless after Ovaltine. So in
about a third of their subjects sleep was more restless
after taking Ovaltine at bedtime. A comparable proportion
was found in my study (Chapter 6) into the effects of
dietary habits on sleep. The benefit to sleep from a
bedtime food drink was presented as the mean difference
in min of, say, total time spent asleep over the five
nights recorded on the food drink minus the mean min
recorded over the five nights recorded when capsules had
been taken at bedtime (for measures of wakefulness the
mean on a food drink was subtracted from the mean on
capsules). A negative difference represents poorer sleep
and inspection of Table 6.5 shows that 5 out of 16
subjects slept, on average, for a shorter length of time
when Horlicks had been taken at bedtime, compared with
sleep after capsules. Table 6.6 shows that 5 out of 16
subjects had more wakefulness between the first onset of
sleep and the end of recording when they had taken
Horlicks compared with when they had taken capsules at
bedtime and similarly Table 6.7 shows that 6 out of 16
subjects had more wakefulness interrupting the first 6h
of sleep after Horlicks than after capsules. These
three examples from my data illustrate that about a
third/
- 371
third of my subjects slept worse after taking Horlicks
at bedtime in comparison with nothing to eat or drink -
this proportion of about a third is the same as
reported by Kleitman et al. (1937) in a comparison of
Ovaltine with nothing to eat at bedtime.
Hamilton et al. (1966) investigated the influence
of a bedtime snack of cereal and milk on nocturnal
motility, over a number of nights, in comparison with
sleep after nothing to eat at bedtime. The experiment
was carried out in two groups: a group of nine middle-
aged convalescent tuberculosis patients and a group of
27 young monastery students. The authors found no
differences between the two conditions of bedtime intake
in either group of subjects. The authors also reported
that not one subject displayed a significant difference
in nocturnal motility between the two conditions of
bedtime intake. These results at first appear to
contradict my and those of others findings. I wonder
if the rather unusual subjects selected to take part
in the Hamilton et al. (1966) study are the reason for
the discrepancy. Young men living in a monastery were
probably adapted to a more spartan way of life, which
I am sure would not have included the luxury of a snack
at bedtime, and in any case young men usually sleep so
well that there is little room for improvement. The
other/
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other group in Hamilton's study were hospital patients.
The authors gave no information about any medication
taken by these patients and I suspect they may xvell
have been taking hypnotics and a bedtime snack has
been shown to be no match for an hypnotic drug in
its ability to promote sound sleep (Chapter 3).
Finally, B^ezinova and Oswald (1973) reported
that in a comparison between Horlicks and a placebo
capsule at bedtime, Horlicks was associated with sleep
of longer total duration and with less interruption
by waking. In Chapter 7, I reported a post-hoc
division of my 16 subjects into two groups of eight.
The criteria for allocation of a subject to one group
or the other depended on the rank order of his/her N%
score. It was predicted that those with higher N%
scores, the bedtime 'Eaters' group (that is those who
usually eat relatively more food at bedtime), would
sleep better after Horlicks than after a placebo capsule
at bedtime. The bedtime Eaters group were found to
sleep better after Horlicks than after capsules, which
led me to speculate that the subjects in the B^ezinova
and Oswald study were predominately drawn from those
who habitually have a snack in the later evening and
that those authors were in fact measuring the
detrimental effects of the lack of bedtime nourishment
after/
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after the capsule and not an improvement in sleep
attributable to Horlicks.
To summarize this overview of some of the
literature on the effects of bedtime nourishment on
sleep, it appears that one can, to a certain extent,
manipulate the outcome of a study of the effects of
bedtime eating on sleep by the selection of subjects
according to their later evening dietary habits and
by imposing a restriction on their food and drink
intake in the later evening. The results of any
study comparing sleep after bedtime nourishment with
nothing to eat, if achieved with the latter restriction,
should be interpreted with caution because the results may
be more representative of deprivation of nourishment at
bedtime than any sleep-promoting qualities of the food
at bedtime. A disturbance of a person*s habitual
pattern of food intake is likely to disrupt sleep.
(d) Examples of the disruption of habitual eating
patterns affecting sleep.
Chronic undernutrition is an extreme example of
disrupted eating habits. In a retrospective study of
survivors from prisoner of war camps and civilians
who had been on meagre rations of food, it was reported




Voluntary restriction of overall calorie intake
has been shown to disturb sleep, for example, dur'ng
therapeutic loss of weight on a very low calorie
diet, obese patients reported that they slept less
(Crisp et al., 1973) and when anorexia nervosa
patients were well below their normal weight their
sleep was of shorter total duration and more fragmented
by waking (Crisp et al., 1971; Lacey et al., 1975).
Rats kept short of food are more restless and sleep
less than normal (Jacobs and McGinty, 1971) and
motility in babies is proportional to the time that has
elapsed since they were last fed (Irwin, 1932). Wada
(1922) simultaneously recorded hunger contractions of
the stomach and body movements in one sleeping subject
and found that powerful stomach contractions were often
synchronous with a period of restlessness.
It is not clear if it is the loss of body weight
or the hunger associated with an inadequate intake of
food that is responsible for the loss of sleep
associated with under-nutrition. The ten anorexia
nervosa patients in the Lacey et al. (1975) study
were fed approximately the same number of calories
throughout the period of weight gain and yet over that
period their sleep increased in duration and became
less broken by wakefulness, suggesting that it was the
restoration/
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restoration of body weight that was responsible.
Crisp and Stonehill (1973) reported an investigation
of 375 psychiatric out-patients. The patients*
recent sleep and their sleep before their illness
was assessed by one interviewer and another assessed
their present and prior body weight. All the
patients were independently rated for mood and other
psychiatric variables by a psychiatrist. It was
found that loss of weight was associated with poorer
sleep and gain in weight with increased sleep and
these relationships were independent of age, mood or
psychiatric status. The latter two studies suggest
that it is change in body weight that is primarily
responsible for the changes in sleep.
I found a correlation between the degree by
which a person was over or underweight and their
mean total sleep time (Chapter 10), in subjects
whose body weights were stable. The degree of over
or under-weight for height is correlated with the
amount of adipose tissue (Hume and Weyers, 1971;
Durnin and Womersley, 1974) and so it may be that
there is an association between body fuel stores and
the rhythm of sleep and wakefulness. I found that
both the mean total sleep time and the percentage
deviation from ideal body weight were significantly
correlated/
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correlated with the mean NREM-REM sleep cycle length
(Chapter 10). It is possible that changes in body
weight may lead to alterations in the sleep cycle
length which, in turn, are responsible for changes
in the total duration of sleep.
The foregoing discussion considered the
disruption of sleep by an overall reduction in the
habitual intake of calories and the associated loss
of weight. Transmeridian travel by air and rotating
shift work both disturb the usual pattern of eating.
Rapid travel to another continent imposes a new
environment, with meal times which are out of phase
with the traveller's internal rhythms of feeding and
this can mean that a newly arrived traveller eats
dinner when, according to his endogenous rhythm, he
would be asleep. In my study of the influence of
customary dietary habit on the effects of bedtime
food on sleep (Chapter 6) I found that when someone
who normally did not eat at bedtime was given food
at that time, even something as innocuous as a cup
of hot milk, then their sleep was impaired. It is
thus easy to see how eating a substantial meal at an
unaccustomed time could disturb subsequent sleep.
If the traveller remains in the new environment for
a sufficient length of time, his internal rhythms
will/
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will gradually synchronize with those of his
surroundings. The time it takes will naturally
depend on by how many hours the endogenous and
exogenous rhythms are out of step and on the age of
the traveller. But, a worker involved in a schedule
of rotating shifts, where for example, one week he
is on night shift, the next week on day shift
followed by a week on the evening shift, will never
fully adjust his internal rhythms to any particular
shift. It is not surprising that indigestion is a
frequent complaint of workers on this type of shift
work (Conroy and Mills, 1970).
The experimental design of my study (Chapter 5)
to investigate the effects of bedtime eating on sleep
allowed subjects 15 nights on a treatment before
coming to the sleep laboratory, and yet the influence
of their usual bedtime dietary habits was still present
when the recordings were made, which suggests that the
detrimental effects on sleep following a change in
eating pattern persists, and that it may take much
longer than two weeks fully to adjust, at least in
older people, to a new regime.
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(e) What is the function of REM sleep?
It has been generally supposed that because NREM
and REM sleep are qualitatively different both
physiologically and in terms of neural mechanisms,
then the underlying functions must be different. Until
recently, speculation about the roles of REM sleep
appeared to be limited to the brain and somatic
correlates for the amount of REM sleep were not even
contemplated. It was NREM (orthodox sleep) that had
been assigned any supposed functions related to bodily
growth and repair. I see no reason why both categories
of sleep should not have many functions, which encompass
the whole body.
The aspects of REM sleep that have particularly
pointed to an association with brain function include
the high proportion of REM sleep in babies (and young
animals) when the brain is still growing (Roffwarg
et al., 1966), the decline in amount when the brain
shrivels in senility (Feinberg et al., 1967), the
disproportionate and prolonged increase in amount of
REM sleep following poisoning by CNS-affecting drugs
(Oswald, 1969; Haider and Oswald, 1970) and the lower-
than-normal quotas found in the mentally retarded
(Petre-Quadens and Jouvet, 1966; Feinberg et al.,
1969; Castaldo and Krynicki, 1973, 1974) and in deaf
children (Stojanovi£ and Durrigl), 1975 whose inform¬
ation/
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information processing is presumed to be impaired.
Oswald (1969, 1970, 1976) has seen some of these as
evidence for REM sleep being associated with the
restoration and repair of brain tissues and more
particularly with brain protein synthesis. Others
have specified that they believe that REM sleep is
not only associated with, but it a stimulus to brain
protein synthesis e.g. (Drucker-Colin et al., 1975a).
There are, however, fundamental reasons, outlined in
Chapter 1 why the latter is unlikely to be the case.
Other biological theories have been suggested
and include the proposal that REM sleep serves to
clear the brain of some product accumulated during
NREM sleep (Hartmann, 1973) or that it provides an
endogenous source of stimulation to the developing
brain of the neonate (Roffwarg et al., 1966), that
it reorganizes neuronal firing patterns, disorganized
by NREM sleep (McGinty et al., 1974), that it may
play a role in maintaining the functioning of the
catecholamine neurones in the central nervous system
(Stern and Morgane, 1974).
It has also been proposed that REM sleep serves
a behavioural role periodically to alert mammals to
be ready for flight or fight and the evidence for
this is that predators have less REM sleep than those
who are potential prey (Snyder, 19661 This latter
theory/
- 380 -
theory appears rather naive; surely to awaken at
intervals would be preferable for the preyed-on animals?
Probably because of the association between REM
sleep and dreaming, it has been thought by the general
public, and some sleep researchers as well, that the
function of REM sleep is for dreaming and that this is
necessary for mental health. Early studies of REM
sleep deprivation reported dramatic changes in psycho¬
logical state and suggested that REM sleep was needed
to maintain mental health (e.g. Dement, 1965; Dement
et al., 1966). However, recent studies have failed
to replicate these findings or even find minor psycho¬
logical changes in subjective mood (reviewed by
Dement, 1970) so that now, even Dement, who perpetrated
the idea, is critical of his original notion that
adequate amounts of REM sleep were necessary for mental
health. Other psychological theories of the function
of REM sleep suggest that it is related to the regulation
of motivated behaviour, evidenced by the pronounced
aggressive and sexual behaviour and increased food
consumption subsequent to REM sleep deprivation in
cats (Dement et al., 1967). But this distorted
behaviour may be due to the non-specific effects of
stress associated with REM sleep deprivation
(Mendleson et al., 1973). Siegel (1975) sought to
determine if there was a relationship between
spontaneous/
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spontaneous variations in the amount of REM sleep and
motivated behaviour in cats, measured by the quantity
of food they ate. He found that the min of REM sleep
in a 12h period was an accurate predicator of the
amount of food eaten in the subsequent 12h. He found
the greater the amount of REM sleep, the smaller the
amount of food eaten in the following 12h, \vhich
suggests to me that REM sleep is related to energy
regulation. There was apparently no significant
correlation between the amount of REM sleep and the
food intake in the previous 12h. However, studies
of caloric regulation, in human subjects with constant
body weights, have shown that the balance between
calorie expenditure and intake is not achieved on a
day to day basis, but over a number of days (Edholm
et al., 1970; Spiegel, 1973). Thus the quota of REM
sleep on any one night could be reflecting the food
intake of several days earlier and not just the
previous day. During acute starvation in normal
volunteers, the min spent in REM sleep (and the
percentage of REM sleep) declined over the four days
without food (MacFadyen et al., 1973). This could
/
be interpreted as a reduction in REM sleep associated
with the need to eat more food to maintain body weight.
Similarly, in starving rats the amount of REM sleep
fell over a number of days and disappeared in the
majority/
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majority (5 out of 7) of rats after an average of 8
days without food (Jacobs and McGinty, 1971). However,
Lacey et al. (1975) found that the amount of REM sleep
was about 29% (100.9 min compared with 141.8 min)
lower when their anorexia nervosa patients were about
30% below target weight, than when they had regained
their target weight. The important point is that
their calorie intake was approximately the same when
the two sets of recordings were made, which suggests
that it is changes in body weight (and perhaps fuel
stores) that are associated with changes in REM sleep.
It would be interesting to see how much REM sleep
anorexia nervosa patients achieve when restricting
their energy intake.
And finally, I have found (Chapter 8) that the
amount of REM sleep is correlated with the stable
body weights of 16 middle-aged subjects.
It is difficult to form a cohesive hypothesis,
from the reports above, relating stable body weight,
changing body weight, food intake, energy expenditure
and the quota of REM sleep. A possible hypothesis
might be when body weight is stable, energy expenditure
and food intake must be equal over time, but on a daily
basis they may not and so body weight (or fat stores)
may vary from day to day but be stable over time.
Small increases in body weight are associated with
increases/
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increases in an individuals quota of REM sleep, which
in turn is associated with a signal to consume less
food during the following day to compensate for the
over-eating of a previous day(s) and so restore the
body to its 'usual' weight. The hypothesis can explain
the reduction in REM sleep during starvation, because
the lack of food means that energy expenditure far
exceeds intake and so the body weight falls,
consequently the amount of REM sleep falls, and this
is associated with a signal to eat more as body
reserves have been depleted.
There are several problems for this theory, e.g.
the young have, on average, more REM sleep than older
people and yet the former also tend to be lighter.
However, the daily energy expenditure of a young
person is usually higher than that of an older person
of comparable body weight. It may be that it is the
daily energy expenditure that is the important factor
in adults and that within an age group this correlates
highly with body weight. Other factors must, of
course, be related to an individual's quota of REM
sleep and the relative contributions of these may vary
according to age.
The question arises as to ivhat determines the
'usual' body weight over a period of time. The
hypothesis outlined above may indicate a mechanism
whereby/
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whereby body weight is regulated through changes in
appetite, even although especially in man, this can
be overridden by external factors. If this hypo¬
thetical mechanism does operate, it suggests that,
associated with REM sleep, there is a homeostatic
process operating which is sensitive to, and perhaps
compensates for, the energy expenditure, and so for
the cellular work of the preceding waking period.
Muscle metabolism accounts for a large percentage
of whole-body oxygen consumption. REM sleep is
characteristically associated with loss of muscle
tone and so might have a compensatory role for the
extent of daytime activity. The amount of compens¬
ation (as min of REM sleep) would depend on energy
expenditure and so on body weight, and could signal
how much energy intake might be required the following
day.
(f) Is sleep cycle duration associated with the
regulation of body weight?
I found that the mean sleep cycle length ivas
correlated with the degree by which a person was over
or under-weight (Chapter 10). This was found in
subjects with stable body weights and so I cannot say
whether the sleep cycle duration is dependent on the
percentage deviation from ideal body weight or if the
sleep/
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sleep cycle length is an inherent characteristic of
a person1s sleep. The latter would suggest that a
person may be predestined to be over or under-weight.
It would be very interesting to see if loss or gain
of body weight would alter the mean sleep cycle
length.
Brezinova (1974b) reported that longer sleep
cycles contained significantly more slow wave sleep
and REM sleep than shorter cycles matched for serial
order and I found that subjects who had, on average,
sleep cycles of longer duration also tended to
accumulate more REM sleep over the first three sleep
cycles (Table 10.5, Chapter 10). I can envisage a
mechanism where weight gain in an individual leads
to lengthening of sleep cycle duration and where
there is an associated increase in REM sleep
accumulated. The increase in REM sleep then would
act as a signal to reduce food intake. However, this
signal must be very feeble in humansI
I found that mean total sleep time was significantly
correlated with the degree by which a person was over
or under-weight (Chapter 10) and Crisp et al. (1973)
reported that their obese patients slept less as they
lost weight and Crisp et al. (1971) and Lacey et al.
(1975) found that as anorexia nervosa patients slept
more as they approached their target weight. I also
found/
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found that mean sleep cycle duration was significantly
correlated with both mean total sleep time and
percentage deviation from ideal body weight and I
would predict that as obese patients lose weight
their sleep cycles would become shorter and when
underweight patients gain weight, their sleep cycles,
would, on average, increase in length.
If the above is true it still cannot, as yet,
be said whether a change in sleep cycle length
associated with an alteration in the degree of under
or over-weight has any homeostatic role or whether
it is just an associated phenomena due to some
alteration in metabolism.
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SUMMARY OF GENERAL CONCLUSIONS FROM MY EXPERIMENTS
1. Eating at bedtime is not a universal panacea for
promoting more restful sleep. It only aids the
sleep of those who habitually eat at bedtime.
2. In those who normally do eat something prior to
retiring to bed, a combination of cereal and milk
is recommended, in preference to other types of
food, as more likely to promote restful sleep.
3. I could find no evidence of any changes in sleep
attributable to a placebo, in my group of ten
healthy middle-aged volunteers.
4. Nitrazepam, 5mg nightly, is a lastingly effective
hypnotic, but its withdrawal leads to disrupted
sleep for many nights. Chronic administration does
not impair nocturnal growth hormone secretion.
5. Nocturnal plasma triglycerides are elevated when
a milk and cereal food drink, Horlicks, is taken
every night by older people over a number of weeks
and because of this it should probably be avoided
by those prone to atherosclerotic disease.
6. REM sleep may have a function for restoration and
repair of the body in addition to any it may have
for the brain. It may have a role in energy
balance.
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Subjective ratings of sleep quality, and anxiety after placebo, drug and a
food drink
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Summary
Ten subjects (mean age 57 years) took part in a cross¬
over study between a food drink and nitrazepam 5 mg.
They rated their anxiety and sleep quality. On half
the sleep laboratory nights during baseline periods
subjects were given an inert pill which they were told
would improve sleep. A comparison was made between
the six pill and six non-pill nights for each subject.
Subjective ratings revealed no significant difference
attributable to the inert pill. Sleep quality was rated to
have been improved during both late drug and early
food drink administration. On early drug withdrawal
sleep quality was rated worse than baseline.
Introduction
There have been very few studies of the effect of
placebo on sleep, and yet this is an important con¬
sideration when a treatment is administered whose
nature cannot be disguised, and with which subjects
may associate an effect. In a study comparing
placebo, flurazepam and no treatment, Kales et al.
(1971) demonstrated no effect of placebo on sleep
induction, maintenance, stages or on subjective
assessment of sleep quality. Davis and Hartmann
(1973) recorded subjects electrophysiologically and
found no significant difference in total sleep time and
sleep onset latency between the means of three
placebo and three treatment nights. In a later experi¬
ment, comparing the EEG recordings of subjects on
placebo for 28 days with a preceding baseline period,
Hartmann and Cravens (1973) believed they had
found a rather tenuous connection between placebo
administration and an increased amount of REM
sleep which continued into early withdrawal from
placebo. The present study differs from those
mentioned above in that our subjects were told that
the inert pill would have a beneficial effect on their
sleep and hence more specifically investigated the
power of suggestion.
Methods
Ten healthy subjects aged 41-62 years (mean 57
years) took part in a cross-over study between a food
drink and nitrazepam 5 mg.
Subjects attended the sleep laboratory in pairs
differing from each other for the experimental
condition. Each subject slept in quiet and comfort¬
able conditions on a total of 58 nights spread over
38 weeks according to the experimental design in
Table 1.
Table 1. The experimental design used
Week No. Treatment
1 and 2 2 Adaptation nights
6 Baseline nights
5 and 6 1 Adaptation night
6 Early treatment nights
7, 8, 9 and 10 Treatment continued at home
11 and 12 1 Adaptation night
6 Late treatment nights
13 and 14 Treatment continued at home
15 and 16 1 Adaptation night
6 Withdrawal nights
Six weeks later, subjects repeated the above
schedule on the alternative treatment. Treatments
were administered about 30 min before lights out
(approximately 10.30 p.m. to 7.30 a.m.).
Subjects rated their own sleep quality in the
morning and in the evening rated their daytime
anxiety using visual analogue scales (0-100 mm)
where sleep quality ranges from 'worst" to 'best' and
anxiety from 'terrible agitation' to 'imperturbable
tranquillity'.
On half the baseline nights and in balanced order
each subject was given a pink placebo pill. They were
told that these would 'help make your sleep more
restful without causing any hangover'. The food
43 Subjective ratings of sleep quality and anxiety
drink was made with 32 g of Horlicks powder mixed
with 250 ml of hot milk. The drug and the food
drink were each taken for 10 weeks by every subject.
Results
Ignoring the subjective ratings collected on the
adaptation nights, each of the ten subjects had a
total of twelve baseline nights (six pill and six non-
pill) and six laboratory nights for each of the other
experimental conditions.
Friedman's analysis of variance (Siegel, 1956) of
the subjective ratings from both baseline periods
demonstrated that when the inert pill had been
taken the night before neither sleep quality im¬
proved (Xr2 = 3-45, d.f. = 3, n.s.) (Table 2) nor
anxiety altered (xr2 = 1-32, d.f. = 3, n.s.) (Table 4).
Table 2
Subjective sleep quality mean ± s.e. (in mm)
Mean baseline: pill 45-6 ±2*4
non-pill 49-2 ±3-3 n.s.
47-4±2-6
Table 3
Subjective sleep quality mean ± s.e. (in mm)
Mean baseline 47-4 ±2-6
Early drug 50-1 ±2-9
Late drug 53 0±30f
Drug early withdrawal 39-9 ±3-0*
Early food drink 50-7 ±2*7f
Late food drink 49-8 ±2-3
Food drink early withdrawal 50-7 ±2-6
* significantly lower than baseline at P< 0 05 level
(1 -tailed test)
f significantly greater than baseline at P< 0 025 level
(1-tailed test)
Sleep quality was rated to have been improved
during both the late drug (t = 2-28, P < 0 025, 1-
tailed) and early food drink (t = 2-63, P < 0 025,
I-tailed) administration, when correlated r-tests were
used to compare them with baseline (Table 2).
A difference between subjective ratings of sleep
quality was seen when comparing the baseline mean
Table 4. Subjective anxiety ratings for the day
before and the day following a night spent at
the sleep laboratory
Mean ± s.e. (in mm)
Before





52-7 ± 1 -9
51-2 ±1-7 n's-
with early withdrawal (laboratory nights I, 2 and 3
from the drug, i.e. sleep being rated worse after druj
withdrawal (f = 1-88, P < 0 05, 1 -tailed).
No significant differences were found between th<
baseline anxiety rating and any subsequent treat
ment.
Discussion
Any experiment which sets out to investigate th<
value of a treatment whose identity cannot be con
cealed is faced with the problem of how big a pari
suggestion may play in the results. In this experi¬
ment subjects were specifically told that their sleep
would be improved and yet this was not reflected in
the subjective ratings. The results of the EEG sleep
recordings made on the nights when subjects
attended the laboratory appear also unaffected by
placebo but will be reported at a later date.
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a-ADRENERGIC RECEPTOR
BLOCKADE INCREASES HUMAN REM SLEEP
IAN OSWALD, V.R. THACORE, KIRSTINE ADAM, VLASTA BREZINOVA
& R. BURACK
Department of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh
EH10 5HF, Scotland
1 An a-adrenergic receptor blocking agent, thymoxamine (150 mg i.v.) in the early night sleep
of young adults increased REM sleep duration and also brief awakenings in the early night,
while slow wave sleep, stage 3 + 4, was diminished. In the later night, however, stage 3 + 4 sleep
was increased. Control experiments demonstrated that thymoxamine (i.v.) was without effect
on blood pressure.
2 REM sleep duration may be inversely proportional to noradrenaline available at central
a-adrenoceptors, but the control mechanisms for REM sleep appear interdependent with those
for NREM sleep.
Introduction
The possible role of brain amines in sleep has
attracted much interest. After imipramine or
related compounds such as desipramine (Dunleavy,
Brezinova, Oswald, MacLean & Tinker, 1972), or
after amphetamine derivatives (Oswald, 1970),
rapid eye movement (REM) (paradoxical) sleep is
reduced in duration, and intra-sleep restlessness
(frequency of transitions into drowsiness or
wakefulness) is increased. It is commonly hypo¬
thesized that both these groups of drugs increase
noradrenaline at post-synaptic receptors, in the
one case through reduced re-uptake and in the
other through greater release. Consequently, in an
earlier experiment, propranolol was investigated, a
drug believed to block the action of noradrenaline
on /3-adrenergic receptors and known readily to
enter the brain. An oral dose of 120 mg at bedtime
had no effect itself on sleep and did not modify
the reduction of REM sleep by imipramine
(75 mg) or by dexamphetamine sulphate (10 mg)
(Dunleavy, MacLean and Oswald, 1971). We have
now investigated an a-adrenergic receptor blocking
agent, thymoxamine, administered intravenously.
/3-adrenergic receptor blocking agents are usod
clinically to lower blood pressure. We had no
reason to believe thymoxamine would do go in
recumbent persons (and no reason to think that
change of blood pressure would affect REM sleep)
but as a control have conducted a secondary
experiment to determine whether thymoxamine
could alter blood pressure.
Methods
Ten healthy young adults slept three nights each in
the laboratory at approximately weekly intervals,
with recording of all-night electroencephalogram
(EEG), electro-oculogram (EOG) and submental
electromyogram (EMG) at 15 mm/second. A
forearm vein catheter was connected with an
extension that passed through the bedroom wall.
The catheter 6 ml dead space was filled with
saline, containing heparin (20,000 i.u./litre). The
first night was for adaptation. Saline or thymoxa¬
mine was injected on the other two nights, the
order being balanced. Five injections were given, at
50 min after first stage 2 sleep onset, and then at
30 min intervals. Injections were of 10 ml, each
given during approximately 2 min, either saline
with thymoxamine (30 mg) or saline alone.
It was assumed that high blood levels of
thymoxamine would exist in the second, third and
fourth hours of sleep and, because of pilot
experimental results, a specific prediction was
made that in these hours enhancement of REM
sleep duration would be caused. When recordings
were complete the all-night electrophysiological
records wero coded and scorod blind for stages of
sleep (Rechtschaffen & Kales, 1968). Raw scores
wore processed by computer to give amounts and
hour by hour distribution of all sleep stages, and
episodes of wakefulness.
In order to investigate the blood pressure effect
of i.v. thymoxamine (30 mg) in recumbent
persons, six healthy young male adults lay for 3 h
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Figure 1 Thymoxamine (•) (30 mg x 5, i.v.) during
the early night increases REM sleep duration when
compared with saline (o). The results are the mean for
ten subjects.
Figure 2 Thymoxamine (•) (30 mg x 5, i.v.)
decreases slow wave sleep stage 3+4, with later
apparent compensatory increase when compared with
saline (o). The results are the mean for ten subjects.
in bed and their blood pressures were recorded
every 5 min by clinical sphygmomanometry, to
the nearest 5 mm of mercury. After 20 min each
was given an i.v. injection of saline (10 ml) into
the other forearm and 15 min later a test dose of
thymoxamine (15 mg) in saline (10 ml). Then
after 25 min the first of four injections of 10 ml at
20 min intervals was given. Two were of
thymoxamine (30 mg) in saline (10 ml) and two of
saline only. The sequence was ABAB, with three
men receiving saline first and three thymoxamine
first. The order of injections was not known to the
experimenter recording the blood pressure, nor to
the subjects.
Results
Three features only of sleep were altered by the
thymoxamine injections compared with saline.
REM sleep (Figure 1): in hours 2-4 mean
hourly REM sleep on saline nights was
10.5 ± 3.0 min and on thymoxamine nights
17.6 ± 7.6 min (r-test for paired observations,
t = 2.92, d.f. = 9, E < 0.01, 1-tailed). In hours 5-7
REM sleep with saline was 18.5 ±4.1 min but
15.3 ± 4.7 min with thymoxamine (NS). Stage
3+4 sleep (Figure 2): in hours 2-4 mean hourly
stage 3 + 4 on saline nights was 17.3 ± 6.7 min and
on thymoxamine nights 7.6 ± 6.4 min (t = 3.85,
d.f. = 9, P<0.01, 2-tailed). In hours 5-7 stage
3 + 4 with saline was 9.0 ±4.1 min but
12.8 ± 7.6 min with thymoxamine (f = 2.45,
d.f. = 9, P < 0.05, 2-tailed). Sleep was more often
punctuated by episodes of wakefulness after
thymoxamine and in the time required to
accumulate the second, third and fourth hours of
sleep there intervened a mean hourly 0.3 ± 0.5 min
of wakefulness on saline nights but 5.5 ± 7.1 min
on thymoxamine nights (t = 2.26, d.f. = 9,
P<0.05, 2-tailed). In hours 5-7 intervening
wakefulness on saline amounted to 1.2 ± 1.2 min,
on thymoxamine 0.9 ±1.9 min (NS).
Apart from the periods of recording clearly
classifiable as stage REM there were episodes on
some thymoxamine nights of similar appearance
except for retention of fairly high muscle tone and
relatively sparse eye movements. This anomalous
sleep stage was excluded from the above figures
but averaged 0.8 min/h in hours 2-4.
Injections of thymoxamine appeared capable of
provoking REM periods. Examining sleep cycle
durations in terms of the time from the start of
the first REM period to the start of the second
REM period and then to the start of the third
REM period, there were four cycles of between
30-36 min duration on thymoxamine nights and
none on saline nights.
The blood pressure data were evaluated by
comparing readings associated in time with the
thymoxamine (30 mg) injection and those
associated with the saline injection. The blood
pressure reading just prior to each injection and
the three immediately following each injection
were selected, the mean of the two instances for
each individual obtained, and then the group mean
and standard error for each of the four blood
pressure values. Figure 3 indicates that there was
no difference between the saline and thymoxa¬
mine condition. A small rise from the time of the
preliminary saline injection may have related to
complaints of increasing discomfort from injec¬
tions into the same arm and often the same vein.




















Figure 3 Blood pressures (mean ± s.e. mean, n = 6, o
systolic; • diastolic) (a) in the early part of the session
in relation to the preliminary i.v. saline injection (b) in
relation to thymoxamine (30 mg, i.v.) (c) in relation
to saline i.v. (administered as often before as after
thymoxamine) (d) at 25 and 30 min after the last
injection. There is a slight rise overall but no
difference between the two principal conditions.
Discussion
The occasional anomalous REM-like sleep, in
which muscle tone remained fairly high, has been
seen not only in this study but in earlier ones in
which drugs affecting brain amines were used
(Akindele, Evans & Oswald, 1970; Dunleavy et al.,
1972).
Sabelli, Bartizal, Giardina & Myles (1972)
found a-adrenergic receptor blocking agents
modified cortical visual evoked potentials in
rabbits, and Rees, Butler, Gosling & Besser (1970)
found that thymoxamine altered the human
pituitary hormone response to methylampheta-
mine. These observations and our own indicate
that thymoxamine acts on the brain, including the
human brain, and, by extended inference, that it
does so through a-adrenergic receptor blockade
(Birmingham & Szolcsanyi, 1965).
Our findings cannot be attributed to secondary
effects through blood pressure changes and are
consistent with beliefs that brain noradrenaline is
involved in the regulation of sleep. Hartmann &
Schildkraut (1973) proposed an inverse correlation
between available brain noradrenaline and REM
sleep duration. They pointed out that the amount
of noradrenaline in the brain can be reduced either
by the administration of a-methylparatyrosine,
with concomitant increase of REM sleep duration
(Hartmann, Bridwell & Schildkraut, 1971; King &
Jewett, 1971; Stern & Morgane, 1973; Wyatt,
Chase, Kupfer, Scott, Snyder, Sjoerdsma &
Engelman, 1971) or by 6-hydroxydopamine, also
with increase of REM sleep (Hartmann, Chung,
Draskoczy & Schildkraut, 1971). Using a different
method we too have reduced available noradrena¬
line and, in harmony with the above authors'
belief have observed REM sleep enhancement.
Specifically our work links REM sleep control to
a-adrenergic receptor action but, more widely,
suggests interdependent mechanisms for the
control of slow wave sleep stages 3 and 4 and of
sleep-wakefulness generally.
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Brain rhythm that correlates witlr
obesity
There is a strong correlation between an adult's body weight and
usual amount of REM (rapid eye movement) (paradoxical) sleep.1 I
now report a connection between the degree of obesity and the
frequency of an ultradian brain rhythm here measured during sleep
but also present by day.2 Sleep is categorised into two types, REM
and NREM (non-rapid eye movement) (or orthodox), which alternate
as sleep progresses. A cycle is made up of a period of NREM sleep
plus an adjacent period of REM sleep and lasts about 100 minutes.
Subjects, methods, and results
The sleep of 16 healthy adults (10 women and 6 men) aged 52 to 67-years
(mean 59 years) was recorded electrophysiologically on six consecutive
nights every four weeks during a 16-week period. They were weighed in
light qlothing on the first and sixth nights. The first night of each six was
for adaptation only. Recordings were from 10.15 pm to 7 am. The length of
each successive sleep cycle in each of the 320 records was computed as
the minutes elapsing between the beginning of one period of NREM sleep
and the end of the following period of REM sleep. Cycles containing over
one minute of wakefulness were excluded. The average length of the first,
second, and third cycles in each subject's 20 records was calculated and then
the mean taken of the average of the first, second, and third cycles.
The mean of each subject's eight weight measures was calculated and his
or her standing height measured. The ideal body weight for each-subject's
height3 was subtracted from their mean measured weight and the deviation
expressed as a percentage of the ideal body weight. The percentage deviation
from ideal body weight was significantly correlated with the mean NREM-
REM cycle length (r = 0-563,. P <0 03, two-tailed) (figure), whereas mean
body weight was not (r=*0*164; NS). The mean total minutes that subjects
slept was also correlated with the percentage deviation from ideal body
weight (r = 0-536, P<0 04, two-tailed), and with the mean sleep cycle length
(r^ 0-572, P<0-03, two-tailed).
Comment
These findings give further evidence for a connection between
metabolism and sleep and show an association between a fundamental
brain rhythm and the degree by which a person is under or overweight.
The correlation with sleep duration confirms the common belief that
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fat people sleep more than thin people, and it agrees with the reported
shortening of sleep in obese patients when they reduce weight4 and the
lengthening of sleep when anorexic patients regain weight.5
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Body weight correlates with
REM sleep
The fact that REM (rapid eye movement) (paradoxical) sleep is a
time when dreaming occurs1 has led to a neglect of somatic functions
and to unsuccessful attempts to relate an individual's
personality traits to his characteristic amount of REM sleep. To
obtain a reliable measure of the latter it is important to allow adapta¬
tion to the sleep laboratory, to record a large number of nights,
preferably consecutive, and to allow adequate time in bed each night.
Methods and results
Sixteen healthy volunteers aged 52-67 (mean 59 years), six men and 10
women, slept in the laboratory every four weeks during a 16-week period
and always did so for six consecutive nights, of which the first was for adapta¬
tion. Lights-out was from 2215 to 0700 h. At the start and end of each week of
attendance they were weighed in light clothing. None of the volunteers were
receiving drugs affecting the nervous system and they were asked to abstain
from alcohol throughout. The 320 electrophysiological records were scored
in terms of the usual international criteria. The amounts of each sleep stage
on each night were calculated and also, for each subject, the means for his or
her 20 nights. The means of the eight weight measures were also calculated.
It was found that body weight and the percentage of total sleep that was
spent in REM sleep were related. Spearman's rank correlation test was
employed and ts 0-774, t 4-57, P< 0-001, 2-tailed. Log body weight was
also correlated with mean total number of minutes of REM sleep (with a
product-moment correlation, r —0*643, t = 3*07, p<001, 2-tailed). The
figure illustrates the simple correlation between body weight and percentage
of REM sleep. No correlations were found between body weight and total
sleep, slow wave sleep or other sleep variables.
Discussion
When patients with anorexia nervosa gained weight the most
significant change in their sleep lay in an increase of REM sleep,2
while in a study of acute starvation REM sleep fell significantly.3
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Simple correlation between body weight and
percentage of REM sleep.
In rats the amount of REM sleep in a 12 h period accurately predicted
food intake in the subsequent 12 h.4 These observations are consistent
with the present finding and since log body weight is highly correlated
with the daily metabolic rate5 it seems likely that REM sleep is
closely linked to general body metabolism and restitution.
I would like to thank Dr Ian Oswald and Beecham Products Ltd for their
help.
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MESORIDAZINE AND HUMAN SLEEP
KIRSTINE ADAM, SUSAN ALLEN, I. CARRUTHERS-JONES,
I. OSWALD & MARY SPENCE
University Department of Psychiatry, Royal Edinburgh Hospital, Edinburgh EH10 5HF, Scotland
1 Mesoridazine, a phenothiazine of short half-life, and potentially useful as an hypnotic, has
here been investigated using volunteers of late middle age.
2 The electrophysiological recording of all-night sleep was studied in seven subjects for a
7-week period during which they received mesoridazine (10 mg nightly) for 3 weeks. The drug
reduced the frequency of transitions into wakefulness and stage 1 (drowsiness) and reduced the
time spent in stage 1; there was a withdrawal rebound. Mesoridazine increased REM sleep above
baseline levels and a rebound fall below baseline occurred on withdrawal. The drug did not alter
the amount of stage 3 + 4 slow wave sleep.
3 Subjective self-ratings were assessed in a 6-week study of sixteen subjects. Sleep quality
improved on mesoridazine (10 mg nightly) but there was diminution of zest and freshness
20 min after rising. Daytime concentration and anxiety were rated as not affected either by
administration or withdrawal.
Introduction
Mesoridazine is a phenothiazine that has been used
for some years in the treatment of psychoses. Its
short half-life has led to employment as an
hypnotic, mesoridazine 10 mg being found
comparable to nitrazepam 5 mg in a clinical trial
utilizing patients' judgements of sleep quality
(Spiegel, 1973). Since phenothiazines have no
reputation as drugs of dependence, further
investigation of the hypnotic function was
merited. We report a study of electrophysiological
variables and of some subjective effects.
Single-night drug studies can be misleading:
drugs taken clinically for long periods need to be
evaluated in chronic laboratory studies. The labour
and expense of these limit the number of subjects.
Conventional statistical methods are ill-adapted to
situations in which there is a gradual evolution of
effects during weeks. This fact and small numbers
of subjects can hamper statistical evaluation.
Sometimes estimation of simple probability is
useful (Oswald, 1973).
Methods
Seven volunteers participated in the principal
study with the agreement of their general
practitioners and of the Ethics Committee of the
Royal Edinburgh Hospital. There were four
women aged 48-62 years, and three men, 52-60
years. None had taken CNS drugs in the preceding
year. They took no alcohol during the study and
11
followed a regular way of life. Their physical
health was satisfactory but, to enhance clinical
relevance, they were chosen for their high
incidence of personal problems, e.g. one had
become a widow in the previous year and another
had been divorced.
Each subject attended the laboratory on a total
of nineteen nights, spread over 7 weeks. The
intervals between nights were identical for all
seven subjects. The plan of attendance was as
follows:
Week 1 2 3 4
Laboratory 2 + 3 3 0 1 + 3
Placebo Drug Drug Drug
Week 5 6 7
Laboratory 3 0 1 + 3
Placebo Placebo Placebo
Where 1+3 or 2 + 3 are shown above, this
means that there were one or two adaptation
nights under full laboratory conditions preceding
actual recording nights.
Mesoridazine (10 mg) in sealed capsules or
matching blanks were taken at night about 10 min
prior to lights-out throughout the whole period of
the sleep study, and during the 2 preceding weeks.
Subjects slept in comfortable beds in ventilated,
sound-attenuated rooms. Mid-line parieto-occipital
electrodes recorded the electroencephalogram, two
electrodes recorded submental electromyogram,
and four electrodes above and below the outer
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canthi recorded in bipolar and diagonal fashion the
eye movements. Paper recording speed was
15 mm/second. Lights-out was 22.30 h till 07.15 h
approximately. All records were ultimately coded,
and then in random order were scored blind in
terms of sleep stages (Rechtschaffen & Kales,
1968). The raw scores were processed by
computer.
In statistical evaluation of the sleep data there
were instances where simple probabilities indicated
that chance could hardly provide an explanation,
and elsewhere analysis of variance has been used.
Preliminary F-tests had shown that the population
variances under the different experimental
conditions were not significantly different, so that
parametric tests could justifiably be employed.
A computer programme carried out the
arithmetic steps involved. From the variance ratio
for each variable, with the degrees of freedom and
standard F-distribution tables, P values were
found. In some instances we have used mean
values for data across the first 7 h of sleep of each
subject and then the mean for that subject across
the 3 nights in each phase of the experiment. Such
a grouping for statistical purposes is conservative
and fails to take account of changing trends, e.g. a
rising trend during early drug withdrawal.
Subjects rated each evening their anxiety and
their ability to concentrate during the preceding
day, using 10 cm visual analogue scale previously
described (Ogunremi, Adamson, Brezinova,
Hunter, MacLean, Oswald & Percy-Robb, 1973).
Each morning, 20 min after rising they similarly
rated their sleep quality and also their feelings of
how full of zest and freshness they felt.
In the light of the results from the seven
subjects of the initial experiment, a further study
was undertaken of subjective ratings using sixteen
subjects, aged 49-68, mean 58 years, eight men
and eight women. They received placebos for
twenty nights, then mesoridazine (10 mg nightly)
for fourteen nights, followed by placebos for seven
nights.
Results
In Tables 1 and 2 are presented data of principal
interest. The study can be divided into five
periods: baseline, early drug, late drug, early
withdrawal, late withdrawal. Where in Table 1
means are given these are for all twenty-one
subject-nights per period and for the first 7 h of
accumulated sleep. In some instances, subjects did
not sleep as long as 7 hours. While there were only
four instances of nights where subjects slept less
than 6 h, there were 25 out of 105 subject-nights
where 7 h of sleep were not completed, spread
fairly evenly across the conditions. The data for
Table 1 have been arrived at by taking the mean
number of minutes for each stage of sleep in the
first hour of sleep, the mean for the second hour
of sleep and so on, and then taking the sum of
these means. Where there had, for example, been
only 40 min sleep in the seventh hour of one
subject, the mean for the seventh hour for the
seven subjects was obtained through division by
655 or 6.67.
In general, mesoridazine (10 mg) did not
greatly affect the normal pattern of sleep and
where it did the effects did not markedly differ
between the first three and the second three hours
of sleep.
REM sleep
The clearest influence of the drug was an increase
in the duration of REM sleep, with a negative
Table 1 Mean ± s.e. mean results of variation in sleep time for twenty-one subject-nights per period for the
first 7 h of accumulated sleep after mesoridazine (10 mg)
REM sleep
(min)








Baseline Early drug Late drug
88.2 ±5.3 100.4 ±5.1 103.0 ±9.2
70.5 ± 17.4 64.2 ± 17.3 66.0 + 16.1
45.0 ± 13.8 42.0 ± 12.1 42.1 ± 9.6











53.0 ± 12.2 53.8 ±10.8
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Successive nights
Figure 1 REM sleep duration is higher during mesoridazine intake. A rebound fall is present with the lowest
out of the fifteen values being present on the second recorded withdrawal night (actually the third withdrawal
night).
rebound, most marked on the second recorded
withdrawal night (the third actual night of
withdrawal). The means for all six drug nights are
higher than the means of eight out of nine of the
non-drug nights (Figure 1). The probability of
such a difference occurring by chance is remote.
On analysis of variance the means for the early
drug week were significantly greater than baseline
(F=6.05; d.f. 1,6; /><0.0S) and the means for
the first withdrawal week lower than for the late
drug week (F = 9.15; d.f. 1,6;F< 0.05).
■ Six of the seven subjects had higher early drug
means than baseline means. The mean of the three
early withdrawal nights was lower than the
baseline mean for six of the seven subjects.
Stage 3 + 4 sleep
As is common in this age group, there were two
subjects who had very little of stages 3 and 4 sleep.
Tables 1 and 2 indicate that the sustained use of
the drug did not suppress stage 3 + 4 sleep during
the period of drug administration. In the third
withdrawal week there are lower mean values, and,
indeed, analysis of variance indicated significantly
lower values than baseline (F = 6.63; d.f. 1,6;
F< 0.05), but two subjects had higher individual
means.
Time in stage 1 (drowsiness)
The proportion of sleep spent in stage 1 after first
sleep onset tended to be less during the period of
the drug administration (Table 1). Among the 15
nights, the three lowest means were all during the
drug period. The highest mean value occurred on
the second recorded withdrawal night and values
tended to remain high throughout the post-drug
period.
Intra-sleep restlessness
Frequency of shifts into stage 1 sleep or
wakefulness from any other stage of sleep fell, as
Table 1 and Figure 2 show, all six means during
drug administration lying below the baseline mean.
A rebound followed withdrawal. Analysis of
variance confirmed the significance of the early








443.3 ± 20.6 453.0+ 14.6 446.3 ± 15.6 436.4 ± 15.4 444.2 ±11.2









% Stage 3 + 4
(whole night)
47.6+ 15.2 42.4 ±8.6
21.3 ± 1.4 24.3 ±1.6
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Figure 2 Intra-sleep restlessness has its lowest values during drug administration and is highest on the first
withdrawal night.
withdrawal rise compared with baseline (F = 6.82,
d.f. 1,6; P< 0.05) and with the late drug period
(F=6.00, d.f. 1,6; P<0.05). Every one of the
seven subjects had higher means scores for
restlessness in the early withdrawal period
compared with the late drug period. The increase
was most apparent on the first withdrawal night,
when the group mean was the highest among the
15 nights.
Sleep duration
Mean total sleep duration was greatest on the first
drug night and least on the first withdrawal night
but the variance was high.
Sleep onset latency
There was a high variance in the delay to falling
asleep and mesoridazine (10 mg) taken
immediately prior to lights-out did not have an
obvious effect, and nor did its withdrawal
(Table 2).
Intervening wakefulness
There was a high variance in the degree to which
sleep was broken. Where, for example, one man
lies awake for 249 min in the middle of one night,
the numerical data are distorted. Table 1 indicates
no clear drug effect. As with stage 1 duration,
however, the values are high after withdrawal.
REM sleep latency
This measure is normally bimodal and means are
inappropriate. The incidence of short latencies
after withdrawal is usually of interest. Latencies
under 45 min were: two among all 63 non-drug
nights and 5 among 42 drug nights.
NREM-REM cycle
The mean cycle duration across each night for
each individual was determined by the method of
Brtfzinova (1974). Overall mean durations and s.e.
mean were: baseline 98.5 ± 4.9 min, early drug
week 96.2 ±4.4, late drug week 99.8 ± 6.4 min,
early withdrawal week 101.2 ±3.1 min and late
withdrawal week 90.3 ± 5.3 min. Analysis of
variance did not reveal any significant differences.
REM profusion
Sample counts were made of the number of 2-s
epochs containing rapid eye movements in the
third and fourth REM periods of the nights. The
first 5 min of each period was excluded and the
counts covered the 5.33 min thereafter. Mean
counts and s.e. mean were 99.0 ± 8.5 for baseline,
95.8 ± 14.0 early drug week and 89.0 ± 19.1 for
early withdrawal week. The variance was high and
there was no indication of change induced by the
drug.
Subjective ratings
The initial study of seven subjects provided
hypotheses for the later study of sixteen subjects.
In the initial experiment mesoridazine improved
the subjective quality of sleep throughout
administration, with mild impairment immediately
after withdrawal. Figure 3 reveals that this was
confirmed in the sixteen-person study and in the
statistical evaluation the last two baseline placebo
weeks were compared with the two mesoridazine
weeks using repeated measures analysis of variance
(Winer, 1962) and the difference was found to be
significant (F = 12.45; d.f. 1,420; P < 0.001).
Twenty minutes after rising from bed subjects
rated themselves as more sleepy and lack-lustre in
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Figure 3 Sleep quality is subjectively improved by mesoridazine. Shown are daily means for sixteen subjects of














Figure 4 Morning vitality is rated poorer after mesoridazine. Shown are daily means for sixteen subjects of the
deviation from the individual's own baseline mean.
both the initial study and in the sixteen-person
study as Figure 4 reveals. Again analysis of
variance revealed a significant difference
(F = 24.826; d.f. 1,420; P < 0.001). Nevertheless
evening ratings of how well it had been possible to
concentrate throughout the day suggested
impairment only on the first day in the initial
study and in the sixteen-person study no marked
or consistent effect of mesoridazine was detected.
There was no effect of the drug on self-rated
anxiety either during administration of withdrawal
(Figure 5).
Discussion
In comparison with the many reports of the
effects of hypnotic drugs on sleep, two features of
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Figure 5 Lack of effect of mesoridazine on daytime anxiety. Shown are daily means for sixteen subjects of the
deviation from the individual's own baseline mean.
the present EEG study are of note. There was no
sign of reduction in slow wave sleep, stages 3 + 4,
during chronic intake, contrasting particularly
with benzodiazepines such as flurazepam (Kales,
Allen, Scharf & Kales, 1970; Kales, Kales, Scharf
& Tan, 1970; Kales & Scharf, 1973; Dement,
Zarcone, Hoddes, Smythe & Carskadon, 1973),
diazepam (Kales & Scharf, 1973), chlor-
diazepoxide (Hartmann & Cravens, 1973), and
flunidazepam (Kales & Scharf, 1973; Oswald,
Lewis, Tagney, Firth & Haider, 1973). Whereas
REM sleep duration is reduced by most hypnotics,
mesoridazine caused an increase above normal of
REM sleep duration, consistent with which was a
rebound fall below baseline after withdrawal.
Also notable was the lack of effect on self-rated
daytime anxiety and especially the absence of
withdrawal-induced anxiety, which contrasts
sharply with the withdrawal anxiety found in a
similar study of a benzodiazepine hypnotic (Allen
& Oswald, 1975).
The decrease of intra-sleep restlessness, of time
in stage 1, and the subjective improvement of sleep
quality with mesoridazine were all as expected of
an hypnotic and the reverse changes during the
withdrawal period are consistent and customary.
The low mean values for stages 3 + 4 in the late
withdrawal period do not conform to any
prediction, and the inconsistency among subjects
suggests chance as an explanation.
The phenothiazines as a class are believed to
interfere with catecholamine action and, in man,
both chlorpromazine and thioridazine (of which
mesoridazine is a metabolite) lead to receptor
blockade for noradrenaline (Tuck, 1973). Arguing
from animal experiments Hartmann & Schildkraut
(1973) proposed an inverse correlation between
available brain noradrenaline and REM sleep
duration, and we too have found that in man the
alpha adrenergic blocking agent, thymoxamine,
given intravenously, increased REM sleep duration
(Oswald, Thacore, Adam, Brezinova & Burack,
1975). Earlier evidence indicating that chlorproma¬
zine may increase REM sleep (Lewis & Evans,
1969), together with the present finding with
mesoridazine, are thus consistent with the
Hartmann and Schildkraut hypothesis.
The biological importance of altered
proportions of electrophysiologically-defined sleep
stages is uncertain but some significance is ►
currently attached to stage 3+4, and to REM
sleep. The large nocturnal release of growth
hormone depends upon the occurrence of stages 3
and 4 sleep in undrugged persons (Sassin, Parker, »
Johnson, Rossman, Mace & Gotlin, 1969; Schnure,
Raskin & Lipman, 1971). The fact that
mesoridazine does not cause suppression suggests
it would not interfere with the secretion of growth
hormone, the anabolic action of which presumably
assists in sleep's restorative role. REM sleep is
tentatively seen as a time especially important for
synthetic and repair processes in the brain
(Oswald, 1969, 1970; Hartmann, 1973; Stern &
Morgane, 1974) and hypnotic drugs that reduce
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this stage of sleep might be thought undesirable:
conversely the slight increase of REM sleep caused
by mesoridazine might be of merit.
When coupled with the low abuse potential of
phenothiazines, mesoridazines's lack of effect on
anxiety, its lack of effect on stage 3+4 sleep and
its enhancement of REM sleep, would make the
drug appear worthy of further serious
consideration.
We are indebted to Dr V. Brezinova and Miss Anne Hogg
for assistance.
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Subjective ratings of sleep quality and anxiety after placebo, drug and a
food drink
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Summary
Ten subjects (mean age 57 years) took part in a cross¬
over study between a food drink and nitrazepam 5 mg.
They rated their anxiety and sleep quality. On half
the sleep laboratory nights during baseline periods
subjects were given an inert pill which they were told
would improve sleep. A comparison was made between
the six pill and six non-pill nights for each subject.
Subjective ratings revealed no significant difference
attributable to the inert pill. Sleep quality was rated to
have been improved during both late drug and early
food drink administration. On early drug withdrawal
sleep quality was rated worse than baseline.
Introduction
There have been very few studies of the effect of
placebo on sleep, and yet this is an important con¬
sideration when a treatment is administered whose
nature cannot be disguised, and with which subjects
may associate an effect. In a study comparing
placebo, flurazepam and no treatment, Kales et al.
(1971) demonstrated no effect of placebo on sleep
induction, maintenance, stages or on subjective
assessment of sleep quality. Davis and Hartmann
(1973) recorded subjects electrophysiologically and
found no significant difference in total sleep time and
sleep onset latency between the means of three
placebo and three treatment nights. In a later experi¬
ment, comparing the EEG recordings of subjects on
placebo for 28 days with a preceding baseline period,
Hartmann and Cravens (1973) believed they had
ly .found a rather tenuous connection between placebo"
administration and an increased amount of REM
sleep which continued into early withdrawal from
placebo. The present study differs from those
mentioned above in that our subjects were told that
the inert pill would have a beneficial effect on their
sleep and hence more specifically investigated the
power of suggestion.
Methods
Ten healthy subjects aged 41-62 years (mean 57
years) took part in a cross-over study between a food
drink and nitrazepam 5 mg.
Subjects attended the sleep laboratory in pairs
differing from each other for the experimental
condition. Each subject slept in quiet and comfort¬
able conditions on a total of 58 nights spread over
38 weeks according to the experimental design in
Table 1.
Table 1. The experimental design used
Week No. Treatment
1 and 2 2 Adaptation nights
6 Baseline nights
5 and 6 1 Adaptation night
6 Early treatment nights
7, 8, 9 and 10 Treatment continued at home
11 and 12 I Adaptation night
6 Late treatment nights
13 and 14 Treatment continued at home
15 and 16 1 Adaptation night
6 Withdrawal nights
Six weeks later, subjects repeated the above
schedule on the alternative treatment. Treatments
were administered about 30 min before lights out
(approximately 10.30 p.m. to 7.30 a.m.).
Subjects rated their own sleep quality in the
morning and in the evening rated their daytime
anxiety using visual analogue scales (0-100 mm)
where sleep quality ranges from 'worst' to 'best' and
anxiety from 'terrible agitation' to 'imperturbable
tranquillity'.
On half the baseline nights and in balanced order
each subject was given a pink placebo pill. They were
told that these would 'help make your sleep more
restful without causing any hangover'. The food
43 Subjective ratings of sleep quality and anxiety
drink was made with 32 g of Horlicks powder mixed
with 250 ml of hot milk. The drug and the food
drink were each taken for 10 weeks by every subject.
Results
Ignoring the subjective ratings collected on the
adaptation nights, each of the ten subjects had a
total of twelve baseline nights (six pill and six non-
pill) and six laboratory nights for each of the other
experimental conditions.
Friedman's analysis of variance (Siegel, 1956) of
the subjective ratings from both baseline periods
demonstrated that when the inert pill had been
taken the night before neither sleep quality im¬
proved (Xr2 = 3-45, d.f. = 3, n.s.) (Table 2) nor
anxiety altered (xr2 = 1-32, d.f. = 3, n.s.) (Table 4).
Table '2
Subjective sleep quality mean ± s.e. (in mm)




Subjective sleep quality mean ± s.e. (in mm)
Mean baseline 47-4±2-6
Early drug 50-1 ±2-9
Late drug 53-0±3-0t
Drug early withdrawal 39-9 ±3-0*
Early food drink 50-7±2-7f
Late food drink 49-8 ±2-3
Food drink early withdrawal 50-7 ±2-6
* significantly lower than baseline at P< 0 05 level
(1-tailed test)
f significantly greater than baseline at P < 0 025 level
(1-tailed test)
Sleep quality was rated to have been improved
during both the late drug (/ = 2-28, P < 0 025, 1-
tailed) and early food drink (t = 2-63, P < 0-025,
1-tailed) administration, when correlated r-tests were
used to compare them with baseline (Table 2).
A difference between subjective ratings of sleep
quality was seen when comparing the baseline mean
Table 4. Subjective anxiety ratings for the day
before and the day following a night spent at
the sleep laboratory
Mean ± s.e. (in mm)
Before
Mean baseline: pill 51-8±l-8
52-9 ±2-1 ns'non-pill
After
Mean baseline: pill 52-7 ±1-9
non-pill 51-2 ±1-7 n's'
with early withdrawal (laboratory nights 1, 2 and 3)
from the drug, i.e. sleep being rated worse after drug
withdrawal (t = 1 -88, P < 0-05, 1-tailed).
No significant differences were found between the
baseline anxiety rating and any subsequent treat¬
ment.
Discussion
Any experiment which sets out to investigate the
value of a treatment whose identity cannot be con¬
cealed is faced with the problem of how big a part
suggestion may play in the results. In this experi¬
ment subjects were specifically told that their sleep
would be improved and yet this was not reflected in
the subjective ratings. The results of the EEG sleep
recordings made on the nights when subjects
attended the laboratory appear also unaffected by
placebo but will be reported at a later date.
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Do placebos alter sleep?
KIRSTINE ADAM, LIISI ADAMSON,
VLASTA BfeEZINOVA, IAN OSWALD
Summary
Deliberate suggestion that an inert capsule was a
sleeping pill was found not to influence subjective ratings
of sleep quality or anxiety or the electrophysiologically
recorded features of sleep in 10 volunteers aged 41-62
years.
Introduction
Efforts are being made to persuade doctors to prescribe fewer
sleeping pills. It is often asked whether an inert substitute might
be effective through suggestion alone. Kales et al' compared
the effect of placebo with that of no treatment in eight young
men with complaints about their sleep and found no difference
in objective measurements—delay to falling asleep, duration
of sleep, or distribution of sleep stages—or in subjective ratings
of sleep. Hartmann et al,2 3 in two studies, also found no clear
effects. Their proposed relationship between placebo administra¬
tion and an increased amount of rapid-eye-movement (REM)
sleep may have been an artefact of unbalanced design.
We here report the results of a further study in which 10
volunteers were given a placebo disguised as a sleeping pill.
Patients and methods
The 10 volunteers, six women and four men, were aged 41-62
(mean 57) years. This age and sex distribution is representative of
patients who most often complain of inadequate sleep. They were
asked to keep to a regular daily routine and to take no drugs or alcohol.
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The volunteers were given the following written statement: "You
will be given a mild sleeping pill; it will help to make your sleep more
restful without causing any hangover." An inert pink pill was given
30 minutes before lights-out on half of the recorded nights. The
volunteers attended the laboratory in pairs, only One of them receiving
the pill on any one night. The experiment was divided into two periods
of two weeks separated by 21 weeks. During each period the volunteers
attended for electrophysiological recording on eight nights, the first
two serving for adaptation. Thus each person received the pill on
six nights and nothing on another six nights, the order being balanced.
The electroencephalogram (EEG), eye movements, and submental
muscle tone were recorded from 22.30 until 07.15. The recordings
were categorised4 by a scorer who was unaware of the experimental
condition, and the sleep and wakefulness data then analysed for their
mean accumulation in minutes after one hour, two hours, and so on
up to seven hours of sleep.
Each evening the volunteers rated their average anxiety for the
day, and each morning rated their sleep, using 10 cm visual analogue
scales. The scales ranged from "terrible agitation" to "imperturbable
tranquillity," and from "the worst" to "the best night imaginable."
Correlated t tests were used to compare the 60 placebo nights and 60
Successive hours of sleep
fig 1—Mean cumulative minutes of wakefulness during night's sleep of
10 volunteers on pill nights and no-treatment nights (t = 0-90; DF = 9; NS).
no-treatment nights using each person's mean score under each
condition.
Results
The subjective ratings showed no change in sleep quality when
the pill nights were compared with the no-treatment nights (mean
2
FIG 2—Mean combined numbers of times that sleep was disrupted by
wakefulness and periods of drowsiness (stage 1) in the 10 volunteers on pill
nights and no-treatment nights.
scores (±SE of mean) 45-6 + 2-4 mm v 49-2±3-3 mm; NS). The
volunteers knew when it was their turn to be given the placebo, but
on the days when they were to take it at night their ratings of anxiety
were not altered (51-8±l-8 mm v 52-9±2-l mm; NS).
The electrophysiological recordings showed no significant differ¬
ences between the 60 pill nights and the 60 no-treatment nights.
This was true for the mean time it took to fall asleep (24-9±3-9 min
v 21.9 ±4-2 min; NS) and for the accumulation of wakefulness that
intervened during the night's sleep or any of its parts (fig 1). The
amounts of stage 1 (drowsiness), stage 2, stages 3 and 4, and REM
sleep, total sleep duration, and REM sleep latency were similarly
unaffected. The numbers of times that sleep was disrupted by waking
or periods of drowsiness were combined and also found to be un¬
affected (fig 2).
Discussion
The absence of any difference between the subjective ratings
under the two conditions was not a result of ihsensitivity of the
method. The same 10 volunteers had taken part in a cross-over
study of nitrazepam 5 mg and a food drink. Their ratings
showed a significant improvement in sleep quality for both
substances, with a deterioration on withdrawal of the drug.5
In older people sleep is frequently broken by periods of
wakefulness6 7 and is thus likely to show any influence of a
3
sedative. In a study of a food drink (Horlicks) no significant
effect was found on EEG-recorded sleep of young people,
whereas the sleep of a group of older people similar to those
studied here became significantly less broken than when a
placebo pill was given." After our report on Horlicks it was
proposed that suggestion could have been responsible.9 Our
present studies offer no support for this, nor for any belief that
when a placebo is prescribed for those of later middle age sleep
will be substantially altered.
We thank Beecham Products Ltd for their help.
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Nitrazepam: lastingly effective
but trouble on withdrawal
KIRSTINE ADAM, LIISI ADAMSON,
VLASTA BREZINOVA, WILLIAM M HUNTER,
IAN OSWALD
British Medical Journal, 1976, 1, 1558-1560
Summary
The sleep of 10 volunteers with an average age of 57 years
was recorded electrophysiological^ before, during, and
after nitrazepam 5 mg nightly for 10 weeks. Sleep was
longer and less broken on the drug and no tolerance was
obvious after two months' use. Withdrawal of the drug,
however, caused sleep to be temporarily worse than
before the drug had been taken. Slow-wave sleep was
reduced by nitrazepam, but the accompanying secretion
of growth hormone was not impaired.
Introduction
We recently described how a placebo had no effect on sleep1;
here, using the same 10 middle-aged volunteers, we report on
the actions of nitrazepam 5 mg. We also looked for any influence
on the nocturnal secretion of growth hormone (GH).
All-night electrophysiological recording makes precise measure¬
ment of the amount of time a person is asleep possible. It also
shows two different kinds. of sleep that alternate through the
night. One is rapid eye movement (REM) or paradoxical sleep,
the other is non-REM or orthodox sleep. The latter is subdivided
into stages 1, 2, 3, and 4. Stages 3 and 4 are known as slow-wave
sleep (SWS) and during these stages the large nocturnal
secretion of GH occurs. In the undrugged condition the
secretion depends on the presence of stages 3 and 4 and does not
take place if these stages are not allowed to develop.2 3 Growth
hormone is thought to be important for sleep's restorative
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function, and since many benzodiazepines will reduce SWS, it
seemed important to find out whether nitrazepam would impair
GH secretion. In clinical practice drugs are taken for long
periods, and so we conducted a study over many weeks.
Methods
Ten volunteers, with the agreement of their general practitioners,
took part in this study of nitrazepam 5 mg nightly. There were six
women and four men aged 41-62 (mean 57) years. They had taken no
drugs in the preceding months and were asked not to take any drugs
other than those given by us and to consume no alcohol. Subjects
attended the laboratory, to sleep in quiet and comfortable bedrooms
according to the experimental design:
Weeks 1 and 2
Weeks 5 and 6
Weeks 7 to 10
Weeks 11 and 12
Weeks 13 and 14
Weeks 15 and 16
2 Adaptation nights, 6 baseline nights
1 Adaptation night, 6 early drug nights
Drug continued at home
1 Adaptation night, 6 late drug nights
Drug continued at home
1 Adaptation night, 6 withdrawal nights
The drug was taken 30 minutes before lights-out (about 2230 to
0715). On all nights the electroencephalogram, eye movements, and
submental muscle tone were recorded.
Seven of the volunteers attended the laboratory for six additional
nights, when blood was sampled through a catheter without disturbing
the sleeper.4 The six nights represented one adaptation night followed
by one recording and blood sampling night during the baseline period
and similarly one adaptation and one measurement night in the early
drug phase and one adaptation and one measurement night in the late
drug period. The blood samples were taken every 30 minutes, and the
plasma was separated and stored deep-frozen until assayed.
The GH concentration in each sample was assayed "blind" as to the
experimental condition by the MRC Radioimmunoassay Team in
Edinburgh using the method of Hunter.5 The GH results were
expressed as mU/1 (in terms of human growth hormone international
reference preparation 66/217) concentration at the clock time when the
blood sample was taken. These clock times were then converted, for
each night, into time in minutes after the first onset of sleep. Graphs
were plotted, and the area under the GH curve, from sleep onset to
six hours later, was measured by a planimeter in cm'-. The vertical
scale was 1 cm/2 mU/1 and the horizontal scale was 2 cm/hour.
The electrophysiological recordings were coded and categorised
"blind" into the different stages of sleep and wakefulness.1' The time
it took subjects to fall asleep, the total amount of time they slept, and
the hourly distribution and total number of minutes after the onset
of sleep that they were awake and in each of the sleep stages were
calculated.
statistics—Friedman's analysis of variance was used to test the
overall significance of the results,7 and t tests for paired observations
were used to compare the different periods of the experiment."
Results
The volunteers slept longer while taking the drug. This improve¬
ment in sleep was maintained throughout the drug period, but on
2
withdrawal from the drug the time spent asleep was significantly
shorter than before the drug had been taken (table I).
TABLE I—Total lime asleep in 10 subjects during six nights in each condition
!
Mean (m SE of mean) Compared with baseline
Condition* time asleep (min) (Df = 9)
Baseline 446 9 -t 10-8
Early drug 4710 t- 7-9 t = 2-50; P <0 025, one-tailed
Late drug 469 1 i 8 5 t = 2-97; P<001, one-tailed
Withdrawal 428-7 ± 12-9 t = 2-61; P <0 025, one-tailed
"Overall significance of differences among conditions: Df = 3;/a -- 20-04; P <0001.
Intervening wakefulness was still significantly reduced after eight
weeks of nitrazepam administration (Df = 9; t = 1-83; P<0-05,
1-tailed) (fig 1). A similar reduction had been present during the early
drug period (Df = 9; t — 2-25; P<0 05, 1-tailed), and the early and
late drug periods did not differ significantly from each other. With¬
drawal from the drug increased intervening wakefulness when
compared with baseline values, (fig 1). We used the means for each
hour, in so far as such data was available, but the fact that sometimes
total sleep was very much reduced (in one case to 42 minutes) made
statistical assessment of these particular data impracticable.
The amount of time awake, between first falling asleep and before
lights-on in the morning, was significantly higher during the with¬
drawal period and considerably higher two nights after the last dose of






















fig 2—Mean total wakefulness recorded after first onset of sleep in 10 subjects.
Overall significance of difference among four conditions: z2
= 3; P<0-001. r
Baseline v early drug; Df = 9; t = 3-24; P<001 (1-tailed).
Baseline v late drug: Df = 9; t = 3-50; P<0-005 (1-tailed).
Baseline withdrawal: Df = 9, t — 1-87; P<005 (1-tailed).
1917; Df
nitrazepam (fig 2). The time it took subjects to fall asleep was not
significantly changed.
During the early drug period reduction in REM sleep occurred
almost exclusively within the first three hours of sleep. This significant
early night reduction was still present in the late drug period. As
table II shows, however, by the late drug period a significant increase
in REM sleep had appeared in the later night (hours 4-7 of sleep).
table II—Total REM sleep (minutes) accumulated in successive hours of sleep











26 2 ± 3-3
16 3 ± 2-6t
18-6 ± 2-8*
26-5 ± 2-6
59 3 ± 3-5
58 5 ± 2-9
65-8 f 2-9*









♦Significant difference from baseline, P<0 05 (2-tailed).
tSignificant difference from baseline, P<0;01 (2-tailed).
The mean duration of SWS accumulated in the first six hours of
sleep (table III.) was significantly reduced during early and late drug
administration when compared with baseline levels. The mean values
recorded during the late drug period were significantly lower than
those of the early drug period (Df = 9; t = 2-40; P<0 05, 2-tailed).
There was a return to baseline levels during the withdrawal period.
4
During drug administration, however, there was no associated decline
in GH secretion, but rather a tendency for higher (not significant)
levels during drug administration. Friedman's non-parametric analysis
of variance by ranks was used to compare the areas under the growth
hormone curves. The mean areas (± SE of mean) under the growth
hormone curves were: baseline 9-3 ± 1-7 cm2; early drug 12-3 ± 2-6
cm2; late drug 18-3 ± 4-8 cm2 (x2 = 3-71; Df = 2; not significant).
TABLE III—Total SIVS in first six hours of sleep in 10 volunteers
Condition*








79 0 ± 10-5
61 3 -b 10-7
49-9 ± 1Q 6
72-7 ± 10 0
t = 4-22; P<0 01, 2-tailev.
i = 4-34; PC0-01, 2-tailed
t = 1-42; not significant
*Overall significant difference among conditions: Df = 3; z1 — 14-88; P<0-005.
Discussion
As we grow older, we sleep less, and sleep is more broken by
periods of wakefulness9 12 and, perhaps as a consequence, there
is an age-related increase in the consumption of sleeping pills.13
Our volunteers were of an older age group and representative of
patients who most often complain of inadequate sleep. The
maintenance of nitrazepam's action in still reducing the amount
of wakefulness after two months of use is parallelled by that of
flurazepam when studied during two weeks of drug administra¬
tion, but contrasts with the diminishing effectiveness of chloral
hydrate (1000 mg) or glutethimide (500 mg).14 The longer drug-
taking period in our study was more likely to show any tolerance
effects.
We found that nitrazepam reduced the amount of REM sleep
in the first three hours of sleep and that, during chronic adminis¬
tration, a late-night REM sleep rebound developed. This REM
sleep rebound in the later night during protracted use of
hypnotics has been reported for barbiturates.15 The lack of REM
sleep rebound after withdrawal contrasts with that which is
present after larger doses.1617
The decrease in the amount of SWS has been found during
chronic intake of other benzodiazepines—for example, fluraze¬
pam,15 chlordiazepoxide,18 diazepam,19 and fosazepam.20 The
lack of any associated decrease in the blood level of GH suggests
that the metabolic functions associated with SWS may not be
impaired by nitrazepam administration.
The poor sleep caused by stopping nitrazepam is a further
reminder of how such drugs create conditions that lead to
perpetuation of intake. Patients should be told that after giving
up nitrazepam 5 mg or similar drugs they may experience an
increase in wakefulness for a week or two, with one or two nights
of little sleep. They should be reassured that this disrupted sleep
5
is a temporary consequence of their dependence on the drug that
has been withdrawn and that as the weeks pass their sleep will
improve again.
We thank Beecham Products Ltd for their help.
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Sleep is for Tissue Restoration
KIRSTINE ADAM, BSc, and IAN OSWALD, MD, DSc, FRCPsych
Department ofPsychiatry, University of Edinburgh
It is traditionally believed that sleep helps children grow and that it restores us
after a hard day. The belief is now supported by some 50 reports showing that
rates of protein synthesis or of mitotic division are higher at the time of rest and
sleep, though in man it has only been well established for the most accessible of
tissues, the skin (Fisher, 1968).
Medical thinking has not yet grasped that tissue healing may be accelerated by
sleep. There persists an assumption that degradation and synthesis in tissues not
only continue all the time (as they do ) but that they are continually equal (which
they are not), and upon this invalid assumption has rested much clinical research
into protein metabolism. In reality, myocardial proteins of rodents, for example,
are synthesised more during the daylight period when they rest and sleep (Rau
and Meyer, 1975), and the same is true of epiphyseal cartilage (Simmons, 1968).
We shall consider why the balance between degradation and synthesis in tissues
should vary so much with activity and rest, why it is that sleep with large EEG
slow waves is 'worth more', and why, too, scratching by itchy patients at night
tells us something about sleep's restorative properties. Only when those restorative
properties can be measured shall we be able to assess the complaint of insomniac
patients that sleep leaves them still exhausted. Actually the rectal temperature of
poor sleepers does not fall as low (Monroe, 1967), which may mean relatively
higher rates of degradation and, thus, less restorative sleep.
Several indirect indicators link sleep with synthetic processes. Growing infants
sleep a lot. Wolff and Money (1973) found that a group of children of short
stature had grown only one-third as fast at times of poor sleep as of good.
Analyses across many animal species have shown a strong correlation between"
sleep duration and metabolic rate (Zepelin and Rechtschaffen, 1974). The higher
the metabolism by day, the higher the relative degradation, and longer sleep could
mean greater compensatory synthesis. In men, the customary individual duration
of sleep correlates positively with the individual's waking body temperature, and
thus, probably, with waking metabolic rate (Taub and Berger, 1976). Daily
metabolism correlates highly with log body weight (Kleiber, 1961) and so does
the amount of REM (paradoxical) sleep that individual men and women get
(Adam, 1977).
376
SLEEP AND ITS HORMONES
There are two types of sleep that alternate, one named NREM, or orthodox sleep,
and the other REM, or paradoxical sleep. Human NREM sleep is divided into four
stages, according to the EEG. Stages 3 and 4 are called slow-wave sleep, or SWS.
The return of interest to sleep's restorative role came with the Japanese
discovery of a link between SWS and the large nocturnal secretion of human
growth hormone (GH) (Takahashi et al., 1968; Honda et al., 1969). The secretion
depends upon the presence of SWS (Sassin et al., 1969; Schnure et al., 1971) and
this itself indicates that sleep is a time that facilitates anabolic processes in man.
Growth hormone stimulates amino acid uptake into tissues, promotes protein and
RNA synthesis (Korner, 1965), and has wide interreactions, such as stimulating
red blood cell formation indirectly through erythropoietin (Peschle et al., 1972).
It raises blood free fatty acids, whose subsequent degradation is a source of
cellular energy (ATP), thereby saving amino acids from catabolism and increasing
their availability for protein synthesis during sleep.
Corticosteroids stimulate protein catabolism (Ardeleanu and Sterescu, 1973;
Friedman and Strang, 1966) and the nocturnal peak of GH secretion comes at
that time in the 24 hours when corticosteroids are lowest. Consequently, there is
even greater net protein synthesis during human sleep, as demonstrated by
Rudman et al. (1973) who injected GH and found significantly greater nitrogen
retention after a 2300-hours dose than after a dose at 0800 hours.
Three other sleep-dependent human hormones are known; prolactin (Sassin et
al., 1973), luteinising hormone and testosterone (Boyar et al., 1974; Rubin et al.,
1976): all four promote anabolism.
SLOW-WAVE SLEEP FOR COMPENSATORY RESTORATION
Sleep seems to compensate for the degree of waking activity. After sleep-
deprivation, men have extra SWS (Berger and Oswald, 1962; Williams et al.,
1964), and monkeys extra GH (Jacoby et al., 1975). The longer the wakefulness
prior to a nap, the more the SWS and GH (Karacan et al., 1974). Even one hour of
extra wakefulness during the night is followed by extra SWS and GH in the later
night (Beck et al., 1975). Extra exercise leads cats to have more SWS (Hobson,
1968), ordinary men get more HGH (Adamson et al., 1974), and athletes greater
amounts of SWS (Baekeland and Lasky, 1966; Shapiro et al., 1975; Maloletnev
and Telia, 1975; Zloty et al., 1973).
Thyroid hormone increases degradation, and whereas hypothyroid patients
lack SWS (Kales et al., 1967), hyperthyroid patients have an excess of it and more
GH (Dunleavy et al., 1974). After days when normal men have had higher
thyroxine secretion they get more SWS (Johns et al., 1975). Acute starvation
increases both SWS (MacFadyen et al., 1973) and GH (Parker et al., 1972;
Karacan et al., 1973) at a time when the latter's protein-sparing action would be
of importance, while after chronic starvation an increase of SWS is associated with
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Table 1. Mitoses maximal during the time of rest and sleep. (It is important to remember that







Frog Crystalline lens epithelium
Rat Pineal parenchyma
Rat Anterior pituitary
Hamster Cheek pouch epithelium
Rat Lachrymal, parotid and submandibular
glands





Halberg et al. (1965), Chekulaeva
(1969)
Sigelman et al. (1954)
Vasama and Vasama (1958)
Kuznetsov et al. (1972)
Renzoni and Quay (1964)
Nouet and Kujas (1975)
Brown and Berry (1968), Izquierdo
and Gibbs (1972)
Vonnahme (1974)


















Inner enamel epithelium, incisor teeth
Mauer (1965)
Simmons (1964)
Clark and Korst (1969), Hunt and
Perris (1974), Uryadnitskaya
(1974)
Clark and Korst (1969)
Sharipov (1967), Saetren (1972)
Hunt and Perris (1974), Kirk
(1972)




Mouse Squamous epithelium of tongue and
oesophagus
Rat Rectal mucosa after injury
Rat Gastric epithelium




Vonnahme (1974), Jaffe (1954)
Barnum et al. (1958)
Burns et al. (1976)
Reeve (1975)
Clark and Baker (1962)
Romanova (1966)
Scheving et al. (1972)
Scheving et al. (1972)
Chang(1971)
378
tissue-rebuilding (Lacey et al., 1975). As will be mentioned later, SWS will also be
most strongly associated with anabolic repair because metabolic rate is then at its
lowest.
The hormones of higher organisms are sophisticated additions to more
primitive controls. Table 1 lists tissues in which there is a higher mitotic rate
during the rest and sleep period of higher animals, but there could be added
examples from the rest phases of lower organisms, in which the kind of hormonal
mechanisms we have outlined could not be responsible. At the simplest level, the
unicellular organism has rhythms of activity, with food-gathering, on the one
hand, and, on the other, of assimilation with repair or reproduction. Rhythms
abound in living systems and, indeed, spontaneous oscillations about a mean are
inevitable in any system subject to feed-back control.
RHYTHMS AND THE ENERGY CHARGE
To sustain life an organism has to maintain a chemical composition that differs
from its surroundings, and to do so it must expend energy. It must repair its
structural molecules and it must reproduce, both activities involving biosynthetic,
energy-using processes. The energy is furnished by the catabolism of food and fuel
stores to yield ATP (adenosine triphosphate) and is released by cleavage of the
terminal phosphate(s), leaving ADP or AMP (the adenosine di- and mono¬
phosphates). These energy-releasing reactions are enzymically coupled to
synthetic reactions to supply the energy that drives them. The adenine nucleotides
AMP, ADP and ATP accept, store and transfer chemical potential energy and
constitute a link among all the cell's activities. These include the maintenance of
chemical gradients (e.g. Na+/K+ pumps), active transport, and energy for motor
activity. Hence, the adenine pool is a link between activity/inactivity rhythms and
the catabolic/anabolic balance of the cell.
To achieve co-ordination, some universal, internal signal must operate to
enhance or inhibit the cell's chemical activities, all of which can be broadly
divided into energy-yielding (ATP-producing) reactions and energy-using (ATP-
depleting) processes. It is the energy state of the cell that provides that signal. Its
influence on metabolic pathways has been defined by Atkinson (1968), who
proposed that the level of energy charge,
ATP + ADP/2
EC = >
ATP + ADP + AMP
varying within a range up to unity, determines the relative rates of flux through
ATP-producing and ATP-depleting pathways. Lower values of EC favour
ATP-producing pathways and higher values of EC promote ATP-utilising
sequences.
The loci of control are regulatory enzymes that are sensitive to the levels of the
adenine nucleotides and catalyse the irreversible steps in biochemical sequences.
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Irreversible steps mean that the end-product of a synthetic sequence is not
degraded by the reverse of the synthetic pathway and, hence, the rates of
synthesis and degradation can be controlled by a single signal that modifies the
activities of the regulatory enzymes in both synthetic and degradative pathways
simultaneously. The EC level provides such a signal and affects these pathways in
opposite ways. Degradative pathways yield ATP and so raise the EC of a cell. A
higher level of EC then acts as a signal to reduce the rate of degradation. Synthetic
pathways depend on ATP to drive them and are promoted by higher levels of EC.
If EC falls, it is a signal to increase degradation and curtail synthesis as the system
tries to restore a higher EC, which is thermodynamically more stable (Goldbeter,
1974).
The control enzymes have response curves with steeper slopes in the region of
higher EC, and physiological values lie in the highly responsive, 'cross-over'
portion of the graphs (Chapman et al., 1971; Atkinson, 1970) where small
changes in EC can disproportionately alter the relative rates of synthesis and
degradation (Fig. 1). In addition, both types of EC response curves can be
modified by the concentration of the biosynthetic end-product in such a way that
if, for example, a synthetic end-product were in short supply, then the
responsiveness to EC of the control enzymes in the synthetic pathway would be
increased and sythesis enhanced (Fig. 2).
Physiological
Fig. 1. In the physiological range small changes in energy charge have a big effect.
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Fig. 2. The difference in energy charge between wakefulness and sleep may be small but it
has a big effect — even bigger if end-product concentration is low.
Protein Synthesis, Growth and Activity
The concept of energy charge was originally applied to intermediary metabolism
but the steps in protein synthesis, too, are sensitive to change in adenine
nucleotides (Walton and Gill, 1975; Ayuso-Parrilla and Parrilla, 1975) and changes
in EC are synchronised with growing and non-growing phases of Escherichia coli
(Chapman et al., 1971).
The simple organism's oscillations between rest and activity must induce
concomitant fluctuations in EC and so, in turn, in other cellular processes. Motor
activity demands ATP, so motility and food-gathering will lower EC, promote
degradative processes, and temporarily suppress biosynthesis. During subsequent
rest, the EC will rise and conditions become optimal for the biosynthetic
processes previously curtailed, and these would be the greater with an added signal
of low protein concentration.
Evidence that motility does inhibit synthetic processes can be seen in an
experiment where the unicellular Stentor coeruleus was cut in half, such that each
half received an equal share of the macronucleus, but only one half had the ciliary
apparatus. Subsequent onset of mitotic activity took place much earlier in the
cilia-free end (Guttes and Guttes, 1959); the EC must have risen during the
enforced rest of the non-ciliated end and acted as a trigger for synthetic processes.
SYNTHESIS DURING REST IN HIGHER ORGANISMS
In complex organisms, motility and responsiveness to the environment are not
characteristics of each cell, but the same principles apply. The house cricket,
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Acbeta domesticus, has a 24-hour rhythm of RNA and protein synthesis in its
brain and sub-oesophageal ganglion, with synthesis highest when these insects are
inactive. Their activity increases sharply with the onset of darkness, whereupon
synthesis of RNA and protein in the brain falls to its lowest (Cymborowski and
Dutkowski, 1969, 1970).
Higher organisms store fuel foods to allow prolonged activity without feeding.
During such activity the energy-requiring biosynthetic pathways will be sup¬
pressed by a downward shift in the EC, which will stimulate catabolic processes in
muscle. Additional tissues will be influenced by concurrent hormone release or, if
their substrates for ATP production and synthesis of macromolecules are diverted,
as fuel for motor activity.
In human muscle two minutes of exercise lowers ATP by 25 per cent (Karlson
and Saltin, 1970) and in rat muscle EC and ATP likewise fall (Crabtree and
Newsholme, 1972; Newsholme and Start, 1973; Wojciechowska et al., 1975).
Conversely, protein synthesis in rat diaphragm muscle (Robolledo and
Gagliardino, 1971) and myocardium (Rau and Meyer, 1975) are higher during the
resting/sleeping period. As examples of tissues linked indirectly, protein synthesis
falls in the hypothalamus if rats exercise (Bordeianu and Butculescu, 1971) and
protein synthesis in rat skin is at its highest during the daylight, when rats rest and
sleep (Chekulaeva, 1969). In man, exercise inhibits skin mitosis for many hours
afterwards (Fisher, 1968). Peaks in mitotic rate in frog crystalline lens epithelium
coincide with episodes of motor inactivity, whereas troughs are associated with
active periods (Kuznetsov et al., 1972). It is important to distinguish such
phenomena from the increased use of tissues that leads to their subsequent
hypertrophy. The latter involves the activation of genetic material in the nucleus,
with increased formation of RNA, and, subsequently, of proteins (Meerson,
1975).
Mitosis depends upon synthesis, whether for tissue maintenance or propagation
of the species. There is a strong relationship between mitotic activity and higher
concentrations of ATP (Guttes and Guttes, 1959). A fall in ATP below a critical
level inhibits mitosis (Epel, 1963). A positive correlation between the rhythm of
ATP level and cell division has been shown for Tetrahymena pyriformis (Plesner,
1964) and, as Table 1 showed, most tissues have a maximum mitotic rate during
the resting/sleeping period, when ATP and EC levels must be highest. It seems
that, through evolution, rhythms of mitosis have become entrained to the
variations of energy state associated with the rest-activity cycle.
Human Sleep is More Than Rest
Rest reduces ATP depletion and so metabolic rate falls. Sleep is more than rest, it
is a state of unresponsiveness brought about by active nervous mechanisms, a form
of rest that ensures that the whole body, including the nervous system, can
recuperate.
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Fig. 3. In stages 3 + 4 (slow wave) sleep, responsiveness is lowest to auditory signals,
scratching is least, blood pressure is lowest, and whole-body oxidative metabolism is lowest:
the demands of cellular work, that compete with the needs of synthesis, are at their lowest.
The stages of human sleep differ in their degrees of unresponsiveness, with
stage 2 being a less responsive state than wakefulness or drowsiness, and SWS a
state of even lesser responsiveness, while REM sleep is about equal to stage 2.
These relationships in the degree of responsiveness are true for response to
auditory stimuli (Williams et al., 1966), blood pressure reflexes (Coccagna et al.,
1971), or scratching by patients with itchy skins (Savin et al., 1975). Precisely the
same relationships are true also of the metabolic rates that accompany these
undisturbed sleep stages (Fig. 3). Human metabolic rate is some 10 per cent lower
in stage 2 than in wakeful rest, with a further 2 per cent fall during SWS (Brebbia
and Altshuler, 1968). Why it is that SWS is 'worth more' (Dement and Greenberg,
1966) can be understood in terms of the low metabolic rate (low cellular work) at
that time, when lower oxygen consumption means less degradation, in response to
higher EC, which, in turn, promotes a higher rate of protein synthesis. A 2 per
cent margin does not seem large but one must remember that the events
concerned are on the steep, highly responsive part of the curve in Fig. 2, where a
small shift in EC leads to a disproportionate change in the rates of both synthesis
and degradation.
SLEEP AND THE BRAIN
It is the brain that controls sleep and it is brain functions such as the power to
sustain attention that are most obviously impaired by sleep deprivation. Although
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the mature brain no longer grows, it still needs synthetic activity. It rivals the liver
in its high rate of turnover of proteins and nucleic acids, consistent with its role in
information processing, storage and retrieval, which rely on synthetic activity over
and above the protein synthesis required for enzymes and renewal of structural
components. The benefit of sleep is most obvious for the brain because during
mere rest the nervous system remains responsive to the environment, whereas in
sleep it becomes unresponsive (Steriade, 1970). The responsiveness of the wakeful
cortex depends upon sustained ascending activation from the mesencephalic
reticular formation, and the high levels of extracellular K+so caused (Katzman and
Grossman, 1975). These higher levels of K+are closely coupled to higher energy
consumption by the ATPase ion pump (Bachelard, 1975a; Jobsis et al., 1975;
Lowry, 1975).
Brain protein synthesis has its highest rates at the time when rats rest and sleep
(Gordon and Scheving, 1968; Richardson and Rose, 1971; Rose et al., 1969). The
cat has several sleep periods and with each of these there is a rise in the protein
content of perfusates from the brain (Drucker-Colin et al., 1975). Jones (1971)
found that brain ATP levels of golden hamsters were higher during sleep. The
protein and RNA content of supraoptic nuclei was higher in sleeping rats than
waking rats, while the latter, in turn, had a higher content than sleep-deprived
animals (Doemin and Rubinskaya, 1974). Van den Noort and Brine (1970)
measured the ATP, ADP and AMP concentrations in rat brain after 13 hours of
sleep deprivation and after one hour of subsequent sleep. Calculations of EC using
their results give a value of 0.77 after 13 hours of sleep deprivation but 0.83 after
the one hour of subsequent sleep. This rise is in the highly responsive portion of
the curve, and Fig. 2 illustrates how protein synthesis in the brain would differ
under these two conditions and how there could be additional enhancement of
protein synthesis during sleep at a time when end-product concentration would
presumably be low, enabling us to understand why men who have suffered
prolonged sleep deprivation can be restored by fewer hours of sleep than those
they lost.
NREM-REM Cycles
The different physiology of NREM and REM sleep suggests that they differ in
function, but a causal interrelationship has been proposed because NREM always
precedes REM sleep (Hartmann, 1973). During SWS the majority of neurones
have a much reduced firing rate compared with waking (McGinty et al., 1974) and
since activation from the reticular formation is at its lowest, ATP depletion would
be reduced and the EC level would rise, whereas during subsequent REM sleep the
higher firing rate (McGinty et al., 1974) would be expected to lower intracellular
ATP and stimulate brain glycolysis and respiration.
The amount of REM sleep has been thought to correlate with the required
intensity of brain synthetic activity (Oswald, 1969, 1970, 1976; Stern and
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Morgane, 1974). However, it is in REM sleep that skeletal muscles are at their
most relaxed, and their ATP, EC and net protein synthesis must be maximal. If
higher rates of brain protein synthesis were to occur during REM sleep itself in
conjunction with the higher rate of cell-firing, this would imply compartments of
ATP pools between, for example, neurones and glia, or intracellular compartments
within neurones, as for glucose transport (Bachelard, 1975b).
In higher organisms, protein is synthesised at the rate of two amino acids per
second, which means 1 to 2 minutes to synthesise a medium-sized protein
molecule (Dintzis, 1961), in addition to the time required to initiate the process.
Oscillations have been found in the rate of protein synthesis in a remarkable
diversity of tissues (Brodsky, 1975). There is a theoretical minimum oscillation
period of the order of minutes, because of the inertia in the protein synthetic
machinery (Goodwin, 1963). The REM periods of most species last only a few
minutes, and this is so short a time that the onset of a REM period could not be
the primary initiator of any increased brain protein synthesis associated with that
period, though peak rates of brain protein synthesis could coincide with the onset
of REM periods. It is tempting to speculate with Brodsky (1975) that these
oscillations in the rate of protein synthesis underlie NREM-REM sleep cycles.
CONCLUSIONS
It has been apparent for some years that sleep is a time that favours synthetic
processes but previous communications (Oswald, 1969, 1976) had no biochemical
base; the survey now presented has been refined by the first author, K.A.
It appears that the rest/activity cycle of simple organisms and the sleeping/
waking rhythm of higher animals induce concomitant fluctuations in cellular work
and, hence, in the cellular energy charge. As a consequence, metabolic balance
alters so that degradative processes are stimulated during activity or waking, and
restorative, synthetic processes are inevitably favoured during inactivity and sleep.
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MOTHER'S RUIN
The College sometimes takes pride in its eighteenth century opposition to the sale
of gin. But two physicians started the whole business. In 1635 the royal
physicians, Sir Theodore de Mayerne and Dr Cadyman, obtained from His Majesty
a patent for 'the sole exercise of a new way of distilling strong waters and making
vinegar out of cider, perry and buck whereof they are the inventors'. Two years
later they joined up with other distillers of spirits, whisky, and geneva or gin to be
granted a charter of incorporation as the Distillers Company. The gin trade was
slow off the mark. In the year 1690 a total of 43,000 gallons was distilled, paying
a duty of tuppence a gallon. By 1721 the output had risen to 2,800,000 gallons
and many were worried that the common people were sodden with gin 'like
opium with the Turks'. The College felt gin drinking had become a hazard to
health and in 1725 petitioned the House of Commons for legislation to curb gin
production having 'observed with concern for some years the fatal effects of
several sorts of distilled spirits upon great numbers of both sexes rendering them
diseased, not fit for business, poor - and too often the cause of weak feeble and
distempered children, who must be instead of an advantage and strength, a charge
to the country'. Perhaps as a result of this the government doubled the duty on
gin and by 1741 the yearly output had risen to 7,500,000 gallons. It was Henry
Fielding's prose and Hogarth's pictures that finally brought a halt to this alcoholic
epidemic.
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SUMMARY
Fifteen patients with a variety of itching skin diseases (atopic eczema, dermatitis herpetiformis,
lichen planus, urticaria and psoriasis) have been studied in the sleep laboratory. Recordings were
made of all-night electroencephalogram, electro-oculogram, submental electromyogram, and muscle
potentials from both forearms.
Bouts of scratching during orthodox (NREM) sleep occurred more frequently in stages 1 and 2
than in stages 3 and 4. The frequency in paradoxical (REM) sleep was close to that in stage 2 sleep.
This pattern was similar for all the diseases studied and seems to be related to the physiology of the
sleep stages rather than to the skin diseases themselves. The mean duration of the bouts of scratching
was not related to the sleep stage in which they started.
We have previously reported (Savin, Paterson & Oswald, 1973) that patients with atopic eczema scratch
during all stages of sleep, and that the incidence of scratch bouts varies in the different stages. We now
report our findings on a larger group of patients with a variety of skin diseases.
Patients
Three groups of patients have been studied:
Group I. Five patients with atopic eczema: four for 1 night and one for 2 nights. Four of these
patients formed the basis of our previous report.
Group II. Five patients with dermatitis herpetiformis: four for 2 nights and one for 1 night. The
diagnosis in all cases had been confirmed by skin biopsy and response to dapsone.
Group III. A miscellaneous group of five patients for 1 night each. Three patients had lichen planus,
one had urticaria, and one an itchy psoriasis.
METHODS
Patients were studied in the sleep laboratory as before (Savin, Paterson & Oswald, 1973). They slept
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in conditions of low illumination at a constant room temperature (i8°C) and remote from all recordings.
The early patients in the series were observed on closed-circuit television allowing all movements,
including scratching, to be noted by hand on the moving paper record. Our experience, gained in this
way, allowed us to dispense with television after it became clear that bouts of scratching could be
identified by their rhythmical quality using the recordings on the paper trace from the forearm leads.
Most of the body movements during the night were associated with scratching.
Recordings were made of all-night electroencephalogram (EEG), electro-oculogram, submental
electromyogram and muscle potentials from both forearms. Records were analysed in 20 s periods in
terms of wakefulness and the usual stages of sleep: that is orthodox (non-rapid eye movement or
NREM) sleep, with its stages, 1,2,3 and 4, and paradoxical (rapid eye movement or REM) sleep
(Rechtschaffen & Kales, 1968).
The records were examined for:
(a) The duration of each bout of scratching.
(b) The stage of sleep in which the bout started.
Our method did not allow us to gain information about the amplitude of the scratching movements
nor the frequency of the individual scratch strokes.
In addition we determined:
(c) The time spent in each sleep stage during the night.
(d) The number of bouts of scratching starting during each stage of sleep.
(e) The frequency with which bouts of scratching started during each stage.
(f) The duration of the bouts of scratching while asleep and while awake.
Several tests were used in the statistical examination of the data:
(1) Analysis ofvariance, a technique that allows a simultaneous comparison ofmore than 2 variables,
was used to compare the duration of scratch bouts in the different stages of sleep.
(2) Correlated t-tests for paired observations in order to compare the duration of scratch bouts for
each subject when in different sleep stages.
(3) Kendall's rank correlation test was used to investigate possible correlations between the
durations, or between durations and frequencies, of scratching bouts in different stages of
sleep. This test only takes into account the ordering and not the absolute values of the results.
RESULTS
Frequency of bouts starting in each stage of sleep
The results for the three groups of patients are shown in Fig. 1.
Scratching was most frequent in stage 1 and this was true of all three groups. The frequency
decreased through stages 2,3 and 4. As we found before, REM sleep was in an intermediate position
(Table 1). The difference between stages 1 and 2 was significant (r = 4-o6, d.f. = i4, Pco-oi). There
was also a significant difference between stage 2 and stages 3 and 4 combined (t = 2-64, d.f. = i4,
P< 0-02). There was no significant difference between stage 2 and REM sleep, between stages 3 and 4
and REM sleep, or between wakefulness and stage 1.
Duration of bouts of scratching starting in each stage
The details of the three groups of patients are shown in Table 2.
There was no significant difference in the length of bouts starting in the different stages of sleep,
when one-way analysis of variance was undertaken (d.f. = 3-42;/=oii2; n.s.). Although intersubject
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figure i. The frequency of bouts of scratching starting in each stage of sleep.
table 1. Mean frequency and standard deviation of scratching bouts starting in
wakefulness and each stage of sleep in scratches/min
Sleep stage
Patients Awake 3+4 REM
Atopic
eczema 0-47 + 0-04 0-46 + 0-40 0-27 + 0-26 0-11 + 0-07 0-21 + 0-22
(n = 5)
Dermatitis
herpetiformis 0-47 + 0-08 0-28 + 0-11 0-09 + 0-02 0-03 + 0-01 0-09 + 0-06
(n = s) (n = 3)
Miscellaneous
group 0-37 + 0-29 0-66 + 0-37 0-09 + 0-12 0-04 + 0-05 o-io + o-io
(n = 5)
Overall
means 0-43 + 0-18 0-47 + 0-34 0-15 + 0-18 0-06 + 0-06 0-13 + 0-15
(11=15) (n= 13)
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table 2. Mean duration of bouts of scratching starting in wakefulness and in each
stage of sleep. Mean ±s.d. (s/bout)
Sleep stage
Average
Patients Awake i 2 3+4 REM 1,2,(3+4)
& REM
Atopic
eczema 17-7 + 5-6 10-4 + 3-4 n-5 + 5'2 12-7 + 6-0 10-8 + 5-0 11-4 + 4-5
(n = 5)
Dermatitis
herpetiformis 11-5 ±4-2 8-5 + 2-9 10-3 + 4-1 9-6 + 4-7 7-0 + 0-6 8-9 + 2-6
(n = 5)
Miscellaneous
group 13-8 + 5-5 12-5 + 2-0 11-7 + 4-4 10-0 + 2-4 14-1 + 7-8 12-1 + 3-0
(n = 5)
Overall
means 14-3 + 5-4 10-5 + 3-1 11-2 + 4-3 10-8 + 4-5 10-6 + 5-8 10-8 + 3-5
(n= 15)
variation was high (d.f. = 42-i4;/=4'52, P<o-oi), the means for each stage were strikingly similar—
approximately 10 s duration per bout.
The significant intersubject variation was analysed further, revealing a characteristic duration of
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Length of bouts of scratching (s)
figure 2. The duration (s) of all scratch bouts recorded during stage i sleep on a single night of
one patient with dermatitis herpetiformis.
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table 3. Correlations (r) and their significance level
between different stages of sleep
Durations of Stages Stage
scratch bouts in Stage 1 Stage 2 3+4 REM
Stage 1 1 = 2-69
P> o-oi
Stage 2 r = 2-55 r = 2-29
P> 0 05 P> 0-05
Stages 3+4 r = 2-29
P> 005
scratching during stage 1 sleep would, on average, sustain this lengthy pattern through the other
stages of sleep. Kendall's ranking test revealed a correlation between the individual subject's mean
duration of bouts in one stage when compared with the other stages of sleep (Table 3).
Individual scratch bouts vary considerably in duration even in the same person in a single stage of
sleep (Fig. 2).
Scratching while awake
Bouts of scratching were also recorded when the patients were in bed but awake. There was no
significant difference between the frequency of occurrence of scratch bouts during wakefulness and
during stage 1 of sleep. However, bouts of scratching when the patients were awake lasted significantly
longer on average (14-3+ 5-45), than during sleep (io-8±3'5s); f= 377, d.f. = i4, P<0 01.
discussion
In our previous paper we showed that in atopic eczema bouts of scratching occurred more frequently
during sleep stages 1 and 2 than in 3 and 4, with paradoxical sleep in an intermediate position. We
have now found this pattern also in patients with other itchy skin diseases such as dermatitis herpeti¬
formis, lichen planus and urticaria (Fig. 1); in other words, this may be a general phenomenon and
not one simply confined to atopic eczema.
The nature of the chemical agents causing the itching in these conditions is not well understood;
but, in such dissimilar diseases, the agents involved may well not be the same. It seems unlikely that
the chemicals involved would vary in the same way in all these diseases during the different stages of
sleep. The differences between the frequency with which bouts of scratching occur in these stages
can be linked more plausibly to changes in the excitability of the central nervous system than to
alterations in the skin lesions themselves. The frequency with which bouts occur during the different
stages is consistent with the order of general reactivity of these stages as judged by other criteria;
for example, the threshold of response to auditory stimuli (Williams, Morlock & Morlock, 1966),
and the level of blood pressure (Coccagna et al., 1971).
In experimental animals there is a spinal reflex pathway for scratching, but in man scratching may
be a 'reaction rather than a reflex, demanding the integrity of at least some part of the brain for its
performance.' (Sinclair, 1973). We have shown that, while the frequency of bouts of scratching varies
among the stages of sleep, the duration of the bouts themselves does not. Bouts of scratching last, on
average, just as long whichever stage of sleep they start in. At first sight, this suggests an 'all or none'
type of response, in which the size of the reaction is fixed and independent of the stimulus, provided
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this is over a threshold value. However, Sherrington (1966) demonstrated that this is not the case in
experimental animals, in whom the greater the stimulus, the longer and more vigorous is the bout of
scratching which follows. Reviewing our figures in this light, it is clear that there is considerable
variation in the length of scratch bouts even for one person in a single sleep stage (Fig. 2). It is only
the means which are the same. If scratching during sleep is a reflex action, our findings suggest that
the excitability of the arc is greatly influenced by the stage of sleep, while the motor side, as judged by
the length of the scratch bouts, is not. During wakefulness, bouts of scratching were frequent (Table
i), and lasted significantly longer than during any of the stages of sleep; perhaps a conscious
'deliberate' component had been added.
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